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   From	   fruit	   fly	   to	   human,	   muscle	   cells	   form	   through	   a	   number	   of	   highly	  conserved	   steps.	   During	   the	   development	   of	   muscle,	   the	   actin	   cytoskeleton	   plays	  critical	   roles	   in	   muscle	   cell	   fusion,	   muscle	   cell	   attachment,	   and	   the	   assembly	   of	  muscle	   contractile	   apparatus,	   known	   as	   the	   sarcomere.	   Disruption	   of	   the	  arrangement	   of	   actin	   severely	   impairs	   muscle	   function	   and	   results	   in	   muscle	  disease.	  To	  better	  understand	  the	  key	  steps	   in	  muscle	  development	  and	  how	  actin	  forms	   different	   structures	   to	   regulate	   muscle	   formation,	   maturation	   and	  homeostasis,	  we	  used	  Drosophila	  melanogaster	  as	  a	  model	  system	  to	  study	  two	  steps	  in	   muscle	   development:	   myoblast	   fusion	   and	   sarcomere	   assembly.	   The	  multinucleated	   muscles	   form	   through	   myoblast	   fusion.	   During	   fusion,	   actin	  filaments	   accumulate	   at	   the	   fusion	   site	   to	   form	   a	   focus	   structure	   that	   mediates	  fusion.	  	  The	  formation	  of	  the	  actin	  focus	  is	  regulated	  by	  Arp2/3—an	  actin	  regulator	  that	   polymerizes	   branched	   actin	   networks.	   	   In	   my	   thesis,	   I	   have	   identified	   two	  additional	  factors,	  the	  phospholipid	  PI(4,5)P2	  and	  the	  formin	  Diaphanous	  (Dia),	  as	  required	  for	  myoblast	  fusion.	   	  During	  fusion,	  both	  PI(4,5)P2	  and	  Dia	  accumulate	  at	  the	  fusion	  site.	  	  PI(4,5)P2	  control	  the	  localization	  and	  activation	  of	  SCAR	  and	  WASp,	  which	   activate	   Arp2/3	   and	   trigger	   the	   formation	   of	   branched	   actin.	   Dia,	   which	  builds	  linear	  actin	  filaments,	  plays	  two	  roles	  during	  actin	  focus	  formation:	  it	  dictates	  the	   level	   of	   linear	   F-­‐actin	   polymerization,	   and	   it	   is	   required	   for	   appropriate	  
branched	   actin	   polymerization	   via	   localization	   of	   SCAR	   and	   WASp.	   The	   actin	  cytoskeleton	   is	   also	   a	   major	   component	   of	   sarcomere.	   	   I	   found	   that	   Dia	   plays	   a	  critical	  role	  for	  sarcomere	  growth	  in	  the	  indirect	  flight	  muscles	  of	  adult	  fruit	  fly.	  	  The	  localization	   of	   Dia	   in	   the	   sarcomere	   is	   mediated	   by	   PI(4,5)P2.	   	   Dia	   genetically	  interacts	  with	   the	   Gelsolin	   superfamily	  member	   Flightless	   I	   (FliI)	   to	   regulate	   thin	  filament	   length	  and	  sarcomere	  size,	  possibly	   through	  maintaining	   the	  G-­‐actin	  pool	  and	   regulating	   actin	   dynamics	   of	   the	   thin	   filaments.	   Together,	   my	   thesis	   work	  identified	   new	   factors	   that	   regulate	  muscle	   formation,	   and	   significantly	   enhanced	  our	  understanding	  of	  how	  the	  actin	  dynamics	  are	  regulated	  during	  different	  stages	  of	  muscle	  development.	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Actin	   is	   one	   of	   the	   most	   conserved	   and	   abundant	   proteins	   found	   in	   all	  eukaryotic	  cells.	   	  Globular	  actin	  (G-­‐actin)	   functions	   like	  the	  Lego	  unit	  of	   the	  cell:	   it	  can	  polymerize	  into	  filaments	  (F-­‐actin),	  which	  serve	  as	  one	  of	  the	  major	  components	  of	  a	  cell’s	  cytoskeleton.	   	   Just	   like	  Legos	  can	  be	  used	  to	  build	  different	  architectural	  forms,	   actin	   can	   also	   form	   different	   structures	   to	   coordinate	   a	   variety	   of	   cell	  behaviors	  and	  functions.	  	  
	   The	   formation	   of	   actin	   structures	   is	   coordinated	   in	   a	   series	   of	   stages:	  intracellular	   and	   extracellular	   signals	   trigger	   actin	   filament	   assembly	   or	  disassembly,	  filament	  organization	  is	  then	  controlled	  by	  molecules	  that	  incorporate	  with	   actin,	   then	   finally,	   the	   pattern	   of	   the	   specific	   actin	   structure	   is	   regulated	  temporally	  by	  the	  dynamics	  of	  actin.	  	  The	  study	  of	  actin	  has	  attracted	  much	  interest	  because	  of	  the	  prevalence	  of	  actin	  and	  actin	  based	  structures	  and	  the	  behaviors	  that	  it	  controls	   in	  eukaryotic	  cells.	   	  Moreover,	   the	  complexity	  of	  actin	  regulation	  allows	  for	   precise	   spatial	   and	   temporal	   control	   of	   actin	   structures	   in	   specific	   cell	   types,	  which	   in	   turn	   provides	   possible	   therapeutic	   targets	   for	   diseases	   in	   which	   actin	  activity	  is	  misregulated,	  such	  as	  muscular	  dystrophy	  and	  tumor	  metastasis.	  	  
	   My	   thesis	   research	   investigates	   actin	   structures	   in	   muscles	   based	   on	   two	  rationales:	   1)	   Muscle	   cells	   contains	   abundant	   actin,	   and	   the	   organization	   and	  dynamics	  of	  actin	  are	  critical	  for	  muscle	  shape	  and	  function.	  In	  fact,	  mutations	  that	  disrupt	  actin	  levels	  or	  organization	  are	  the	  major	  causes	  of	  muscular	  dystrophy	  such	  as	   nemaline	   myopathy,	   actin	   myopathy	   and	   intranuclear	   rod	   myopathy,	   and	   2)	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Myogenesis	   involves	   a	   series	   of	   actin-­‐based	   cellular	   events,	   such	   as	   cytokinesis,	  migration,	  myoblast	   fusion,	  cell-­‐cell	  adhesion,	  endocytosis,	  and	  contraction.	   	  These	  cellular	   events	   are	   also	   seen	   in	   other	   types	   of	   cells.	   Studying	   actin	   structures	   in	  muscles	  gives	  us	  insights	  to	  how	  these	  cellular	  events	  are	  regulated.	  	  
	   Drosophila	  provides	   an	   ideal	   system	   for	   studying	   muscles.	   	   As	   in	   humans,	  
Drosophila	  muscle	   forms	  through	  a	  number	  of	  conserved	  steps,	   from	  specification,	  to	   fusion,	   to	   attachment	   to	   tendon	   cells	   and	   finally	   to	   sarcomere	   and	   myofibril	  formation.	  	  Unlike	  human	  skeletal	  muscles,	  which	  contain	  bundles	  of	  muscle	  fibers,	  
Drosophila	   muscle	   has	   a	   simple	   structure,	   yet	   the	   signaling	   pathways	   and	  machineries	   required	   for	   muscle	   formation,	   and	   the	   basic	   contractile	   unit	   share	  similarities	  to	  what	  is	  found	  in	  humans.	   	  These	  similarities	  and	  highly	  tractable	  fly	  genetics	  allow	  us	  to	  study	  muscle	  in	  Drosophila	  and	  apply	  what	  we	  learn	  to	  humans.	  
At	  the	  time	  I	  started	  my	  thesis,	  it	  was	  known	  that	  actin	  plays	  important	  roles	  in	   both	  Drosophila	  myoblast	   fusion	   and	   sarcomere	   function.	   For	  myoblast	   fusion,	  Arp2/3,	  which	  polymerizes	  branched	  actin	  filaments,	  was	  identified	  as	  essential	  for	  remodeling	  actin	  networks	  at	  the	  site	  of	  fusion.	  	  However,	  questions	  remained	  as	  to	  how	  signals	  are	  transduced	  from	  membrane	  to	  actin	  cytoskeleton	  and	  trigger	  fusion.	  It	   was	   also	   unknown	   whether	   there	   are	   additional	   actin	   regulators	   other	   than	  Arp2/3	   that	  play	   roles	  during	  myoblast	   fusion.	   	   In	  my	   thesis	   research,	   I	   identified	  two	  additional	  factors,	  the	  phospholipid	  PI(4,5)P2	  and	  the	  formin	  Diaphanous	  (Dia),	  as	  required	  for	  myoblast	  fusion.	  I	  also	  elucidated	  that	  the	  actin	  regulator	  Dia,	  which	  builds	  linear	  actin	  filaments,	  is	  also	  required	  for	  sarcomere	  elongation.	  My	  study	  of	  the	   role	   of	   Dia	   in	   myogenesis	   answered	   the	   long-­‐standing	   question	   of	   what	  elongates	   actin	   filaments	   at	   the	   fusion	   site	   and	   in	   the	   sarcomere.	   I	   also	  demonstrated	   how	   Dia	   interacts	   with	   other	   actin	   regulators	   to	   build	   different	  structures	  at	  different	  stages	  of	  muscle	  development.	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   To	  place	  my	  work	  into	  context,	  the	  first	  section	  of	  this	  chapter	  will	  introduce	  the	   basic	   concepts	   in	   myogenesis,	   with	   a	   focus	   on	   myoblast	   fusion	   and	  sarcomerogenesis.	   I	  will	  also	  summarize	   the	  similarities	  and	  differences	   in	  muscle	  development	   between	   vertebrates	   and	  Drosophila.	   	   To	   familiarize	   the	   reader	  with	  actin	   remodeling,	   the	   second	   section	   of	   Chapter	   One	   will	   present	   the	   current	  knowledge	   of	   actin	   regulation.	   	   Chapter	   Two	   presents	   our	   findings	   on	   the	   role	   of	  phospholipids	   during	   myoblast	   fusion.	   	   Chapter	   Three	   presents	   the	   role	   of	   the	  formin,	  diaphanous,	   during	  myoblast	   fusion	   in	  Drosophila	  embryos.	   	   Chapter	   Four	  investigates	   the	   interplay	   between	   the	   actin	   regulator	   Diaphanous	   and	   Scar.	  	  Chapter	  Five	   focuses	  on	  sarcomere	   formation	  and	  homeostasis	   in	  Drosophila	  adult	  flight	  muscles	  and	  demonstrates	  the	  role	  of	  Diaphanous	  during	  sarcomere	  assembly.	  	  Chapter	  Six	  presents	  the	  conclusion.	  	  Chapter	  Seven	  covers	  materials	  and	  methods,	  and	  Chapter	  Eight	  lists	  the	  references.	  	  
II.	  Muscle	  development	  in	  Drosophila	  
A.	  Muscle	  cell	  differentiation	  in	  Drosophila	  embryos	  
The	  Drosophila	  muscles	  develop	  from	  the	  mesoderm.	  	  The	  mesoderm	  is	  the	  middle	  germ	  layer	  of	  an	  early	  embryo.	  	  The	  formation	  and	  specification	  of	  the	  mesoderm	  in	  the	  Drosophila	  embryo	  occur	   in	   three	   sequential	   steps:	   the	   first	   is	   to	   establish	   the	  dorsal-­‐ventral	  axis	  of	  the	  embryo	  through	  a	  Transforming	  Growth	  Factor-­‐α	  (TGF-­‐α)-­‐like	  signaling	  pathway.	  	  The	  second	  step	  is	  to	  activate	  the	  Toll	  pathway	  in	  a	  group	  of	  cells	   localized	   at	   the	   ventral	   side	   of	   embryo,	   which	   constitute	   the	   presumptive	  mesoderm.	  	  The	  third	  step	  is	  the	  activation	  of	  zygotic	  genes	  that	  trigger	  mesoderm	  formation	  (Figure	  1.1).	  	  
The	   establishment	   of	   dorsal-­‐ventral	   polarity	   starts	   at	   oogenesis.	   	   The	  localization	  of	  the	  oocyte’s	  nucleus	  restricts	  the	  distribution	  of	  gurken	  mRNA	  to	  the	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Figure	  1.1.	  An	  overview	  of	  mesoderm	  formation.	  A.	  Establishment	  of	  dorsal-­‐ventral	   polarity	   in	   the	   oocyte	   through	   the	   Gurken-­‐Torpedo	   pathway.	   	   The	  oocyte’s	  nucleus	   localizes	  to	  the	  dorsal-­‐anterior	  side	  of	  the	  oocyte	  and	  provides	  positional	   information	  to	  restrict	  active	  Gurken	  to	  this	  region.	   	  Gurken	  interacts	  with	  its	  receptor	  Torpedo	  on	  the	  dorsal	  follicle	  cells	  and	  establishes	  dorsal	  fate.	  	  On	  the	  ventral	  side,	  without	   inhibition	  by	   the	  Gurken-­‐Torpedo	  pathway,	  Pipe	   is	  expressed	  and	  activates	  the	  Toll	  pathway	  in	  the	  ventral	  oocyte	  through	  a	  serine	  protease-­‐dependent	   cascade.	   	  B.	   Spatial	   restriction	  of	  active	  Toll	  pathway.	   	  The	  serine	   protease	   cascade	   triggered	   by	   ventrally	   localized	   Pipe	   results	   in	  proteolytic	   cleavage	   and	   activation	   of	   Spätzle.	   	   Spätzle	   binds	   and	   activates	   the	  Toll	   receptor	   pathway	   in	   the	   ventral	   region	   of	   the	   embryo.	   	   C.	   Activated	   Toll	  receptor	   promotes	   nuclei-­‐entry	   of	   Dorsal.	   	  When	   the	   Toll	   signaling	   pathway	   is	  inactive,	  Cactus	  and	  Dorsal	  form	  a	  complex	  within	  a	  cell’s	  cytoplasm.	  	  Activation	  of	   the	   Toll	   pathway	   results	   in	   the	   degradation	   of	   Cactus,	   and	   allows	   Dorsal	   to	  enter	  the	  nucleus.	  	  D.	  The	  transcription	  factor	  Dorsal	  and	  its	  downstream	  targets	  Twist	   and	   Snail	   work	   together	   to	   establish	   mesodermal	   cell	   fates	   and	   initiate	  mesoderm	   invagination.	   	   E-­F.	   Schematic	   diagrams	   show	   the	   formation	   of	   the	  mesoderm	   (green)	   through	   invagination	   of	   ventral	   cells	   during	   gastrulation.	  	  (Adapted	   with	   permission	   from	   (Hartenstein,	   1993;	   Wakabayashi-­‐Ito	   and	   Ip,	  2013)).	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Figure	  1.1.	  An	  overview	  of	  mesoderm	  formation	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dorsal	   side	   of	   the	   oocyte	   (Neuman-­‐Silberberg	   and	   Schüpbach,	   1993).	   Gurken	   is	   a	  TGF-­‐α-­‐like	   ligand	   that	   can	   bind	   and	   activate	   its	   receptor	   Torpedo	   on	   the	   dorsal	  follicle	   cells	   (Roth	   et	   al.,	   1995).	   	   The	   interaction	   between	   Gurken	   and	   Torpedo	  triggers	  the	  establishment	  of	  dorsal-­‐ventral	  polarity	  in	  the	  oocyte	  by	  activating	  the	  mitogen-­‐activated	  protein	   kinase	   (MAPK)	  pathway	   (Nilson	   and	   Schüpbach,	   1999).	  	  The	   Gurken-­‐Topedo	   pathway	   also	   inhibits	   the	   expression	   of	  pipe,	   restricting	   Pipe	  expression	   to	   the	  ventral	   follicle	   cells	   (Sen	  et	   al.,	   1998).	   	  Pipe	   triggers	  a	  protease-­‐dependent	   cascade	   reaction,	   which	   ultimately	   leads	   to	   cleavage	   of	   Spätzle	   at	   the	  ventral	  follicle	  cells	  (Chasan	  et	  al.,	  1992).	  	  Cleaved	  Spätzle	  binds	  its	  receptor	  Toll	  on	  the	   oocyte’s	  membrane,	   and	   activates	   the	  Toll	   pathway	   on	   the	   ventral	   side	   of	   the	  embryo	   (Anderson	   et	   al.,	   1985;	   Hashimoto	   et	   al.,	   1991).	   	   Activation	   of	   the	   Toll	  pathway	  induces	  the	  degradation	  of	  Cactus	  (Belvin	  et	  al.,	  1995).	  	  Cactus	  is	  a	  member	  of	   the	   NF-­‐𝛋-B inhibitor family	   that	   retains	   Dorsal	   in	   the	   cytoplasm.	   	   Upon	   Cactus	  degradation,	   Dorsal	   is	   allowed	   to	   enter	   the	   nuclei	   and	   induce	   specification	   of	   the	  mesoderm	   (Bergmann	   et	   al.,	   1996).	   	  Dorsal	   is	   an	  NF-­‐𝛋-B	   transcription	   factor	   that	  regulates	  the	  expression	  of	  many	  zygotic	  genes.	  	  Among	  these	  genes,	  snail	  (Kosman	  et	   al.,	   1991)	   and	   twist	  are	   the	  most	   crucial	   ones,	   as	   the	   proteins	   that	   these	   genes	  encode	   are	   required	   for	   mesoderm	   specification	   and	   ventral	   invagination—a	  process	   that	   forms	   the	  mesoderm	   layer.	   	   Snail	   is	   a	   zinc-­‐finger	   transcription	   factor	  that	  represses	  the	  expression	  of	  mesectodermal	  genes,	  and	  restricts	  neuroectoderm	  fate	   in	  the	  mesoderm	  (Ip	  et	  al.,	  1992;	  Kosman	  et	  al.,	  1991).	   	  Twist	   is	  a	  basic	  helix-­‐loop-­‐helix	   (bHLH)	   transcription	   factor	   that	   further	   activates	   the	   expression	   of	  downstream	   mesoderm	   proteins,	   such	   as	   tinman	   (tin)	   and	   Drosophila	   myocyte	  
enhancer	  factor	  2	  (Dmef2).	   	  Twist	   is	  also	  a	   co-­‐activator	  of	  Dorsal,	  which	  maintains	  the	  expression	   level	  of	   Snail	   (Leptin,	  1991).	   	  Among	   the	  genes	  activated	  by	  Twist,	  
folded	  gastrulation	  (fog),	  which	  encodes	  a	  putatively	  secreted	  protein,	  is	  crucial	  for	  mesoderm	   invagination	   (Parks	   and	   Wieschaus,	   1991).	   	   The	   secrete	   protein	   Fog	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activates	   Rho	   GTPase	   through	   RhoGEF2	   and	   triggers	   actin	   network	   remodeling	  (Barrett	  et	  al.,	  1997).	  	  The	  change	  of	  actin	  organization	  subsequently	  results	  in	  cell	  morphological	  changes,	  which	  are	  required	  for	  mesoderm	  invagination	  (Costa	  et	  al.,	  1994).	  	  
	   After	   invagination,	   the	  mesoderm	  cells	  undergo	   two	   rounds	  of	   cell	   division	  and	   migrate	   dorsally	   to	   coat	   the	   inner	   surface	   of	   the	   ectoderm	   (Leptin	   and	  Grunewald,	   1990).	   	   The	   subsequent	   differentiation	   of	   the	   mesoderm	   depends	   on	  ectoderm-­‐expressed	   proteins	   such	   as	   Decapentaplegic	   (Dpp)	   (Frasch,	   1995;	  Staehling-­‐Hampton	  et	  al.,	  1994),	  Hedgehog	  (Hh),	  Wingless	  (Wg)	  and	  Engrailed	  (En)	  (Azpiazu	  et	  al.,	  1996),	  as	  well	  as	  the	  pair-­‐rule	  gene	  even-­skipped	  (eve)	  (Azpiazu	  et	  al.,	  1996)	   and	   sloppy	   paired	   (slp)	   (Riechmann	   et	   al.,	   1997).	   	   Dpp	   is	   a	   TGFβ	   family	  member	   protein:	   high	   Dpp	   levels	   define	   the	   dorsal	   domain	   of	   the	  mesoderm	   and	  restrict	   the	  expression	  of	   tin	   to	   this	  region	  (Frasch,	  1995).	   	  The	  NK	  homeodomain	  transcription	   factor	   Tin	   induces	   specification	   of	   the	   dorsal	   mesoderm	   into	   the	  visceral	  mesoderm,	  heart	  and	  dorsal	  muscles	  (Bodmer,	  1993).	  	  The	  ventral	  domain	  of	   the	   mesoderm,	   influenced	   by	   Hh	   and	  Wg,	   will	   form	   the	   fat	   body	   and	   somatic	  muscles	   (Baylies	   et	   al.,	   1998).	   	   Eve	   and	   Slp	   are	   transcription	   factors	   that	   control	  segment	   patterning	   (Cadigan	   et	   al.,	   1994;	   Grossniklaus	   et	   al.,	   1992;	   Jaynes	   and	  Fujioka,	  2004).	  Eve	  and	  Slp,	  in	  coordination	  with	  the	  ectodermally	  secreted	  Hh	  and	  Wg,	  establish	  the	  anterior-­‐posterior	  section	  of	  each	  segment	  (reviewed	  in	  (Dobi	  et	  al.,	  2015)).	  	  In	  the	  Eve	  expressing	  compartment,	  Eve	  represses	  Twi	  expression	  in	  the	  mesoderm	   through	   the	   Notch	   signaling	   pathway	   (Tapanes-­‐Castillo	   and	   Baylies,	  2004).	   	   The	   combination	   of	   high	   Dpp	   and	   low	   Twi	   at	   the	   dorsal-­‐anterior	   domain	  induces	  this	  region	  of	  the	  mesoderm	  to	  form	  the	  visceral	  mesoderm.	  	  In	  the	  ventral-­‐anterior	  domain	  of	  the	  mesoderm,	  extrinsic	  Hh	  signaling	  and	  low	  Twi	  expression	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Figure	   1.2.	   Signaling	   pathways	   that	   determine	   mesoderm	   partitioning.	   A.	  Diagram	  showing	  a	  stage	  9	  Drosophila	  embryo.	   	  The	  mesoderm	  is	  labeled	  in	  green.	  One	   presumptive	   hemisegment	   is	   shown	   in	   the	   boxed	   area.	   	   B.	   Ectodermally	  secreted	   proteins	   such	   as	   Decapentaplegic	   (DPP),	   Hedgehog	   (Hh)	   and	   Wingless	  (Wg)	  signal	  to	  the	  mesoderm,	   leading	  to	  subsequent	  partitioning	  of	  the	  mesoderm	  into	  different	  subtypes.	   	  C.	  Controlled	  by	  combinations	  of	  signaling	  pathways,	  cells	  in	  different	  regions	  of	  the	  mesoderm	  adopt	  a	  variety	  of	  cell	  fates,	  including	  cardiac	  muscles,	   visceral	   muscles,	   fat	   body,	   mesodermal	   glia	   and	   somatic	   muscles.	  Specification	   into	   somatic	  muscles	   depends	   on	   high	  Wg,	   Sloppy-­‐Paired	   and	   Twist	  signaling	  at	  the	  ventral-­‐posterior	  side	  of	  each	  mesodermal	  segment.	  (Adapted	  with	  permission	  from	  (Baylies	  et	  al.,	  1998;	  Hartenstein,	  1993;	  Riechmann	  et	  al.,	  1998))	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  lead	   to	   the	   formation	   of	   the	   fat	   body	   and	   other	   mesoderm	   tissues.	   In	   the	   Slp	  expressing	  domain,	   Slp	  maintains	   the	   expression	  of	  Twi	   in	   this	   area	  of	  mesoderm	  (Riechmann	   et	   al.,	   1997).	   	   Dpp,	   Slp	   and	   Twi	   activities	   dorsally	   determine	   the	  formation	   of	   the	   heart,	   while	   Wg,	   Slp	   and	   Twi	   activities	   control	   the	   pattern	   of	  somatic	  muscle	  tissues	  	  (reviewed	  in	  (Baylies	  et	  al.,	  1998;	  Dobi	  et	  al.,	  2015))	  (Figure	  1.2).	  	  
	   After	   the	  allocation	  of	   the	  mesoderm	   to	  different	   tissues,	   the	  bHLH	  protein	  Lethal	   of	   Scute	   (L’sc)	   is	   expressed	   in	   clusters	   of	   promuscle	   cell	   groups,	   under	   the	  control	  of	  the	  RTK	  pathway	  (Carmena	  et	  al.,	  1995).	  	  In	  each	  cluster,	  a	  combination	  of	  the	  Notch	  and	  RTK-­‐Ras	  signaling	  pathway	  activities	   restrict	   the	  expression	  L’sc	   to	  one	  cell—the	  muscle	  progenitor	  cell	  (Carmena	  et	  al.,	  1995;	  1998b;	  Fuerstenberg	  and	  Giniger,	   1998).	   	   Each	   progenitor	   cell	   then	   undergoes	   one	   round	   of	   asymmetric	  division	   to	   form	   either	   two	   founder	   cells	   (FC)	   or	   a	   FC	   and	   an	   adult	   muscle	  progenitor	   (AMP)	   (Carmena	   et	   al.,	   1998a;	   Ruiz	   Gomez	   and	   Bate,	   1997).	   	   The	  cytoplasmic	  membrane-­‐associated	  protein	  Numb	  plays	  a	  critical	  role	  in	  determining	  muscle	   fate.	   	   Numb	   antagonizes	   Notch-­‐mediated	   lateral	   inhibition	   and	   allows	   the	  expression	  of	  muscle	   identity	  proteins	   in	   the	  muscle	  progenitor	  cells	   (Ruiz	  Gomez	  and	   Bate,	   1997).	   	   Different	   combinations	   of	   identity	   transcription	   factor	   genes	  expressed	   in	   each	   muscle	   progenitor,	   such	   as	   slouch,	   eve,	   Krüppel,	   apterous,	   and	  
Nautilus,	  determine	  the	  different	  cell	   identities	  of	  each	  FC,	  and	  hence,	   final	  muscle	  pattern	   (review	   in	   (Dobi	   et	   al.,	   2015)).	   	   Thirty	   FCs	   are	   specified,	   leading	   to	   the	  formation	  of	  30	  muscles	  in	  each	  hemisegment.	  	  Each	  muscle	  has	  its	  own	  unique	  size,	  shape	  and	  orientation	  (Figure	  1.3).	  
	   After	  L’sc	   is	  restricted	  to	  one	  progenitor	  cell	   in	  each	  promuscle	  cell	  cluster,	  the	  remaining	  cells	  in	  the	  cluster	  adopt	  a	  fusion	  competent	  myoblast	  (FCM)	  fate	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Figure	  1.3.	  Overview	  of	  myoblast	  specification.	  A.	  Diagram	  of	  somatic	  muscle	  cell	   specification.	   	   The	   promuscle	   cell	   groups	   (blue)	   are	   determined	   by	   the	  expression	   of	   L‘scute	   (L’sc).	   	   A	   combination	   of	   Notch	   and	   RTK-­‐Ras	   signaling	  determines	  muscle	  progenitor	  cell	  fate	  (orange);	  the	  remainder	  of	  the	  promuscle	  cells	  become	   fusion	  competent	  myoblasts	   (FCMs,	  pink).	   	  Progenitor	   cells	  divide	  once	   to	   give	   rise	   to	   either	   two	   founder	   cells	   (FCs,	   grey)	   or	   a	   FC	   and	   an	   adult	  muscle	  progenitors	  (AMPs,	  yellow).	   	  B.	  The	  arrangement	  of	   the	   founder	  cells	   in	  one	  hemisegment	  of	  a	  stage	  12	  Drosophila	  embryo.	   	  Names	  of	   the	   final	  muscles	  are	  labeled	  with	  text.	   	  C.	  Color-­‐coded	  muscles	  in	  one	  hemisegment	  of	  a	  stage	  16	  
Drosophila	   embryo.	   Different	   colors	   show	   the	   expression	   patterns	   of	   muscle	  identity	  transcription	  factors.	  (Adapted	  with	  permission	  from	  (Artero	  et	  al.,	  2003;	  Dobi	  et	  al.,	  2015)).	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Figure	  1.3.	  Overview	  of	  myoblast	  specification.	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though	  Notch	  mediated	  lateral	  inhibition.	  	  Two	  key	  transcription	  factors,	  Lame	  duck	  (Lmd)	   and	   Tramtrack69	   (Trk),	   are	   required	   for	   FCM	   specification.	   	   Lmd,	   a	   Gli	  superfamily	  protein,	  functions	  through	  activating	  and	  maintaining	  the	  expression	  of	  
Dmef2	  and	  the	  FCM-­‐specific	   fusion	  gene	  sticks-­and-­stones	  (sns)	   (Duan	  et	  al.,	  2001).	  	  Ttk,	  a	  zinc	  finger	  protein,	  functions	  through	  repressing	  the	  expression	  of	  FC	  genes,	  such	  as	  dumbfounded	  (duf),	  in	  the	  FCMs	  (Ciglar	  et	  al.,	  2014).	  	  The	  specification	  of	  FCs	  and	  FCMs	  allows	  for	  fusion	  between	  the	  two	  cell	  types,	  and	  generates	  the	  syncytial	  muscle	  cells.	  	  
B.	  Myoblast	  fusion	  
Starting	   from	   embryonic	   stage	   12	   (7.5-­‐9.5	   hours	   AEL)	   and	   following	   the	  specification	   of	   FCs	   and	   FCMs,	   fusion	   between	   FCs	   and	   FCMs	   occurs	   to	   form	   the	  multinucleated	   body	  wall	  muscles	   (Richardson	   et	   al.,	   2008a).	   	   Later	   in	   the	   pupae	  stage,	   another	   wave	   of	   myoblast	   fusion	   occurs	   in	   order	   to	   generate	   the	   adult	  musculature.	  	  
	   The	  fusion	  between	  two	  cells	  requires	  a	  series	  of	  events.	  	  First,	  cells	  need	  to	  recognize	  and	  adhere	  to	  one	  another.	  Recognition	  and	  adhesion	  between	  the	  FC	  and	  FCMs	  are	  mediated	  by	   cell-­‐specific	   immunoglobulin	   super	   family	   (IgSF)	  members.	  The	  IgSF	  members	  expressed	  in	  the	  FC	  are	  Dumbfounded	  (Duf)	  and	  Roughest	  (Rst)	  (Ruiz	  Gomez	  et	  al.,	  2000).	   	  Duf	  and	  Rst	  are	   transmembrane	  proteins	   that	   function	  redundantly	  to	  mediate	  recognition	  and	  adhesion	  (Strünkelnberg	  et	  al.,	  2001).	  	  The	  counterparts	  of	  Duf	  and	  Rst	   in	  FCMs	  are	  Sns	  and	  Hibris	  (Hbs)	  (Artero	  et	  al.,	  2001;	  Bour	  et	  al.,	  2000).	  	  Hbs	  can	  partially	  compensate	  for	  Sns	  function,	  but	  its	  activity	  is	  less	   efficient	   than	  Sns	   (Shelton	  et	   al.,	   2009).	  The	   interaction	  between	  Duf-­‐Sns	  and	  Rst-­‐Hbs	  is	  required	  for	  recognition	  and	  adhesion.	  	  Ectopic	  expression	  of	  Duf	  induces	  myoblast	  aggregation,	  but	  is	  insufficient	  to	  trigger	  fusion	  (Ruiz	  Gomez	  et	  al.,	  2000).	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Figure	  1.4.	  Molecular	  mechanisms	  that	  mediate	  myoblast	  fusion.	  A.	  Cellular	  events	   before	   fusion.	   Prior	   to	   fusion,	   a	   FC/myotube	   and	   a	   FCM	   recognize	   and	  adhere	   to	   each	   other.	   	   On	   the	   FCM	   side,	   actin	   filaments	   organize	   into	   a	   dense	  focus	   structure	   used	   to	   invade	   the	   opposing	   FC/myotube.	   	   On	   the	   FC/myotube	  side,	   a	   thin	   layer	   of	   actin	   filaments	   and	  myosin-­‐II	   accumulates	   underneath	   the	  membrane	  and	  provides	  resistance	  against	  FCM	  invasion.	   	  B.	  Fusion	  machinery	  that	  mediates	  myoblast	  fusion.	  Recognition	  and	  adhesion	  between	  a	  FC/myotube	  and	   a	   FCM	   are	   mediated	   by	   transmembrane	   proteins	   Duf,	   Sns,	   Rst	   and	   Hbs.	  	  Signals	  from	  the	  membrane	  are	  transduced	  by	  PI(4,5)P2,	  which	  then	  triggers	  the	  remodeling	   of	   the	   actin	   cytoskeleton.	   Arp2/3	   is	   one	   actin	   regulator	   that	   is	  required	  for	  myoblast	  fusion.	  	  In	  the	  FCMs,	  Arp2/3	  is	  regulated	  by	  both	  SCAR	  and	  WASp.	  	  While	  in	  the	  FC/myotubes,	  Arp2/3	  is	  only	  regulated	  by	  SCAR.	  	  (Adapted	  with	  permission	  from	  (Kim	  et	  al.,	  2015;	  Schulman	  et	  al.,	  2015)).	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  myoblast	  fusion	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If	   the	   FC	   or	   myotube	   and	   FCMs	   are	   not	   in	   direct	   contact	   before	   adhesion,	   cell	  migration	   is	   required	   to	   bring	   two	   cells	   into	   close	   proximity	   (Richardson	   et	   al.,	  2007;	  Rochlin	  et	  al.,	  2010).	  	  After	  the	  cells	  adhere	  to	  one	  another,	  signals	  from	  these	  recognition	  and	  adhesion	  molecules	  cause	  the	  actin	  cytoskeleton	  in	  both	  the	  FC	  and	  FCM	  to	  undergo	  remodeling,	   resulting	   in	  a	   filamentous-­‐actin	   (F-­‐actin)	  based	   focus	  structure	  in	  the	  FCM,	  and	  a	  thin	  sheath	  of	  an	  F-­‐actin	  network	  on	  the	  opposing	  inner	  membrane	  in	  the	  FC.	   	  The	  actin	  focus	  in	  the	  FCM	  mediates	  the	  formation	  of	  finger-­‐like	  membrane	  protrusions	  (Sens	  et	  al.,	  2010).	   	   It	   is	  thought	  this	  actin	  structure	  at	  the	   fusion	   site	  provides	   the	  needed	   force	   to	  bring	   the	   lipid	  bilayers	  of	   the	   cells	   in	  close	   proximity,	   allowing	   for	   fusion	   pore	   formation.	   	   The	   fusion	   pore	   expands	   to	  allow	   cytoplasmic	  mixing	   and	   enables	   two	   cells	   to	   fuse	   into	   one.	   The	   binucleated	  myotube	  then	  reprograms	  the	  newly	  acquired	  nucleus	  to	  adopt	  the	  transcriptional	  profile	  of	  that	  particular	  FC	  and	  to	  repress	  the	  FCM	  program.	  	  The	  cell	  then	  prepares	  for	  another	  round	  of	  fusion	  (Baylies	  et	  al.,	  1998;	  Frasch,	  1999)	  (Figure	  1.4).	  	  Studies	  in	   C.	   elegans	   have	   revealed	   a	   role	   of	   fusogens	   such	   as	   EFF-­‐1	   and	   AFF-­‐1	   during	  epithelial	   cell	   fusion	  (Mohler	  et	  al.,	  2002;	  Sapir	  et	  al.,	  2007;	  Zeev-­‐Ben-­‐Mordehai	  et	  al.,	   2014).	   Fusogens	   are	   proteins	   that	   modify	   lipid	   bilayers	   to	   allow	   membrane	  fusion.	   Genetic	   screens	   performed	   thus	   far	   in	   Drosophila,	   however,	   have	   not	  identified	  a	  fusogen	  that	  is	  required	  for	  myoblast	  fusion,	  possibly	  due	  to	  maternally	  contributed	   fusogenic	   proteins,	   as	   well	   as	   redundant	   effects	   of	   more	   than	   one	  protein	  that	  contributes	  to	  the	  fusogenic	  activity	  or	  multiple	  fusogens	  (Chen,	  2011).	  	  
	   Before	  I	  started	  my	  thesis,	  Arp2/3	  was	  thought	  to	  be	  the	  only	  actin	  regulator	  that	  controlled	  actin	  rearrangement	  at	  the	  site	  of	  fusion.	   	  Arp2/3	  can	  bind	  with	  an	  actin	  filament	  and	  polymerize	  new	  actin	  filaments	  at	  a	  70-­‐degree	  angle	  from	  a	  pre-­‐existing	   actin	   filament.	   Arp2/3	   is	   activated	   by	   the	   nucleation-­‐promoting	   factors	  (NPFs):	   the	  Wiskott-­‐Aldrich	   Syndrome	   protein	   (WASp)	   and	   SCAR	   (also	   known	   as	  
	   16	  
WAVE).	  The	  detailed	  molecular	  mechanism	  of	  Arp2/3	  activation	  and	   function	  will	  be	  discussed	  in	  the	  “Actin	  cytoskeleton”	  section.	  In	  this	  section	  we	  will	  focus	  on	  the	  signaling	   pathways	   that	   trigger	   actin	   rearrangement	   during	   fusion.	   In	   my	   thesis	  work,	   we	   added	   another	   two	   factors	   that	   regulate	  myoblast	   fusion	   to	   the	   known	  fusion	   network:	   the	   phosphoinositide	   PI(4,5)P2	   and	   the	   formin	   family	   protein	  Diaphanous	   (Dia).	   PI(4,5)P2	   regulates	   both	   SCAR	   and	  WASp	   activity	   by	   localizing	  myoblast	   city	   (Mbc),	   Rac,	   and	   Blown	   fuse	   (Blow)	   at	   the	   fusion	   site	   (Bothe	   et	   al.,	  2014).	  Dia	   is	   another	   actin	   nucleation	   and	  polymerization	   factor	   that	   functions	   at	  the	   fusion	   site.	   Dia	   activity	   is	   also	   required	   for	   the	   proper	   localization	   of	   Arp2/3	  regulators	  SCAR	  and	  WASp	  (Deng	  et	  al.,	  2015).	  The	  details	  of	  how	  PIP2	  and	  Dia	  are	  involved	   in	  myoblast	   fusion	  will	  be	  discussed	   in	  Chapter	  Two,	  Chapter	  Three,	  and	  Chapter	  Four.	  
	   Signal	  transduction	  from	  the	  membrane	  to	  the	  actin	  cytoskeleton	  is	  partially	  mediated	  by	  the	  activity	  of	  Crk,	  as	  well	  as	  Dreadlock	  (Dock),	  the	  Drosophila	  homolog	  of	  Nck.	   	   Both	  Dock	   and	   Crk	   are	   adapter	   proteins	  with	   src	  homology	   2	   (SH2)/SH3	  domains.	   	   Dock	   can	   interact	  with	   all	   four	   IgSF	   transmembrane	  proteins	   that	   have	  SH2	  or	  SH3	  domains,	  but	  it	  only	  genetically	  interacts	  with	  Duf,	  Sns	  and	  Hbs	  (Kaipa	  et	  al.,	  2013).	   	   In	  addition,	  rescue	  experiments	  using	  a	  series	  of	  sns	  deletions	  and	  site-­‐directed	  mutations	  suggested	  that	  Sns	  functions	  through	  interacting	  with	  a	  complex	  array	   of	   proteins	   (Kocherlakota	   et	   al.,	   2008).	   	   In	   the	   FCMs,	   the	  Dock	   SH3	   domain	  biochemically	  and	  genetically	   interacts	  with	  WASp,	  as	  well	  as	   the	  WASp	  regulator,	  Solitary	  (Sltr,	  also	  known	  as	  Vrp1	  and	  DWip)	  (Kaipa	  et	  al.,	  2013).	  	  In	  both	  the	  FC	  and	  FCMs,	   Dock	   biochemically	   and	   genetically	   interacts	   with	   Arp2/3	   NPF	   SCAR.	  	  Through	  a	  similar	  mechanism	  as	  Dock,	  Crk	  biochemically	  interacts	  with	  Sns.	   	  In	  an	  FCM,	  Crk	  physically	  interacts	  with	  the	  WASp	  regulatory	  proteins	  Sltr	  and	  Blow	  (Kim	  et	   al.,	   2007).	   	   Thus,	   the	   adaptor	  proteins	  Dock	   and	  Crk	   function	   as	  potential	   links	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that	   transfer	   signals	   from	   the	   membrane	   to	   the	   actin	   cytoskeleton.	   	   In	   the	   FC,	  another	   adaptor	   protein	   that	   links	   the	   membrane	   and	   the	   actin	   cytoskeleton	   is	  Rolling	  pebbles	  (Rols,	  also	  known	  as	  Ants/Rols).	  	  Rols	  is	  recruited	  to	  the	  fusion	  site	  by	  Duf.	  	  In	  a	  positive	  feedback	  loop,	  Rols	  replenishes	  Duf	  at	  the	  membrane,	  and	  thus	  enables	  the	  additional	  rounds	  of	  fusion	  (Menon	  et	  al.,	  2005).	  	  Rols	  interacts	  with	  two	  proteins	   that	   regulate	   the	   actin	   cytoskeleton	   organization:	   Myoblast	   city	   (Mbc)	  (Chen	  and	  Olson,	  2001;	  Rau	  et	  al.,	  2001)	  and	  D-­‐titin	  (Menon	  and	  Chia,	  2001).	  	  Mbc	  is	  the	   Drosophila	   homolog	   of	   the	   human	   protein	   DOCK180,	   which	   mediates	   actin	  rearrangements	   by	   acting	   as	   a	   guanine	   nucleotide	   exchange	   factor	   (GEF)	   for	   the	  small	  GTPase	  Rac.	  	  However,	  recent	  data	  suggest	  that	  the	  downstream	  target	  of	  Rols	  is	  not	  Mbc:	  	  rescue	  experiments	  suggest	  that	  the	  activity	  of	  Mbc	  is	  not	  required	  in	  FC	  for	  fusion.	  	  Another	  actin	  cytoskeletal	  protein	  that	  can	  bind	  to	  Rols	  is	  D-­‐titin	  (Menon	  and	   Chia,	   2001).	   	   D-­‐titin	   is	   recruited	   to	   the	   fusion	   site	   by	   Rols,	   and	   mediates	  myoblast	   fusion	   in	   a	   mechanism	   that	   remains	   unclear.	   It	   also	   is	   involved	   in	  maintaining	   myotube	   morphology	   (Menon	   and	   Chia,	   2001;	   Zhang	   et	   al.,	   2000).	  Recently	   study	  also	   reported	   the	   requirement	  of	   the	  non-­‐muscle	  myosin	   IIA	   (NM-­‐MHC-­‐IIA)	  during	  myoblast	   fusion.	  NM-­‐MHC-­‐IIA	   is	   involved	   in	   the	   formation	  of	   the	  cortical	   actin	   wall	   in	   FC/myotube,	   as	   well	   as	   the	   appearance	   of	   the	   membrane-­‐bound	   vesicle-­‐like	   structures	   required	   for	   fusion	   pore	   formation	   (Duan	   and	  Gallagher,	  2009).	  
	   While	   Mbc	   appears	   not	   to	   be	   required	   by	   the	   FCs	   during	   fusion,	   Loner,	  another	   GEF	   that	   regulates	   actin	   rearrangements,	   is	   required	   in	   FCs	   to	   mediate	  fusion.	   	  Loner	  is	  recruited	  to	  the	  fusion	  site	  by	  Duf	  and	  Rst	  (Bulchand	  et	  al.,	  2010).	  	  Domain	   analysis	   suggests	   that	   the	   function	   of	   Loner	   is	   to	   recruit	   and	   activate	   the	  small	   GTPase	   dARF6	   at	   the	   fusion	   site.	   Loner	   and	   dARF6	   control	   the	   membrane	  localization	  of	  Rac	  (Chen	  et	  al.,	  2003).	  However,	  arf6	  maternal/zygotic	  null	  mutants	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does	  not	   affect	  myoblast	   fusion	   (Dyer	   et	   al.,	   2007),	   and	   the	   fusion	  phenotype	   in	   a	  dominant	  negative	  dARF6	  background	   is	  not	  as	  severe	  as	   that	   in	   the	   loner	  mutant,	  suggesting	   the	   real	   downstream	   target	   of	   Loner	   is	   another	   GTPase,	   or	   a	   possible	  redundancy	  with	   other	   dARF	   family	  members	   such	   as	   dARF1	   (Chen	   et	   al.,	   2003).	  Once	   activated,	   Rac	   regulates	   the	   function	   of	   SCAR,	   and	   is	   critically	   important	   for	  both	   FCs	   and	   FCMs	   to	  mediate	   fusion.	   	   The	   activity	   of	   SCAR	   is	   controlled	   by	   the	  pentameric	   complex	   WRC	   (the	   WAVE/SCAR	   regulatory	   complex).	   	   The	   WRC	   is	  composed	   of	   Kette/Nap1,	   Sra1,	   Abi,	   Hspc300	   and	   SCAR	   itself	   (Eden	   et	   al.,	   2002).	  	  Rac	  activity	  is	  essential	  for	  the	  localization	  of	  the	  WRC	  to	  the	  fusion	  site,	  as	  well	  as	  activation	  of	  SCAR	  via	  the	  release	  of	  the	  SCAR	  VCA	  domain	  from	  an	  inhibited	  state	  (Chen	  et	  al.,	  2010;	  Gildor	  et	  al.,	  2009).	  	  The	  molecular	  mechanism	  of	  SCAR	  activation	  will	  be	  discussed	  in	  detail	   in	  the	  “Actin	  cytoskeleton”	  section.	   	  As	  part	  of	  the	  WRC,	  Kette	  is	  also	  essential	  for	  myoblast	  fusion	  as	  it	  controls	  the	  localization	  and	  stability	  of	  SCAR	  (Richardson	  et	  al.,	  2007).	  	  It	  has	  not	  been	  reported	  whether	  the	  other	  WRC	  components,	  Sra1,	  Abi	  and	  Hspc300,	  play	  a	  role	  in	  myoblast	  fusion.	  This	  may	  be	  due	  to	  a	  lack	  of	  null	  mutant	  alleles,	  as	  well	  as	  a	  maternal	  supply	  of	  protein/mRNA	  in	  the	  embryo	  that	  masks	  the	  role	  of	  these	  proteins	  during	  the	  time	  period	  in	  which	  fusion	  takes	   place.	   	   In	   the	   FC,	   SCAR	   activates	   its	   downstream	   target,	   Arp2/3,	   and	  rearranges	  the	  actin	  cytoskeleton	  into	  a	  thin	  sheath	  along	  the	  fusion	  site	  (Sens	  et	  al.,	  2010).	  	  
	   In	  an	  FCM,	  SCAR	  activity	  is	  also	  regulated	  by	  Rac.	  	  However,	  Rac	  localization	  and	  activation	   is	  not	  regulated	  through	  Loner/Arf6/Arf1,	  but,	  as	  discussed	  earlier,	  through	   Mbc	   (Haralalka	   et	   al.,	   2011).	   	   Mbc	   is	   recruited	   to	   the	   fusion	   site	   by	   the	  phospholipids	  PI(4,5)P2	  (PIP2)	  (Bothe	  et	  al.,	  2014).	  	  Mbc	  can	  bind	  with	  ELMO	  with	  its	  SH3	  domain	  and	  form	  the	  Mbc/ELMO	  complex.	  	  The	  GEF	  activity	  of	  Mbc/ELMO	  is	  tightly	  regulated	  during	  myoblast	  fusion,	  and	  it	  controls	  the	  level	  of	  active	  Rac.	  	  Both	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overexpression	  and	  loss	  of	  function	  of	  Mbc/ELMO	  cause	  defects	  in	  myoblast	  fusion,	  which	   are	   reminiscent	   of	   constitutively	   active	   Rac	   and	   Rac	   mutants,	   respectively	  (Geisbrecht	  et	  al.,	  2008).	   	  When	  activated	  by	  Mbc/ELMO,	  Rac,	   in	  turn,	  binds	  to	  the	  WRC	  and	  regulates	  Arp2/3	  activity	  at	  the	  fusion	  site.	  
	   In	  addition	  to	  SCAR,	  the	  other	  NPF,	  WASp,	  also	  regulates	  Arp2/3	  at	  the	  fusion	  site.	   	   Unlike	   SCAR,	   which	   functions	   both	   in	   FCs	   and	   FCMs,	  WASp	   activity	   is	   only	  required	  in	  the	  FCM.	  	  The	  activity	  of	  WASp	  is	  regulated	  by	  Blow	  and	  Sltr.	  	  The	  WASp-­‐homology-­‐1	  (WH1)	  domain	  in	  WASp	  can	  bind	  to	  the	  WASp-­‐binding	  domain	  (WBD)	  in	   Sltr	   (Ramesh	   and	   Geha,	   2009).	   	   The	   interaction	   between	   WASp	   and	   Sltr	   is	  required	   to	   stabilize	   and	   localize	  WASp	   at	   the	   fusion	   site	   (Jin	   et	   al.,	   2011).	   	   The	  interaction	  is	  disrupted	  when	  Blow	  competes	  with	  WASp	  for	  Sltr	  WBD	  binding	  (Jin	  et	  al.,	  2011).	   	  Thus,	  after	  cell	  recognition	  and	  adhesion,	  a	  signal	  is	  transduced	  from	  the	  membrane	  via	  the	  adaptor	  protein	  Crk,	  which	  recruits	  Blow	  and	  Sltr	  to	  the	  site	  of	  fusion.	  	  At	  the	  fusion	  site,	  the	  WASp-­‐Sltr	  complex	  promotes	  actin	  polymerization	  by	   regulating	   Arp2/3	   activity.	   Blow	   suppresses	  WASp	   activity	   by	   competing	  with	  WASp	  for	  Sltr	  binding	  and	  by	  dissociating	  the	  WASp-­‐Sltr	  complex.	  Since	  the	  binding	  affinity	  between	  Blow-­‐Sltr	  is	  lower	  than	  WASp-­‐Sltr,	  dissociated	  WASp	  can	  bind	  back	  to	  Sltr	  again	  and	  promote	  another	  round	  of	  branched	  actin	  polymerization	  (Jin	  et	  al.,	  2011).	  	  
C.	  Muscle	  maturation	  
After	   myoblast	   fusion	   is	   completed,	   multiple	   events	   take	   place	   to	   ensure	   final	  muscle	   differentiation,	   including	   myotube	   elongation,	   myotendinous	   junction	  formation,	  myonuclear	  positioning,	  and	  sarcomere	  assembly.	  	  
Myotendinous	  junction	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The	  myotendinous	   junction	   is	   the	   site	  where	   a	  muscle	   forms	   contact	  with	   tendon	  cells.	  The	  force	  generated	  from	  muscle	  sarcomere	  contraction	  is	  transmitted	  to	  the	  tendon	   cell	   from	   the	  muscle	   via	   extracellular	   connective	   tissues,	  which	   altogether	  make	   up	   the	  myotendinous	   junction.	   	   The	   components	   that	   link	   the	   extracellular	  matrix	  to	  the	  cells,	  which	  form	  the	  myotendinous	  junction,	   include	  Laminin	  (Lam),	  Integrin,	  and	  Thrombospondin	  (Tsp).	  	  These,	  in	  turn,	  link	  to	  actin	  filaments	  both	  in	  the	  muscles	  and	  in	  the	  tendon	  cells	  (Figure	  1.5). 
	   The	  specification	  of	  tendon	  cells	  occurs	  around	  stage	  12	  (AEL	  7.5h).	  	  Both	  Wg	  and	   Hh	   signaling	   is	   required	   in	   the	   ectoderm	   for	   tendon	   precursor	   specification.	  	  Both	  Wg	  and	  Hh	  promote	  the	  expression	  of	  the	  Egr-­‐like	  transcription	  factor	  StripeB	  (SrB)	  in	  the	  epidermal	  cells	  at	  the	  segment	  borders.	  	  SrB	  is	  an	  isoform	  of	  the	  stripe	  gene	   that	   regulates	   the	   specification	   of	   tendon	   progenitor	   cells	   through	   its	  transcriptome	   (reviewed	   in	   (Schweitzer	   et	   al.,	   2010)).	   	   One	  downstream	   target	   of	  SrB	  is	  Held	  out	  wings	  (How),	  which	  suppresses	  SrB	  expression	  through	  a	  negative	  feedback	  loop.	  	  How	  maintains	  the	  low	  SrB	  level	  in	  the	  tendon	  progenitor	  cells	  and	  inhibits	   further	   tendon	   cell	   differentiation	   (Nabel-­‐Rosen	   et	   al.,	   2002).	   	   Several	  downstream	  targets	  of	  SrB	  are	  required	  to	  mediate	  muscle	  targeting	  to	  tendon	  cells,	  such	   as	   slit,	   Leucine-­rich	   tendon-­specific	   protein	   (Lrt),	   Thrombospondin	   (Tsp),	   and	  
slowdown	   (slow).	   	   Tsp	   is	   an	   ECM	   protein	   and	   a	   component	   of	   the	   myotendinous	  junction;	   Slow	   can	   temporarily	   sequester	   Tsp	   to	   prevent	   myotendinous	   junction	  prematurity	   (Gilsohn	   and	   Volk,	   2010).	   	   Both	   Slit	   and	   Lrt	   can	   bind	   with	   the	  transmembrane	   protein	   Robo	   (present	   at	   the	   muscle	   surface)	   and	   guide	   the	  elongation	  and	   targeting	  of	  muscles	   to	   tendon	  cells	   (Kramer	  et	   al.,	   2001).	   	  Muscle	  elongation	   is	   controlled	   by	   the	   transmembrane	   protein	   Kon-­‐tiki	   and	   the	   adaptor	  protein	  Echinoid.	  	  Both	  proteins	  are	  located	  at	  the	  muscle	  elongation	  tips,	  promote	  muscle	  cell	  elongation	  and	  stabilize	  the	  connection	  between	  the	  muscle	  and	  tendon	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Figure	   1.5	   Overview	   of	   myotendinous	   junction	   formation.	   A.	   Diagram	  showing	  signaling	  pathways	  that	  guide	  muscle	  elongation	  and	  muscle-­‐tendon	  recognition.	   	   At	   stage	   12,	   tendon	   precursor	   cells	   express	   SrB,	   under	   the	  control	  of	  Hh	  and	  Wg.	  	  The	  level	  of	  SrB	  is	  controlled	  by	  its	  downstream	  target	  How	   through	   an	   inhibitory	   feedback	   mechanism.	   	   SrB	   also	   mediates	   the	  expression	  of	  ECM	  proteins	   such	  as	  Slit,	  Tsp	  and	  Slow.	   	  On	   the	  muscle	   side,	  transmembrane	   proteins	   Robo,	   Kon-­‐tiki	   and	   the	   adaptor	   protein	   Echinoid	  (Ed)	   are	   required	   for	   targeting	   the	   muscle	   to	   tendon	   cells.	   	   B.	   Diagram	  showing	   proteins	   at	   the	   site	   of	   muscle-­‐tendon	   attachment.	   αPS1-­‐	   βPS	  expressed	   in	   the	   tendon	   cell	   binds	   with	   Lam	   in	   the	   ECM,	   while	   αPS2-­‐	   βPS	  expressed	   in	   the	   muscle	   cell	   binds	   to	   Tiggrin	   and	   the	   tendon	   cell	   secreted	  ECM	  components,	  Tsp	  and	  Slow,	  to	  mediate	  attachment	  to	  the	  ECM.	  (Adapted	  with	  permission	  from	  (Schweitzer	  et	  al.,	  2010))	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cell	   ECM	   (Schnorrer	   et	   al.,	   2007).	   After	   muscles	   attach	   to	   tendon	   cells,	   the	   EGFR	  ligand,	   Vein,	   is	   secreted	   by	   muscles	   into	   the	   muscle-­‐tendon	   junction	   site.	   	   Vein	  activates	   the	   EGFR	   signaling	   pathway,	  which	   promotes	   terminal	   differentiation	   of	  the	  tendon	  cells	  that	  connect	  with	  muscles,	  while	  suppressing	  differentiation	  of	  the	  neighboring	  tendon	  precursors	  (Yarnitzky	  et	  al.,	  1997).	  	  	  
	   Mature	  tendon	  cells	  express	  the	  tendon	  specific	  proteins	  Tsp,	  Laminin	  (Lam),	  αPS1	  integrin	  and	  βPS	  integrin.	  	  Muscle	  cells	  express	  Tiggrin,	  αPS2	  integrin	  and	  βPS	  integrin.	   	  αPS1-­‐	  βPS	  heterodimers	  can	  bind	  with	  Lam	   in	   tendon	  cells,	  while	  αPS2-­‐	  βPS	  can	  bind	  with	  both	  Tiggrin	  and	   the	   tendon	  cell	   secreted	  ECM	  component	  Tsp,	  and	  mediate	  attachment	  to	  the	  ECM	  (reviewed	  in	  (Schweitzer	  et	  al.,	  2010)).	  	  
Myonuclear	  positioning	  After	   fusion	   is	   complete,	   each	   myotube	   contains	   3-­‐25	   nuclei,	   depending	   on	   the	  specific	  muscle.	  	  These	  myonuclei	  need	  to	  be	  positioned	  at	  specific	  locations	  in	  order	  to	  ensure	  proper	  muscle	  function.	  	  Using	  the	  four	  lateral	  transverse	  (LT)	  muscles	  as	  an	   example,	   the	   positioning	   of	   myonuclei	   is	   a	   multi-­‐step	   process.	   	   Before	  myonuclear	  movement,	   all	   the	  nuclei	   in	   the	   LT	  muscles	   are	   located	   at	   the	   ventral	  side	   of	   the	  myotube	   (stage	   14,	   10h	  AEL).	   At	   stage	   15	   (11.5h	  AEL),	   the	  myonuclei	  separate	   into	   two	  clusters,	   one	  dorsal	   and	  one	  ventral;	   these	  migrate	   towards	   the	  opposite	  ends	  of	  the	  myotube,	  completing	  this	  step	  at	  the	  end	  of	  stage	  16	  (13h	  AEL).	  	  At	   stage	   17	   (18h	   AEL),	   nuclei	   in	   the	   two	   clusters	  move	   away	   from	   the	   poles	   and	  distribute	  evenly	  throughout	  the	  myotube	  (Metzger	  et	  al.,	  2012).	  	  
	   The	  proper	  positioning	  of	  myonuclei	   involves	   the	  microtubule	  cytoskeleton	  and	   motor	   proteins	   that	   move	   on	   microtubules.	   	   Still	   using	   LT	   muscles	   as	   an	  example,	  the	  microtubules	  originate	  from	  the	  nuclear	  envelope	  of	  each	  nucleus	  and	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extend	   towards	   the	   poles	   of	   the	   LT	   muscle	   fiber.	   	   The	   microtubule-­‐associated	  protein	   Ensconsin	   (Ens)	   links	   the	   motor	   protein	   Kinesin	   to	   the	   microtubule	  cytoskeleton.	  Kinesin	   crosslinks	  microtubules	   and	   slides	  microtubules	   to	   opposite	  directions,	  pushing	  nuclei	  away	  from	  each	  other	  (Metzger	  et	  al.,	  2012).	  	  Kinesin	  can	  also	  translocate	  a	  nucleus	  directly	  by	  pulling	  the	  nucleus	  at	  the	  front	  edge	  (Folker	  et	  al.,	  2014),	  a	  process	  that	  also	  requires	  the	  motor	  protein	  Dynein	  to	  function	  at	  the	  rear	   edge.	   	   After	   being	   transported	   to	   the	   cell	   cortex	   by	   Kinesin,	   Dynein	   can	   also	  function	  at	   the	  cell	  cortex	  and	  relocate	   the	  myonucleus	  by	  pulling	  microtubules	   to	  the	  cortex	  (Folker	  et	  al.,	  2012).	  	  
	   Another	   protein	   that	   plays	   a	   role	   in	   Drosophila	   myonuclear	   positioning	   is	  MSP-­‐300.	   	   MSP-­‐300	   contains	   the	   Klaricht-­‐Anc-­‐1-­‐Syne	   Homology	   (KASH)	   domain,	  and	   spans	   the	   outer	   nuclear	   membrane.	   	   The	   function	   of	   MSP-­‐300	   is	   thought	   to	  anchor	  the	  nucleus	  in	  place,	  since	  MSP-­‐300	  loss	  of	  function	  does	  not	  affect	  nuclear	  relocation	   in	   embryos,	   but	   it	   does	   impair	   nuclear	   position	   in	   later	   larval	   stages	  (reviewed	  in	  (Schulman	  et	  al.,	  2015)).	  
Sarcomerogenesis	  
	   A	  sarcomere	  is	  the	  basic	  contractile	  unit	  in	  striated	  muscles.	  The	  assembly	  of	  sarcomeres	   in	   a	   Drosophila	   embryo	   occurs	   at	   stage	   17	   (18h	   AEL).	   	   Sarcomeres	  arrange	  one	  after	  another	  to	  form	  a	  myofibril,	  and	  many	  myofibrils	  form	  within	  the	  muscle	   fiber.	   	   The	   proper	   formation	   of	   sarcomeres	   is	   critical	   for	   larval	   behaviors	  such	  as	  crawling	  and	  feeding.	  	  
	   Sarcomeres	   are	   muscle	   structures	   that	   are	   well	   conserved	   across	   several	  species.	   	   Sarcomeres	   are	   composed	   of	   actin	   thin	   filaments	   and	   myosin	   thick	  filaments,	   as	   well	   as	   other	   sarcomeric	   proteins	   including	   α-­‐actinin,	   Zasp,	  Tropomodulin	  (Tmod).	   	  Since	  sarcomere	  structure	   is	  similar	   in	   larval	  musculature	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and	   adult	   musculature,	   sarcomerogenesis	   will	   be	   discussed	   in	   detail	   in	   the	  “Sarcomerogenesis	  in	  Drosophila	  indirect	  flight	  muscles”	  section.	  	  
D.	  Adult	  muscle	  formation	  
The	  Drosophila	   adult	  muscles	   form	  during	  metamorphosis.	   	  Metamorphosis	   is	   the	  process	   in	  which	   the	  majority	   of	   larval	   tissues	   are	   eliminated,	   and	   the	   adult	   body	  plan	   is	   established.	   	   The	   adult	   tissues	   are	   generated	   either	   from	  differentiation	  of	  stem	  cells,	  or	   from	  remodeling	  of	   larval	  cells.	   	  At	   the	  beginning	  of	  metamorphosis,	  most	  of	  the	  muscles	  are	  destroyed	  through	  histolysis,	  but	  a	  few	  muscles,	  such	  as	  the	  dorsal	  oblique	  (DO1-­‐3)	  muscles,	  escape	  degradation	  and	  serve	  as	  templates	  for	  the	  adult	  muscles	  (Fernandes	  et	  al.,	  1991).	  	  
	   Based	  on	  their	  morphology	  and	  gene	  expression,	   the	  adult	  somatic	  muscles	  can	   be	   divided	   into	   two	   types:	   tubular	   muscles	   and	   fibrillar	   muscles.	   	   The	  abdominal,	   jump,	   leg	   and	   direct	   flight	   muscles	   are	   tubular	   muscles,	   while	   the	  indirect	  flight	  muscles	  (IFMs)	  are	  fibrillar	  muscles	  (Peckham	  et	  al.,	  1990).	  	  Tubular	  muscles	  have	  aligned	  myofibrils.	   In	   some	   tubular	  muscles,	   such	  as	   the	   leg	  muscle,	  the	  myonuclei	   are	   located	   in	   the	   tube	   center.	   	   The	   fibrillar	  muscles	   have	   distinct,	  unaligned	   myofibrils.	   	   The	   myonuclei	   in	   the	   fibrillar	   muscles	   are	   usually	   located	  between	  myofibrils.	  	  The	  fibrillar	  muscles	  in	  Drosophila	  IFMs	  and	  vertebrate	  skeletal	  muscles	  have	  similar	  structures	  (Fernandes	  et	  al.,	  1991).	  	  
	   The	   transcription	   factor	   Spalt	  major	   (Salm)	   determines	   fibrillar	   cell	   fate	   in	  IFMs.	  	  Salm	  functions	  downstream	  of	  the	  transcription	  factor	  vestigial	  (vg).	  	  In	  turn,	  Salm	  maintains	  Vg	   levels	   through	   a	   feedback	   loop.	   	   Salm	  drives	   the	   expression	   of	  IFM-­‐specific	   proteins,	   such	   as	   Fln,	   TpnC4,	   and	  determines	   the	   fibrillar	  muscle	   cell	  type	   in	   IFMs	   (Schönbauer	   et	   al.,	   2011).	   	   In	   addition	   to	   regulating	   IFM-­‐specific	  protein	   expression,	   Salm	   activates	   the	   expression	   of	   the	   ribonucleic	   acid-­‐binding	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protein	   Arrest	   (Aret).	   	   Through	   regulating	   alternative	   splicing,	   Arrest	   determines	  the	   isoforms	  of	   sarcomeric	  proteins,	   such	  as	  Sallimus	   (Sls)	  and	  Zasp52	   (Oas	  et	  al.,	  2014).	  	  	  
	   IFMs	  control	   the	  contraction	  of	   the	   thorax	  and	  enable	   flight.	   	   In	  each	  hemi-­‐thorax,	   there	   are	   7	   dorsal	   ventral	   muscles	   (DVMs)	   that	   regulate	   the	   upstroke	   of	  wings,	   and	   another	   6	   dorsal	   longitudinal	   muscles	   (DLMs)	   that	   regulate	   the	  downstroke	   of	   wings	   (AC,	   1978).	   	   The	   DVMs	   form	   de	   novo	   from	   adult	   muscle	  progenitors	   (AMPs),	   fusing	   during	   the	   early	   pupal	   stage	   (8-­‐36	   hours	   APF),	   while	  DLMs	  form	  through	  fusion	  between	  AMPs	  and	  muscle	  templates	  that	  are	  preserved	  during	  histolysis	  (Fernandes	  et	  al.,	  1991).	  	  
	   The	   AMPs	   derive	   from	  muscle	   progenitor	   cells.	   	   In	   the	   embryonic	   stage,	   a	  muscle	  progenitor	  cell	  divides	  once	  into	  two	  sibling	  cells.	  	  The	  two	  sibling	  cells	  give	  rise	   to	   either	   two	   founder	   cells,	   or	   one	   FC	   and	   one	   AMP	   based	   on	   asymmetric	  expression	   of	  Numb	   (Carmena	   et	   al.,	   1998b;	  Ruiz	  Gomez	   and	  Bate,	   1997).	   	   Under	  control	  of	  the	  Notch	  signaling	  pathway,	  twi	  is	  expressed	  in	  AMPs.	  	  The	  transcription	  factor	  Twi	  then	  triggers	  the	  expression	  of	  genes	  that	  repress	  differentiation,	  such	  as	  the	  Holes	  in	  muscle	  (Him),	   thus	  maintaining	   the	  undifferentiated	  state	  of	   the	  AMPs	  (Anant	  et	  al.,	  1998;	  Liotta	  et	  al.,	  2007).	  	  AMPs	  proliferate	  at	  the	  larval	  wing	  imaginal	  discs	   (Fernandes	   et	   al.,	   1991).	   	   The	   differentiation	   of	   adult	   muscles	   requires	   the	  inhibition	   of	   the	   Notch	   pathway,	  which	   subsequently	   leads	   to	   decreased	   levels	   of	  Twi	  and	  Him	  (Anant	  et	  al.,	  1998).	   	  The	  elimination	  of	  Him	  allows	  the	  activation	  of	  Dmef2,	   which	   functions	   as	   the	   major	   differentiation	   factor	   for	   adult	   muscle	  development	  (Caine	  et	  al.,	  2014;	  Soler	  and	  Taylor,	  2009)	  (Figure	  1.6).	  
	   The	   signaling	   pathways	   that	   regulate	   myoblast	   fusion	   in	   Drosophila	   adult	  muscles	  are	  not	  fully	  understood.	  	  According	  to	  our	  current	  knowledge,	  the	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Figure	  1.6	  Formation	  of	  Drosophila	  adult	  muscles.	  A.	  Diagram	  showing	  the	  development	   of	   indirect	   flight	  muscles	   (IMFs)	   in	   adult	  Drosophila.	   	  Starting	  from	   0	   hours	   after	   pupae	   formation	   (APF),	   larvae	   muscles	   are	   degraded	  through	   histolysis.	   	   Only	   the	   larval	  muscles	   that	   serve	   as	   templates	   for	   the	  dorsal	  ventral	  muscles	  (DVMs)	  are	  preserved	  during	  histolysis.	   	  At	  12	  hours	  APF,	   histolysis	   is	   completed.	   	   Adult	   precursor	   cells	   (AMPs)	   from	   the	   wing	  discs	   migrate	   to	   the	   muscle-­‐forming	   region.	   Around	   16	   hours	   APF,	   DVM	  templates	   split	   and	   fuse	   with	   the	   myoblasts.	   	   At	   the	   same	   time,	   dorsal	  longitudinal	   muscles	   (DLMs)	   are	   formed	   de	   novo	   through	   myoblast	   fusion.	  	  Indirect	   flight	  muscles	   are	   formed	  by	  24	  hours	  APF.	   	  B.	   Signaling	  pathways	  involved	  in	  AMP	  differentiation.	   	   In	  the	  wing	  discs,	  the	  AMPs	  proliferate	  and	  migrate	   to	  muscle-­‐forming	  regions.	   	   In	   the	  wing	  discs	  and	  during	  migration,	  AMP	   differentiation	   is	   repressed	   by	   the	   Notch	   signaling	   pathway,	   which	  triggers	  expression	  of	  twi	  and	  inhibits	  the	  expression	  of	  fusion	  genes	  such	  as	  
sns.	   	  When	   migration	   is	   completed,	   the	   Notch	   pathway	   is	   inhibited,	   which	  subsequently	  leads	  to	  the	  expression	  of	  genes	  that	  mediate	  fusion.	  	  C.	  Diagram	  showing	  muscles	  of	   adult	  Drosophila.	   	  D.	  Diagram	  showing	   the	   two	   types	  of	  IFMs:	  the	  dorsal	  ventral	  muscles	  (DVMs)	  that	  regulate	  the	  upstroke	  of	  wings,	  and	  the	  dorsal	   longitudinal	  muscles	  (DLMs)	  that	  regulate	  the	  downstroke	  of	  wings.	   	   (Adapted	  with	  permission	   from	  (Dickinson,	  2005;	  Dutta	  et	  al.,	  2004;	  Gildor	  et	  al.,	  2012;	  Hartenstein,	  1993))	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Figure	  1.6	  Formation	  of	  Drosophila	  adult	  muscles	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mechanisms	   that	   regulate	  myoblast	   fusion	  during	   adult	  myogenesis	   are	   similar	   to	  those	   that	   regulate	   embryo	  myogenesis.	   	   The	   same	   transmembrane	   proteins	   Duf,	  Rst,	  Sns	  and	  Hbs	  are	  required	  to	  mediate	  cell	  recognition	  and	  adhesion	  (Gildor	  et	  al.,	  2012).	   	   After	   adhesion,	   the	   myoblast	   flatten	   on	   the	   myotube,	   such	   that	   the	   cell	  membranes	  are	   in	   tight	  apposition	  (Dhanyasi	  et	  al.,	  2015).	   	  Receiving	  signals	   from	  the	  cell	  membrane,	  actin	  accumulates	  at	  the	  fusion	  site	  and	  forms	  a	  focus	  structure,	  which	   enables	   the	   formation	   and	   expansion	   of	   fusion	   pores.	   	   As	   with	   embryonic	  myogenesis,	  actin	  rearrangement	  during	  adult	  myogenesis	  requires	  both	  WASp	  and	  SCAR	   (Mukherjee	   et	   al.,	   2011).	   	   Despite	   all	   the	   similarities,	   however,	   there	   are	  differences	  between	  embryonic	   and	  adult	  myogenesis.	   	   In	   the	  embryos,	   FCMs	  and	  FCs	   are	  positioned	   relatively	   close	   to	   one	   another	  before	   fusion.	   	   FCMs	   in	   contact	  with	   FCs/myotubes	   are	   responsible	   for	   the	   early	   fusion	   events.	   	   FCMs	   that	   are	  located	  more	  internally	  need	  to	  migrate	  before	  making	  contact	  and	  fusing	  with	  the	  FCs/myotubes	  (Richardson	  et	  al.,	  2008b).	  	  During	  adult	  myogenesis,	  myoblasts	  need	  to	  migrate	  long	  distances	  from	  the	  imaginal	  discs	  to	  the	  muscle	  template/myotubes.	  	  More	  importantly,	  during	  migration,	  myoblasts	  maintain	  a	  semi-­‐differentiated	  state	  through	   the	  Notch	   signaling	   pathway.	   	   Each	  myoblast	   expresses	   the	  Notch	   ligand,	  Delta,	   and	   represses	   the	   differentiation	   of	   its	   neighboring	   cells.	   	   Notch	   signaling	  decays	  when	  myoblasts	  reach	  the	  vicinity	  of	   the	  myotubes,	  and	  this	  allows	   for	   the	  terminal	   differentiation	   of	  myoblasts	   and	   the	   expression	   of	   FCM	  markers	   such	   as	  Sns	  (Gildor	  et	  al.,	  2012).	  
E.	  Sarcomerogenesis	  in	  Drosophila	  indirect	  flight	  muscles	  
Sarcomere	  structure	  
Drosophila	   indirect	   flight	  muscles	   (IFMs)	   are	   fibrillar	  muscles	   formed	   by	   parallel,	  but	   unaligned,	   myofibrils.	   	   Myofibrils	   are	   composed	   of	   a	   highly	   ordered	   array	   of	  sarcomeres	  (reviewed	  in	  (Schulman	  et	  al.,	  2015)).	  	  The	  most	  important	  components	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of	   a	   sarcomere	   are	   the	   actin	   thin	   filaments	   and	   myosin	   thick	   filaments.	   	   In	   each	  sarcomere,	  actin	  thin	  filaments	  are	  arranged	  along	  the	   long	  axis	  of	   the	  muscle	  and	  attach	  to	  the	  Z-­‐discs,	  which	  are	  located	  at	  the	  ends	  of	  each	  sarcomere.	  	  Myosin	  is	  a	  protein	   with	   a	   fibrous	   tail	   and	   globular	   head.	   	   Myosin	   is	   arranged	   into	   a	   bipolar	  structure	  with	   tails	   facing	   the	  middle	   and	   attached	   to	   the	  M-­‐line,	  while	   heads	   are	  positioned	   at	   the	   ends.	   	   Both	   the	   Z-­‐disc	   and	  M-­‐line	   can	   be	   visualized	   as	   electron-­‐dense	   lines	  under	  electron	  microscopy.	   	  Muscle	   contraction	   is	  achieved	  when	   thin	  filaments	  and	  thick	  filaments	  slide	  across	  each	  other.	   	  In	  addition	  to	  the	  Z-­‐disc	  and	  M-­‐line,	  there	  are	  also	  other	  distinct	  regions	  such	  as	  the	  A-­‐band	  (A	  for	  Anisotropic)	  and	  the	  I-­‐band	  (I	  for	  isotropic).	  	  The	  A-­‐band	  covers	  the	  length	  of	  the	  thick	  filaments,	  while	  the	  I-­‐band	  is	  the	  area	  where	  thin	  filaments	  do	  not	  overlap	  with	  thick	  filaments	  (Figure	  1.7).	  	  
	   The	   relative	   movement	   of	   thin	   and	   thick	   filaments	   is	   mediated	   by	   the	  ATP/ADP-­‐dependent	   conformational	   change	   of	   the	   myosin	   head.	   	   Signals	   from	  motor	  neuron	  synapses	  are	  relayed	  to	  the	  muscle,	  changing	  the	  membrane	  potential	  of	  muscles	   and	   triggering	   the	   release	   of	   calcium	   from	   the	   sarcoplasmic	   reticulum	  (SR).	  	  Calcium	  binds	  to	  Troponin	  C	  and	  changes	  its	  conformation,	  revealing	  myosin-­‐binding	  sites	  on	   the	  actin	   thin	   filaments.	   	  The	  myosin-­‐ADP	   then	  binds	   to	   the	  actin	  filament,	   followed	   by	   the	   dissociation	   of	   myosin	   and	   ADP.	   	   The	   release	   of	   ADP	  triggers	   distortion	   of	   the	  myosin	   head,	  which	   bends	   and	   therefore	   pulls	   the	   actin	  filament.	  	  The	  simultaneous	  pulling	  of	  actin	  filaments	  by	  all	  the	  myosin	  in	  the	  same	  sarcomere	  generates	   the	  contractile	   force.	   	  The	  releasing	  of	  actin	   from	  the	  myosin	  head	   is	   triggered	   when	   ATP	   binds	   to	   the	   myosin	   head	   and	   changes	   the	   myosin	  conformation.	  	  When	  calcium	  is	  transported	  back	  into	  the	  SR,	  the	  muscle	  relaxes	  as	  Troponin	   C	   masks	   the	   myosin-­‐binding	   sites	   on	   the	   thin	   filaments	   (reviewed	   in	  (Geeves	  and	  Holmes,	  1999)).	  	  In	  Drosophila	  IFMs,	  muscle	  contraction	  is	  initiated	  	  
	   30	  
	  
Figure	   1.7.	   Dissecting	   the	   mechanism	   of	   muscle	   contraction.	   A.	   Diagram	  showing	   the	   organization	   of	   Drosophila	   flight	   muscles	   at	   different	   scales.	   B.	  Images	  taken	  by	  a	  Transmission	  Electron	  Microscope	  showing	  a	  section	  of	  three	  myofibrils.	   	   Each	   myofibril	   is	   subdivided	   by	   a	   Z-­‐disc	   (black	   line,	   arrows)	   into	  sarcomeres.	  Scale	  bar:	  5	  μm.	   	  C.	  Basic	  structure	  of	  a	  sarcomere.	  Sarcomeres	  are	  composed	   of	   thin	   (actin)	   filaments	   and	   thick	   (myosin)	   filaments.	   	   The	   region	  where	  thin	  filaments	  attach	  is	  called	  a	  Z-­‐disc,	  and	  the	  site	  where	  thick	  filaments	  attach	  is	  the	  M-­‐line.	  	  The	  region	  spanned	  by	  thick	  filaments	  is	  the	  A-­‐band.	  	  The	  I-­‐band	   is	   the	   region	  where	   there	   are	   no	   thick	   filaments.	   	  D.	  Model	   of	  molecular	  mechanisms	   of	   muscle	   contraction.	   The	   relative	   movement	   between	   thick	   and	  thin	   filaments	   requires	   energy	   released	   from	   ATP	   hydrolysis,	   as	   well	   as	   a	  conformational	   change	   of	   the	   myosin	   head.	   (Adaped	   with	   permission	   from	  (Hwang	  and	  Sykes,	  2015;	  Vigoreaux,	  2005))	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Figure	  1.7.	  Dissecting	  the	  mechanism	  of	  muscle	  contraction	  
	  
	   32	  
	  through	  a	  similar	  mechanism.	  	  However,	  the	  oscillation	  frequency	  required	  for	  flight	  is	  too	  rapid	  for	  the	  influx	  and	  outflux	  of	  calcium;	  therefore,	  the	  asynchromous	  IFMs	  adapted	   other	   ways	   to	   maintain	   muscle	   contraction.	   	   IFMs	   can	   be	   activated	  mechanically	   by	   periodic	   stretching,	   and	   low	   calcium	   concentration	   is	   enough	   to	  maintain	  constant	  contraction	  and	  relaxation	  of	  the	  IFMs	  (reviewed	  in	  (Bullard	  and	  Pastore,	  2011)).	   	  Since	  IFMs	  are	  very	  sensitive	  to	  stretching,	  special	  structures	  are	  required	  to	  ensure	  IFMs’	  stiffness.	  	  Drosophila	  IFMs	  maintain	  stiffness	  by	  expressing	  IFM-­‐specific	   isoforms	   of	   sarcomeric	   proteins	   such	   as	   Tropomyosin	   (isoform	   127)	  and	  Troponin	  (TnT)	  (Bullard	  and	  Pastore,	  2011).	  	  Another	  mechanism	  that	  sustains	  sarcomere	  stiffness	  is	  through	  a	  connecting	  filament	  that	  links	  a	  thick	  filament	  and	  actin.	   The	   vertebrate	   connecting	   filament	   contains	   the	   elastic	   protein	   Titin	   (also	  known	  as	  connectin),	  which	  extends	  from	  a	  Z-­‐disc	  to	  the	  M-­‐line.	  	  In	  Drosophila	  IFMs,	  elastic	  proteins	  do	  not	   extend	   from	  a	  Z-­‐disc	   to	   the	  M-­‐line,	   instead,	   the	   function	  of	  Titin	   is	   delegated	   to	   smaller	   proteins	   such	   as	   Projectin	   and	   Sls	   protein	   isoforms.	  	  Elastic	   proteins	   in	   Drosophila	   usually	   contain	   the	   immunoglobulin	   (Ig)	   domain,	  elastic	   PEVK	   domains,	   and	   fibronectin	   (Fn)	   domains	   (reviewed	   in	   (Bullard	   et	   al.,	  2005)).	   	   In	   the	   IFMs,	   sls	   encodes	   three	   different	   isoforms	   through	   alternative	  splicing:	  D-­‐Titin	  (Sls),	  Zormin,	  and	  Kettin.	  D-­‐Titin	  and	  Kettin	  extend	  from	  a	  Z-­‐disc	  to	  the	  end	  of	  the	  A-­‐band	  (Machado	  and	  Andrew,	  2000).	  	  Zormin	  is	  the	  N-­‐terminal	  part	  of	  Sls;	   it	  exists	  at	  both	  the	  Z-­‐disc	  and	  the	  M-­‐line.	   	  In	  the	  non-­‐flight	  muscles	  such	  as	  leg	   muscles,	   sls	   encodes	   longer	   isoforms	   with	   different	   elastic	   PEVK	   regions,	  therefore	  contributing	  to	  the	  different	  length	  that	  sarcomeres	  are	  able	  to	  extend	  to	  in	  different	  type	  of	  muscles	  (Burkart	  et	  al.,	  2007).	  	  
	   The	   elastic	   protein	   D-­‐Titin	   is	   anchored	   to	   a	   Z-­‐disc	   through	   α-­‐actinin.	   	   α-­‐actinin	  is	  a	  member	  of	  the	  F-­‐actin	  crosslinking	  superfamily	  proteins	  o(Oikonomou	  et	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al.,	   2011).	   	   It	   is	   involved	   in	   linking	   the	   actin	   cytoskeleton	   to	   different	  transmembrane	  proteins.	  	  In	  Drosophila	  muscles,	  α-­‐actinin	  localizes	  at	  Z-­‐discs	  in	  all	  types	   of	   larval	   and	   adult	   muscles	   (Saide	   et	   al.,	   1989;	   Vigoreaux	   et	   al.,	   1991).	   	   It	  contains	   an	   actin-­‐binding	   domain,	   a	   calcium-­‐binding	   domain,	   and	   an	   internal	  domain	   composed	   of	   four	   spectrin	   repeats	   (Blanchard	   et	   al.,	   1989).	   	   α-­‐actinin	   is	  required	  for	  Z-­‐disc	  stabilization.	  
	   The	  size	  of	  a	  sarcomere	  is	  thought	  to	  be	  set	  by	  the	  ruler	  protein	  Lasp.	  	  Lasp	  belongs	  to	  the	  nebulin	  family	  of	  proteins.	  	  Nebulin	  is	  an	  actin-­‐binding	  protein,	  which	  contains	  185	  copies	  of	  nebulin	  repeats	  (Pappas	  et	  al.,	  2011).	  	  As	  the	  only	  member	  of	  the	   nebulin	   family	   in	  Drosophila,	   Lasp	   is	   detectable	   in	  Drosophila	   larva	   body	  wall	  muscles	   (BWMs),	   jump	   muscles	   and	   IFMs.	   	   In	   BWMs	   and	   jump	   muscles,	   Lasp	  localizes	  at	  the	  Z-­‐disc,	  as	  well	  as	  the	  A-­‐band.	  	  In	  IFMs,	  however,	  Lasp	  is	  only	  found	  at	  the	  edge	  of	  the	  Z-­‐disc	  (Fernandes	  and	  Schöck,	  2014).	  	  Lasp	  contains	  a	  LIM	  domain,	  nebulin	  repeats,	  and	  SH3	  domain.	  	  Both	  LIM	  and	  nebulin	  domains	  are	  important	  for	  Lasp	   localization	   in	   BWMs,	   but	   deletion	   or	   mutation	   of	   both	   domains	   does	   not	  change	  Z-­‐disc	   localization	   in	  both	  BWMs	  and	   IFMs	   (Fernandes	  and	  Schöck,	  2014).	  	  Lasp	  determines	  the	  length	  of	  a	  sarcomere	  by	  setting	  the	  thin	  filament	  length,	  either	  by	   binding	   with	   capping	   proteins	   CapZ	   (Pappas	   et	   al.,	   2008),	   or	   by	   binding	   and	  stabilizing	   the	   thin	   filament	   with	   nebulin	   domains	   (Pappas	   et	   al.,	   2010).	   	   It	   also	  determines	   the	   diameter	   of	   a	   sarcomere	   by	   interacting	   with	   myosin	   and	   setting	  filament	  spacing	  at	  the	  A-­‐band.	  Lasp	  also	  sets	  the	  width	  of	  the	  I-­‐band	  by	  interacting	  with	  α-­‐actinin	  (Fernandes	  and	  Schöck,	  2014).	  	  
III.	  Muscle	  development	  in	  vertebrates	  	  
Muscle	  cells	  make	  up	  about	  half	  of	  human	  body	  mass.	  	  Muscle	  function	  is	  crucial	  to	  many	   basic	   physiological	   activities,	   such	   as	   breathing,	   heartbeat	   and	   locomotion.	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Based	   on	   differences	   in	   structure,	   localization,	   ways	   of	   stimulation,	   and	   function,	  muscles	   can	   be	   categorized	   into	   smooth	   muscles,	   cardiac	   muscles	   and	   skeletal	  muscles.	   	   Among	   them,	   skeletal	  muscle	   is	   the	  most	   abundant.	   	   Skeletal	  muscle	   is	  striated	   muscle	   that	   attaches	   to	   tendon	   cells	   and	   primarily	   exhibits	   voluntary	  contraction.	   	   In	   this	  section	   I	   summarize	   the	  process	  of	  vertebrate	  skeletal	  muscle	  development,	   aging	   and	   repair,	   and	   compare	   vertebrate	   muscles	   with	  Drosophila	  muscles.	  
	   Vertebrate	   muscle	   develops	   from	   the	   mesoderm.	   Similar	   to	   Drosophila	  development,	  the	  allocation	  of	  the	  mesoderm	  into	  different	  types	  also	  occurs	  during	  early	  development.	  	  The	  anterior-­‐most	  portion	  of	  the	  paraxial	  mesoderm	  gives	  rise,	  in	  the	  trunk,	  to	  somites,	  which	  differentiate	  along	  the	  dorsal-­‐ventral	  axis.	  	  The	  dorsal	  epithelial	   region	  of	   the	  somites	   then	  differentiates	   into	   the	  dermomyotome,	  which	  gives	   rise	   to	   muscle	   and	   the	   dermis.	   	   The	   ventral	   region	   differentiates	   into	   the	  sclerotome,	  which	  gives	  rise	  to	  cartilage	  and	  the	  skeleton	  (reviewed	  in	  (Tajbakhsh	  and	  Cossu,	  1997)).	  	  Similar	  to	  Drosophila,	  the	  specification	  of	  muscle	  progenitor	  cells	  also	  requires	  a	  combination	  of	  signals	  from	  adjacent	  tissues.	   	  The	  BMP	  signal	  from	  the	  lateral	  plate	  mesoderm	  (Pourquié	  et	  al.,	  1996),	  Wnt	  signaling	  from	  the	  ectoderm	  (Fan	   et	   al.,	   1997)	   and	   the	   neural	   tube,	   as	  well	   as	   Sonic	   hedgehog	   signaling	   (Shh)	  from	  the	  floor	  plate	  and	  notocord	  (Münsterberg	  et	  al.,	  1995)	  are	  all	  required	  for	  the	  subdivision	  of	  somites	  and	  the	  development	  of	  muscles	  (Figure	  1.8).	   	  Extracellular	  signals	   induce	   the	   expression	   of	   Paired	   Box	   3	   (Pax3)	   and	   Pax7	   in	   the	   somites	  (Duprez	  et	  al.,	  1998).	   	  Pax	  genes	  have	  dual	  roles:	  they	  enhance	  the	  proliferation	  of	  muscle	  precursor	  cells	  (Relaix	  et	  al.,	  2005),	  and	  they	  activate	  the	  expression	  of	  the	  myogenic	   regulatory	   factors	   (MRFs)	   (Sato	  et	  al.,	  2010).	   	  MRFs	  are	  a	   family	  of	   four	  transcription	   factors:	   MyoD,	   Myf5,	   myogenin	   and	   MRF4.	   	   MRFs	   are	   transcription	  factors	   that	   activate	   the	   expression	   of	   genes	   required	   for	   muscle	   differentiation.	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MyoD	  and	  Myf5	  are	  the	  first	  MRFs	  expressed	  in	  muscles	  and	  function	  redundantly	  to	   trigger	  myoblast	  specification.	   	  Mice	  doubly	  mutant	   for	  Myf5	  and	  MyoD	  have	  no	  muscle	  progenitor	  cells	  and	  therefore	  no	  muscle	   formation	  (Rudnicki	  et	  al.,	  1993).	  	  Myogenin	  is	  thought	  to	  function	  after	  muscle	  progenitor	  formation	  and	  regulate	  the	  terminal	   differentiation	   of	   committed	   myoblasts	   (Hasty	   et	   al.,	   1993).	   	   Similar	   to	  Myogenin,	  MRF4	   also	   regulates	   terminal	   differentiation	   of	  myoblasts,	   but	   there	   is	  also	   a	   report	   that	   suggests	   MRF4	   can	   function	   upstream	   of	   MyoD	   to	   direct	   the	  specification	  of	  myogenic	  cells	  (Kassar-­‐Duchossoy	  et	  al.,	  2004).	  	  In	  addition	  to	  MRFs,	  other	  transcription	  factors,	  such	  as	  the	  Myocyte	  enhancer	  factor	  2	  (Mef2),	  are	  also	  required	   for	  muscle	   differentiation.	   	   Mef2	   is	   a	   downstream	   target	   of	   MyoD.	   	   The	  combined	   activity	   of	  MyoD	   and	  Mef2	   induces	   transcription	   of	   downstream	   target	  genes	  that	  contain	  E-­‐box	  and	  MEF2-­‐binding	  sites	  (Dodou	  et	  al.,	  2003;	  Molkentin	  et	  al.,	  1995).	  
The	   final	   pattern	   of	   vertebrate	   muscle	   is	   determined	   by	   two	   waves	   of	  myogenesis.	   	   The	   first	   wave	   generates	   primary	   myofibers.	   	   The	   primary	   fibers	  function	   similarly	   to	   founder	   cells	   in	   Drosophila	   and	   determine	   the	   shape	   and	  identity	  of	  muscles	  (slow	  or	  fast).	  	  The	  second	  wave	  generates	  secondary	  myofibers	  	  that	  align	  alongside	  the	  primary	  myofibers	  and	  add	  mass	  to	  the	  muscles	  (Harris	  et	  al.,	  1989).	   	  The	   formation	  of	  both	  myofibers	  requires	   fusion	  of	  myoblasts.	   	   In	  vitro	  experiments	  suggest	  that	  the	  fusion	  process	  occurs	  in	  two	  phases:	  the	  first	  involves	  the	  fusion	  of	  individual	  myoblasts	  to	  form	  the	  nascent	  myotubes;	  the	  second	  phase	  involves	   fusion	   between	   the	   myotube	   and	   additional	   single-­‐nucleated	   myoblasts	  (reviewed	  in	  (Rochlin	  et	  al.,	  2010)).	  	  
	   Similar	  to	  the	  process	  of	  Drosophila	  myoblast	  fusion,	  the	  myotube-­‐myoblast	  fusion	   in	  mammals	   is	  also	  asymmetric	  and	  requires	   recognition	  molecules	   located	  on	  the	  cell	  membrane.	  	  Examples	  of	  the	  recognition	  molecules	  are	  the	  integrin	  vLA-­‐4	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on	   the	  myotubes,	   and	   its	   receptor	  VCAM-­‐1	  on	   the	  myoblast.	   	   Interaction	  between	  vLA-­‐4	  and	  VCAM-­‐1	  is	  required	  for	  the	  alignment	  of	  the	  secondary	  myofiber	  with	  the	  primary	  myofiber,	   as	  well	   as	   the	   second	  phase	  of	  muscle	   cell	   fusion	   (Rosen	   et	   al.,	  1992).	   	   In	   addition	   to	   vLA-­‐4	   and	   VCAM-­‐1,	   the	   transcription	   factor	   NFAT2C	   also	  mediates	  cell	  recognition	  by	  regulating	  the	  expression	  of	  IL-­‐4.	  	  IL-­‐4	  is	  a	  cytokine	  that	  functions	  as	  a	  secreted	  myoblast	  recruitment	  factor	  (Horsley	  et	  al.,	  2003).	  	  A	  recent	  study	   has	   shown	   that	   Nephrin,	   an	   ortholog	   of	   the	   Drosophila	   transmembrane	  protein	  Sns,	  localizes	  at	  the	  myoblast	  side	  and	  mediates	  cell	  recognition	  (Sohn	  et	  al.,	  2009).	   	  After	  recognition,	  adhesion	  molecules	  such	  as	  M-­‐cadherin	  (Hollnagel	  et	  al.,	  2002),	  N-­‐cadherin	  (Radice	  et	  al.,	  1997)	  and	  integrin	  family	  members	  (Schwander	  et	  al.,	   2003)(Schwander	  2003)	  mediate	   the	   adhesion	   and	   alignment	  of	   the	  myoblast.	  	  Unlike	   in	   Drosophila,	   an	   actin	   focus	   structure	   has	   not	   been	   observed	   during	  vertebrate	  myoblast	  fusion.	  	  Nevertheless,	  the	  actin	  cytoskeleton	  still	  plays	  a	  critical	  role	   in	  vertebrate	  muscle	   formation.	   	  Similar	   to	  Drosophila	  mbc	  mutants,	  Dock180-­‐null	  mice	  embryos	  exhibit	  severely	  impaired	  myoblast	  fusion	  and	  skeletal	  muscle	  is	  reduced	   (Laurin	  et	   al.,	   2008).	   	  Dock180	   is	   the	  mammalian	  ortholog	  of	  Mbc,	   and	   it	  functions	  as	  a	  GEF	  protein	  to	  activate	  Rac	  GTPase.	   	  In	  a	  conditional	  Rac1	  knockout	  mouse	  model,	   Arp2/3	   and	   F-­‐actin	   accumulation	   is	   reduced,	   resulting	   in	   impaired	  myoblast	  migration	  and	  fusion	  (Vasyutina	  et	  al.,	  2009).	  	  Experiments	  using	  a	  C2C12	  mouse	  myoblast	  cell	  culture	  suggest	  that	  Nap1,	  the	  mammlian	  ortholog	  of	  Kette	  and	  the	   downstream	   target	   of	   Rac1,	   is	   required	   for	   regulating	  WAVE	   dependent	   actin	  remodeling	   during	   myoblast	   fusion	   (Nowak	   et	   al.,	   2009).	   	   These	   data	   suggest	   a	  conserved	  role	  of	  actin	  during	  muscle	  development.	  
	   Cell	   fusion	   is	   required	  not	   only	   in	   early	   embryonic	  myogenesis,	   but	   also	   in	  muscle	   regeneration	   at	   the	   later	   stages	   of	   life.	   	   As	   with	   Drosophila	   adult	   muscle	  progenitors	  (AMPs),	  a	  pool	  of	  myoblasts	  remains	  undifferentiated	  during	  vertebrate	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Figure	  1.8.	  Development	  of	  vertebrate	  muscles.	  A.	  Myogenesis	  from	  a	  somite	  (S)	   requires	   signals	   from	   adjacent	   tissues.	   Bone	  Morphogenetic	   Protein	   (BMP)	  signals	  from	  the	  lateral	  mesoderm	  (LM),	  Wnt	  signaling	  from	  the	  dorsal	  ectoderm	  (DE)	   and	   the	   neural	   tube	   (NT),	   and	   Sonic	   hedgehog	   signaling	   (Shh)	   from	   the	  notocord	   (NC)	   are	   all	   required	   for	   somite	   partitioning.	   	  B.	   	   Signaling	   pathways	  that	  regulate	  muscle	  cell	  specification.	   	  Pax3	  and	  Pax7	  enhance	  the	  proliferation	  of	  muscle	  precursor	  cells	  and	  activate	  the	  expression	  of	  the	  myogenic	  regulatory	  factors.	  	  MyoD	  and	  Myf5	  function	  redundantly	  to	  trigger	  myoblasts	  specification.	  	  Myogenin	   and	   MRF4	   regulate	   the	   terminal	   differentiation	   of	   committed	  myoblasts.	   	   C.	   Stages	   of	   muscle	   development	   in	   mice.	   The	   diagram	   shows	   the	  formation	   of	   the	   myotome	   (Ci).	   	   Embryonic	   myoblasts	   from	   the	   myotome	  differentiate	   and	   fuse	   to	   form	   primary	   muscle	   fibers	   (Cii).	   	   Fetal	   myoblasts	  differentiate	  and	  fuse	  to	  form	  secondary	  fibers	  that	  surround	  the	  primary	  fibers	  (Ciii).	  Muscles	  then	  mature	  to	  form	  muscle	  fibers	  at	  the	  postnatal	  stage	  (Civ).	  	  D.	  Diagram	   showing	   vertebrate	   sarcomere	   structure	   and	   examples	   of	   conserved	  sarcomeric	   proteins.	   (Adapted	   with	   permission	   from	   (Chargé	   and	   Rudnicki,	  2004;	  Kollias	  and	  McDermott,	  2008;	  Sparrow	  and	  Schöck,	  2009;	  Tajbakhsh	  and	  Cossu,	  1997)).	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Figure	  1.8.	  Development	  of	  vertebrate	  muscles	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myogenesis.	   	   These	   myoblasts	   are	   satellite	   cells	   that	   locate	   around	   myofibers.	  Satellite	  cells	  are	  responsible	  for	  post-­‐natal	  muscle	  growth,	  as	  well	  as	  muscle	  repair.	  	  The	  specification	  of	  satellite	  cells	  is	  critically	  dependent	  on	  Pax7,	  as	  no	  satellite	  cells	  are	   found	   in	  Pax7	  mutant	  mice	   (Seale	   et	   al.,	   2000).	   	  With	   intact	  muscles,	   satellite	  cells	   are	   mitotically	   quiescent	   and	   express	   Pax7	   and	   Myf5,	   but	   not	   Myogenin	   or	  MyoD	   (reviewed	   in	   (Yin	   et	   al.,	   2013)).	   	   Upon	   muscle	   injury,	   myofiber	   necrosis	  triggers	  inflammatory	  responses,	  which	  induce	  satellite	  cells	  to	  proliferate	  (Tidball,	  1995).	   	   After	   proliferation,	   the	  majority	   of	   satellite	   cells	   differentiate	   and	   start	   to	  express	  MyoD	   and	  myogenin	   (Rantanen	   et	   al.,	   1995).	   	   These	   cells	   later	   fuse	  with	  damaged	  myofibers	  or	  fuse	  with	  each	  other	  to	  generate	  new	  muscle	  fibers	  (Grounds	  and	  Yablonka-­‐Reuveni,	  1993).	  The	  process	  of	  satellite	  cell	  fusion	  is	  mechanistically	  similar	  to	  myoblast	  fusion	  during	  primary	  and	  secondary	  myofiber	  formation.	  	  	  
	   In	  both	  Drosophila	  and	  vertebrates,	  muscle	   fibers	   form	  and	  mature	  through	  similar	  mechanisms.	  	  In	  the	  mature	  muscle,	  the	  basic	  contractile	  unit,	  a	  sarcomere,	  is	  structurally	  conserved	  from	  flies	  to	  humans.	  	  As	  with	  the	  Drosophila	  sarcomere,	  the	  human	   sarcomere	   contains	   actin-­‐based	   thin	   filaments	   and	   myosin-­‐based	   thick	  filaments,	   and	   has	   a	   similar	   structure	   under	   an	   electron	   microscope.	   	   Many	  sarcomeric	   proteins	   that	   regulate	   sarcomere	   assembly	   and	   function	   are	   also	  conserved	  between	  flies	  and	  humans.	  	  
IV.	  Actin	  cytoskeleton	  	  
	  A.	  Overview	  of	  actin	  networks	  in	  cells	  
	   The	  actin	  monomer	  (G-­‐actin)	  is	  one	  of	  the	  most	  conserved	  proteins.	  	  G-­‐actin	  exists	   in	   different	   isoforms	   and	   can	   undergo	   different	   post-­‐translational	  modifications.	   	   The	  most	   common	   isoform	   is	   the	   α-­‐actin,	  which	   exists	   in	   skeletal,	  cardiac	  and	  smooth	  muscles.	   	  G-­‐actin	  is	  able	  to	  assemble	  into	  filamentous	  actin	  (F-­‐
	   40	  
actin)	   even	   without	   actin	   nucleation	   and	   polymerization	   factors.	   	   However,	   the	  nucleation	   process	   is	   not	   favored	   thermodynamically.	   	   It	   is	   after	   the	   actin	   trimer	  forms	   that	   the	   elongation	   rate	   accelerates	   rapidly	   (Wegner	   and	   Engel,	   1975).	   	   G-­‐actin	   under	   physiological	   conditions	   is	   associated	   with	   ATP.	   After	   actin	  polymerization,	  ATP	  is	  hydrolyzed	  into	  ADP.	  	  The	  ADP-­‐bound	  actin	  then	  dissociates	  from	   the	  minus	   end	  of	   the	   actin	   filament.	   	   There	   are	  many	   actin-­‐binding	  proteins	  that	   regulate	   the	   hydrolysis	   and	   dissociation	   process,	   and	   therefore	   regulate	   the	  dynamics	  between	  the	  G-­‐actin	  and	  F-­‐actin	  state.	  	  
The	   tertiary	  structure	  of	  globular	  actin	   is	  composed	  of	   two	  domains,	  which	  are	  separated	  by	  a	  cleft.	  	  Because	  all	  the	  G-­‐actins	  in	  the	  same	  F-­‐actin	  are	  orientated	  towards	   the	   same	  direction,	   the	   F-­‐actin	   polymer	   has	   structural	   polarity.	   	   The	   end	  where	   the	  cleft	   is	   exposed	   is	   called	   the	  barbed	  end,	  or	   the	  plus	   (+)	  end,	  while	   the	  opposite	  end	  where	  the	  ATP	  binding	  site	  is	  exposed	  is	  called	  the	  pointed	  end,	  or	  the	  minus	  (-­‐)	  end	  (reviewed	  in	  (Allingham	  et	  al.,	  2006))	  (Figure	  1.9).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	   actin	   cytoskeleton	   undergoes	   remodeling	   in	   response	   to	   intracellular	  and	   extracellular	   signals.	   	   The	   result	   of	   actin	   cytoskeletal	   remodeling	   is	   the	  formation	  of	   specific	   cellular	   structures,	   such	  as	   filopodia,	   lamellipodia,	   and	  stress	  fibers,	  which	  mediate	   cell	   behaviors	   including	  migration,	   cell	  morphology	   change,	  and	   cytokinesis.	   	   Actin	   remodeling	   involves	   several	   processes	   including	   actin	  polymerization,	   the	   organization	   of	   actin	   filaments,	   and	   the	   depolymerization	   of	  actin	  filaments.	  	  
	   Filopodia	  are	  thin,	  actin-­‐based	  protrusions.	  	  Cells	  use	  filopodia	  to	  probe	  their	  surrounding	  environment	  and	  sense	  mechanical	   forces	   in	   the	  extracellular	  matrix.	  For	  cells	   that	  undergo	  migration	  and	  elongation,	   filopodia	  are	  usually	   found	  at	   the	  leading	   edge	   of	   these	   cells.	   	   The	   actin	   filaments	   in	   filopodia	   are	   organized	   into	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parallel	   bundles.	   	   Several	   actin-­‐regulating	   proteins	   are	   responsible	   for	   filopodia	  formation,	  including	  Ena/VASP,	  formins,	  Fascin,	  I-­‐BAR	  domain	  proteins	  and	  myosin-­‐X.	  	  Among	  these	  proteins,	  Ena/VASP	  and	  formins	  promote	  actin	  polymerization	  and	  elongate	   the	   actin	   filaments	   (Bear	   et	   al.,	   2002;	   Goode	   and	   Eck,	   2007).	   	   Ena/VASP	  enhances	  actin	  filament	  formation	  through	  two	  mechanisms:	  1)	  it	  protects	  the	  actin	  filament	   from	  capping	  proteins,	   and	  2)	   it	   can	   increase	   local	  G-­‐actin	   levels	   through	  profilin-­‐binding	  regions	  (Bear	  et	  al.,	  2002).	   	  Fascin	  can	  bundle	  actin	   filaments	  and	  maintain	   the	   integrity	   of	   the	   actin	   bundles	   in	   the	   filopodia	   (DeRosier	   and	   Edds,	  1980).	  	  The	  I-­‐BAR	  domain	  proteins	  promote	  filopodia	  formation	  through	  membrane	  deformation	   activity	   (Mattila	   et	   al.,	   2007).	   	   Myosin-­‐X	   is	   a	   motor	   protein	   that	  transports	  filopodial	  components	  to	  the	  tip	  of	  the	  filopodia	  (Tokuo	  and	  Ikebe,	  2004).	  	  
	   Lamellipodia	  are	  sheet-­‐like,	  actin-­‐based	  protrusions.	   	  The	  actin	   filaments	   in	  lamellipodia	  are	  organized	  into	  a	  branched	  network.	  	  Lamellipodia	  push	  the	  leading	  edge	  forward	  and	  enable	  cell	  migration.	  	  The	  actin	  network	  in	  lamellipodia	  is	  mainly	  regulated	  by	  Arp2/3,	  which	  generates	  actin	  filaments	  that	  branch	  off	  from	  the	  pre-­‐existing	  filament.	  	  The	  end	  of	  the	  newly	  generated	  actin	  filament	  is	  either	  capped	  by	  capping	  proteins	  or	  elongated	  under	  control	  of	  ENA/VASP	  or	  formins	  (reviewed	  in	  (Krause	  and	  Gautreau,	  2014)).	  	  
	   Stress	  fibers	  are	  actin-­‐	  and	  myosin-­‐	  based	  structures.	  	  The	  actin	  structures	  in	  stress	   fibers	   are	   composed	   of	   both	   actin	   bundles	   and	   a	   branched	   actin	   network.	  	  Stress	   fibers	   are	   organized	   parallel	   to	   the	   cell	  membrane	   and	   provide	   support	   to	  resist	  shear	  force.	  	  The	  interaction	  between	  actin	  and	  myosin	  in	  the	  stress	  fibers	  also	  provide	  contractile	  forces	  for	  cell	  morphological	  changes	  (reviewed	  in	  (Mattila	  and	  Lappalainen,	  2008)).	  	  
	   42	  
	  
	  	  
Figure	   1.9.	   Overview	   of	   actin	   dynamics	   and	   actin-­based	   structures.	   A.	   The	  polymerization	  and	  depolymerization	  of	  actin	   filaments	  (F-­‐actin).	   	  The	  turnover	  of	  an	   actin	   filament	   involves	  ATP-­‐bound	  G-­‐actin	   assembly	   at	   the	  plus	   end	  or	   barbed	  end,	  ATP	  hydrolysis,	  the	  release	  of	  Pi	  and	  ADP-­‐bound	  G-­‐actin	  disassembly	  from	  the	  minus	   or	   pointed	   end.	   	   B.	   Examples	   of	   actin-­‐based	   structures	   in	   a	   cell.	   	   The	   cell	  cortex	   is	   a	   network	  of	   crosslinked	   actin	   filaments	   beneath	   the	  plasma	  membrane.	  The	  stress	  fibers	  contain	  antiparallel	  actin	  bundles.	  The	  lamellipodium	  is	  a	  network	  of	  branched	  actin	   filaments	  at	   the	   leading	  edge	  of	  a	  migrating	  cell.	  The	   filopodium	  contains	   thin,	   parallel	   actin	   bundles	   that	   cell	   uses	   to	   probe	   its	   surrounding	  environment.	   C.	   Arp2/3	   nucleates	   an	   actin	   filament	   at	   a	   70°	   angle	   from	   a	   pre-­‐existing	   filament.	  Formins	  nucleate	  and	  elongate	  actin	   filaments	  de	  novo.	   (Adapted	  with	  permission	  from	  (Blanchoin	  et	  al.,	  2014;	  Chen	  et	  al.,	  2000;	  Pak	  et	  al.,	  2008))	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B.	  Actin	  regulators	  that	  control	  the	  dynamics	  of	  actin	  
Actin-­related	  protein-­2/3	  (Arp2/3)	  
As	   mentioned	   previously,	   the	   polymerization	   of	   actin	   is	   not	   thermodynamically	  favored	   until	   the	   actin	   trimer	   forms.	   	   The	   Arp2/3	   complex	   promotes	   actin	  polymerization	   by	   mimicking	   the	   structure	   of	   an	   actin	   dimer	   and	   serves	   as	   a	  template	   to	   initiate	   F-­‐actin	   formation	   (reviewed	   in	   (Goley	   and	   Welch,	   2006)).	  	  Arp2/3	   is	  composed	  of	   seven	  subunits.	   	  The	  subunit	  Arp2	  and	  Arp3	  belong	   to	   the	  same	  superfamily	  as	  actin,	  and	  structurally	  resemble	  G-­‐actin	  (Robinson	  et	  al.,	  2001).	  	  The	  other	  5	  subunits	  of	  the	  Arp2/3	  complex	  are	  ARPC1-­‐5.	  	  The	  Arp2/3	  complex	  can	  bind	  to	  the	  side	  of	  a	  pre-­‐existing	  actin	  filament	  through	  subunit	  ARPC2	  and	  ARPC4,	  and	   generate	   a	   new	   filament	   at	   a	   70-­‐degree	   angle.	   	   The	   pointed	   end	   of	   the	   new	  filament	   is	   attached	  with	  Arp2	   and	  Arp3	   (Beltzner	   and	   Pollard,	   2004;	   Egile	   et	   al.,	  2005).	   	   Similar	   to	   actin,	   Arp2	   and	   Arp3	   can	   bind	   to	   ATP.	   	   The	   binding	   of	   ATP	  promotes	   a	   conformational	   change	   in	   Arp2/3	   and	   is	   crucial	   for	   its	   actin	  polymerization	   activity	   (Goley	   et	   al.,	   2004).	   	   The	   influence	   of	   ATP	   hydrolysis	   on	  Arp2/3	  activity	  is	  controversial.	  	  It	  has	  been	  shown	  that	  ATP	  hydrolysis	  is	  crucial	  for	  actin	  nucleation	  and	  branching	  (Dayel	  and	  Mullins,	  2004),	  while	  other	  studies	  have	  reported	  that	  ATP	  hydrolysis	  is	  essential	  for	  actin	  branch	  disassembly	  and	  Arp2/3	  complex	  recycling	  (Le	  Clainche	  et	  al.,	  2003).	  	  
	   The	   nucleation-­‐promoting	   factors	   (NPFs)	   activate	   Arp2/3,	   partly	   by	  increasing	  Arp2/3’s	  affinity	  for	  nucleotide	  binding.	   	  There	  are	  numerous	  NPFs,	  but	  the	  most	  well	  studied	  NPFs	  are	  the	  Wiskott-­‐Altrich	  syndrome	  protein	  (WASp),	  and	  the	  suppressor	  of	  cAMP	  receptor	  (SCAR),	  also	  known	  as	  the	  WASp	  family	  verprolin	  homolog	  (WAVE).	  	  Both	  WASp	  and	  SCAR	  share	  a	  C-­‐terminal	  WCA	  domain,	  which	  is	  the	  functional	  domain	  that	  can	  activate	  Arp2/3.	  	  The	  WCA	  domain	  contains	  a	  WASp-­‐
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homology-­‐2	  (W)	  domain	  that	  binds	  with	  G-­‐actin,	  a	  cofilin-­‐homology	  and	  acidic	  (CA)	  domain	  that	  can	  bind	  to	  Arp2/3	  and	  promote	  its	  conformation	  change	  (Goley	  et	  al.,	  2004).	  	  
	   Although	   both	   WASp	   and	   SCAR/WAVE	   activate	   Arp2/3	   through	   the	   WCA	  domain,	  the	  activities	  of	  the	  two	  NPFs	  are	  regulated	  through	  different	  mechanisms.	  	  WASp	   is	   auto-­‐inhibited	   by	   the	   interaction	   between	   the	   WCA	   domain	   and	   the	  Cdc42/Rac	   interactive	  binding	   (CRIB)	  domain	   (also	   known	  as	   the	  GTPase	  binding	  domain	   (GBD)),	   which	   sequesters	   WCA	   domain	   activity	   (Kim	   et	   al.,	   2000).	   	   The	  binding	   of	   a	   small	   GTPase	   and	   PI(4,5)P2	   can	   compete	   with	   the	   WCA	   for	   GBD	  binding,	  and	  therefore	  release	  WCA	  from	  an	  inhibited	  state.	   	   In	  addition	  to	  a	  small	  GTPase	   and	   PI(4,5)P2,	   WASp	   activity	   is	   also	   regulated	   by	   tyrosine	   kinase	  phosphorylation.	   	  Phosphorylation	  of	   the	  WCA	  domain	  can	   increase	   its	  affinity	   for	  Arp2/3	  and	  promote	  actin	  nucleation	  (Cory	  et	  al.,	  2003).	   	   In	  addition	  to	  activating	  WASp,	   PI(4,5)P2	   and	   tyrosine	   kinase,	   Nck,	   could	   also	   regulate	   the	   membrane	  localization	  of	  WASp	  (Miki	  et	  al.,	  1996).	  	  
	   Unlike	  WASp,	  which	  is	  auto-­‐inhibited,	  the	  WAVE	  protein	  by	  itself	  is	  activated	  and	  sufficient	  to	  promote	  Arp2/3-­‐based	  actin	  nucleation.	  	  Under	  in	  vivo	  conditions,	  however,	  WAVE	  forms	  a	  complex	  with	  Nap1/Hem-­‐2,	  Sra1/Cyfip1,	  Abi	  and	  Hspc300.	  This	   hetero-­‐pentameric	   WAVE	   regulatory	   complex	   (WRC)	   inhibits	   WAVE	   activity	  towards	   Arp2/3.	   	   Analysis	   of	   the	   crystal	   structure	   of	   the	   WRC	   reveals	   the	  mechanism	  for	  WRC	  inhibition.	  	  In	  the	  WRC,	  Sra1	  and	  Nap1	  have	  similar	  structures	  and	   interact	   to	   form	  a	  pseudo-­‐symmetric	  dimer.	   	  HSP300,	  Abi2	  and	  WAVE	   form	  a	  trimer	  that	  contacts	  the	  Sra1-­‐Nap1	  dimer	  in	  a	  tripartite	  manner.	  	  Sra1	  can	  bind	  with	  the	   functional	   WCA	   region	   of	   WAVE,	   making	   the	   WCA	   inaccessible	   to	   actin	   and	  Arp2/3.	  	  Mutations	  in	  the	  WCA-­‐binding	  region	  of	  Sra1	  constitutively	  activate	  WAVE,	  and	  trigger	  Arp2/3-­‐based	  actin	  nucleation	  (Chen	  et	  al.,	  2010).	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   WAVE	   can	   be	   activated	   by	   various	   stimuli,	   such	   as	   Rac	   GTPase,	  phospholipids,	   and	   kinases.	   	   Rac	   activates	   WAVE	   by	   competing	   with	   the	   WCA	  domain	  for	  Sra1	  binding,	  and	  releasing	  the	  WCA	  from	  an	  inhibitory	  state	  (Ismail	  et	  al.,	   2009).	   	   WAVE	   could	   also	   be	   activated	   by	   phosphorylation	   of	   a	   conserved	  sequence,	  such	  as	  Tyr	  125	  and	  Tyr	  150	  (Ardern	  et	  al.,	  2006;	  Stuart	  et	  al.,	  2006).	  	  The	  phosphorylation	   destabilizes	   the	   interaction	   between	   the	   WCA	   region	   and	   Sra1,	  leading	   to	   the	   release	   of	   the	  WCA	   from	   Sra1,	   and	   increases	   the	  WRC	   activity	   for	  Arp2/3.	  
	   When	  WAVE	  is	  activated,	  the	  WCA	  domain	  dissociates	  from	  Sra1.	  	  However,	  the	   WAVE	   regulatory	   complex	   (containing	   Nap1/Hem-­‐2,	   Sra1/Cyfip1,	   Abi	   and	  Hspc300)	  itself	  does	  not	  dissociate	  and	  remains	  intact.	  	  It	  is	  reported	  that	  the	  WRC	  maintains	   the	   stability	  of	  WAVE,	   as	   ablation	  of	  Nap1/Hem-­‐2,	   Sra1/Cyfip1	  and	  Abi	  leads	   to	   the	   degradation	   of	  WAVE	   (Kunda	   et	   al.,	   2003).	   	   In	   addition	   to	   stabilizing	  WAVE,	   the	  WRC	  also	   regulates	   the	   localization	  of	  WAVE	  (Richardson	  et	  al.,	  2007).	  	  Phosphorylation	   can	   also	   promote	   the	   cell-­‐edge	   localization	   of	  WAVE.	   	   Therefore,	  tyrosine	  kinases,	  such	  as	  Abl	  and	  Src,	  not	  only	  activate	  WAVE,	  but	  also	  regulate	  WRC	  localization.	   	   The	   negatively-­‐charged	   phospholipids	   such	   as	   PI(3,4,5)P3	   and	  PI(4,5)P2	   could	   also	   bind	   with	   the	   WRC	   and	   contribute	   to	   the	   membrane	  localization	  of	  WAVE	  (Mendoza,	  2013).	  	  
Formins	  
Formins	   are	   a	   family	   of	   proteins	   that	   regulate	   actin	   assembly	   and	   microtubule	  stability.	   	   The	   first	   formin	  was	   identified	  when	   characterizing	   the	   limb	   deformity	  (ld)	   locus	   (Mass	  et	  al.,	  1990;	  Woychik	  et	  al.,	  1990).	   	  The	   ld	   gene	  was	  assigned	   the	  name	   formin	   (fmn),	   because	   it	  was	   thought	   to	  be	   involved	  with	  anterior-­‐posterior	  limb	   pattern	   formation.	   	   Although	   later	   studies	   have	   shown	   that	   the	   limb	   defects	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were	  actually	  caused	  by	  a	  mutation	  of	  the	  neighboring	  gene	  gremlin	  (Michos	  et	  al.,	  2004;	   Zuniga	   et	   al.,	   2004),	   the	   name	   formin	  was	   retained.	   	   After	   the	   discovery	   of	  Fmn,	  more	  formin	  homologs	  were	  discovered,	  such	  as	  Diaphanous	  and	  Cappuccino	  in	   Drosophila	   (Castrillon	   and	   Wasserman,	   1994;	   Emmons	   et	   al.,	   1995),	   Bni1p	   in	  
Saccharomyces	  cerevisiae	  (Evangelista	  et	  al.,	  1997;	  Kohno	  et	  al.,	  1996)	  and	  Fus1	   in	  
Schizosaccharomyces	  pombe	  (Petersen	  et	  al.,	  1998).	  	  Formins	  were	  characterized	  by	  the	  formin	  homology	  2	  (FH2)	  domains,	  which	  have	  strong	  actin	  nucleation	  activity.	  	  Based	   on	   bioinformatics	   analysis,	   there	   are	   15	   formins	   in	   humans	   with	   the	   FH2	  domain,	   and	   in	  Drosophila	   there	   are	   6	   formins	   (Higgs	   and	   Peterson,	   2005).	   	   The	  best-­‐studied	   formins	   are	   the	   Diaphanous	   (Dia)-­‐related	   formins	   (DRFs),	  which	   are	  regulated	  through	  similar	  mechanisms.	  	  In	  Drosophila,	  DRFs	  include	  Dia	  and	  DAAM.	  Here	  we	  use	  Dia	  as	  an	  example	  to	  explain	  the	  domains	  of	  DRFs	  (Figure	  10).	  	  
	   The	   FH2	   domain	   is	   the	   functional	   actin-­‐binding	   domain	   that	   exists	   in	   all	  formins.	   	   In	   vivo	   experiments	   demonstrate	   that	   FH2	   is	   sufficient	   to	   trigger	   actin	  polymerization	   (Evangelista	   et	   al.,	   2002;	   Pruyne	   et	   al.,	   2002).	   	   FH2	   binds	   to	   the	  barbed	   ends	   of	   actin	   filaments	   and	   nucleates	   linear	   F-­‐actin	   (Pruyne	   et	   al.,	   2002;	  Sagot	   et	   al.,	   2002).	   	   FH2	  domains	   in	  different	   formins	  bind	   to	   actin	  with	  different	  affinities,	   which	   is	   likely	   the	   reason	   why	   different	   formins	   catalyze	   actin	  polymerization	  with	  different	  efficiencies	  (Moseley	  et	  al.,	  2006).	  	  At	  the	  barbed	  end	  of	   F-­‐actin,	   the	   FH2	   domain	   dimerizes	   and	   processively	   moves	   with	   the	   growing	  filament	  (Xu	  et	  al.,	  2004).	   	  The	  FH1	  domain	   is	   located	  adjacent	  to	  the	  FH2	  domain	  and	  is	  present	  in	  almost	  all	  formins.	   	  FH1	  can	  bind	  to	  Profilin,	  which	  recruits	  ATP-­‐bound	  actin	  monomers	   (Witke,	  2004).	   	  Therefore,	   the	  FH1	  domain	   increases	   local	  actin	  monomer	   concentration	  by	   interacting	  with	  Profilin.	   	   Increased	   local	  G-­‐actin	  levels	  drive	  the	  equilibrium	  to	  actin	  polymerization,	  and	  therefore	  increase	  the	  rate	  of	  actin	  filament	  elongation.	  	  The	  Dia	  auto-­‐regulatory	  domain	  (DAD)	  is	  located	  at	  the	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C-­‐terminal	  ends.	  DAD	  can	  bind	  to	  the	  Dia	  inhibitory	  domain	  (DID),	  located	  at	  the	  N-­‐terminal	   of	   the	   FH1	   domain.	   	   The	   binding	   between	   DAD	   and	   DID	   results	   in	   a	  conformation	  change	  that	  masks	  the	  activity	  of	  the	  FH1	  and	  FH2	  domains.	  	  At	  the	  N-­‐terminal	  end	  of	  DRFs	  is	  the	  GTPase-­‐binding	  domain	  (GBD).	   	  When	  GTP-­‐bound	  Rho	  interacts	   with	   the	   GBD,	   it	   triggers	   the	   disassociation	   of	   DAD	   from	   DID,	   and	   thus	  activates	   the	  DRF	   from	  an	  auto-­‐inhibitory	   state.	   	   In	   addition	   to	   the	   functional	   and	  regulatory	  domains,	  there	  are	  also	  a	  dimerization	  domain	  (DD)	  and	  a	  coiled	  coil	  (CC)	  domain,	  which	  mediate	   the	   activation	  of	  DRFs.	   	  The	   regulatory	  domains	   including	  DAD,	  DID,	  GBD,	  DD	  and	  CC	  are	  not	  always	  present	  in	  formins,	  suggesting	  alternative	  ways	  of	  regulation	  (reviewed	  in	  (Higgs,	  2005)).	   
	   The	   functions	   of	   formins	   have	   been	   documented	   in	   various	   species.	   	   In	  humans,	   DRF	   loss	   of	   function	   is	   associated	   with	   a	   variety	   of	   diseases,	   such	   as	  premature	  ovarian	   failure	   (Bione	   et	   al.,	   1998)	   and	   tumor	  metastasis	   (Hager	   et	   al.,	  2012).	  	  Over-­‐expression	  of	  DIAPH2	  is	  characterized	  as	  the	  cause	  for	  non-­‐syndromic	  auditory	   neuropathy	   (AUNA1)	   (Schoen	   et	   al.,	   2010).	   	   Mouse	   models	   show	   that	  progressive	  hearing	  loss	  might	  be	  due	  to	  a	  reduction	  of	  synapses	  and	  abnormal	  cell	  fusion	  of	  inner	  hair	  cells	  caused	  by	  mDia3	  over-­‐expression	  (Schoen	  et	  al.,	  2013).	  	  In	  
Drosophila,	  the	  most	  well	  studied	  formin,	  Dia,	  was	  identified	  in	  a	  P-­‐element	  screen	  for	  male-­‐sterile	  mutations:	  males	  homozygous	  for	  dia	  null	  alleles	  are	  sterile	  due	  to	  defects	  in	  cytokinesis	  during	  spermatogenesis	  (Castrillon	  et	  al.,	  1993).	  	  Formin	  loss	  or	  gain	  of	  function	  leads	  to	  misregulated	  actin	  polymerization	  and	  disrupts	  F-­‐actin	  organization.	   	   Impaired	   actin	   structure	   in	   cells	   leads	   to	   defects	   in	   cell	   division,	  adhesion,	   migration	   and	   intracellular	   trafficking	   	   (reviewed	   in	   (Goode	   and	   Eck,	  2007)).	   	   Interestingly,	   formins	   can	   also	   regulate	   cell	   behavior	   by	   controlling	  microtubule	  dynamics	  and	  arrangement	  (Bartolini	  and	  Gundersen,	  2010;	  Chesarone	  et	  al.,	  2010).	  	  mDia	  was	  reported	  to	  regulate	  the	  stability	  and	  orientation	  of	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microtubules	   in	  NIH	  3T3	   cells	   (Palazzo	   et	   al.,	   2001),	   potentially	   by	  binding	   to	   the	  microtubule	   plus	   end	   protein	   EB1	   and	   the	   Adenomatous	   Polyposis	   Coli	   protein	  (APC)	  to	  form	  a	  complex	  that	  stabilizes	  microtubules	  (Wen	  et	  al.,	  2004).	  	  FHOD1	  and	  Cappuccino	   	   (Capu)	  were	   reported	   to	   crosslink	  microtubules	  with	  F-­‐actin	   in	  HeLa	  cells	  (Gasteier	  et	  al.,	  2005)	  and	  Drosophila	  oocytes	  (Rosales-­‐Nieves	  et	  al.,	  2006).	  	  
Actin	  depolymerization	  factors	  
The	   actin	   cytoskeleton	   in	   cells	   is	   a	   dynamic	   system	   that	   undergoes	   constant	  polymerization	   and	   depolymerization.	   	   In	   vitro	   experiments	   show	   that	   at	   steady	  state,	   G-­‐actin	   is	   spontaneously	   added	   to	   the	   plus	   end.	   	   However,	   as	   the	   G-­‐actin	  concentration	  needed	  for	  spontaneous	  polymerization	  at	  the	  minus	  end	  (~0.6μM)	  is	  six-­‐fold	  higher	  than	  at	  the	  plus	  end	  (~0.1μM),	  F-­‐actin	  depolymerizes	  from	  the	  minus	  end	   (Ono,	   2007).	   	   This	   process	   is	   called	   treadmilling	   (Cleveland,	   1982).	   	   The	  spontaneous	  depolymerization	  rate	  is	  low.	  	  However,	  under	  in	  vivo	  conditions,	  actin	  depolymerization	   factors	   can	   enhance	   actin	   turnover	   by	   accelerating	   G-­‐actin	  dissociation	  from	  the	  minus	  ends,	  or	  severing	  F-­‐actin	  to	  make	  more	  minus	  ends.	  	  
	   The	  Gelsolin	  family	  of	  proteins	  is	  widely	  present	  in	  various	  species.	  	  Gelsolin	  family	  proteins	  such	  as	  Gelsolin	  and	  Villin	  contain	  repeats	  of	  the	  Gelsolin	  homology	  domains.	   	   Gelsolin	   family	   proteins	   sever	   and	   cap	   actin	   filaments	   in	   a	   calcium-­‐dependent	   manner.	   	   Here	   we	   use	   the	   most	   well-­‐studied	   Gelsolin	   to	   explain	   the	  functions	  of	  the	  gelsolin-­‐like	  domain,	  and	  how	  it	  regulates	  the	  severing	  and	  capping	  of	  an	  actin	  filament	  (reviewed	  in	  (McGough	  et	  al.,	  2003)).	  	  
	   Gelsolin	  contains	  six	  gelsolin-­‐like	  domains	  (G1-­‐G6).	  	  G1	  can	  bind	  with	  actin	  in	  a	   calcium	   independent	  manner.	   	  The	  binding	   site	   for	  G1	  on	  actin	   is	   located	  at	   the	  cleft	  between	  actin	  subdomains	   (McLaughlin	  et	  al.,	  1993),	  which	   is	  exposed	  at	   the	  surface	   of	   the	   F-­‐actin	   plus	   (barbed)	   end,	   and	   overlaps	   with	   Profilin	   and	   the	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ADF/cofilin	   binding	   site.	   	   Similar	   to	   Dia,	   the	   activity	   of	   Gelsolin	   is	   also	   controlled	  through	   auto-­‐regulation.	   	   The	   N-­‐terminal	   and	   C-­‐terminal	   can	   bind	   together	   and	  mask	   the	   actin-­‐binding	   domains.	   	   Upon	   calcium	   binding,	   Gesolin	   undergoes	   a	  conformational	   change	   that	  exposes	  actin-­‐binding	  domains	   (Burtnick	  et	  al.,	  1997).	  	  After	  binding	  with	   the	  plus	  end,	  Gesolin	   severs	  actin	   filaments	  by	   triggering	  an	  F-­‐actin	   conformational	   change	   and	   weakening	   longitudinal	   actin-­‐actin	   interaction	  (Selden	   et	   al.,	   1998).	   	   In	   addition	   to	   calcium,	  Gesolin	   activity	   is	   also	   controlled	  by	  various	   factors	   such	   as	   pH,	   phospholipids,	   and	   ATP	   levels	   (Gremm	   and	   Wegner,	  1999;	  Janmey	  and	  Stossel,	  1987;	  Lamb	  et	  al.,	  1993).	  
	   Another	   family	   of	   proteins	   that	   depolymerizes	   actin	   filaments	   is	   the	  ADF/cofilin	  family.	  	  ADF/cofilin	  has	  a	  structure	  similar	  to	  the	  G1	  domain	  in	  Gelsolin,	  while	   sharing	  no	   sequence	   similarity	   (reviewed	   in	   (Ono,	   2007)).	   	  Due	   to	  different	  severing	   mechanisms,	   ADF/cofilin	   severs	   actin	   filaments	   less	   efficiently	   than	  Gelsolin	   (Ono	   et	   al.,	   2004).	   	   ADF/cofilin	   binds	   to	   F-­‐actin	   and	   induces	   a	  conformational	   change	   in	   lateral	   contacts	   between	   G-­‐actin	   and	   F-­‐actin.	   	   The	  structural	  change	  results	  in	  an	  unstable	  conformation	  that	  triggers	  fragmentation	  of	  the	   F-­‐actin	   (McGough	   and	   Chiu,	   1999).	   	   In	   addition	   to	   actin	   severing	   activity,	  ADF/cofilin	  also	  enhances	  disassembly	  of	  actin	  monomer	  from	  the	  minus	  (pointed)	  ends	   (Carlier	   et	   al.,	   1997).	   	   Similar	   to	   Gelsolin,	   the	   activity	   of	   ADF/cofilin	   is	   also	  regulated	   by	   cellular	   pH	   (Hawkins	   et	   al.,	   1993;	   Maciver	   et	   al.,	   1998)	   and	   the	  presence	   of	   phospholipids	   (Ojala	   et	   al.,	   2001).	   	   Phosphorylation	   and	  dephosphorylation	   provide	   another	   level	   of	   ADF/cofilin	   regulation	   (Meberg	   et	   al.,	  1998).	  	  
V.	  Summary	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Actin	   is	   one	   of	   the	   most	   conserved	   and	   abundant	   proteins	   present	   in	   muscles.	  Mutations	  in	  actin	  and	  actin-­‐related	  proteins	  are	  linked	  to	  muscle	  disease	  (Sparrow	  et	  al.,	  2003).	  	  The	  molecular	  mechanisms	  and	  regulatory	  proteins	  that	  control	  actin	  dynamics	  are	  highly	  conserved	  in	  Drosophila	  muscle	  and	  human	  muscle.	  	  Therefore,	  we	  use	  the	   less	  complicated	  Drosophila	  muscle	  as	  a	  model	  system	  to	  study	  muscle	  formation.	  	  Investigating	  how	  actin	  structure	  is	  organized	  not	  only	  gives	  us	  insights	  to	   muscle	   development,	   but	   also	   promotes	   an	   understanding	   of	   how	   similar	  processes	  are	  regulated	  in	  humans.	   	  For	  example,	  studying	  the	  fusion	  of	  myoblasts	  in	  Drosophila	  reveals	  regulatory	  mechanisms	  of	  membrane	  fusion	  that	  can	  be	  found	  in	   a	   variety	   of	   pathological	   and	   developmental	   events,	   such	   as	   cancer	   cell	   fusion,	  fertilization,	   the	   formation	   of	   multinucleated	   syntrophoblasts	   and	   osteoclasts	  ((Horsley	  and	  Pavlath,	  2004;	  Martens	  and	  McMahon,	  2008)).	   	   Studying	   sarcomere	  assembly	  in	  Drosophila	  flight	  muscles	  reveals	  how	  cells	  contract	  and	  change	  shape	  in	   cardiac	   and	   smooth	   muscles,	   and	   in	   epithelial	   cells	   during	   apical	   constriction	  ((Clark	  et	  al.,	  2002;	  Martin	  et	  al.,	  2009)).	  	  
	   In	   different	  model	   systems,	   it	   has	   been	   demonstrated	   that	   actin	   structures	  are	  regulated	  by	  proteins	  that	  polymerize,	  depolymerize,	  and	  crosslink	  actin.	  	  In	  my	  thesis	   I	   report	   that	   the	   same	   actin	   polymerization	   factor,	   Diaphanous,	   in	  combination	  with	  different	  actin	  regulators,	  forms	  different	  actin	  structures	  during	  different	   developmental	   stages.	   	   I	   also	   propose	   another	   possible	   mechanism	   to	  regulate	  actin	  homeostasis:	  the	  maintenance	  of	  an	  actin	  monomer	  pool.	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CHAPTER	  TWO	  
PI(4,5)P2	  REGULATES	  MYOBLAST	  FUSION	  THROUGH	  ARP2/3	  LOCALIZATION	  
AT	  THE	  FUSION	  SITE*	  
I.	  Introduction	  
To	  convey	  extracellular	  signaling	   to	   the	  actin	  cytoskeleton,	  many	  molecules	  on	  the	  membrane	  function	  as	  messengers.	  	  One	  such	  example	  is	  the	  membrane	  lipid	  Phosphatidylinositol-­‐(4,5)-­‐bisphophate	   [PI(4,5)P2]	   and	   its	   metabolic	   derivatives	  (reviewed	  in	  (Zhang	  et	  al.,	  2012)).	  	  PI(4,5)P2	  is	  a	  minor	  component	  of	  membranes	  in	  eukaryotic	   cells.	   	   In	   human	   erythrocytes,	   PI(4,5)P2	   constitutes	   about	   1%	   of	   the	  membrane	   lipids	   (Ferrell	   and	   Huestis,	   1984).	   	   In	   cells,	   PI(4,5)P2	   is	   synthesized	  either	  through	  phosphorylation	  of	  PI(4)P	  or	  PI(5)P	  by	  the	  respective	  PIP	  kinases,	  or	  through	  dephosphorylation	  of	  PI(3,4,5)P3	  by	  	  a	  range	  of	  phosphatases.	  	  The	  level	  of	  PI(4,5)P2	   is	   therefore	   controlled	   through	   metabolic	   synthesis	   and	   dissipation	  (reviewed	   in	   (Balakrishnan	   et	   al.,	   2015)).	   	   One	   enzyme	   that	   decreases	   PI(4,5)P2	  levels	   is	   the	   phosphoinositide-­‐specific	   phospholipase	   C	   (PLC),	   which	   hydrolyzes	  PI(4,5)P2	   to	   generate	   the	   second	   messengers	   diacyl	   glycerol	   (DAG)	   and	   inositol-­‐(1,4,5)-­‐trisphosphate	  (IP3).	  	  The	  physical	  interaction	  between	  PLC	  and	  PI(4,5)P2	  is	  mediated	  through	  the	  pleckstrin	  homology	  (PH)	  domain	  on	  PLC.	  	  The	  PH	  domain	  is	  a	   common	   feature	   in	   a	   variety	   of	   proteins	   that	   interact	  with	   phosphatidylinositol	  lipids	  and	  the	  actin	  cytoskeleton.	   	  Due	   to	   its	  high	  binding	  affinity	   to	  PI(4,5)P2,	   the	  GFP-­‐tagged	  PH	  domain	  of	  PLC	  has	  been	  used	  to	  monitor	  the	  dynamics	  of	  PI(4,5)P2	  
*Bothe	  I,	  Deng	  S,	  Baylies	  M.	  PI(4,5)P2	  regulates	  myoblast	  fusion	  through	  Arp2/3	  regulator	  localization	  at	  the	  fusion	  site.	  Development	  2014	  141:	  2289-­‐2301;	  doi:	  10.1242/dev.100743	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in	  various	  cellular	  events,	   such	  as	  phagocytosis	   (Botelho	  et	  al.,	  2000),	   	   cytokinesis	  (Wong	  et	   al.,	   2005),	   endocytosis	   (Honda	  et	   al.,	   1999),	   reviewed	   in	   (Czech,	  2000)),	  and	  myoblast	   fusion	   (Bach	   et	   al.,	   2010;	   Nowak	   et	   al.,	   2009).	   	   In	   these	   processes,	  PI(4,5)P2	   is	   often	   observed	   to	   concentrate	   at	   actin-­‐rich	   structures	   on	   the	   plasma	  membrane	   (Tall	   et	   al.,	   2000).	   	   PI(4,5)P2	   influences	   actin	   remodeling	   possibly	  through	  two	  mechanisms:	  1)	  PI(4,5)P2	  interacts	  with	  actin	  capping	  proteins	  such	  as	  CapZ,	   and	   inhibits	   actin	   capping	   activity,	   thereby	   promoting	   actin	   poymerization	  (Heiss	   and	   Cooper,	   1991).	   	   Or	   2)	   PI(4,5)P2	   localizes	   and	   activates	   actin	  polymerization	   factors	   such	   as	   WASp	   (Higgs	   and	   Pollard,	   2000),	   triggering	   the	  polymerization	  and	  branching	  of	  the	  actin	  network.	  	  
In	  vitro	  experiments	  in	  C2C12	  myoblasts	  showed	  that	  PI(4,5)P2	  accumulates	  at	   the	   adhesion	   site	   between	   myoblast/myotube	   and	   myotube.	   	   Depletion	   of	  PI(4,5)P2	   in	   C2C12	  myoblasts	   results	   in	   decreased	   cell	   fusion	   (Bach	   et	   al.,	   2010;	  Leikina	   et	   al.,	   2013;	   Nowak	   et	   al.,	   2009).	   	   Due	   to	   the	   lack	   of	   markers	   that	   could	  reliably	   label	   the	   fusion	   site,	  where	   and	   how	  PI(4,5)P2	   is	   involved	   in	  mammalian	  myoblast	   fusion	   has	   not	   been	   sufficiently	   investigated.	   	   In	   the	  Drosophila	  embryo,	  we	  used	  PHplc::GFP	   to	  record	   the	  spatial	  and	   temporal	  dynamics	  of	  PI(4,5)P2.	   	  We	  dissected	  the	  role	  of	  PI(4,5)P2	  in	  Drosophila	  myoblast	  fusion	  and	  investigated	  how	  PI(4,5)P2	  regulates	  F-­‐actin	  structures	  at	  the	  site	  of	  fusion.	  	  
Results:	  	  
PI(4,5)P2	  is	  enriched	  at	  the	  site	  of	  fusion	  
To	   investigate	   the	   role	   of	   PI(4,5)P2	   in	  Drosophila	  myogenesis,	  we	   first	   used	   time-­‐lapse	   imaging	   to	   record	   the	   temporal	   and	   spatial	   dynamics	   of	   PI(4,5)P2	   during	  myoblast	   fusion.	   	   Two	   constructs,	   PHplcδ::GFP	   (Verstreken	   et	   al.,	   2009)	   and	  PHplcγ::GFP	  (Pinal	  et	  al.,	  2006),	  were	  used	  to	  label	  PI(4,5)P2	  and	  both	  showed	  similar	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Figure	  2.1	  PI(4,5)P2	  is	  enriched	  at	  the	  site	  of	  fusion.	  A.	  Time-­‐lapse	  imaging	  of	  a	  stage	  14	  Drosophila	  embryo.	  	  Boxed	  areas	  are	  magnified	  to	  show	  the	  attachment	  site	  between	   a	   VA1	   muscle	   (turquoise)	   and	   a	   FCM	   (magenta).	   	   The	   localization	   of	  PI(4,5)P2	   is	   detected	   using	  UAS-­PHplcγ::GFP	   (arrow).	   	   The	   PI(4,5)P2	   signals	   at	   the	  fusion	   site	   are	   quantified	   by	   measuring	   fluorescence	   intensity	   (line	   scan	   at	   the	  yellow	  bar,	  a.u.,	  arbitrary	  units).	  	  A	  single	  peak	  of	  fluorescence	  signal	  is	  found	  before	  fusion,	  and	  then	  it	  resolves	  as	  fusion	  proceeds.	  	  B.	  Time-­‐lapse	  imaging	  of	  myoblasts	  expressing	   UAS-­PHplcγ::GFP	   and	   UAS-­mCherry:moesin.	   	   F-­‐actin	   and	   PI(4,5)P2	  reporters	   overlap	   spatially	   and	   temporally	   (arrow)	   at	   the	   fusion	   site,	   and	   this	   is	  quantified	   by	   plotting	   fluorescence	   intensity	   	   curves.	   Scale	   bars:	   5	   μm.	   	  C.	   Fusion	  index	  of	  stage	  17	  lateral	  transverse	  (LT)	  muscles.	  	  The	  nuclei	  in	  the	  LT	  muscles	  are	  labeled	   with	   apME-­‐NLS::dsRed.	   	   The	   number	   of	   nuclei	   in	   each	   hemisegment	   is	  counted	  for	  each	  genotype	  (n=15	  embryos).	  	  D.	  Average	  time	  to	  F-­‐actin	  or	  PI(4,5)P2	  enrichment	   in	   different	   genotypes.	   	   Expressing	   F-­‐actin	   or	   PI(4,5)P2	   reporter	  constructs	  had	  no	  detectable	  effect	  on	   fusion.	   (Ingo	  Bothe	  and	  Su	  Deng	  performed	  the	  experiments.	  Ingo	  Bothe	  analyzed	  the	  data)	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Figure	  2.1	  PI(4,5)P2	  is	  enriched	  at	  the	  site	  of	  fusion.	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  distribution	   and	   dynamics.	   	   Taking	   advantage	   of	   the	  well-­‐characterized	   UAS-­‐Gal4	  system,	  we	  expressed	  the	  PI(4,5)P2	  reporter	  specifically	  in	  the	  developing	  muscles.	  	  The	   signal	   of	   the	   PI(4,5)P2	   reporters	   are	   present	   throughout	   the	   plasma	  membranes,	   with	   an	   accumulation	   at	   the	   attachment	   sites	   between	   the	   fusion	  competent	   myoblasts	   (FCMs)	   and	   founder	   cell	   (FC)/myotubes,	   suggesting	   a	  potential	  role	  of	  PI(4,5)P2	  during	  fusion	  (Figure	  2.1A).	  	  
Prior	   to	   fusion,	   F-­‐actin	   accumulates	   at	   the	   fusion	   site	   to	   form	   a	   focus	  structure.	   We	   therefore	   used	   mCherry::Moeact	   to	   label	   the	   fusion	   site.	  	  mCherry::Moeact	   is	   a	   fusion	   protein	   that	   contains	   the	   actin	   binding	   domain	   of	  
Drosophila	  moesin	  (C-­‐terminal	  137	  residues)	  and	  the	  fluorophore	  mCherry	  (Millard	  and	   Martin,	   2008).	   	   Expression	   of	   mCherry::Moeact	   did	   not	   alter	   myoblast	   fusion	  dynamics	  nor	  the	  fusion	  index.	  When	  the	  reporters	  of	  PI(4,5)P2	  and	  F-­‐actin	  are	  co-­‐expressed	   in	   the	   muscles,	   time-­‐lapse	   imaging	   revealed	   that	   the	   accumulation	   of	  PI(4,5)P2	  spatially	  and	  temporally	  coincides	  with	  the	  F-­‐actin	  focus	  at	  the	  fusion	  site	  (Figure	  2.1B).	  	  
PI(4,5)P2	  accumulates	  at	  the	  fusion	  site	  after	  cell	  recognition	  and	  adhesion	  
We	  next	  attempted	   to	  place	  PI(4,5)P2	   in	   the	  known	   fusion	  pathway	  by	  examining	  PI(4,5)P2	  localization	  in	  the	  known	  fusion	  mutants.	   	  The	  transmembrane	  molecule	  Sns	   is	   a	   component	   of	   the	   machinery	   that	   regulates	   FC-­‐FCM	   recognition	   and	  adhesion.	   	   In	   sns	  mutants,	   myoblast	   fusion	   is	   blocked	   due	   to	   impaired	   cell-­‐cell	  recognition	  and	  adhesion.	   	  We	  did	  not	   find	  PI(4,5)P2	  accumulation	   in	  sns	  mutants,	  placing	  PI(4,5)P2	  downstream	  of	   cell	   recognition	  and	  adhesion	   (Figure	  2.2B).	   	  We	  also	   checked	   PI(4,5)P2	   localization	   in	   mutations	   that	   reduce	   Arp2/3	   activity	   and	  found	  that	  PI(4,5)P2	  is	  enriched	  at	  the	  fusion	  site,	  as	  identified	  by	  the	  presence	  of	  an	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Figure	   2.2	   PI(4,5)P2	   localization	   at	   the	   fusion	   site	   is	   dependent	   on	   FC/FCM	  
recognition	  and	  adhesion,	  but	  independent	  of	  actin	  regulators.	  A-­K.	  Time-­‐lapse	  imaging	  of	  a	  stage	  14	  Drosophila	  embryo.	  	  The	  PI(4,5)P2	  reporter,	  UAS-­PHplcγ::GFP,	  is	  expressed	  in	  the	  developing	  muscle	  and	  shows	  accumulation	  of	  PI(4,5)P2	  in	  a	  wild-­‐type	  control	  or	  in	  different	  fusion	  mutants.	   	  A.	  PI(4,5)P2	  accumulates	  at	  the	  fusion	  site	  in	  wild-­‐type	  control	  embryos	  (arrow).	   	  B.	  No	  PI(4,5)P2	  enrichment	  is	  detected	  in	   a	   snsXB3	   homozygous	   mutant	   embryo.	   	   C-­K.	   Arrows	   showing	   PI(4,5)P2	  accumulations	   are	  detected	   in	   rolsT687,	   lonerT1032,	  DWipD30,	  DWipsltr,	  Rac1Tj11,	  Rac2Δ,	  
MtlΔ	   triple	  mutant,	  mbcc1,	  ketteJ4-­48,	  blow1,	   and	   SCARΔ37	  mutant	   backgrounds.	   Scale	  bar:	   10	   μm.	   (Ingo	   Bothe	   and	   Su	   Deng	   performed	   the	   experiments.	   Ingo	   Bothe	  analyzed	  the	  data)	  
	  
	   58	  
Figure	   2.2	   PI(4,5)P2	   localization	   at	   the	   fusion	   site	   is	   dependent	   on	   FC/FCM	  
recognition	  and	  adhesion,	  but	  independent	  of	  actin	  regulators	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  actin	   focus.	   	   The	  mutants	  we	  examined	   include	   loner,	  sltr,	  blow,	  WASp,	  Rac1,	  mbc,	  
kette	   and	   scar.	   	   Loner	   encodes	   an	   ARF-­‐GEF	   family	   member	   that	   regulates	   actin	  	  rearrangement	   in	   the	   FCs.	   	   Sltr,	   blow	   and	   WASp	   are	   involved	   with	   the	   WASp-­‐mediated	  Arp2/3	  activation.	   	  Rac,	  mbc,	  kette	  and	  scar	  are	   involved	  with	  the	  SCAR-­‐mediated	   Arp2/3	   activation.	   	   The	   enrichment	   of	   PI(4,5)P2	   in	   these	   genetic	  backgrounds	   suggests	   PI(4,5)P2	   localization	   is	   independent	   of	   Arp2/3	   activity	  (Figure	  2.2).	  	  
PI(4,5)P2	  is	  required	  for	  myoblast	  fusion	  
The	   enrichment	   of	   PI(4,5)P2	   	   at	   the	   fusion	   site	   suggested	   that	   it	   might	   play	   an	  essential	  role	  during	  myoblast	  fusion.	   	  To	  address	  the	  function	  of	  PI(4,5)P2	  during	  fusion,	   we	   examined	   the	   muscle	   phenotype	   in	   embryos	   with	   reduced	   PI(4,5)P2	  levels.	  	  One	  way	  to	  decrease	  PI(4,5)P2	  levels	  is	  through	  manipulating	  the	  	  metabolic	  pathways	   that	   synthesize	   or	   deplete	   PI(4,5)P2.	   	   Mutants	   that	   impair	   PI(4,5)P2	  generation,	  including	  the	  PI5-­‐kinase	  sktl	  and	  PI4-­‐kinase	  fwd,	  were	  analyzed	  for	  their	  muscle	  phenotype.	  	  Myoblast	  fusion	  proceeds	  normally	  when	  Sktl	  or	  Fwd	  levels	  are	  reduced	  in	  muscles.	  
Another	  way	  to	  reduce	  PI(4,5)P2	  is	  to	  sequester	  PI(4,5)P2	  from	  binding	  with	  its	   endogenous	   interaction	  partner.	   	  One	  molecule	   that	   can	   sequester	  PI(4,5)P2	   is	  the	   PHplcγ::GFP	   reporter	   protein.	   	   When	   we	   examined	   the	   localization	   of	   the	  PI(4,5)P2	  reporter,	  	  PHplcγ::GFP	  is	  	  expressed	  at	  low	  levels	  (one	  genetic	  copy).	  	  In	  this	  context,	   fusion	  was	  unaffected,	  quantified	  by	  counting	   the	  number	  of	  nuclei	   in	   the	  lateral	  transverse	  (LT)	  muscles	  in	  each	  hemisegment	  (29±4	  nuclei/hemisegment	  vs	  30±2	   nuclei/hemisegment	   in	   control,	   n=14,	   p>0.1)	   (Figure	   2.1C-­‐D).	   	   When	   the	  PHplcγ::GFP	  reporter	  level	  is	  increased	  through	  manipulating	  temperature	  and	  copy	  number	   of	   the	   transgenes,	   fusion	   defects	   were	   observed	   in	   a	   dosage	   dependent	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manner	  (Figure	  2.3A).	   	  Expressing	  two	  copies	  of	  PHplcγ::GFP	  in	  the	  muscles	  at	  both	  25°C	   and	   29°C	   resulted	   in	   decreased	   myoblast	   fusion.	   	   The	   block	   of	   fusion	   was	  quantified	  via	  the	  fusion	  index	  (Figure	  2.3B).	   	  The	  differentiation	  of	  myoblasts	  was	  unaffected	   by	   PHplc::GFP	   overexpression,	   as	   confirmed	   by	   the	   expression	   of	   the	  muscle	   specific	   gene	   myosin	   heavy	   chain	   (MHC)	   and	   the	   muscle	   identify	   gene	  
apterous.	  
PI(4,5)P2	  is	  required	  for	  the	  formation	  of	  actin	  focus	  
PI(4,5)P2	   has	   been	   shown	   to	   regulate	   actin	   remodeling	   in	   various	   cellular	   events	  (Botelho	   et	   al.,	   2000;	   Czech,	   2000;	   Honda	   et	   al.,	   1999;	   Wong	   et	   al.,	   2005).	   	   To	  investigate	   whether	   PI(4,5)P2	   mediates	   myoblast	   fusion	   through	   organizing	   the	  actin	   cytoskeleton	   during	   fusion,	   we	   examined	   actin	   structures	   in	   PI(4,5)P2	  sequestering	  background.	  	  Under	  sequestering	  conditions,	  in	  embryos	  fixed	  with	  4%	  PFA,	  accumulation	  of	  PI(4,5)P2	  and	  F-­‐actin	  were	  observed	  in	  the	  majority	  of	  FCMs	  (Figure	  2.4A).	  	  Over	  75%	  of	  these	  PI(4,5)P2	  accumulation	  sites	  were	  also	  sites	  of	  F-­‐actin	  accumulations,	  reminiscent	  of	  the	  F-­‐actin	  focus	  (Figure	  2.4B).	  	  These	  actin	  foci	  were	   smaller	   in	   size	   than	   in	   wildtype	   embryos	   (1.12±0.34μm2	   vs	   2.01±0.52μm2,	  p<0.001,	  n=25).	  	  In	  addition,	  these	  actin	  foci	  were	  flat	  in	  morphology,	  which	  did	  not	  resemble	   the	   protrusive,	   podosome-­‐like	   structure	   reported	   in	   wildtype	   embryos	  (Sens	   et	   al.,	   2010).	   	  We	   also	  noticed	   that	   in	  PI(4,5)P2	   sequestered	   embryos,	  most	  FCMs	  with	   an	   actin	   focus	  were	  not	   attached	   to	   a	   FC/myotube.	   	   As	   the	   actin	   focus	  forms	   after	   FC-­‐FCM	   recognition	   and	   adhesion,	   our	   data	   suggests,	   that	   most	   FCM	  detach	  from	  the	  FC/myotube	  after	  adhesion	  and	  formation	  of	  the	  actin	  focus.	  	  Loss	  of	  PI(4,5)P2	  accumulation	   in	  the	  sns	  mutant	  background	  suggests	  that	  PI(4,5)P2	  is	  involved	   in	   the	   process	   after	   cell	   recognition	   and	   adhesion.	   	   This	   hypothesis	  was	  confirmed	   by	   examination	   of	   the	   adhesion	   receptors	   Duf	   and	   Sns	   in	   PI(4,5)P2	  sequestering	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Figure	  2.3	  PI(4,5)P2	   is	   required	   for	  myoblast	   fusion.	  A.	  Overexpressing	  of	   the	  PI(4,5)P2	  reporter	  PHplcγ::GFP	  blocks	  myoblast	  fusion	  in	  a	  dose-­‐dependent	  manner.	  	  Increasing	  UAS-­PHplcγ::GFP	   concentration	   in	  myoblasts	   by	   raising	   the	   temperature	  and	   increasing	   the	   genetic	   copy	   number	   leads	   to	   an	   increased	   fusion	   block.	  	  Myoblasts	  were	  labeled	  for	  PHplcγ::GFP	  and	  Myosin	  heavy	  chain	  (MHC).	  Scale	  bar:	  10	  μm.	  	  B.	  Fusion	  index	  based	  on	  nuclei	  number	  in	  LT	  muscles.	  	  Single-­‐copy	  expression	  of	  UAS-­PHplcγ::GFP	   appears	  as	  wildtype	  at	  18°C	  and	  25°C.	   	  At	  29°C,	  expression	  of	  a	  single	  copy	  of	  UAS-­PHplcγ::GFP	  leads	  to	  a	  mild	  fusion	  defect.	  Expression	  of	  two	  copies	  of	  UAS-­PHplcγ::GFP	  produces	  a	  complete	  fusion	  block	  at	  25°C	  and	  29°C.	  (Ingo	  Bothe	  and	  Su	  Deng	  performed	  the	  experiments.	  Ingo	  Bothe	  analyzed	  the	  data)	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  background	  embryos	  (Figure	  2.4C-­‐D).	  	  Sns	  is	  found	  to	  localize	  to	  the	  fusion	  sites	  in	  attached	  FCMs.	   	   In	  detached	  cells,	   Sns	  still	   localized	  close	   to	   the	  actin	   focus,	  but	   it	  does	  not	  form	  a	  ring	  structure	  as	  described	  in	  earlier	  reports	  (Kesper	  et	  al.,	  2007).	  	  Comparable	  to	  wildtype,	  Duf	  was	  also	  found	  to	  localize	  to	  the	  FCM	  attachment-­‐site	  in	   the	   FC/myotubes.	   	   However,	   no	   enrichment	   of	   Duf	   was	   detected	   on	   the	  FC/myotube	   membrane	   without	   FCM	   attachment,	   or	   with	   detached	   FCMs.	  	  Together,	  our	  data	  indicate	  that	  PI(4,5)P2	  is	  not	  involved	  in	  cell	  recognition	  nor	  the	  initiation	   of	   fusion,	   but	   rather	   in	   the	   expansion	   of	   the	   fusogenic	   interface	   at	   the	  fusion	  site.	  	  
PI(4,5)P2	  regulates	  myoblast	  fusion	  through	  localizing	  Mbc	  
We	  next	   investigated	  how	  PI(4,5)P2	  regulates	  actin	  cytoskeleton	  structures	  during	  myoblast	   fusion	   through	   both	   in	   vitro	   and	   in	   vivo	   assays.	   	   PI(4,5)P2	   is	   known	   to	  interact	   with	   actin	   regulators	   through	   binding	   with	   pleckstrin	   homology	   (PH)	  domains	  and	  calcium-­‐binding	  (C2)	  domains	  on	  these	  proteins.	  	  In	  Drosophila,	  the	  PH	  domain	   is	   present	   in	   several	   proteins	   that	   are	   involved	   in	   fusion,	   including	   blow	  (207-­‐305),	   Loner	   (991-­‐1089)	   and	  WASp	   (35-­‐104).	   	   The	   C2	   domain	   is	   present	   in	  Mbc.	  	  Based	  on	  an	  alignment	  algorithm,	  we	  identified	  a	  short	  (444-­‐633),	  and	  a	  long	  version	  of	  the	  Mbc	  C2	  domain.	  	  To	  examine	  if	  PI(4,5)P2	  regulates	  fusion	  by	  directly	  interacting	   with	   actin	   regulators,	   we	   first	   tested	   lipid	   binding	   with	   these	   lipid-­‐binding	   domains	   in	  vitro	   (Figure	   2.5A).	   	   Among	   all	   the	   tested	   domains	   from	   actin	  regulators,	   the	   PH	   domain	   of	   Blow	   interacted	   with	   all	   tested	   phophoinositides	  except	   PI(3,4)P2.	   	   LonerPH	   interacted	   with	   all	   PIPs	   and	   PIP2s	   species,	   but	   only	  weakly	   with	   PIP3.	   	   The	   short	   Mbc	   C2	   domain	   bound	   with	   PIPs,	   PI(4,5)P2	   and	  PI(3,5)P2,	  while	  the	   long	  C2	  domain	  had	  similar	  binding	  pattern,	  but	  more	  weakly	  with	  PI(3)P	  and	  PI(4)P.	  	  The	  WASpPH	  domain	  bound	  PIPs	  and	  PIP2s,	  but	  only	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Figure	   2.4	   Effects	   of	   PI(4,5)P2	   sequestration	   on	   the	   F-­actin	   focus	   and	   FCM-­
FC/myotube	  attachment.	  A.	  Stage	  15	  embryo	  expressing	  2x	  UAS-­PHplcγ::GFP	  in	  the	  developing	  muscles.	  	  The	  embryo	  was	  stained	  with	  phalloidin	  (red)	  and	  an	  antibody	  against	  GFP	  (green).	   	  PI(4,5)P2	  aggregations	  were	   found	   in	   the	  FCMs.	   	  75%	  of	   the	  aggregations	  colocalize	  with	  the	  F-­‐actin	  foci	  (arrow).	  Scale	  bars:	  10	  μm	  	  B.	  Bar	  chart	  showing	   percentages	   of	   FCMs	   with	   an	   F-­‐actin	   focus,	   F-­‐actin	   and	   PI(4,5)P2	  aggregations,	   or	   just	   PI(4,5)P2	   aggregations.	   	   C-­D.	   Recognition	   and	   adhesion	  between	  FCMs	  and	  FC/myotubes	  are	  unaffected	  in	  PI(4,5)P2	  sequestered	  embryos.	  	  Similar	   to	   wildtype,	   embryos	   with	   PI(4,5)P2	   sequestration	   showed	   Duf	   (C)	  accumulation	  at	  the	  fusion	  site	  in	  the	  FC/myotube.	  Sns	  (D)	  was	  also	  present	  at	  the	  fusion	   site	   in	   the	   attached	   FCMs.	   Scale	   bar:	   5	   μm.	   (Ingo	   Bothe	   and	   Su	   Deng	  performed	  the	  experiments.	  Ingo	  Bothe	  analyzed	  the	  data)	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  weakly	  to	  PI(3,4,5)P3.	   	  Our	  data	   indicate	  that	  all	   the	  tested	  proteins	  can	  bind	  with	  PI(4,5)P2	  in	  vitro	  and	  could	  serve	  as	  potential	  downstream	  targets	  of	  PI(4,5)P2.	  
If	  PI(4,5)P2	  regulates	  myoblast	   fusion	  through	  localizing	  actin	  regulators	  to	  the	  fusion	  site,	  sequestering	  of	  PI(4,5)P2	  would	  result	  in	  the	  mislocalization	  of	  these	  actin	  regulators.	   	  We	  therefore	  tested	  this	  hypothesis	   in	  vivo	   (Figure	  2.5B-­‐E).	   	  As	  a	  control,	   we	   examined	   the	   localization	   of	   the	   target	   actin	   regulators	   in	   embryos	  expressing	   one	   genetic	   copy	   of	   PHplcδ::GFP	   (1x	   Dmef2-­>UAS-­PHplcδ::GFP),	   where	  fusion	   is	   unaffected.	   	   In	   the	   control	   embryos,	   Blow	   was	   localized	   on	   the	   plasma	  membrane	   in	   the	  FCM,	  with	   slight	   accumulation	  at	   the	  actin	   focus.	   	   In	   accordance	  with	  previous	  report	  (Jin	  et	  al.,	  2011),	  no	  Blow	  was	  detected	  in	  the	  FC.	  	  In	  PI(4,5)P2	  sequestering	   embryos	   (2x	   Dmef2-­>UAS-­PHplcδ::GFP),	   Blow	   was	   no	   longer	  accumulated	   at	   the	   fusion	   site.	   	   Instead,	   Blow	   localized	   in	   puncta	   on	   the	   plasma	  membrane	  of	  FCMs	   that	  were	  attached	   to	  FC/myotubes.	   	  Compared	  with	  controls,	  the	   localization	   of	   Loner	   was	   not	   significantly	   altered	   in	   embryos	   with	   PI(4,5)P2	  sequestering:	   Loner	   localized	   in	   puncta	   in	   the	   cytoplasma	   of	   both	   FCM	   and	  FC/myotubes.	  	  In	  control	  embryos,	  Mbc	  was	  localized	  at	  the	  base	  of	  the	  actin	  focus.	  	  The	  localization	  pattern	  of	  Mbc	  is	  disrupted	  in	  embryos	  with	  PI(4,5)P2	  sequestering.	  	  Mbc	  was	  no	  longer	  accumulated	  at	  the	  fusion	  site,	  but	  relocated	  to	  the	  cytoplasm.	  	  
Mbc	  is	  a	  guanine	  nucleotide	  exchange	  factor	  (GEF)	  that	  activates	  Rac	  during	  myoblast	   fusion	   (Haralalka	   et	   al.,	   2011).	   	   The	  mislocalization	   of	  Mbc	   in	   PI(4,5)P2	  sequestering	   embryos	   suggested	   that	   the	   localization	   of	   	   activated	   Rac,	   RacGTP,	  might	  also	  be	  altered.	  	  In	  control	  embryos,	  RacGTP	  is	  present	  at	  the	  fusion	  site	  in	  the	  FCMs.	  	  Similar	  to	  Mbc,	  RacGTP	  also	  marks	  the	  base	  of	  the	  actin	  focus.	  	  In	  PI(4,5)P2	  sequestering	   embryos,	   however,	   RacGTP	   is	   absent	   from	   the	   fusion	   site.	   	   Instead,	  RacGTP	  is	  present	  at	  the	  distal	  side	  of	  the	  cell	  with	  respect	  to	  the	  fusion	  interface.	  	  	  
	   65	  
	  
	  
Figure	  2.5	  PI(4,5)P2	  regulates	  RacGTP	  localization	  through	  Mbc.	  A.	  Relative	  phospholipid	   binding	   affinity	   of	   Blow,	   Loner,	   WASp	   PH	   domains	   and	   Mbc	   C2	  domains.	   	   GST	  was	   used	   as	   a	   negative	   control.	   	   PlcδPH	  was	   used	   as	   a	   positive	  control	  for	  PI(4,5)P2	  binding.	   	  B-­E.	  Localization	  of	  Blow	  (B),	  Loner	  (C),	  Mbc	  (D)	  and	   RacGFP	   (E)	   in	   wild-­‐type	   embryos	   and	   PI(4,5)P2	   sequestered	   embryos.	  Fusion	  sites	  are	  double	   labeled	  with	  PHplcγ::GFP	  (green)	  and	  F-­‐actin	  (phalloidin,	  red).	   	   Compared	   with	   the	   control,	   Blow	   is	   less	   concentrated	   in	   FCMs	   in	   the	  PI(4,5)P2	  sequestering	  background	  (B).	  	  Loner	  is	  present	  throughout	  the	  FCMs	  in	  puncta	  in	  both	  wild-­‐type	  and	  in	  a	  PI(4,5)P2	  sequestering	  background	  (C).	  	  Mbc	  is	  present	  at	   the	  FCM	  cortex	  and	  fusion	  site	   in	  wild-­‐type,	  but	   is	  depleted	  from	  the	  cell	   cortex	   and	   fusion	   site	   in	   PI(4,5)P2	   sequestering	   conditions	   (D).	   	   RacGTP	  localizes	   to	   the	   fusion	   site	   in	   wild-­‐type,	   but	   in	   a	   PI(4,5)P2	   sequestering	  background,	   RacGTP	   displays	   a	   reversed,	   distal	   localization	   (E).	   	   F.	   RacGTP	  localization	   in	   mbcc1	   mutant	   embryos.	   Similar	   to	   PI(4,5)P2	   sequestering	  condition,	   RacGTP	   displays	   distal	   localization	   from	   the	   fusion	   site	   in	   a	  mbcc1	  mutant	   background	   (n=25	   cells/genotype).	   Scale	   bar:	   5	   μm.	   (Su	  Deng	   and	   Ingo	  Bothe	  performed	  the	  experiments.	  Su	  Deng	  and	  Ingo	  Bothe	  analyzed	  the	  data)	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Figure	  2.5	  PI(4,5)P2	  regulates	  RacGTP	  localization	  through	  Mbc	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Similar	   RacGTP	   localization	  was	   observed	   in	  mbc	   mutant	   embryos	   (Figure	  2.5F),	   confirming	  RacGTP	  mislocalization	   in	  PI(4,5)P2	  sequestering	  embryo	   is	  due	  to	   the	   irregular	  Mbc	  distribution.	   	   Together,	   our	  data	   suggest	   a	  pathway	   in	  which	  PI(4,5)P2	   signals	   to	   the	   actin	   cytoskeleton	   during	   fusion:	   PI(4,5)P2	   regulates	   the	  localization	  of	  Mbc,	  which	  in	  turn	  determines	  the	  activation	  of	  Rac	  at	  the	  fusion	  site.	  	  
PI(4,5)P2	  controls	  the	  localization	  of	  Arp2/3	  regulators	  during	  fusion	  
In	  PI(4,5)P2	  sequestered	  myoblasts,	  both	  Blow	  and	  Mbc/RacGTP	  are	  mislocalized.	  	  Blow	   regulates	   WASp	   activity	   by	   competing	   with	   WASp	   activator	   Sltr	   for	   WASp	  binding	  (Jin	  et	  al.,	  2011).	  	  Rac	  regulates	  SCAR	  activity	  by	  releasing	  SCAR’s	  functional	  domain	   from	   its	   inhibited	   state	   (Chen	   et	   al.,	   2010).	   	   The	   mislocalized	   Blow	   and	  RacGTP	   suggests	   that	   the	   activity	   of	   WASp	   and	   SCAR	   is	   misregulated.	   	   The	  downstream	   target	   of	   both	  WASp	   and	   SCAR	   is	  Arp2/3,	  which	   nucleates	   branched	  actin	   structures.	   	   We	   therefore	   asked	   whether	   PI(4,5)P2	   sequestering	   leads	   to	  mislocalization	  of	  WASp	  and	  SCAR,	  and	  furthermore,	  if	  the	  reduced	  actin	  focus	  size	  was	  caused	  by	  reduced	  Arp2/3	  activity.	   	  In	  control	  embryos,	  SCAR	  accumulates	  on	  the	   membrane	   at	   the	   fusion	   site,	   while	   in	   PHplcγ::GFP-­‐overexpressing	   	   embryos,	  SCAR	  displays	  a	  diffuse	  localization	  (Figure	  2.5A).	  	  Similarly,	  WASp	  concentrated	  at	  the	  fusion	  site	  in	  control	  embryos,	  while	  being	  distributed	  unevenly	  throughout	  the	  FCM	  in	  PHplcγ::GFP-­‐overexpressing	  	  embryos	  (Figure	  2.5B).	  	  Our	  data	  confirmed	  our	  hypothesis	   that	  overexpressing	  of	  PHplcγ::GFP	  embryos	   leads	  to	  the	  mislocalization	  of	  Arp2/3	  regulators.	  
We	  next	  tested	  if	  the	  reduced	  actin	  focus	  size	  in	  PHplcγ::GFP-­‐overexpressing	  embryos	  was	   due	   to	   diminished	   WASp	   and	   SCAR	   activity,	   and	   therefore	   reduced	   Arp2/3	  activity.	   	  The	  activity	  of	  WASP	  and	  SCAR	  can	  be	  abolished	  by	  reducing	  the	   level	  of	  the	  WASP-­‐activator	  Sltr	  (DWip)	  and	  the	  SCAR-­‐regulator	  Kette.	  	  In	  DwipD30;	  ketteJ4-­48	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Figure	   2.6	   PI(4,5)P2	   regulates	   the	   localization	   of	   Arp2/3	   fusion	  
machinery.	   A-­B.	   Stage	   15	   embryos	   stained	   with	   phalloidin	   (F-­‐actin)	   and	  antibodies	   against	   SCAR	   or	   WASp.	   In	   the	   wild-­‐type	   control,	   SCAR	   (A)	   and	  WASp	  (B)	  accumulate	  at	  the	  fusion	  site.	   	   In	  PI(4,5)P2-­‐sequestering	  embryos,	  both	   SCAR	   and	  WASp	   are	  mislocalized	   and	  display	   cytoplasmic	   localization.	  	  
C-­D.	  Analysis	  of	   actin	   structures	   in	  Dwip	   and	  kette	   double	  mutant	   embryos.	  	  Embryos	   were	   stained	   with	   phalloidin	   (F-­‐actin)	   and	   antibodies	   against	  myosin	  heavy	  chain	  (MHC).	   	  Two	  different	  null	  alleles	  of	  DWip	  (DWipD30	  and	  
DWipsltr)	  and	  one	  kette	  allele	  (ketteJ4-­48)	  were	  used	  to	  abolish	  SCAR	  and	  WASp	  activity.	   	   No	   actin	   focus	   was	   observed	   at	   the	   fusion	   site	   in	   both	   genetic	  backgrounds	   (n=25	   cells/genotypes).	   Scale	   bar:	   5	   μm.	   (Ingo	   Bothe	   and	   Su	  Deng	  performed	  the	  experiments.	  Ingo	  Bothe	  analyzed	  the	  data)	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or	   sltrS1946;	   ketteJ4-­48	   double	   mutants,	   the	   activity	   of	   both	   WASp	   and	   SCAR	   is	  abolished,	   leading	   to	   Arp2/3	   inactivation.	   Therefore,	   in	   the	   double	   mutant	  background,	  there	  was	  no	  actin	  focus	  detected	  at	  the	  fusion	  site	  (Figure	  2.5C-­‐D).	  Our	  data	   suggest	   that	   the	   reduced	  actin	   focus	   size	   in	  PI(4,5)P2-­‐sequestered	  embryo	   is	  indeed	  due	  to	  misregulated	  Arp2/3	  activity.	  
In	   conclusion,	   our	   research	   demonstrates	   the	   role	   of	   PI(4,5)P2	   during	  myoblast	  fusion.	  	  PI(4,5)P2	  accumulates	  at	  the	  fusion	  site	  after	  the	  recognition	  and	  adhesion	  between	  FC	  and	  FCM.	  	  The	  accumulation	  of	  PI(4,5)P2	  provides	  localization	  cues	   for	   SCAR,	  WASp	   and	   their	   regulators,	   which	   in	   turn	   controls	   the	   activity	   of	  Arp2/3	  at	  the	  fusion	  site.	  	  Loweing	  PI(4,5)P2	  availability	  reduces	  Arp2/3	  activity	  at	  the	  fusion	  site,	  resulting	  in	  reduced	  actin	  focus	  size	  and	  a	  block	  in	  myoblast	  fusion.	  	  
Discussion:	  	  
In	  this	  study,	  we	  found	  that	  PI(4,5)P2	  is	  enriched	  at	  the	  interface	  between	  the	  FCM	  and	   FC/myotube	   during	   myoblast	   fusion.	   	   The	   accumulation	   of	   PI(4,5)P2	  overlapped	   with	   the	   actin	   foci	   at	   the	   fusion	   site	   both	   spatial	   and	   temporally,	  suggesting	   a	   role	   of	   PI(4,5)P2	   during	   cell-­‐cell	  membrane	   fusion.	   In	   this	   study	  we	  focused	  on	  the	  function	  of	  PI(4,5)P2	  and	  its	  interaction	  with	  actin	  at	  the	  fusion	  site.	  	  We	  found	  that	  PI(4,5)P2	  functions	  downstream	  of	  cell	  recognition	  and	  regulates	  the	  	  localization	   of	   the	   Arp2/3	  machinery	   at	   the	   fusion	   site.	   	   Our	   findings	   expand	   our	  understanding	   of	   myoblast	   fusion	   and	   places	   PI(4,5)P2	   as	   part	   of	   the	   fusion	  machinery	  that	  regulate	  Arp2/3-­‐mediated	  actin	  dynamics.	  	  
	   During	  myoblast	  fusion,	  F-­‐actin	  accumulates	  at	  the	  fusion	  site	  and	  forms	  the	  actin	   focus	   (Richardson	   et	   al.,	   2007);	   this	   actin	   focus	   serves	   as	   the	   core	   of	   the	  invasive,	  podosome-­‐like	  structure	  (Sens	  et	  al.,	  2010)	  on	  the	  FCM	  side	  of	  fusion.	  	  The	  formation	   of	   the	   actin	   focus	   depends	   on	   the	   function	   of	   Arp2/3,	   which	   can	   be	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activated	  by	  both	  SCAR	  and	  WASp.	  	  Abolishing	  SCAR	  and	  WASp	  activities	  result	  in	  a	  lack	  of	  actin	   focus	   formation	  ((Mukherjee	  et	  al.,	  2011),	   this	  study).	   	  The	  activity	  of	  SCAR	   is	   regulated	   through	   the	   Mbc-­‐Rac-­‐Kette	   pathway,	   while	   WASp	   activity	   is	  regulated	   through	   the	   Blow-­‐Dwip	   pathway.	   	   Our	   phospholipid	   binding	   assay	  suggests	   that	   Mbc,	   Blow	   and	   WASp	   have	   the	   potential	   to	   bind	   to	   PI(4,5)P2,	  suggesting	   further	   possible	   pathways	   of	   signaling	   transduction	   from	   the	   cell	  membrane	   to	   the	   actin	   cytoskeleton.	   	   Examination	  of	  Mbc,	  Blow,	  WASp	  and	   SCAR	  localization	  in	  PI(4,5)P2	  sequestering	  condition	  supports	  the	  phospholipid	  binding	  assay	   and	   suggests	   that	   PI(4,5)P2	   signaling	   is	   involved	   in	  myoblast	   fusion	   via	   the	  localization	   of	   Arp2/3	   regulators.	   	   Notably,	   when	   Arp2/3	   activity	   is	   completely	  abolished,	  no	  actin	   focus	   forms.	   	   In	  contrast,	  when	  PI(4,5)P2	   is	   sequestered,	   small	  actin	   foci	   are	   observed	   in	   myoblast.	   	   We	   reason	   this	   may	   be	   due	   to	   incomplete	  masking	  of	  PI(4,5)P2,	  which	  allows	  for	  baseline	  activity	  of	  Arp2/3	  at	  the	  fusion	  site.	  Our	  data	  show	  that	  SCAR	  and	  WASp	  are	  diffused,	  but	  still	  present	  at	  the	  fusion	  site	  under	  the	  sequestering	  conditions,	  which	  agrees	  with	  our	  hypothesis.	  	  
	   Mbc	   has	   been	   reported	   to	   bind	   strongly	   to	   PI(3,4,5)P3	   in	   both	  Drosophila	  embryos	   and	  mammalian	   cell	   culture	   (Balagopalan	   et	   al.,	   2006;	   Côté	   et	   al.,	   2005).	  	  However,	  our	  phospholipid	  binding	  assay	  shows	  that	  the	  Mbc	  C2	  domain	  only	  binds	  weakly	  with	  PI(3,4,5)P2.	  	  We	  also	  found	  that	  manipulation	  of	  PI(3,4,5)P3	  levels	  does	  not	  generate	   fusion	  defects	  (data	  not	  shown).	   	  These	  data	  suggest	   the	  PI(3,4,5)P3-­‐Mbc	  pathway	   is	  not	  utilized	   in	   the	  context	  of	  Drosophila	  myoblast	   fusion.	   	   Instead,	  we	   find	   that	   Mbc	   is	   mislocalized	   in	   PI(4,5)P2	   sequestration	   background,	   which	  suggests	   that	   	  Mbc	   receives	   its	   localization	   cue	   through	   PI(4,5)P2.	   	  Moreover,	  we	  report	  that	  RacGTP	  displays	  a	  distal	  localization	  in	  the	  FCM	  cell	  under	  the	  PI(4,5)P2	  sequestering	  condition	  compared	  to	  control	  conditions.	  A	  similar	  distal	  location	  was	  detected	  in	  mbc	  mutants.	  Together,	  these	  data	  suggest	  that	  PI(4,5)P2	  regulates	  the	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actin	  cytoskeleton	  through	  the	  PI(4,5)P2-­‐Mbc-­‐Rac-­‐Kette-­‐SCAR	  pathway.	  	  Lastly,	  our	  data	  show	  that	  Mbc	   loss	  of	   function	  results	   in	  RacGTP	  mislocalization,	  rather	   than	  Rac	   inactivation;	   this	   agrees	  with	   the	   finding	   that	   constitutively	   active	  Rac1	   could	  not	   rescue	  mbc	  mutants	   (Haralalka	   et	   al.,	   2011),	   as	   overexpressed	  Rac	   can	  not	  be	  correctly	  localized.	  	  
	   Based	  on	  our	  data,	  we	  propose	  a	  model	  in	  which	  transmembrane	  molecules	  that	  mediate	  FCM-­‐FC/myotube	  recognition	  and	  adhesion	  trigger	  a	  signaling	  cascade	  that	   leads	  to	  PI(4,5)P2	  enrichment	  at	  the	  fusion	  site.	   	  PI(4,5)P2	  then	  facilitates	  the	  	  localization	  of	  Mbc,	  which	  leads	  to	  proper	  localization	  of	  active	  Rac	  and	  Blow	  at	  the	  fusion	   site.	   	   PI(4,5)P2	   and	   these	   upstream	   regulators	   control	   the	   localization	   and	  activation	   of	   SCAR	   and	   WASp,	   which	   ultimately	   leads	   to	   Arp2/3	   activation.	  	  Signaling	   from	   PI(4,5)P2	   to	   Arp2/3	   triggers	   the	   rearrangement	   of	   the	   actin	  cytoskeleton	  and	  the	  formation	  of	  the	  invasive	  podosome-­‐like	  structure	  at	  the	  site	  of	  fusion.	  	  
	   72	  
CHAPTER	  THREE	  
DIAPHANOUS	  REGULATES	  MYOBLAST	  FUSION	  THROUGH	  ACTIN	  
POLYMERIZATION	  AND	  ARP2/3	  REGULATION*	  
	  
Abstract:	  
The	  formation	  of	  multinucleated	  muscle	  cells	  through	  cell-­‐cell	  fusion	  is	  a	  conserved	  process	  from	  fruit	  flies	  to	  humans.	  	  Numerous	  studies	  have	  shown	  the	  importance	  of	  Arp2/3,	   its	   regulators,	   and	  branched	  actin	   for	   the	   formation	  of	   an	  actin	   structure,	  the	  F-­‐actin	  focus,	  at	  the	  fusion	  site.	  	  This	  F-­‐actin	  focus	  forms	  the	  core	  of	  an	  invasive	  podosome-­‐like	  structure	  that	  is	  required	  for	  myoblast	  fusion.	  	  In	  this	  study,	  we	  find	  that	  the	  formin	  Diaphanous	  (Dia),	  which	  nucleates	  and	  facilitates	  the	  elongation	  of	  actin	   filaments,	   is	   essential	   for	   Drosophila	   myoblast	   fusion.	   	   Following	   cell	  recognition	  and	  adhesion,	  Dia	   is	  enriched	  at	   the	  myoblast	   fusion	  site,	   concomitant	  with,	  and	  having	  the	  same	  dynamics	  as,	  the	  F-­‐actin	  focus.	   	  Through	  analysis	  of	  Dia	  loss-­‐of-­‐function	   conditions	   using	   mutant	   alleles,	   but	   particularly	   a	   dominant	  negative	  Dia	  transgene,	  we	  demonstrate	  that	  reduction	  in	  Dia	  activity	  in	  myoblasts	  leads	   to	   a	   fusion	   block.	   	   Significantly,	   no	   actin	   focus	   is	   detected,	   and	   neither	  branched	  actin	   regulators,	   SCAR	  or	  WASp,	   accumulate	  at	   the	   fusion	   site	  when	  Dia	  levels	  are	  reduced.	  	  Expression	  of	  constitutively	  active	  Dia	  also	  causes	  a	  fusion	  block	  that	   is	   associated	   with	   an	   increase	   in	   highly	   dynamic	   filopodia,	   altered	   actin	  turnover	   rates	   and	   F-­‐actin	   distribution,	   and	  mislocalization	   of	   SCAR	   and	  WASp	   at	  the	  fusion	  site.	  	  Together	  our	  data	  indicate	  that	  Dia	  plays	  two	  roles	  during	  invasive	  
*	  Deng	  S,	  Bothe	  I,	  Baylies	  MK	  (2015)	  The	  Formin	  Diaphanous	  Regulates	  Myoblast	  Fusion	  through	  Actin	  Polymerization	  and	  Arp2/3	  Regulation.	  PLoS	  Genet	  11(8):	  e1005381.	  doi:10.1371/journal.pgen.1005381	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podosome	   formation	   at	   the	   fusion	   site:	   it	   dictates	   the	   level	   of	   linear	   F-­‐actin	  polymerization,	  and	  it	  is	  required	  for	  appropriate	  branched	  actin	  polymerization	  via	  localization	   of	   SCAR	   and	   WASp.	   	   These	   studies	   provide	   new	   insight	   to	   the	  mechanisms	  of	  cell-­‐cell	  fusion,	  the	  relationship	  between	  different	  regulators	  of	  actin	  polymerization,	   and	   invasive	   podosome	   formation	   that	   occurs	   in	   normal	  development	  and	  in	  disease.	  
	  
Author	  Summary:	  
Muscle	  formation	  and	  homeostasis	  critically	  depend	  on	  fusion	  between	  myoblasts	  to	  create	   and	  maintain	  multinucleated	  muscle	   fibers.	   	  Despite	   the	   importance	  of	   this	  process,	   the	   mechanisms	   regulating	   myoblast	   fusion	   are	   not	   fully	   understood.	  	  Previous	  studies	  have	  shown	  that	  actin	  polymerization	  factor	  Arp2/3	  plays	  a	  critical	  role	  during	  myoblast	   fusion.	   	  However,	  whether	  other	  actin	   regulators	  also	  play	  a	  role	   during	   fusion,	   and	   how	   they	   coordinate	   with	   Arp2/3	   in	   controlling	   actin	  dynamics	   remain	   unclear.	   	   Taking	   advantage	   of	   the	   model	   organism,	   Drosophila	  
melanogaster,	  which	  shares	  the	  conserved	  muscle	  fiber	  with	  mammals,	  we	  identify	  the	  formin	  Diaphanous	  (Dia),	  which	  polymerizes	  linear	  actin	  filaments,	  as	  essential	  for	  myoblast	  fusion.	  	  We	  show	  that	  Dia	  is	  present	  at	  the	  fusion	  site,	  and	  with	  a	  new	  dominant	   negative	   Dia	   allele,	   we	   demonstrate	   that	   Dia	   functions	   after	   myoblast	  recognition	   and	   adhesion,	   but	   upstream	  of	   Arp2/3.	   	  Moreover,	   using	  dia	   loss	   and	  gain	   of	   function	   experiments,	   we	   show	   that	   Dia	   regulates	   myoblast	   fusion	   by	  regulating	  actin	  dynamics	  and	  by	  localizing	  the	  Arp2/3	  regulators,	  SCAR	  and	  WASp,	  to	   the	   fusion	  site.	   	  Our	   study	   thus	   identifies	  new	  regulatory	   factors	  during	  muscle	  formation.	   	   It	   also	   suggests	   mechanisms	   by	   which	   Dia	   and	   Arp2/3	   activities	   are	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coordinated	   to	   regulate	   actin	   dynamics	   in	   vivo	   during	   development	   and	  homeostasis.	  
Introduction:	  	  
Actin	   filaments	   are	   major	   components	   of	   a	   cell’s	   dynamic	   cytoskeleton.	   	   The	  remodeling	  of	  actin	  networks	  controls	  cell	  autonomous	  behaviors,	  such	  as	  cell	  shape	  changes	   and	   intracellular	   trafficking	   (Revenu	   et	   al.,	   2004).	   	  Highly	   regulated	   actin	  remodeling	   is	   also	   required	   in	   intercellular	   processes,	   such	   cell-­‐cell	   adhesion	   and	  cell-­‐cell	   fusion.	   	   Cell-­‐cell	   fusion	   of	   myoblasts	   gives	   rise	   to	   the	   functional	   unit	   of	  muscle,	  the	  multinucleated	  myofiber	  (Aguilar	  et	  al.,	  2013;	  Shemer	  and	  Podbilewicz,	  2000).	   	   A	   series	   of	   conserved	   steps,	   including	   cell-­‐cell	   recognition,	   adhesion,	  membrane	   alignment,	   membrane	   pore	   formation	   and	   cytoplasmic	   mixing,	   have	  been	   identified	   during	   myogenic	   cell	   fusion	   across	   species.	   	   Given	   its	   powerful	  genetic	   approaches,	   its	   optical	   tractability,	   and	   its	   simplicity,	   the	   Drosophila	  embryonic	   body	   wall	   musculature	   is	   an	   ideal	   system	   to	   study	   the	   mechanisms	  underlying	   these	   steps	   in	  myoblast	   fusion	   in	  vivo.	   	   In	  Drosophila,	   a	  multinucleated	  muscle	  fiber	  arises	  through	  the	  fusion	  of	  two	  types	  of	  myoblasts:	  a	  single	  Founder	  Cell	  (FC),	  which	  determines	  muscle	  identity	  by	  expressing	  a	  unique	  combination	  of	  transcription	   factors	   (Bate,	   1990;	   Beckett	   and	   Baylies,	   2006;	   de	   Joussineau	   et	   al.,	  2012;	   Dohrmann	   et	   al.,	   1990),	   and	  multiple	   Fusion	   Competent	  Myoblasts	   (FCMs)	  (reviewed	   in	   (Abmayr	   and	   Pavlath,	   2012;	   Rochlin	   et	   al.,	   2010;	   Simionescu	   and	  Pavlath,	   2011)).	   	   Upon	   fusion,	   the	   nucleus	   of	   the	   FCM	   adopts	   the	   identity	   and	  transcriptional	  profile	  of	  the	  FC/Myotube	  (reviewed	  in	  (Baylies	  et	  al.,	  1998;	  Tixier	  et	  al.,	  2010)).	  	  As	  in	  vertebrates,	  fusion	  in	  Drosophila	  is	  an	  iterative	  process	  and	  in	  the	  fly	   embryo,	   the	   different	   individual	  muscles	   result	   from	   as	   few	   as	   2	   events	   to	   as	  many	  as	  24	  events	  (Bate,	  1990).	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   Recognition	  and	  adhesion	  between	  the	  FCs/Myotubes	  and	  FCMs	  is	  mediated	  by	   four	   transmembrane	  molecules	   belonging	   to	   the	   immunoglobulin	   superfamily:	  the	   FC/Myotube-­‐specific	   proteins,	   Dumbfounded	   (Duf;	   also	   known	   as	   Kirre)	   and	  Roughest,	   and	   their	   binding	   partners	   on	   the	   FCMs,	   Sticks	   and	   Stones	   (Sns)	   and	  Hibris	  (Artero	  et	  al.,	  2001;	  Bour	  et	  al.,	  2000;	  Ruiz	  Gomez	  et	  al.,	  2000;	  Strünkelnberg	  et	   al.,	   2001).	   	   After	   bidirectional	   signaling	   via	   these	   transmembrane	   receptors,	   a	  fusogenic	   synapse	   is	   established	   between	   the	   FC/Myotube	   and	   FCM,	   and	  accumulations	  of	  filamentous	  actin	  (F-­‐actin)	  are	  observed	  on	  the	  opposing	  sides	  of	  the	  fusion	  site	  (Berger	  et	  al.,	  2008;	  Kesper	  et	  al.,	  2007;	  Kim	  et	  al.,	  2007;	  Richardson	  et	  al.,	  2007).	   	  On	   the	  FC/Myotube	  side,	  a	   thin	  sheath	  of	  F-­‐actin	   is	  present.	   	  On	   the	  FCM	  side,	  the	  F-­‐actin	  focus,	  which	  makes	  up	  the	  podosome-­‐like,	   invasive	  structure	  (PLS),	   forms	   (Sens	  et	  al.,	  2010).	   	  These	  enrichments	  of	  F-­‐actin	  are	  highly	  dynamic	  and	   resolve	   prior	   to	   cytoplasmic	  mixing	   between	   the	   two	   cells	   (Richardson	   et	   al.,	  2007).	   	  F-­‐actin	  accumulation	  and	  resolution	  at	   the	   fusion	  site	   suggest	  a	   functional	  role	  for	  actin	  during	  fusion.	   	  Supporting	  this	  role,	  genetic	  screens	  have	  identified	  a	  number	   of	   fusion	   mutants	   that	   map	   to	   genes	   involved	   in	   Arp2/3-­‐based	   actin	  remodeling	  (Abmayr	  and	  Pavlath,	  2012;	  Haralalka	  et	  al.,	  2011;	  Rochlin	  et	  al.,	  2010;	  Simionescu	   and	   Pavlath,	   2011).	   Arp2/3	   is	   regulated	   by	   two	   nucleation-­‐promoting	  factors	   (NPFs),	   SCAR/WAVE	   (WASp	   family	   verprolin-­‐homologous	   protein)	   and	  WASp	   (Wiskott-­‐Aldrich	   syndrome	   protein)	   (Higgs	   et	   al.,	   1999;	   Machesky	   et	   al.,	  1999).	  	  Both	  SCAR	  and	  WASp	  activate	  Arp2/3	  through	  simultaneous	  binding	  of	  actin	  and	   Arp2/3	   (Dayel	   and	   Mullins,	   2004;	   Machesky	   et	   al.,	   1999).	   	   During	   myoblast	  fusion,	   the	   stability,	   localization,	   and	   activity	   of	   SCAR	   are	   regulated	   by	   the	  WAVE	  complex	  member,	   Kette	   (Nap1),	   and	   by	   the	   small	   GTPase	   Rac	   (Eden	   et	   al.,	   2002;	  Kunda	  et	  al.,	  2003;	  Richardson	  et	  al.,	  2007),	  which	  is	  activated	  by	  the	  bipartite	  GEF,	  Myoblast	   city	   (Mbc;	   Dock180)	   and	   Elmo	   (Geisbrecht	   et	   al.,	   2008;	   Haralalka	   et	   al.,	  2011).	   	   WASp	   is	   recruited	   to	   the	   fusion	   site	   via	   the	   WASp-­‐interacting	   protein	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Solitary	  (Sltr)	  (also	  known	  as	  DWIP	  and	  Verprolin)	  and	  Blown	  fuse	  (Blow)	  (Jin	  et	  al.,	  2011).	  	  The	  coordinated	  activities	  of	  SCAR	  and	  WASp	  lead	  to	  Arp2/3	  activation	  and	  subsequently	   the	   formation	   of	   the	   F-­‐actin	   focus,	   the	   invasive	   podosome,	   a	   fusion	  pore	   (Sens	   et	   al.,	   2010)	   and	   finally,	   cytoplasmic	   continuity	   (Berger	   et	   al.,	   2008;	  Gildor	  et	  al.,	  2009).	  	  
Arp2/3	  has	  been	  shown	  to	  bind	  to	  an	  existing	  F-­‐actin	  filament	  and	  nucleate	  a	  new	   branch.	   	   While	   Arp2/3	   can	   nucleate	   F-­‐actin	   filaments	   de	   novo,	   it	   does	   this	  slowly	  (Blanchoin	  et	  al.,	  2000).	   	  The	  presence	  of	  pre-­‐existing	   filaments	  accelerates	  Arp2/3’s	  ability	  to	  form	  branched	  F-­‐actin(Pollard,	  2007).	  	  Formins,	  another	  group	  of	  actin	   regulators,	   complement	   the	   activity	   of	   Arp2/3	   by	   generating	   linear	   actin	  filaments.	   	  Studies	  have	  revealed	  both	  collaborative	  and	  antagonistic	   relationships	  between	   members	   of	   the	   WAVE	   regulatory	   complex,	   Arp2/3,	   and	   formins.	   	   As	  examples,	  Abi,	  a	  member	  of	  the	  WAVE	  complex,	  has	  been	  shown	  to	  interact	  with	  the	  formin	  mDia1	  to	  positively	  regulate	  cell-­‐cell	  adhesion	  in	  tissue	  culture	  cells	  (Ryu	  et	  al.,	   2009).	   	   In	   contrast,	   mDia2,	   WAVE,	   and	   Arp2/3	   have	   been	   shown	   to	   form	   a	  multimeric	   complex,	   which	   inhibits	   mDia2-­‐dependent	   filopodium	   formation	   in	  cultured	  cells	  (Beli	  et	  al.,	  2008).	  	  Arp2/3	  and	  formins	  often	  act	  together	  in	  different	  in	   vivo	   contexts,	   including	   pseudocleavage	   furrow	   formation,	   cytokinesis,	   and	  filopodia	  formation	  in	  Drosophila	  primary	  neurons	  (Bogdan	  et	  al.,	  2013;	  Campellone	  and	   Welch,	   2010).	   	   Particularly	   relevant	   for	   our	   studies	   in	   myoblast	   fusion	   are	  findings	  that,	  in	  cancer	  cells	  and	  macrophages,	  Arp2/3	  and	  formins	  are	  required	  for	  the	  formation	  of	  podosomes,	  which	  resemble	  the	  invasive	  structure	  at	  the	  myoblast	  fusion	   site	   (Lizárraga	   et	   al.,	   2009;	   Mersich	   et	   al.,	   2010;	   Sens	   et	   al.,	   2010).	   	   How	  Arp2/3	  and	  formins	  interact	  to	  regulate	  actin	  dynamics	  in	  different	  in	  vivo	  contexts,	  particularly	  myoblast	  fusion,	  remains	  to	  be	  investigated.	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The	  best	  characterized	  formin	  in	  Drosophila	  is	  Diaphanous	  (Dia),	  where	  it	  is	  critical	  for	  cellularization	  (Afshar	  et	  al.,	  2000;	  Grosshans	  et	  al.,	  2005),	  wound	  healing	  (Abreu-­‐Blanco	   et	   al.,	   2014;	   Antunes	   et	   al.,	   2013),	   segmental	   groove	   formation	  (Mulinari	   et	   al.,	   2008),	   dorsal	   closure	   (Homem	   and	   Peifer,	   2009),	   and	   synapse	  growth	  (Pawson	  et	  al.,	  2008).	   	  Dia	  nucleates	  and	  elongates	  actin	  filaments	  through	  its	  FH1	  and	  FH2	  domains.	  	  The	  FH1	  domain	  interacts	  with	  Profilin,	  which	  is	  an	  actin	  monomer-­‐binding	   protein,	   to	   increase	   the	   local	   actin	   monomer	   concentration	  (Manseau	   et	   al.,	   1996;	   Watanabe	   et	   al.,	   1997).	   	   The	   FH2	   domain	   binds	   to	   actin	  barbed	  ends,	  stabilizes	  newly	  formed	  actin	  dimers,	  and	  promotes	  the	  elongation	  of	  actin	  filaments	  (Bogdan	  et	  al.,	  2013;	  Campellone	  and	  Welch,	  2010;	  Higgs,	  2005;	  Paul	  and	  Pollard,	  2009).	   	  The	  regulation	  of	  Dia	  activity	   involves	  autoinhibition	  and	  Rho	  GTPase-­‐mediated	  activation.	  	  Dia	  autoinhibition	  relies	  on	  the	  interaction	  between	  its	  C-­‐terminal	   DAD	   (Diaphanous	   Autoinhibitory	   Domain)	   region	   and	   the	   N-­‐terminal	  DID	   (Diaphanous	   Inhibitory	   Domain)	   region	   (Alberts,	   2001;	   Li	   and	   Higgs,	   2005).	  	  The	   autoinhibited	   state	   of	   Dia	   is	   relieved	  when	   Rho-­‐GTP	   binds	   to	   the	   N-­‐terminal	  GBD	  (GTPase	  binding	  domain)	  region,	  thereby	  disrupting	  the	  DID-­‐DAD	  interaction.	  	  Deletion	  of	   the	  Dia	  DAD	  domain	   inhibits	   the	   folding	  of	  Dia	   into	   the	  autoinhibitory	  conformation	   and	   results	   in	   constitutively	   active	   Dia	   (Homem	   and	   Peifer,	   2009).	  	  Given	   the	   well-­‐established	   role	   that	   Dia	   plays	   in	   actin	   regulation	   during	  development	  and	  the	  central	  position	  that	  actin	  plays	  in	  myoblast	  fusion,	  it	  is	  likely	  that	   Dia	   would	   play	   a	   role	   in	   myoblast	   fusion.	   	   However,	   no	   such	   role	   has	   been	  established.	  
Here	  we	  show	  that	  Dia-­‐mediated	  F-­‐actin	  polymerization	   is	   required	   for	   the	  formation	  of	  the	  podosome-­‐like	  structure	  at	  the	  myoblast	  fusion	  site	  and	  is	  essential	  for	  the	  invasion	  of	  the	  FC/myotubes	  by	  the	  FCMs.	  	  We	  show	  that	  Dia	  is	  localized	  to	  the	  fusion	  site	  and	  there	  regulates	  F-­‐actin	  polymerization:	  loss	  of	  Dia	  activity	  blocks	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fusion,	  and	  no	  actin	  focus	  forms	  at	  the	  fusion	  site.	  	  Failure	  in	  focus	  formation	  arises	  from	   a	   block	   in	   F-­‐actin	   polymerization	   as	   well	   as	   an	   inability	   to	   accumulate	   the	  Arp2/3	  NPFs,	   SCAR	  and	  WASp,	   at	   the	   fusion	   site.	   	   Gain	  of	  Dia	   activity	   also	  blocks	  fusion	   and	   significantly	   changes	   the	   organization	   of	   the	   F-­‐actin	   focus	   through	  increased	  actin	  turnover,	  leading	  to	  an	  excess	  of	  non-­‐invasive	  filopodia	  at	  the	  fusion	  site.	   	   We	   further	   demonstrate	   that	   Dia-­‐mediated	   SCAR	   and	   WASp	   localization	   is	  disrupted	   at	   the	   fusion	   site	   under	   these	   conditions.	   	   Based	   on	   our	   findings,	   we	  propose	   that	   Dia	   is	   necessary	   for	   two	   activities	   at	   the	   fusion	   site:	   Dia	   initiates	  invasive	   podosome	   formation	   through	   formation	   of	   linear	   actin	   filaments.	   	   Dia	  activity	  is	  also	  required	  for	  the	  accumulation	  of	  the	  Arp2/3	  NPFs,	  SCAR	  and	  WASp,	  whose	   activity	   subsequently	   leads	   to	   Arp2/3	   activation	   at	   the	   fusion	   site.	   	   The	  concerted	  F-­‐actin	  elongation	  and	  branching	  processes	   likely	  provide	  the	  structural	  integrity	   and	   the	   necessary	   force	   generation	   for	   the	   invasive	   podosome,	   which	  ultimately	  leads	  to	  cell-­‐cell	  fusion.	  
Results:	  
Diaphanous	  is	  Localized	  to	  the	  Fusion	  Site	  during	  Myoblast	  Fusion	  
To	   investigate	   the	   role	   of	   Dia	   during	   myoblast	   fusion,	   we	   first	   examined	   its	  subcellular	  localization	  in	  fusing	  myoblasts	  (S1	  Fig).	  	  The	  fusion	  site	  is	  identified	  by	  the	   presence	   of	   the	   F-­‐actin	   focus	   (Richardson	   et	   al.,	   2007;	   Sens	   et	   al.,	   2010).	  Immunostaining	   revealed	   that	   Dia	   is	   present	   in	   the	   cytoplasm	   and	   cell	   cortex	   of	  myoblasts	   (S1	  Fig)	  and	  accumulates	  at	   the	   fusion	  site	  between	  adhered	  myoblasts	  (Fig	   1A-­‐1B).	   	   The	   specific	   accumulation	   of	   Dia	   at	   the	   fusion	   site	   was	   verified	   by	  quantification	   of	   Dia	   fluorescence	   intensity	   and	   comparison	   to	   phalloidin	   and	  Actin::GFP	   intensities	   (Fig	   1B-­‐1C,	   n=10;	   S2	   Fig).	   	   Together,	   our	   analysis	   of	   fixed	  embryos	  indicates	  that	  Dia	  is	  enriched	  at	  the	  fusion	  site.	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The	   F-­‐actin	   focus	   is	   a	   dynamic	   structure	   that	   forms	   and	   subsequently	  resolves	  upon	  myoblast	  fusion.	  	  To	  determine	  whether	  Dia	  displays	  a	  similar	  profile,	  we	  used	   time-­‐lapse	  analysis	   to	   compare	   the	   spatial	   and	   temporal	  dynamics	  of	  Dia	  and	   F-­‐actin	   during	   fusion.	   	   Moesin::mCherry	   (Millard	   and	   Martin,	   2008)	   and	  Dia::GFP	   (Homem	   and	   Peifer,	   2009)	  were	   expressed	   in	  myoblasts	   to	   label	   F-­‐actin	  and	   Dia,	   respectively.	   Dia::GFP	   is	   reported	   to	   retain	   all	   Dia	   activity	   (Homem	   and	  Peifer,	  2009).	  	  In	  myoblasts	  co-­‐expressing	  both	  constructs,	  the	  lifetime	  of	  the	  F-­‐actin	  focus	  was,	  on	  average,	  16.8±6.9	  minutes	  (n=5),	  with	  a	  range	  from	  9	  to	  25	  min.	  	  This	  is	   comparable	   to	   expression	   of	   F-­‐actin	   reporters	   alone	   (Bothe	   et	   al.,	   2014;	  Richardson	   et	   al.,	   2007).	   	   We	   also	   confirmed	   that	   expression	   of	   these	   constructs	  under	   these	   conditions	   had	   no	   observable	   effects	   on	   muscle	   differentiation.	  	  Subsequent	  analysis	  of	  Dia::GFP	  and	  Moesin::mCherry	  revealed	  that	  Dia	   is	  present	  at	  the	  fusion	  site	  during	  F-­‐actin	  focus	  formation	  and	  resolution	  (Fig	  1D-­‐Di).	   	  While	  Dia	  localizes	  to	  the	  cell	  cortex	  before	  and	  after	  a	  fusion	  event,	  it	  clearly	  accumulates	  at	   the	   fusion	   site	   coincident	  with	   the	   F-­‐actin	   focus.	   	   Together,	   these	   data	   indicate	  that	   Dia	   becomes	   enriched	   at	   the	   fusion	   site	   with	   the	   same	   spatial	   and	   temporal	  dynamics	  as	  the	  F-­‐actin	  focus.	  	  
Myoblast	   fusion	   is	   an	   asymmetric	   process	   in	   which	   the	   FCM	   produces	   a	  podosome-­‐like	   structure	   that	   invades	   and	   promotes	   fusion	  with	   the	   FC/myotube.	  	  On	   the	   subcellular	   level,	   this	  asymmetry	  manifests	   in	  an	  uneven	  distribution	  of	  F-­‐actin	   (Sens	   et	   al.,	   2010).	   	   We	   therefore	   examined	   if	   Dia	   was	   also	   asymmetrically	  localized.	  	  To	  do	  this,	  we	  expressed	  Dia::GFP	  specifically	  in	  either	  FC/Myotubes	  or	  in	  FCMs	  and	  co-­‐stained	  with	  the	  Dia	  antibody.	  	  By	  examining	  the	  overlap	  of	  exogenous	  and	  endogenous	  Dia	  signal,	  we	  can	  determine	  whether	  Dia	  is	  localized	  at	  the	  fusion	  site	  in	  one	  or	  both	  cell	  types.	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We	   first	   expressed	   Dia::GFP	   specifically	   in	   FCs/Myotubes	   and	   examined	  Dia::GFP	  and	  Dia	  distribution.	  	  Before	  fusion	  pore	  formation	  and	  cytoplasm	  mixing,	  Dia::GFP	   could	   readily	   be	   detected	   only	   in	   the	   FC/Myotube.	   	   Dia	   antibody,	   in	  contrast,	   detected	  endogenous	  Dia	   in	  both	   the	  FC/Myotubes	   and	  FCMs.	   	  With	   this	  labeling	  approach,	   the	  Dia	  and	  Dia::GFP	  signals	  partially	  overlapped	  (Fig	  1E).	   	  The	  partial	   colocalization	  between	   the	  FC/Myotube	  derived	  Dia::GFP	  and	  Dia	  antibody	  staining	  was	  confirmed	  by	  the	  separated	  peaks	  of	  the	  fluorescence	  intensity	  curves	  (Fig	   1F).	   	   Thus,	   Dia	   is	   present	   in	   the	   FC/Myotube	   side	   during	   fusion,	   but	   this	  expression	  only	  constitutes	  a	  small	  portion	  of	  the	  total	  Dia	  enrichment	  at	  the	  fusion	  site.	  
Next,	   we	   examined	   the	   Dia	   accumulation	   on	   the	   FCM	   side.	   	  We	   expressed	  Dia::GFP	  specifically	  in	  FCMs,	  and	  assessed	  the	  localization	  of	  Dia::GFP	  and	  Dia.	  	  To	  prevent	  cytoplasmic	  mixing	  and	   the	   introduction	  of	  Dia::GFP	   into	   the	  FC/Myotube	  after	   fusion,	   Dia::GFP	   was	   expressed	   in	   FCMs	   of	  mbc	   mutant	   embryos,	   in	   which	  myoblast	   fusion	  is	  blocked	  prior	  to	   fusion	  pore	  formation	  (Doberstein	  et	  al.,	  1997;	  Rushton	  et	  al.,	  1995).	  	  Hence,	  no	  cytoplasmic	  exchange	  occurs	  between	  FCM	  and	  FC	  in	  mbc	   mutants.	   In	   FCMs,	   Dia::GFP	   accumulated	   at	   the	   fusion	   site	   (Fig	   1G)	   and	  colocalized	   with	   endogenous	   Dia	   and	   the	   F-­‐actin	   focus.	   	   The	   colocalization	   of	  Dia::GFP,	  Dia,	  and	  F-­‐actin	  was	  confirmed	  by	  the	  overlapping	  fluorescence	  intensity	  curves	  (Fig	  1H).	  	  These	  findings	  demonstrate	  that	  Dia	  enrichment	  at	  the	  fusion	  site,	  like	  F-­‐actin,	  occurs	  primarily	   in	  the	  FCM,	  whereas	   in	  FC,	  only	  a	   thin	   layer	  of	  Dia	   is	  detected	  along	  the	  fusion	  interface.	  	  
Dia	   Localization	   is	   Dependent	   on	   FC/FCM	   Recognition	   and	   Adhesion,	   but	   is	  
Independent	  of	  Arp2/3	  dependent	  Actin	  Regulation	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Dia	   enrichment	   at	   the	   fusion	   site	   suggested	   a	   role	   for	  Dia	   in	  myoblast	   fusion.	   	   To	  determine	   where	   in	   the	   fusion	   pathway	   Dia	   could	   function,	   we	   examined	   Dia	  localization	  in	  mutants	  in	  which	  myoblast	  fusion	  is	  blocked	  (Fig	  2;	  S1	  Table;	  S2	  Fig).	  	  In	  sns	  mutants,	  where	  FCM-­‐FC	  recognition	  is	  disrupted	  and	  no	  F-­‐actin	  focus	  forms,	  Dia	   did	   not	   accumulate	   at	   the	   fusion	   site,	   but	   showed	   diffuse	   localization	   in	   the	  cytoplasm	   (Fig	   2B,	   S1	   Table),	   suggesting	   that	   Dia	   functions	   downstream	   of	   cell	  recognition	  and	  adhesion	  during	  fusion.	  	  Embryos	  carrying	  mutations	  in	  genes	  that	  regulate	  SCAR	  activity	   -­‐-­‐	  rac,	  mbc	   and	  kette	   -­‐-­‐	  display	  an	  enlarged	  actin	   focus	   that	  does	   not	   resolve.	   	   In	   these	  mutants,	   Dia	   accumulation	   is	   largely	   unaffected	   in	   the	  examined	  actin	  foci	  (Fig	  2C-­‐2E;	  S1	  Table).	   	  We	  next	  examined	  embryos	  mutant	  for	  genes	  that	  regulate	  WASp	  activity:	  mutants	  in	  blow	  and	  wsp	  show	  enlarged	  F-­‐actin	  foci,	   whereas	   mutants	   in	   sltr/Dwip/vrp,	   show	   normal	   sized	   foci.	   	   Dia	   localization	  appeared	  unchanged	   in	   all	   these	  mutants	   (Fig	  2G-­‐2I;	   S1	  Table).	   	  Mutants	   in	   loner,	  which	  encodes	  an	  ARF-­‐GEF	  family	  member	  (Chen	  et	  al.,	  2003)	  display	  normal-­‐sized	  actin	  foci.	  	  In	  loner	  mutants,	  Dia	  accumulated	  at	  the	  F-­‐actin	  focus	  at	  the	  stalled	  fusion	  site	   (Fig	   2F;	   S1	   Table).	   	   Dia’s	   enrichment	   at	   the	   fusion	   site	   in	   all	   these	   mutant	  conditions	   was	   quantified	   by	   fluorescence	   intensity	   curves	   (Fig	   2Aiv-­‐Iiv,	   n=	  5/genotype;	  S2	  Fig).	  	  Together	  these	  data	  indicate	  that	  Dia	  localization	  at	  the	  fusion	  site	   is	   dependent	   on	   FC/FCM	   recognition	   and	   adhesion,	   but	   appears	   to	   be	  independent	  of	  Arp2/3	  actin	  regulation.	  	  
Dia	  Loss	  of	  Function	  Leads	  to	  a	  Myoblast	  Fusion	  Block	  
The	   localization	   of	   Dia	   in	   fusion	   mutant	   embryos	   suggested	   a	   role	   for	   Dia	  downstream	   of	   FC/FCM	   recognition	   and	   adhesion.	   	   Hence,	   we	   examined	   muscle	  formation,	   and	   myoblast	   fusion	   in	   particular,	   in	   dia	  mutant	   embryos,	   using	   well-­‐established	  dia	  alleles	  (Afshar	  et	  al.,	  2000;	  Castrillon	  and	  Wasserman,	  1994).	  	  During	  
Drosophila	   embryogenesis,	   Dia	   is	   required	   in	   numerous	   processes,	   including	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metaphase	   furrow	  organization	  during	  division,	  cellularization,	  pole	  cell	   formation	  (Afshar	  et	  al.,	  2000),	  segmental	  groove	  formation	  (Mulinari	  et	  al.,	  2008)	  and	  dorsal	  closure	   (Homem	   and	   Peifer,	   2008).	   	   In	   zygotic	   dia5/dia5	   and	   dia2/dia2	   mutants,	  abnormalities	   in	   the	   muscle	   pattern	   were	   found,	   including	   insufficient	   fusion	  (detected	   by	   free	   myoblasts),	   missing	   muscles,	   muscle	   morphology	   changes,	   and	  muscle	  detachment	  from	  its	  tendon	  cell	  (S2	  Table;	  S3A	  Fig).	  	  We	  quantified	  the	  level	  of	   myoblast	   fusion	   by	   counting	   the	   total	   number	   of	   nuclei	   in	   the	   four	   Lateral	  Transverse	  (LT)	  muscles/hemisegments	  in	  both	  dia2	  and	  dia5	  homozygous	  mutants.	  	  Using	   this	   approach,	  we	   found	   a	   reduction	   in	   fusion	   (fusion	   index:	  dia2:	   14.1±1.3,	  n=21;	  dia5:	  21.5±1.3	  n=20;	  control:	  27.8±0.3	  n=12;	  p<0.001;	  S3B	  Fig).	  	  These	  defects	  in	   the	   musculature	   could	   contribute	   to	   reduced	   viability	   of	   the	   dia2	   and	   dia5	  homozygous	  mutants,	  as	  less	  than	  10%	  of	  dia2	  homozygous	  mutants	  and	  only	  20%	  of	  dia5	  homozygous	  mutants	  hatched	  into	  larvae.	  	  While	  these	  data	  suggested	  a	  role	  for	  dia	  in	  myoblast	  fusion,	  we	  sought	  out	  genetic	  conditions	  that	  would	  enable	  us	  to	  study	  myoblast	  fusion	  in	  more	  detail.	   	  In	  particular,	  we	  wanted	  to:	  1-­‐	  eliminate	  the	  effects	  of	  loss	  of	  Dia’s	  function	  in	  the	  ectoderm.	   	  The	  ectoderm	  is	  known	  to	  impact	  muscle	  development	  (Beckett	  and	  Baylies,	  2006;	  Dobi	  et	  al.,	  2015);	  2-­‐	   increase	  the	  number	   of	   embryos	   which	   have	   Dia’s	   function	   abrogated;	   and	   3-­‐	   increase,	   if	  possible,	   the	   level	   of	   fusion	   block	  when	  Dia’s	   function	   is	   reduced.	   	   The	   Gal4/UAS	  system	  (Brand	  and	  Perrimon,	  1993)	  allows	  generation	  of	  embryos	  in	  which	  100%	  of	  the	  embryos	  express	  the	  transgene	  and	  can	  have	  a	  phenotype	  rather	  than	  25%	  that	  results	   from	   traditional	   genetic	   alleles.	   	   Pairing	   the	   mesoderm/muscle	   specific	  
Dmef2-­GAL4	  with	  an	  appropriate	  UAS-­‐line	  would	  allow	  manipulation	  of	  Dia	   in	   the	  cell	  type	  and	  during	  the	  time	  period	  in	  which	  fusion	  occurs.	  	  Available	  UAS-­‐DiaRNAi	  lines,	   however,	   did	   not	   prove	   effective	   in	   knocking	   down	   Dia	   function	   during	  embryonic	  muscle	  development	  (S2	  Table).	   	  We	  thus	  generated	  dominant	  negative	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Dia	  (DiaDN::GFP)	  transgenic	  flies	  to	  reduce	  Dia	  activity	  specifically	  in	  the	  developing	  mesoderm/muscle	  during	  myoblast	  fusion.	  	  
The	  FH2	  domain	  of	  mDia1,	   the	  mammalian	  homologue	  of	  Drosophila	  Dia,	   is	  required	  for	  its	  function	  in	  stress	  fiber	  generation	  in	  cultured	  cells	  (Copeland	  et	  al.,	  2004;	  Staus	  et	  al.,	  2007).	  	  A	  deletion	  of	  the	  first	  21	  amino	  acids	  of	  this	  domain	  was	  reported	   to	   act	   as	   a	   dominant	   negative	   protein,	   either	   by	   competing	   with	  endogenous	  mDia	   for	   F-­‐actin	   binding	   or	   by	   binding	   to	   endogenous	  mDia	   to	   form	  non-­‐functional	   dimmers	   (Copeland	   et	   al.,	   2004;	   Staus	   et	   al.,	   2007).	   	   Since	   the	   key	  amino	   acids	   in	   this	   domain	   are	   identical	   between	  mDia1	   and	  Drosophila	   Dia,	   we	  designed	   a	   Drosophila	   dominant	   negative	   Dia	   (DiaDN)	   modeled	   after	   this	   mouse	  construct	  (Fig	  3A).	  	  
To	   confirm	   that	   the	  DiaDN	   construct	   affects	  Dia-­‐based	   actin	   regulation,	  we	  examined	  filopodia	  in	  cultured	  cells	  and	  in	  the	  Drosophila	  epidermis.	  	  Previous	  work	  indicated	  that	  reduction	  of	  Dia	  leads	  to	  reduction	  of	  actin-­‐based	  structures,	  such	  as	  filopodia,	   in	   cell	   culture	   and	   in	   vivo	   (Homem	   and	   Peifer,	   2009;	  Mellor,	   2010).	   	   In	  S2R+	   cells	   that	   express	   DiaDN	   the	   number	   of	   filopodia	   was	   greatly	   reduced	  compared	  to	  the	  neighboring	  control	  cells	  (5.7±	  3.0	  vs	  17.5±5.8,	  n=20,	  p<0.001)	  (Fig	  3B),	   consistent	   with	   a	   reduction	   of	   endogenous	   Dia	   activity.	   	   This	   reduction	   in	  filopodia	  was	  rescued	  by	  overexpression	  of	  a	   full	   length	  Dia	  with	  DiaDN,	  revealing	  the	   specificity	   of	   the	   DN	   construct	   (S3C-­‐3D	   Fig).	   	  We	   also	   tested	   the	   efficiency	   of	  DiaDN	   in	  vivo,	   specifically	  by	  examining	   filopodia	   in	   leading	  edge	  (LE)	  cells	  during	  
Drosophila	   dorsal	   closure.	   	   Similar	   to	   dia5	   maternal	   and	   zygotic	   mutant	   embryos	  (Homem	  and	  Peifer,	  2009),	  filopodium	  number	  was	  reduced	  in	  embryos	  expressing	  DiaDN	   (Fig	   3C-­‐Cii).	   	   Both	   these	   data	   sets	   are	   consistent	   with	   a	   reduction	   of	   Dia	  activity	   via	   our	   DiaDN	   construct.	   	   As	   additional	   test	   of	   our	   DiaDN	   construct,	   we	  examined	  another	  context	   in	  which	  Dia	   is	  known	  to	  play	  a	  role.	   	  dia1	  homozygous	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mutants	   are	   sterile	   due	   to	   defects	   in	   cytokinesis	   in	   the	   germline	   (Castrillon	   and	  Wasserman,	   1994).	   	   Expression	   of	   DiaDN	   in	   the	   male	   germline	   leads	   to	   reduced	  fertility	  due	  to	  fewer	  sperm	  (S3F-­‐3G	  Fig),	  consistent	  with	  a	  reduction	  in	  Dia	  activity	  in	   this	   context.	   	   Collectively,	   these	   data	   indicate	   the	   DiaDN	   construct	   reduces	   Dia	  activity.	  	  
We	   next	   examined	   the	   effects	   of	   DiaDN	   when	   expressed	   specifically	   in	  myoblasts.	  	  When	  one	  copy	  of	  DiaDN	  was	  expressed,	  we	  observed	  defects	  in	  muscle	  development,	  including	  myoblast	  fusion,	  in	  50%	  of	  embryos	  (n=20;	  Fig	  3D).	   	  Other	  muscle	  differentiation	  processes	  also	  were	  disrupted,	   including	  muscle	  attachment	  and	  morphology	  (S3E	  Fig).	  	  These	  phenotypes	  were	  similar	  to	  those	  observed	  in	  dia	  mutant	   embryos	   (S2	   Table;	   S3A-­‐3B	   Fig),	   reinforcing	   that	   the	   defects	   using	  DiaDN	  were	  due	  to	  Dia	  loss	  of	  function.	  	  
To	   increase	   the	   penetrance	   and	   expressivity	   of	   the	   fusion	   phenotype	   in	  embryos	   expressing	   DiaDN,	   we	   increased	   DiaDN	   expression	   levels	   in	   two	   ways:	  increasing	  genetic	  copy	  numbers	  of	  the	  mesoderm/muscle	  driver	  DMef2-­Gal4	  driver	  and	  UAS-­DiaDN	   and	   increasing	   the	   temperature	   at	  which	  we	   raised	   the	   embryos,	  since	  higher	  temperatures	  correlated	  with	  increased	  Gal4/UAS	  activity	  (Brand	  and	  Perrimon,	  1993;	  Seroude	  et	  al.,	  2002).	  	  We	  generated	  a	  fusion	  index	  as	  described	  for	  
dia	  mutants	  (Fig	  3E-­‐3F;	  S3	  Fig).	  	  Expression	  of	  one	  copy	  of	  DiaDN	  with	  one	  copy	  of	  the	  Gal4	  driver	  (1X)	  resulted	  in	  a	  significant	  decrease	  in	  myoblast	  fusion	  (22.5±2.2	  vs	  27.1±2.3	  LT	  nuclei/	  hemisegment	  in	  control,	  p<0.001).	  	  Free	  myoblasts	  also	  were	  detected,	  in	  addition	  to	  detached	  muscles.	  Expression	  of	  two	  copies	  of	  Dia	  DN	  with	  two	  copies	  of	  the	  Gal4	  driver	  (2X)	  resulted	  in	  a	  more	  severe	  fusion	  block	  (15.5±2.7	  p<0.001)	   and	  more	   free	  myoblasts	  were	   observed.	   	  Under	   these	   conditions,	   some	  myotubes	   also	   failed	   to	   properly	   attach	   to	   tendon	   cells,	   and,	   as	   a	   result,	   formed	  myospheres	  (Fig	  3D,	  arrowheads;	  S3E	  Fig).	  	  Specification	  and	  differentiation	  of	  both	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FCs	  and	  FCMs	  occurred	  normally	  under	  these	  conditions,	  as	  revealed	  by	  expression	  of	  MHC	  and	  apRed	  positive	  nuclei	  (Fig	  3D-­‐3E)	  (Bothe	  et	  al.,	  2014;	  Richardson	  et	  al.,	  2007).	  	  In	  combination	  with	  Dia’s	  localization	  at	  the	  fusion	  site,	  these	  data	  indicate	  that	  Dia	  activity	  is	  necessary	  for	  myoblast	  fusion.	  
	   To	   determine	   which	   cellular	   step	   of	   fusion	   requires	   Dia	   activity,	   we	   next	  examined	  F-­‐actin	  foci	  and	  myoblast	  morphology	  in	  embryos	  where	  DiaDN::GFP	  was	  expressed	   in	  myoblasts.	   	  We	   found	   that	   FCMs	   oriented	   towards	   the	   FC/Myotube,	  showing	  the	  characteristic	  teardrop	  shape	  (Doberstein	  et	  al.,	  1997;	  Richardson	  et	  al.,	  2007;	   Rochlin	   et	   al.,	   2010).	   	   FCMs	   also	   attached	   to	   FC/Myotubes.	   	   Localized	  expression	  of	  the	  recognition	  and	  adhesion	  receptors,	  Duf	  and	  Sns,	  at	  the	  fusion	  site	  confirmed	  that	  these	  FCMs	  were	  adhered	  to	  the	  FC/Myotube	  (Fig	  4A).	  	  However,	  in	  40%	  of	  the	  attached	  FCMs,	  an	  actin	  focus	  failed	  to	  form,	  consistent	  with	  the	  extent	  of	  fusion	   block	   found	   under	   these	   conditions	   (Fig	   4B-­‐4C).	   	   Further	   confirmation	   of	  these	  data	  was	  obtained	  using	  time-­‐lapse	   imaging	  of	  myoblast	   fusion	  (Fig	  4D,	  S3H	  Fig).	   	   Embryos	   expressing	   DiaDN::GFP	   in	   myoblasts	   showed	   movement	   of	   FCMs	  towards	  and	  attachment	  to	  FC/myotubes.	  	  A	  subset	  of	  these	  adhering	  FCMs	  showed	  no	  significant	  accumulation	  of	  actin	  that	  resembled	  the	  F-­‐actin	  focus.	  	  The	  FCMs	  that	  failed	  to	  form	  a	  F-­‐actin	  focus	  also	  failed	  to	  fuse	  to	  the	  FC/Myotube	  during	  the	  time-­‐lapse	  sequence,	  consistent	  with	  reduction	  of	  Dia	  activity	  causing	  a	  fusion	  block.	   	  In	  agreement	   with	   Dia	   regulating	   actin	   at	   the	   fusion	   site,	   expression	   of	   DiaDN	   also	  significantly	   reduces	   actin	   focus	   size	   in	   the	   blow1	  mutant,	   which	   normally	   has	   an	  enlarged	  actin	   focus	  (S3I	  Fig).	   	  Together	   these	  data	  support	   the	  critical	  role	  of	  Dia	  for	  the	  formation	  of	  the	  F-­‐actin	  focus	  as	  well	  as	  the	  importance	  of	  the	  F-­‐actin	  focus	  during	  the	  fusion	  process.	  	  
	   Previous	   data	   (Bothe	   et	   al.,	   2014;	   Sens	   et	   al.,	   2010)	   indicated	   that	  simultaneous	   loss	   of	   both	   Arp2/3	  NPFs,	   SCAR	   and	  WASp,	   leads	   to	   a	   fusion	   block	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with	  no	  F-­‐actin	  foci,	  due	  to	  the	  loss	  of	  Arp2/3	  activity.	  	  To	  address	  whether	  the	  lack	  of	  the	  actin	  focus	  in	  the	  DiaDN	  expressing	  myoblasts	  was	  due	  just	  to	  reduced	  F-­‐actin	  polymerization	  by	  Dia	  or	  whether	  Dia	  loss	  could	  also	  influence	  Arp2/3	  activity,	  we	  examined	  the	   localization	  of	   the	  Arp2/3	  regulators,	  SCAR	  and	  WASp,	   in	  myoblasts	  expressing	   the	   DiaDN	   construct	   (Fig	   4E-­‐4F).	   	   We	   found	   that	   neither	   Arp2/3	  regulator	  was	  present	  at	  the	  fusion	  site	  in	  those	  FCMs	  in	  which	  a	  focus	  failed	  to	  form	  (WASp:	  enrichment	  at	  0%	  fusion	  site	  versus	  100%	  in	  control.	  SCAR:	  enrichment	  at	  20%	  fusion	  site	  vs	  70%	  in	  control).	  	  These	  data	  suggest	  that	  Dia	  activity	  is	  required,	  through	  localization	  of	  SCAR	  and	  WASp,	  for	  Arp2/3	  activity	  at	  the	  fusion	  site.	  	  
	   To	   further	   investigate	   whether	   Dia	   functions	   upstream	   of	   the	   Arp2/3	  pathway,	  we	  examined	  Dia	  localization	  in	  sltrs1946;	  ketteJ4-­48	  double	  zygotic	  mutants.	  	  In	  this	  double	  mutant,	  Arp2/3	  activity	  is	  reduced,	  due	  to	  the	  lack	  of	  activated	  SCAR	  and	  WASp,	   and	   no	   actin	   focus	   is	   observed	   at	   the	   fusion	   site	   (Bothe	   et	   al.,	   2014).	  	  Immunostaining	  of	   these	  mutants	  revealed	   that	  Dia	  accumulated	  at	   the	   fusion	  site	  (Fig	   4G),	   suggesting	   that	   Dia	   accumulates	   at	   the	   fusion	   site	   prior	   to	   actin	   focus	  formation,	  and	  Dia’s	  localization	  is	  independent	  to	  Arp2/3	  activity.	  	  Moreover,	  these	  data	   imply	   that	   Dia	   expression,	   in	   the	   absence	   of	   Scar	   and	  Wasp	   activity	   (and	   by	  extension,	  absence	  of	  Arp2/3	  activity),	  is	  not	  sufficient	  to	  build	  the	  F-­‐actin	  focus.	  
	   As	  another	  test	  of	  our	  model,	  we	  examined	  Dia	  expression	  in	  embryos	  where	  PI(4,5)P2	  signaling	   is	   reduced.	   	   In	  other	   contexts	   (Seroude	  et	  al.,	   2002),	  PI(4,5)P2	  signaling	  provides	  a	   localization	  cue	   for	  Dia.	   	  However,	  under	  conditions	   in	  which	  reduction	  of	  PI(4,5)P2	  signaling	  leads	  to	  a	  myoblast	  fusion	  block	  (Bothe	  et	  al.,	  2014),	  Dia	  was	  still	  localized	  to	  the	  fusion	  site	  (Fig	  4H).	  	  Hence,	  PI(4,5)P2	  signaling	  appears	  not	   to	   be	   required	   for	   Dia	   localization	   during	   fusion.	   	  	   In	   addition,	   reduction	   in	  PI(4,5)P2	   signaling	   at	   the	   fusion	   site	   leads	   to	   a	   reduction	   in	   actin	   focus	  size.	   	  PI(4,5)P2	  signaling	   functions	   upstream	   of	   Arp2/3	   activity	   and	   the	   reduced	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focus	   size	   correlated	   with	   reduced	   recruitment/maintenance/activity	   of	   Arp2/3	  NPFs	  at	  the	  fusion	  site	  (Bothe	  et	  al.,	  2014).	  	  Localization	  of	  Dia	  at	  the	  fusion	  site	   in	  this	   background	   now	   provides,	   in	   part,	   a	   possible	   explanation	   for	   this	   smaller	  actin	  focus.	   Dia	   localization	   in	   this	  PI(4,5)P2	  signaling	   mutant	   background	   would	  lead	  to	  low	  level	  recruitment/activity	  of	  Arp2/3	  NPFs,	  subsequent	  Arp2/3	  activity,	  and	   actin	   focus	   formation	   (albeit	   smaller).	   	   Nevertheless,	  Dia	  requires	  PI(4,5)P2	  signaling	   to	   build	   an	   effective	   actin	   focus,	   capable	   of	  mediating	  myoblast	  fusion.	  
	  
	   Taken	   together,	  we	   conclude	   that	   Dia	   is	   essential	   for	  myoblast	   fusion,	   and	  this	  function	  occurs	  after	  recognition	  and	  adhesion	  between	  FC	  and	  FCMs,	  but	  prior	  to	   Arp2/3-­‐based	   actin	   polymerization.	   	   Importantly,	   Dia	   activity	   appears	   to	   be	  required	   for	   actin	   focus	   formation,	   both	   through	   its	   regulation	   of	   F-­‐actin	  polymerization	  and	  the	  accumulation	  of	  Arp2/3	  regulators	  at	  the	  fusion	  site.	  
	  
Constitutively	  active	  Diaphanous	  blocks	  myoblast	  fusion	  
To	  gain	  further	  insight	  to	  Dia’s	  role	  in	  actin	  polymerization	  and	  in	  the	  localization	  of	  the	  Arp2/3	  NPFs	  at	  the	  fusion	  site,	  we	  examined	  the	  effects	  of	  constitutively	  active	  Dia	   on	   myoblast	   fusion	   (Fig	   5,	   S4	   Fig,	   S5	   Fig).	   	   Several	   well-­‐characterized	  constitutively	   active	   Dia	   constructs	   (DiaCA)	   were	   employed,	   including	   DiaΔDAD,	  which	  has	  a	  deletion	  of	  the	  DAD	  domain,	  and	  FH1FH2,	  which	  consists	  of	  only	  Dia’s	  FH1	  and	  FH2	  domains	  (Fig	  5A,	  S4A	  Fig)	  (Homem	  and	  Peifer,	  2008).	   	  Expression	  of	  any	  of	  these	  DiaCA	  constructs	  in	  myoblasts	  blocked	  myoblast	  fusion	  in	  100%	  of	  the	  embryos,	  as	  witnessed	  by	  the	  presence	  of	  unfused,	   free	  myoblasts	  (Fig	  5B;	  S4B-­‐4C	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Fig).	   	   FCs	   were	   properly	   specified	   and	   myoblast	   recognition	   and	   adhesion,	   as	  measured	  by	  Sns	  and	  Duf	  localization,	  were	  unaffected	  (S5	  Fig);	  however,	  fusion	  did	  not	  occur	  (LT	  muscle	  fusion	  index:	  5.2±1.0	  vs	  26.6±1.5,	  p<0.001/	  hemisegment;	  Fig	  5C;	  S4C	  Fig).	  	  
Examination	  of	   the	   localization	  of	   constitutively	  active	  Dia	  during	  myoblast	  fusion	   revealed	   that,	   as	   with	   endogenous	   Dia,	   all	   DiaCA	   constructs	   showed	  enrichment	   at	   the	   fusion	   site	   (Fig	   5D,	   S4D	   Fig).	   	   Time	   lapse	   imaging	   showed,	  however,	   that	   DiaCA	   was	   associated	   with	   highly	   dynamic	   filopodia;	   for	   example,	  DiaΔDAD::GFP	  was	  found	  concentrated	  at	  the	  tip	  of	  each	  of	  the	  multiple	  filopodia	  at	  the	   fusion	   site	   (Fig	   5D,	   arrows).	   	   Under	  wild-­‐type	   conditions	   or	  when	  Dia::GFP	   is	  overexpressed,	  such	  increased	  numbers	  of	  dynamic	  filopodia	  were	  not	  detected.	  	  
We	  next	  examined	  actin	  organization	   in	  myoblasts	  expressing	  DiaCA.	   	  GFP-­‐tagged	  actin,	  which	  labels	  both	  G-­‐	  and	  F-­‐actin,	  was	  used	  to	  visualize	  actin	  (Fig	  5E).	  	  We	  observed	  Actin::GFP	  accumulation	  at	  fusion	  sites,	  which	  were	  similar	  in	  size	  to	  that	   in	   control	   embryos	   (1.8±0.37μm	   vs	   1.9±0.43μm,	   respectively;	   n=50,	   p=0.25).	  	  Multiple	  filopodia	  were	  also	  detected	  with	  Actin::GFP,	  extending	  from	  both	  the	  FCM	  and	   the	   FC/Myotube.	   	   The	   actin	   accumulation	   did	   not	   resolve	   during	   the	   1h	  observation	  time,	  as	  fusion	  failed	  to	  occur.	  	  Together,	  these	  data	  indicate	  that	  DiaCA	  is	   recruited	   appropriately	   to	   the	   fusion	   site.	   	   There,	   DiaCA	   enhances	   actin	  polymerization,	   visualized	   as	   increased	   filopodia;	   however,	   this	   increase	   in	   actin	  polymerization	  appears	  not	  to	  be	  productive,	  as	  fusion	  progression	  is	  blocked.	  	  
Constitutively	  active	  Dia	  alters	  actin	  dynamics	  and	  organization	  at	  the	  fusion	  
site	  
The	  highly	  dynamic	  filopodia	  at	  the	  fusion	  site	  suggested	  that	  actin	  undergoes	  rapid	  remodeling	   in	   myoblasts	   expressing	   DiaCA.	   	   We	   employed	   fluorescence	   recovery	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after	   photobleaching	   (FRAP)	   to	   quantify	   the	   consequence	   of	   expressing	   DiaCA	   on	  actin	   dynamics	   at	   the	   fusion	   site.	   	   In	   control	   experiments,	   photobleaching	   of	  individual	  actin	  foci	  in	  wild-­‐type	  embryos	  expressing	  Actin::GFP	  resulted	  in	  a	  rapid	  recovery	  of	  the	  fluorescent	  signal	  to	  pre-­‐bleaching	  levels	  (Fig	  6,	  S3	  Table).	  	  Parallel	  experiments	   in	   myoblasts	   expressing	   both	   Actin::GFP	   and	   DiaCA	   revealed	   that	  DiaCA	  significantly	  enhanced	  the	  actin	  recovery	  rate	  relative	  to	  control	  (Fig	  6A-­‐6C):	  the	   half	   time	   of	   fluorescence	   recovery	   in	   embryos	   expressing	   DiaCA	   was	  significantly	   less	   than	   that	   in	   control	   (16.3±6.7s	   vs	   53.3±17.7s,	   respectively,	  p<0.001).	   	   The	   percentage	   recovery	   for	   embryos	   expressing	  DiaCA,	   however,	  was	  similar	   to	   controls	   (Fig	   6D).	   	   The	   rapid	   turnover	   rate	   of	   Actin::GFP	   upon	   DiaCA	  expression	   suggests	   that	   actin	   filaments	   undergo	   faster	   polymerization	   and	  depolymerization	  cycles	  than	  in	  control	  myoblasts.	   	  These	  data	  are	  consistent	  with	  the	   increase	   of	   rapidly	   extending	   filopodia	   observed	   in	   time	   lapse	   of	   myoblasts	  expressing	  constitutively	  active	  Dia.	  	  
	   The	  previous	  experiments	  with	  Actin::GFP	  measured	  both	  G-­‐	  and	  F-­‐actin	  at	  the	  fusion	  site.	   	  To	  examine	  the	  organization	  and	  distribution	  of	  F-­‐actin	  alone	  at	  the	  fusion	   site,	   we	   used	   phalloidin	   staining	   in	   fixed	   preparations.	   	   In	   myoblasts	  expressing	   DiaCA,	   the	   F-­‐actin	   focus	   displayed	   a	   diffuse	   distribution	   rather	   than	   a	  compact	   spherical	   organization	   seen	   in	  wild-­‐type	   FCMs	   (Fig	   7A-­‐7B).	   	   This	   altered	  distribution	  was	   reflected	   in	   the	   fluorescence	   intensity	   curve:	   the	   peak	   of	   F-­‐actin	  intensity	   curve	   in	  DiaCA	  myoblasts	   is	   broader	   in	   comparison	   to	   controls	   (Fig	  7C).	  	  Together	  with	  the	  FRAP	  experiments,	  these	  data	  imply	  that	  DiaCA	  blocks	  myoblast	  fusion	  by	  altering	  actin	  dynamics	  and	  the	  actin	  focus	  organization	  at	  the	  fusion	  site.	  
Constitutively	  active	  Dia	   leads	  to	  mislocalization	  of	  Arp2/3	  Regulators,	  SCAR	  
and	  WASp	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Our	   loss-­‐of-­‐function	   experiments	   indicate	   that	   Dia	   is	   required,	   not	   only	   for	  filamentous	  actin	  polymerization,	  but	  also	  for	  the	  localization	  of	  the	  Arp	  2/3	  NPFs,	  SCAR	  and	  WASp,	  at	  the	  fusion	  site.	  	  To	  better	  understand	  the	  link	  between	  Dia	  and	  the	  two	  Arp2/3	  NPFs	  during	  fusion,	  we	  employed	  epistasis	  experiments,	  using	  the	  DiaCA	  and	  mutants	   in	  the	  NPF	  regulators	  (Fig	  7).	   	  We	  first	  examined	  F-­‐actin	   focus	  morphology	  in	  ketteJ4-­48	  mutant	  embryos	  in	  which	  DiaCA	  is	  expressed	  in	  myoblasts.	  	  Kette	   regulates	   the	   stability	   and	   localization	   of	   SCAR	   during	   myoblast	   fusion.	   In	  
kette	  mutants,	  myoblast	  fusion	  is	  blocked	  and	  F-­‐actin	  foci	  are	  enlarged	  (Richardson	  et	   al.,	   2007).	   	  When	   expressing	  DiaCA	   in	   the	  ketteJ4-­48	  background,	   F-­‐actin	   did	   not	  form	  a	  dense	  focus,	  but	  rather,	  displayed	  diffuse	   localization,	  reminiscent	  of	  the	  F-­‐actin	   distribution	   in	   DiaCA	   expressing	  myoblasts	   (Fig	   7D).	   	  We	   also	   examined	   F-­‐actin	   focus	   morphology	   in	   sltrS1946	  mutant	   myoblasts;	   Sltr	   directly	   binds	   to	   and	  activates	  WASp.	  	  In	  sltrS1946	  mutants,	  myoblast	  fusion	  is	  blocked	  but	  the	  size	  of	  the	  F-­‐actin	  focus	  is	  not	  changed	  (Richardson	  et	  al.,	  2007).	  	  When	  expressing	  DiaCA	  in	  the	  
sltrS1946	   background,	   F-­‐actin	   was	   diffuse	   at	   the	   fusion	   site	   and	   did	   not	   form	   a	  restricted	   focus,	   which	   again	   resembled	   F-­‐actin	   distribution	   when	   DiaCA	   was	  expressed	  in	  myoblasts	  alone	  (Fig	  7E).	  	  The	  distribution	  of	  F-­‐actin	  in	  kette-­/-­	  and	  sltr-­
/-­	  backgrounds	  when	  DiaCA	  was	  expressed	  suggested	  that	  Dia	  functions	  upstream	  of	  Arp2/3	  in	  regulating	  F-­‐actin	  assembly	  at	  the	  fusion	  site.	  	  
To	  confirm	  and	  build	  upon	  these	  data,	  we	  examined	  the	  localization	  of	  SCAR	  and	  WASp,	   the	   targets	   of	  Kette	   and	   Sltr	   activity	   in	   embryos	   expressing	  DiaCA.	   	   In	  control	   embryos,	   SCAR	   accumulated	   at	   the	   fusion	   site	   (Fig	   7F).	   	   In	   embryos	  expressing	  DiaCA	  in	  myoblasts,	  SCAR	  was	  still	  present,	  but	  it	  was	  no	  longer	  enriched	  at,	  or	  restricted	  to,	  the	  fusion	  site:	  SCAR	  was	  found	  mislocalized	  throughout	  the	  FCM	  (Fig	  7F).	  	  The	  mislocalization	  of	  SCAR	  was	  verified	  by	  fluorescence	  intensity	  curves:	  SCAR	   displayed	   several	   peaks	   in	   myoblasts	   expressing	   DiaCA,	   and	   only	   one	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overlapped	   with	   the	   F-­‐actin.	   	   WASp	   also	   localized	   at	   the	   fusion	   site	   in	   control	  embryos	   (Fig	   7G).	   	   In	  myoblasts	   expressing	   DiaCA,	  WASp,	   like	   SCAR,	   displayed	   a	  diffuse	  localization	  in	  the	  cytosol.	  	  Interestingly,	  when	  we	  evaluated	  the	  localization	  of	  WASp	  using	  fluorescence	  intensity	  curves,	  we	  found	  that	  WASp	  colocalized	  with	  the	  diffuse	  F-­‐actin	  foci	  at	  the	  fusion	  site	  (Fig	  7G).	   	  The	  mislocalization	  of	  SCAR	  and	  WASp	   suggests	   that,	   in	  myoblasts	   expressing	  DiaCA,	   Arp2/3	  was	   activated	   over	   a	  larger	   area	   compared	   to	   control,	   therefore,	   could	   contribute	   to	   the	   diffuse	  localization	  of	  F-­‐actin	  at	  the	  fusion	  site.	   	  The	  mislocalization	  of	  SCAR	  and	  WASp	  in	  both	  DiaDN	  and	  DiaCA	  expressing	  myoblasts,	  as	  well	  as	  the	  lack	  of	  an	  F-­‐actin	  focus	  in	  myoblasts	  expressing	  DiaDN,	  indicates	  that	  Dia	  functions	  upstream	  of	  Arp2/3	  and	  its	  regulators	  and	  that	  a	  particular	   level	  of	  Dia	  actin	  polymerization	  activity	  at	   the	  fusion	  site	  is	  required	  for	  optimal	  Arp2/3	  activity	  and	  focus	  formation	  at	  the	  fusion	  site.	  	  
Discussion:	  	  
In	   this	  study,	  we	  provide	   the	   first	  evidence	   that	   the	   formin	   family	  member,	  Dia,	   is	  essential	   for	   Drosophila	   myoblast	   fusion.	   	   We	   show	   that	   Dia	   is	   expressed	   in	   all	  myoblasts	   and	   is	   recruited	   to	   the	  myoblast	   fusion	   site.	   	   The	   spatial	   and	   temporal	  distribution	  of	  Dia	  at	  the	  fusion	  site	  parallels	  that	  of	  the	  F-­‐actin	  focus,	  which	  forms	  the	   core	   of	   an	   invasive	   podosome.	   	   This	   actin	   rich	   podosome	   is	   critical	   for	   FCM	  invasion	  of	   the	  FC/Myotube	  during	  fusion.	   	   In	  keeping	  with	   its	  expression	  pattern,	  Dia	  is	  essential	  for	  myoblast	  fusion	  progression:	  both	  loss	  and	  gain	  of	  Dia	  function	  lead	  to	  a	  fusion	  block.	  	  Under	  both	  conditions,	  the	  integrity	  of	  the	  F-­‐actin	  focus	  and	  hence	   the	   invasive	  podosome	   is	  compromised;	  myoblasts	  expressing	  DiaDN	   fail	   to	  form	  the	  focus,	  whereas	  myoblasts	  expressing	  DiaCA	  have	  many	  filopodia	  and	  have	  a	   diffuse	   organization	   of	   F-­‐actin,	   both	   of	  which	   contribute	   to	   a	   failure	   in	   invasive	  podosome	  formation	  and	  fusion.	  	  Dia	  activity	  is	  required	  after	  FC/Myotube	  and	  FCM	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recognition	  and	  adhesion	  but	  upstream	  of	  Arp2/3	  activity.	  	  It	  is	  required,	  in	  parallel	  with	  PI(4,5)P2	  signaling,	   to	  build	  a	   functional	  F-­‐actin	   focus	  at	   the	   fusion	  site.	   	  Our	  experiments	   further	   indicate	   that	   Dia	   activity	   is	   critical	   for	   actin	   dynamics	   at	   the	  fusion	  site,	  which,	   in	   turn,	   regulate	   fusion	  progression.	   	  Moreover,	   the	  aberrant	  F-­‐actin	  organization	  at	  the	  fusion	  site	  in	  both	  loss	  and	  gain	  of	  function	  is	  also	  due	  to	  altered	  localization	  of	  the	  Arp2/3	  regulators,	  SCAR	  and	  WASp.	  	  Taken	  together,	  our	  data	  support	  a	  role	  for	  the	  formin	  Dia	  in	  a	  critical	  first	  step	  of	  actin	  polymerization	  at	   the	   fusion	   site,	   downstream	   of	   cell-­‐cell	   recognition	   and	   adhesion,	   and	   link	   its	  activity	  to	  the	  formation	  of	  F-­‐actin	  foci,	  required	  for	  myoblast	  fusion.	  	  
Dia	  is	  required	  for	  actin	  polymerization	  at	  the	  fusion	  site	  
	   Actin	   remodeling	   is	   critical	   for	   myoblast	   fusion,	   but	   Arp2/3	   was	   the	   only	  known	   actin	   polymerization	   factor	   that	   was	   shown	   to	   be	   necessary	   for	   myoblast	  fusion	  (Berger	  et	  al.,	  2008;	  Richardson	  et	  al.,	  2007).	  	  We	  now	  show	  that	  the	  formin	  Dia	   is	   also	   required	  during	  myoblast	   fusion.	   	  Whereas	  Arp2/3	  preferably	  binds	   to	  pre-­‐existing	   actin	   filaments	   and	   generates	   uncapped	   F-­‐actin,	   formins	   nucleate	   F-­‐actin	  both	  de	  novo	  and	  from	  the	  barbed	  ends	  of	  pre-­‐existing	  actin	  filaments.	   	  Thus,	  Dia	   can	   generate	   actin	   filaments	   de	   novo,	   which	   Arp2/3	   can	   bind	   or	   elongate	  (Pollard	  and	  Borisy,	  2003;	  Pruyne	  et	  al.,	  2002).	  
	   We	  also	  show	  that	  the	  level	  of	  Dia	  activity	  is	  critical	  for	  myoblast	  fusion.	  Too	  much	  actin	  polymerization	   leads	   to	   too	  many	   filopodia	  and	  absence	  of	  an	   invasive	  podosome	  with	   its	   characteristic	   F-­‐actin	   core.	   	   Too	   little	   polymerization	   leads	   no	  actin	   focus	   and	   no	   podosome	   formation.	   	   Our	   FRAP	   data	  with	   DiaCA	   also	   hint	   at	  whether	   a	   limited	   pool	   of	   actin	   is	   available	   for	   the	   actin	   polymerization	   factors	  during	  myoblast	  fusion.	  	  Despite	  the	  high	  rates	  of	  actin	  turnover	  with	  expression	  of	  DiaCA,	  the	  final	  fluorescence	  levels	  of	  actin	  returns	  to	  the	  same	  value	  as	  in	  controls.	  	  
	   93	  
Additional	   actin	  monomers	   are	   not	   recruited	   to	   the	   site,	   even	  with	   high	   levels	   of	  polymerization	   activity.	   	   Interestingly,	   the	   rate	   of	   actin	   turnover	   has	   also	   been	  measured	   in	   mutants	   that	   affect	   Arp2/3	   activity:	   specifically,	   mutations	   in	   blow,	  which	  regulates	  the	  Arp2/3	  NPF	  WASp,	  show	  lower	  rates	  of	  actin	  exchange	  than	  in	  controls,	  due	  to	  a	  reduced	  exchange	  rate	  for	  WASp	  on	  the	  barbed	  ends	  of	  actin	  at	  the	  fusion	  site	  (Jin	  et	  al.,	  2011).	  	  Together	  these	  data	  suggest	  future	  experiments	  aimed	  at	  examination	  of	  whether	  rates	  of	  actin	  polymerization	  regulated	  by	  both	  Dia	  and	  Arp2/3	  are	  optimized	  for	  the	  available	  actin	  pool	  and	  tightly	  controlled	  for	  myoblast	  fusion	  to	  properly	  occur.	  	  
Dia	  and	  Arp2/3	  activities	  are	  linked	  during	  myoblast	  fusion	  
Both	   cooperative	   and	   antagonistic	   functions	   between	   Dia	   and	   Arp2/3	   have	   been	  reported	   (Fukumi-­‐Tominaga	   et	   al.,	   2009;	   Yan	   et	   al.,	   2013).	   	  Here	  we	  demonstrate	  that	   the	   coordinated	   and	   cooperative	   activities	   of	   these	   two	   actin	   polymerization	  factors	   leads	   to	   the	   formation	   of	   the	   F-­‐actin	   focus.	   	   With	   the	   exception	   of	  
sltr/Dwip/vrp	   mutants	   that	   form	   a	   focus	   of	   wild-­‐type	   size,	   single	   mutants	   in	   the	  Arp2/3	   NPF	   pathways,	   WASp	   and	   SCAR,	   lead	   to	   enlarged	   foci;	   however,	   double	  mutants	  in	  WASp	  and	  SCAR	  pathways	  do	  not	  form	  foci	  (Bothe	  et	  al.,	  2014).	  	  This	  is	  the	  same	  phenotype	  that	  we	  have	  seen	  in	  myoblasts	  expressing	  the	  DiaDN.	  	  Our	  data	  support	  Dia	  activity	  being	  upstream	  of	  WASp	  and	  SCAR	  activation	  of	  Arp2/3	  at	  the	  fusion	  site.	  	  This	  suggests	  that,	  at	  the	  fusion	  site,	  Dia	  initially	  provides	  the	  necessary	  context	   upon	  which	   Arp2/3	   can	   act	   and	   not	   vice	   versa,	   as	   has	   been	   suggested	   in	  other	  contexts	  in	  which	  linear	  actin	  filaments	  emerge	  from	  Arp2/3	  based	  structures	  (Jin	   et	   al.,	   2011).	   	   Nevertheless,	   both	   sets	   of	   actin	   regulators	   are	   necessary	   for	   F-­‐actin	  focus	  formation	  that	  provides	  the	  core	  of	  the	  invasive	  podosome.	  	  Neither	  Dia	  nor	  Arp2/3	  alone	  are	  sufficient.	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   The	  interplay	  between	  Dia	  and	  Arp2/3	  at	  the	  fusion	  site	  is	  also	  reflected	  by	  our	   localization	   studies.	   	   Too	   little	   or	   too	  much	   Dia	   activity	   resulted	   in	   improper	  localization	   and,	   by	   extension,	   improper	   activity	   of	   Arp2/3	   NPFs.	   How	   could	   Dia	  regulate	   this	   localization?	   	   One	   possibility	   is	   that	   Dia	   indirectly	   regulates	   Arp2/3	  localization.	  	  Dia	  could	  nucleate	  linear	  actin	  filaments,	  which	  then	  would	  provide	  the	  necessary	  substrate	  for	  recruitment,	  maintenance	  and	  /or	  activation	  of	  Arp2/3	  and	  its	  regulators,	  such	  as	  the	  WASp-­‐WIP	  complex	  (Jin	  et	  al.,	  2011).	  	  Another	  possibility	  is	  that	  Dia,	  through	  its	  interactions	  with	  members	  of	  the	  SCAR/WAVE	  complex	  such	  as	  Abi,	  may	  directly	  localize	  and/or	  maintain	  the	  localization	  of	  Arp2/3	  regulators,	  which	  are	  then	  activated	  at	  the	  fusion	  site.	   	  Abi	  has	  been	  reported	  to	  bind	  directly	  with	  Dia	  in	  vitro,	  and	  this	  interaction	  is	  required	  for	  the	  formation	  and	  stabilization	  of	   cell-­‐cell	   junctions	   (Ryu	   et	   al.,	   2009).	   	   Dia	   likely	   changes	   the	   localization	   and	  integrity	   of	   the	   SCAR/WAVE	   complex	   by	   competitively	   binding	   to	   the	   N-­‐terminal	  part	   of	   Abi,	   dissociating	   Kette/Nap1	   from	   the	   complex,	   and	   thus	   changing	   the	  stability	   and	   localization	   of	   SCAR/WAVE.	   	   It	   has	   also	   been	   established	   that	   the	  recognition	   and	   adhesion	   receptor,	   Sns,	   is	   capable	   of	   recruiting	   the	  Arp2/3	  NPFs,	  such	  as	  WASp,	  to	  the	  fusion	  site	  (Jin	  et	  al.,	  2011).	  	  While	  Sns	  is	  still	  clustered	  at	  the	  fusion	   site	   in	  DiaDN	   and	  DiaCA,	   its	   recruitment	   activity	   appears	   not	   sufficient	   for	  focus	  formation	  capable	  of	  supporting	  an	  invasive	  podosome.	  	  
	   We	  have	  shown	  that	   localization	  of	  Arp2/3	  NPFs	   is	  affected	   in	  Dia	   loss	  and	  gain	   of	   function.	   	   In	   addition	   to	   this	   spatial	   control,	   another	   important	   way	   of	  controlling	   Arp2/3	   activity	   is	   through	   activation	   of	   the	   NPFs	   via	   small	  GTPases.	   	   	  SCAR	   is	   activated	   through	   Rac-­‐dependent	   dissociation	   from	   SCAR	  inhibitory	  complex	  (Eden	  et	  al.,	  2002;	  Kunda	  et	  al.,	  2003;	  Richardson	  et	  al.,	  2007).	  	  WASp	  is	  activated	  by	  binding	  to	  Cdc42,	  which	  releases	  it	   from	  auto-­‐inhibited	  state	  (Berger	  et	  al.,	  2008;	  Kesper	  et	  al.,	  2007;	  Kim	  et	  al.,	  2007;	  Richardson	  et	  al.,	  2007).	  	  In	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this	  study,	  we	  did	  not	  examine	  the	  localization	  of	  these	  activated	  GTPases.	  	  However,	  previous	  work	  has	  shown	  that	  PI(4,5)P2	  signaling	  is	  required	  for	  proper	  localization	  of	   activated	   Rac	   at	   the	   fusion	   site	   (Bothe	   et	   al.,	   2014).	   	   How	   the	   localization	   and	  activity	   of	   small	   GTPases	   at	   the	   fusion	   site	   contribute	   to	   the	   spatial	   and	   temporal	  interplay	   between	   Dia	   and	   Arp2/3	   regulation	   of	   actin	   polymerization	   requires	  further	  investigation.	  
	   It	  remains	  unresolved	  how	  Dia	  itself	  is	  recruited	  to	  the	  fusion	  site.	  	  Our	  data	  suggest	  that	  the	  recognition	  and	  adhesion	  receptors	  Duf	  and	  Sns	  would	  be	  involved	  either	  directly	  or	  indirectly	  in	  recruiting	  Dia	  to	  the	  fusion	  site,	  as	  embryos	  that	  fail	  to	  express	  either	  of	   these	  adhesion	  receptors	   fail	   to	   recruit	  Dia	   to	   the	   fusion	  site.	   	   In	  addition,	  recent	  data	  from	  Drosophila	  epithelial	  tubes	  (Rousso	  et	  al.,	  2013)	  indicate	  that	   PI(4,5)P2	   serves	   as	   a	   localization	   cue	   for	   Dia.	   	   Previous	  work	   in	   our	   lab	   has	  shown	   that	  PI(4,5)P2	  accumulates	  at	   the	   fusion	   site	   after	  FC-­‐FCM	  recognition	  and	  adhesion;	  sequestering	  of	  PI(4,5)P2	  results	  in	  a	  significant	  fusion	  block	  (Bothe	  et	  al.,	  2014).	   	  We	   thus	   tested	  whether	   PI(4,5)P2	   regulates	  Dia	   localization	   at	   the	   fusion	  site.	   	  We	   find	   that	  Dia	   is	   recruited	   to	   the	   fusion	   site	   in	   the	   PI(4,5)P2	   sequestered	  myoblasts,	  suggesting	  that,	  in	  this	  context,	  PI(4,5)P2	  signaling	  is	  not	  required	  for	  Dia	  localization.	   	   These	   data	   provide	   possible	   explanations	   for	   why	   in	   PI(4,5)P2	  sequestering	   embryos,	   smaller	   actin	   foci	   are	   detected:	   the	   localized	   Dia	   may	   be	  sufficient	  to	  recruit	  low	  levels	  of	  Arp2/3	  and	  its	  NPFs,	  which,	  upon	  activation,	  lead	  to	   the	   formation	   of	   small	   F-­‐actin	   foci.	   	   Nevertheless,	   in	   the	   absence	   of	   PI(4,5)P2	  signaling,	   Dia	   that	   is	   recruited	   to	   the	   fusion	   site	   is	   not	   sufficient	   to	   produce	   a	  functional	   actin	   focus,	   capable	   of	   directing	   a	   fusion	   event.	   	   Recent	   work	  (Ramalingam	   et	   al.,	   2010)	   also	   indicates	   that	   charged	   residues	   in	   the	   N-­‐	   and	   C-­‐termini	  of	  mDia1	  are	  sufficient	  both	  for	  mDia’s	  clustering	  of	  PI(4,5)P2	  and	  its	  own	  membrane	   anchorage.	   	   This	   interaction	   between	   mDia1	   and	   PI(4,5)P2,	   in	   turn,	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regulates	   mDia1	   activity.	   	   Whether	   such	   a	   mechanism	   is	   in	   play	   at	   the	   myoblast	  fusion	  site	  needs	  to	  be	  further	  investigated.	  	  
	  
A	   model	   for	   interactions	   between	   actin	   polymerization	   factors	   during	  
myoblast	  fusion	  	  
We	  propose	  a	  working	  model	  for	  the	  interplay	  between	  the	  actin	  regulators	  during	  myoblast	  fusion	  (Fig	  8).	   	  Dia	  is	  recruited	  to	  the	  fusion	  site	  upon	  engagement	  of	  the	  recognition	   and	   adhesion	   receptors	   by	   a	   yet-­‐to-­‐be	   determined	   mechanism.	   	   We	  propose	   that	   PI(4,5)P2	   signaling	   at	   the	   fusion	   site	   regulates	   the	   localization	   and	  activation	  of	  downstream	  targets	  such	  as	  Rho-­‐family	  of	  small	  GTPases.	  	  These	  small	  GTPases	  lead	  to	  the	  activation	  of	  Dia.	  	  Activated	  Dia,	  in	  turn,	  polymerizes	  linear	  actin	  filaments	   and,	   in	   combination	   with	   the	   recognition	   and	   adhesion	   receptors	   and	  PI(4,5)P2,	   recruits	   the	  Arp2/3	  NPFs,	  SCAR	  and	  WASp.	   	  Activation	  of	   these	  Arp2/3	  NPFs	  at	  the	  fusion	  site	  would	  be	  accomplished	  by	  small	  GTPases	  such	  as	  Rac.	  	  These,	  in	   turn,	  would	   activate	  Arp2/3,	   leading	   to	  branched	   actin	   and	   formation	  of	   the	  F-­‐actin	   focus	   and	   the	   invasive	   podosome.	   	   Whether	   the	   Arp2/3	   NPFs	   such	   as	  SCAR/WAVE	   would	   negatively	   regulate	   Dia	   to	   downregulate	   linear	   actin	  polymerization,	  as	  suggested	  for	  mDia2	  in	  cell	  culture	  (Beli	  et	  al.,	  2008),	  or	  whether	  Dia	  competes	  with	  WASp	  for	  barbed	  end	  binding	  remains	  to	  be	  investigated	  (Co	  et	  al.,	  2007).	   	  However,	   these	  mechanisms	  would	  underscore	  a	   switch	   from	   linear	  F-­‐actin	  filopodium	  formation	  to	  the	  linear	  and	  branched	  F-­‐actin	  invasive	  podosome–like	  structure	  that	  is	  necessary	  for	  fusion.	  
Invasive	  podosomes	  in	  development	  and	  disease	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The	  actin	  focus	  formed	  at	  the	  fusion	  site	  is	  an	  F-­‐actin	  rich,	   invasive	  podosome-­‐like	  structure	  that	  has	  been	  suggested	  to	  provide	  a	  mechanical	  force	  for	  FCMs	  to	  invade	  the	   FC/Myotube	   (Jin	   et	   al.,	   2011).	   	   Similar	   invasive	   actin	   structures	   named	  invadosomes	   have	   been	   seen	   in	   different	   cell	   types,	   such	   as	   podosomes	   in	  macrophages	  and	   invadopodia	   in	  cancer	  cells	   (Linder,	  2009).	   	  Arp2/3	   is	  known	  to	  play	   a	   key	   role	   in	   invadosome	   formation,	   and	   recent	   studies	   have	   revealed	   the	  involvement	  of	  formins	  in	  developing	  invadosomes	  (Lizárraga	  et	  al.,	  2009;	  Mersich	  et	   al.,	   2010).	   	   Our	   data	   indicate	   that	   specific	   temporal	   and	   spatial	   interactions	  between	   the	   formin	  Dia	   and	  Arp2/3	   are	   required	   for	   the	   actin	   focus	   and	   invasive	  podosome	   formation.	   	   Our	   data	   thus	   provide	   new	   mechanistic	   insights	   for	   the	  interplay	  of	  Arp2/3	  and	  Formins	  during	  invadosome	  formation	  in	  these	  contexts.	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Figures	  and	  Figure	  Legends:	  	  
Fig	  1:	  Diaphanous	  is	  localized	  to	  the	  fusion	  site	  
A-­D.	  Dia	   colocalizes	  with	   the	   actin	   focus	   at	   the	   site	   of	   fusion.	  A.	   Fusing	  myoblast	  (FCM,	  false	  colored	  magenta	  in	  all	  Figures)	  and	  FC/Myotube	  (false	  colored	  turquoise	  in	  all	  Figures,	  see	  Methods	  and	  S1	  Fig)	  in	  a	  stage	  15	  twist-­actin::GFP	  embryo	  stained	  for	  F-­‐actin	  (phalloidin,	  white)	  and	  antibodies	  against	  Dia	  (red)	  and	  GFP	  (green).	  Dia	  accumulates	  at	  the	  fusion	  site,	  colocalizing	  with	  the	  F-­‐actin	  focus.	  B.	  Signal	  intensity	  plot	   confirms	   Dia	   enrichment	   with	   actin	   at	   the	   fusion	   site.	   Average	   fluorescence	  intensity	  measured	  across	   the	  F-­‐actin	   foci	   as	   shown	   in	  A.	  A	   line	  of	  predetermined	  length	  was	  dropped	  across	  the	  fusion	  site;	  fluorescence	  intensity	  along	  the	  line	  was	  measured	  in	  different	  channels,	  normalized,	  and	  plotted	  (n=10).	  See	  Methods	  and	  S2	  Fig	   for	   details	   on	   intensity	   measurements	   and	   normalization.	   C.	   Fluorescent	  intensity	  curves	  with	  error	  bars	  for	  both	  control	  (n	  =10)	  and	  proteins	  of	  interest	  (n	  =10).	  D.	  Still	  images	  from	  a	  time-­‐lapse	  series	  of	  a	  fusion	  event	  in	  a	  stage	  14	  embryo	  expressing	   Dia::GFP	   and	   Moesin::mCherry	   driven	   by	   DMef2-­Gal4	   indicates	   that	  Dia::GFP	   has	   the	   same	   spatial	   and	   temporal	   pattern	   as	   actin	   at	   the	   fusion	   site.	  Moesin::mCherry	  (red)	  labels	  F-­‐actin	  at	  the	  fusion	  site	  (arrows).	  Di.	  Signal	  intensity	  curve	  showing	  Dia::GFP	  (green)	  and	  Moesin::mCherry	  (red)	  colocalize	  during	  fusion	  at	  each	   time	  point.	  E-­H.	  Dia	   is	   localized	   to	   the	   fusion	  site	   in	  both	   the	  FC/Myotube	  (turquoise)	   and	   FCM	   (magenta).	   Dia::GFP	   (green),	   phalloidin	   (white),	   endogenous	  Dia	  (red)	  E.	  duf5.1-­Gal4	  driven	  Dia::GFP	  shows	  expression	  in	  myotubes/FCs	  in	  stage	  14	   embryos.	   Fusing	   FCM	   and	  myotube	  were	   captured	   before	   cytoplasmic	  mixing.	  Dia	   antibody	   staining	   (red)	   is	   present	   at	   the	   F-­‐actin	   focus	   (phalloidin,	   white).	   FC	  driven	   Dia::GFP	   (green)	   expressed	   in	   FC/Myotubes	   partially	   overlaps	   with	  endogenous	  Dia	   at	   the	   fusion	   site.	  F.	   The	   signal	   intensity	   curve	   confirms	   that	   the	  peak	  of	  FC	  driven	  Dia::GFP	  partially	  overlaps	  with	  endogenous	  Dia.	  G.	  Stage	  16	  sns-­
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Gal4	   driven	   Dia::GFP	   shows	   expression	   in	   mbcC1	   mutant	   FCMs,	   where	   fusion	   is	  blocked.	   Staining	  as	   in	  F.	  Dia	  enrichment	   is	   seen	  on	  FCM	  side	  with	  both	  Dia	   (red)	  and	  FCM	  driven	  Dia::GFP	   (green).	  H.	   Signal	   intensity	   curve	   confirms	  Dia::GFP	  and	  Dia	  overlap	  and	  are	  within	  the	  F-­‐actin	  peak.	  Scale	  bar:	  2.5μM	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Fig	  1:	  Diaphanous	  is	  localized	  to	  the	  fusion	  site	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Fig	  2:	  Dia	   localization	  at	   the	   fusion	  site	   is	  dependent	  on	  FC/FCM	  recognition	  
and	  adhesion,	  but	  independent	  of	  regulators	  of	  Arp2/3.	  	  
Stage	   15	   embryos	   stained	   with	   phalloidin	   (i.),	   antibodies	   against	   Dia	   (ii.),	   and	  Myosin	  Heavy	  Chain	  (iii.,	  MHC).	  Phalloidin	   labels	  F-­‐actin	  (focus	  and	  sheath)	  at	   the	  fusion	  site;	  MHC	  identifies	  myoblasts.	  FCM	  (magenta)	  and	  FC/Myotube	  (turquoise).	  
A-­iv.	   Dia	   localization	   in	   FCM	   and	   FC/myotube	   in	   a	   wild-­‐type	   embryo	   during	  myoblast	   fusion.	   Dia	   accumulates	   at	   the	   fusion	   site.	   The	   averaged	   fluorescence	  intensity	   curve	   (Aiv,	   n=5)	   in	   wild-­‐type	   embryos	   confirms	   Dia	   colocalization	   with	  actin.	  B-­iv.	  In	  sns	  mutants,	  no	  F-­‐actin	  focus	  is	  formed	  and	  no	  specific	  accumulation	  of	   actin	   or	   Dia	   are	   observed.	   Average	   fluorescence	   intensity	   curve	   of	   sns	   mutant	  embryos	  (Biv,	  n=5)	  supports	  that	  Dia	  does	  not	  accumulate	  at	  the	  fusion	  site	  and	  is	  cytoplasmic.	  C-­E-­iv.	  In	  rac,	  mbc,	  and	  kette	  mutants,	  SCAR	  activity	  is	  lost,	  an	  enlarged	  focus	   is	   observed	   at	   the	   fusion	   site,	   and	   Dia	   is	   enriched	   at	   the	   fusion	   site.	  Fluorescence	  intensity	  curves	  confirm	  Dia	  and	  actin	  colocalization	  in	  rac	  (Civ),	  mbc	  (Div),	  and	  kette	   (Eiv)	  mutants	   (n=5/genotype).	  F-­iv.	   In	   loner	  mutant	  embryos,	  Dia	  accumulates	  at	  the	  F-­‐actin	  focus,	  as	  confirmed	  by	  the	  fluorescence	  intensity	  curves	  (n=5).	   G-­I-­iv.	   In	   blow,	   sltr(Dwip)	   and	   wsp	   mutants,	   where	   WASp-­‐mediated	   actin	  remodeling	   is	   lost,	   Dia	   accumulation	   at	   the	   fusion	   site	   is	   unaffected.	   Fluorescence	  intensity	   curves	   confirm	   the	   colocalization	   of	   Dia	   and	   F-­‐actin	   in	   blow	   (Giv),	  
sltr(Dwip)	  (Hiv),	  and	  wsp	  (Iiv)	  mutants	  (n=5/genotype).	  Scale	  bar:	  2.5μM	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Fig	  2:	  Dia	   localization	  at	   the	   fusion	  site	   is	  dependent	  on	  FC/FCM	  recognition	  
and	  adhesion,	  but	  independent	  of	  regulators	  of	  Arp2/3.	  	  
	  
	  
	   103	  
	  Fig	  3:	  Diaphanous	  is	  required	  for	  myoblast	  fusion	  A.	  Schematic	  diagram	  of	  Dia	  domain	   structure	   and	   a	   deletion	   construct	   that	   renders	   Dia	   dominant	   negative	  (DiaDN).	  DiaDN	  consists	  of	  the	  FH1	  domain	  and	  a	  partially	  deleted	  FH2	  domain;	  the	  deleted	  aa	  750-­‐770	  in	  the	  FH2	  domain	  is	  indicated	  by	  the	  dashed	  area.	  B.	  Expression	  of	  DiaDN	  reduces	   filopodia	  number	   in	  S2R+	  cells.	  S2R+	  cells	   that	  were	  transfected	  with	  DiaDN::GFP	   (green	   in	  merge,	   grey	   in	   single	   channel)	   have	   less	   filopodia-­‐like,	  protrusive	   structures	   (phalloidin,	   red	   in	  merge,	   grey	   in	   single	   channel)	   relative	   to	  untransfected	  cells	  (n=20,	  p<0.001).	  Scale	  bar:	  10µM.	  This	  reduction	  was	  rescued	  by	  expression	   of	   Dia::GFP	   (S3C	   Fig).	   C-­Ci.	  UAS-­diaDN::GFP	   was	   expressed	   in	   leading	  edge	  cells	  using	  wg-­Gal4.	  Moesin::mCherry	  was	  also	  expressed	  in	  leading	  edge	  cells	  to	   visualize	   actin.	   In	   stage	   15,	   GFP-­‐negative	   control	   cells,	   filopodia	   structures	   are	  seen	   (C,	   arrow).	   DiaDN::GFP	   significantly	   reduced	   filopodia	   formation	   (Ci).	   Scale	  bar:	   2.5µM.	   Cii.	   Filopodium	   number	   was	   quantified	   in	   each	   wg-­‐Gal4	   expressing	  stripe.	  DiaDN	  significantly	  reduced	  filopodia	  formation	  in	  leading	  edge	  cells	  relative	  to	   control	   (2.1±1.29µM	   vs	   3.95±1.15µM,	   p<0.001).	   D.	   Increasing	   DiaDN	  concentration	   in	  myoblasts	   through	  higher	   temperature	   and	  genetic	   copy	  number	  leads	  to	  an	  increased	  fusion	  block.	  Three	  hemisegments	  of	  a	  lateral	  view	  of	  a	  stage	  16	   embryos	   stained	   with	   GFP	   and	   MHC	   antibody	   are	   shown.	   Myoblast	   fusion	   is	  relatively	   normal	   in	   1xDMef2-­Gal4>1xdiaDN::GFP	   embryos	   at	   29°C	   (upper	   panel),	  with	   few	   free	  myoblasts	   (arrow).	   In	   2xDMef2-­Gal4>2xdiaDN::GFP	   embryos	   (lower	  panel),	   a	   higher	   degree	   of	   fusion	   block	   (arrows)	   and	   muscle	   detachment	  (arrowheads)	   are	   observed.	   E.	   One	   hemisegment	   of	   stage	   17	   embryo	   showing	  apME-­‐NLS::dsRed	   labeled	  nuclei	   in	   the	   four	   lateral	   transverse	   (LT)	  muscles:	  From	  left	   to	   right:	  apME-­‐NLS::dsRed	   labeled	  nuclei	   in	  stage	  17	  LT	  muscles	   in	  control,	   in	  
1xDMef2-­Gal4>	   1xUAS-­diaDN::GFP,	   and	   in	   2xDMef2-­Gal4>	   2xUAS-­diaDN::GFP	  embryos	  F.	   Fusion	   index	  of	   Stage	  17	   lateral	   transverse	   (LT)	  muscles	   confirms	   the	  degree	  of	  fusion	  block	  in	  DiaDN	  embryos.	  In	  control	  embryos,	  27.1±2.3	  nuclei	  were	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counted	   in	   each	   hemisegment	   (n=40	   hemisegments).	   1xDMef2-­Gal4>	   1xUAS-­
diaDN::GFP	   reduces	   the	   number	   of	   dsRed	   positive	   nuclei	   in	   each	   hemisegment	   to	  22.5±2.2	  (p<0.001),	  whereas	  2xDMef2-­Gal4>	  2xUAS-­diaDN::GFP	  further	  reduces	  the	  number	  to	  15.5±2.7(p<0.001).	  Scale	  bar:	  24µM	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Fig	  3:	  Diaphanous	  is	  required	  for	  myoblast	  fusion	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Fig	   4.	   Dia	   regulates	   actin	   and	   Arp2/3	   activity	   during	  myoblast	   fusion.	   A.	   In	  stage	   15	   embryos	   expressing	   2xUAS-­diaDN::GFP,	   myoblasts	   are	   stained	   with	  phalloidin	  and	  antibodies	  against	  DiaDN::GFP.	  Immunostaining	  for	  Sns	  and	  Duf	  was	  used	   to	   examine	   cell	   adhesion.	   Sns	   and	   Duf	   localize	   correctly	   at	   the	   fusion	   site,	  confirming	   adhesion	   between	   FCMs	   and	   FC/myotube.	   B.	   Stage	   15	   embryos	  expressing	   2xUAS-­diaDN::GFP	   with	   2xDMef2-­Gal4.	   Myoblasts	   are	   stained	   with	  phalloidin	  and	  antibodies	  against	  GFP.	  Arrowhead	  points	  to	  a	  myoblast	  adhering	  to	  the	  myotube	  but	  failing	  to	  generate	  a	  F-­‐actin	  focus.	  C.	  Percentage	  of	  fusion	  sites	  with	  and	  without	  actin	  focus.	  Embryos	  expressing	  2x	  UAS-­diaDN::GFP	  were	  stained	  with	  phalloidin,	  and	  the	  formation	  of	  actin	  focus	  was	  quantified	  in	  these	  embryos.	  Actin	  focus	   forms	   in	  60%	  of	   fusion	  sites	  and	   is	  absent	   in	  40%.	  D.	  Time-­‐lapse	   imaging	  of	  DiaDN	   fusion	   block.	   Three	   copies	   of	   UAS-­diaDN::GFP	   and	   one	   copy	   of	   UAS-­
moesin::mCherry	  were	  driven	  by	   two	  copies	  of	  Dmef2-­Gal4.	   F-­‐actin	  dynamics	  were	  visualized	  by	  moesin::mCherry.	  Still	  images	  from	  the	  time-­‐lapse	  sequence	  show	  2-­‐3	  myoblasts	  adhered	  to	  a	  myotube	  (dashed	  lines),	  but	  unable	  to	  fuse.	  No	  F-­‐actin	  focus	  was	   detected	   at	   the	   fusion	   site	   (arrow)	   (S3I	   Fig).	   E-­F.	   Comparison	   of	   SCAR	   and	  WASp	  localization	  in	  DiaDN-­‐expressing	  FCMs.	  In	  embryos	  expressing	  high	  levels	  of	  DiaDN,	  immunostaining	  was	  used	  to	  examine	  the	  localization	  of	  SCAR	  and	  WASp.	  At	  a	   fusion	   site	   in	  which	   an	   actin	   focus	   forms	   (upper	   panels),	   SCAR	   and	  WASp	   both	  correctly	  localize	  to	  the	  actin	  focus	  (arrow;	  phalloidin).	  When	  actin	  focus	  formation	  is	  disrupted	  by	  DiaDN	  (lower	  panels),	  SCAR	  and	  WASp	  no	  longer	  accumulate	  at	  the	  fusion	  site	  (asterisk).	  G.	  Dia	   localization	   in	  sltrs1946;	  ketteJ4-­48	  double	  mutant.	   In	  this	  double	  mutant,	  phalloidin	  was	  used	  to	  label	  F-­‐actin,	  and	  Dia	  antibody	  to	  detect	  the	  localization	  of	  Dia.	  Fusion	  is	  blocked	  in	  double	  mutants,	  with	  no	  actin	  focus	  forming.	  Dia	  still	  accumulates	  at	   the	   fusion	  site.	  H.	  Dia	   localization	   in	  myoblasts	  expressing	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UAS-­PHplcγ::GFP.	   Stage	   15	   embryos	   expressing	   2xPHplcγ::GFP	   with	   2xDMef2-­Gal4.	  Myoblasts	   are	   labeled	   with	   antibodies	   against	   GFP.	   PHplcγ	   sequesters	   PI(4,5)P2,	  generating	  a	  small	  actin	  focus	  and	  blocking	  myoblast	  fusion	  (Bothe	  et	  al.,	  2014).	  In	  an	  FCM	   that	   adheres	   to	   a	  FC,	   immunostaining	   reveals	   that	  Dia	   accumulates	   at	   the	  fusion	  site.	  Scale	  bar:	  2.5μM	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Fig	  4.	  Dia	  regulates	  actin	  and	  Arp2/3	  activity	  during	  myoblast	  fusion.	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Fig	  5:	  Constitutively	  active	  Dia	  blocks	  myoblast	  fusion.	  	  
A.	  Schematic	  diagram	  of	  Dia	  domain	  structure	  and	  different	  constitutively	  active	  Dia	  deletion	   constructs	   used	   in	   this	   study.	   B.	   Whole	   mount	   lateral	   view	   of	   three	  hemisegments	   from	   stage	   16	   embryos	   showing	   the	   (MHC)	   labeled	   muscles	   and	  nuclei	   (apME-­‐NLS::dsRed)	  of	   the	   lateral	   transverse	   (LT)	  muscles.	   Scale	  bar:	  24μM.	  Expression	  of	  DiaCA	  blocks	  myoblast	   fusion	  as	  visualized	  by	  many	   free	  myoblasts	  (arrows).	  This	  fusion	  defect	  is	  not	  due	  to	  a	  failure	  in	  FC	  specification	  as	  witnessed	  by	  expression	  of	  apME-­‐NLS::dsRed	  in	  nuclei.	  C.	  Fusion	  index	  confirms	  a	  total	  block	   in	  myoblast	   fusion:	  dsRed	  positive	  nuclei	   in	  LT	  muscles/	  hemisegment	  were	  counted	  in	   control	   (26.6±1.5)	   and	   DMef2-­Gal4>UAS-­diaΔDAD::GFP	   (5.2±1.0)	   (n=40	  hemisegments/genotype)	   (p<0.001).	  D.	   Dynamics	   of	   DiaΔDAD::GFP	   expression	   in	  myoblasts.	  Still	  images	  from	  time-­‐lapse	  of	  a	  stage	  14	  DMef2-­Gal4>UAS-­diaΔDAD::GFP	  embryo.	   Saturated	   image	   shows	   outline	   of	   cells	   and	   is	   used	   to	   localize	  myoblasts	  attempting	   to	   fuse.	   Filopodia-­‐like	   protrusions	   undergo	   highly	   dynamic	   extension	  and	   retraction	   at	   areas	   of	   cell	   contact.	   DiaΔDAD::GFP	   localizes	   at	   the	   tip	   of	   those	  protrusions	  (arrows),	  and	  this	  signal	  moves	  as	  the	  filopodium	  extends	  and	  retracts.	  Scale	  bar:	  5μM	  E.	   Still	   images	   from	  time-­‐lapse	  of	   stage	  14	   twist-­actin::GFP;	  DMef2-­
Gal4>UAS-­diaFH1FH2	   embryo.	   Images	   at	   0	   and	   3	   min	   show	   filopodia-­‐like	  protrusions	   (arrows)	   emanating	   from	   the	   FCM,	   which	   adheres	   to	   the	   FC	   but	   is	  unable	  to	  fuse.	  The	  Actin::GFP	  signal	  is	  enriched	  at	  the	  fusion	  site	  during	  the	  entire	  time	  lapse	  sequence	  (1	  hr).	  Compare	  to	  control	  FCM	  (twist-­actin::GFP,	  lower	  panel),	  which	  fuses	  with	  FC	  in	  30	  minutes.	  Scale	  bar:	  4μM	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Fig	  5:	  Constitutively	  active	  Dia	  blocks	  myoblast	  fusion.	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Fig	  6:	  Constitutively	  active	  Diaphanous	  accelerates	  the	  actin	  exchange	  rate	  at	  
the	  fusion	  site.	  
Fluorescence	  recovery	  of	  Actin::GFP	  after	  photobleaching.	  Newly	  formed	  Actin::GFP	  foci	  in	  stage	  14	  embryos	  were	  photobleached	  (arrows)	  to	  approximately	  30%	  of	  the	  original	  intensity.	  The	  recovery	  rate	  was	  recorded	  every	  3s	  after	  photobleaching	  for	  a	  total	  of	  165	  sec	  (endpoint).	  A.	  Stills	  from	  time-­‐lapse	  showing	  Actin::GFP	  recovery	  at	  an	  actin	  focus	  after	  photobleaching	  in	  wild-­‐type	  and	  DMef2-­Gal4>	  UAS-­diaFH1FH2	  embryos.	   Scale	   bar:	   2.5μM	   B.	   Comparison	   of	   representative	   recovery	   kinetics	   of	  Actin::GFP	  foci	  in	  control	  (green)	  and	  DMef2-­Gal4>	  UAS-­diaFH1FH2	  (red)	  myoblasts.	  
C.	   Half	   time	   of	   fluorescent	   recovery	   in	   control	   (n=8)	   and	   DMef2-­Gal4>UAS-­
diaFH1FH2	  embryos	  (n=10).	  The	  half	  time	  of	  fluorescence	  recovery	  in	  DMef2-­Gal4>	  
UAS-­diaFH1FH2	   embryos	   (t1/2=17.7±6.7s)	   is	   significantly	   lower	   than	   control	  (t1/2=53.3±6.7s).	  D.	   Percentage	   of	   final	   recovery	   in	   control	   and	  DMef2-­Gal4>UAS-­
diaFH1FH2	   embryos.	   Final	   recovery	   in	   DMef2-­Gal4>	   UAS-­diaFH1FH2	   embryos	  (77.9±10.6%)	  is	  similar	  to	  wild-­‐type	  embryos	  (78.6±10.5%)	  (p>0.1).	  	  
	   112	  
Fig	  6:	  Constitutively	  active	  Diaphanous	  accelerates	  the	  actin	  exchange	  rate	  at	  
the	  fusion	  site.	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Fig	   7.	   Constitutively	   active	  Dia	   alters	   the	   F-­actin	   structure	   at	   the	   fusion	   site	  
and	  regulates	  localization	  of	  Arp2/3	  regulators.	  	  
A-­B.	   Stage	   14	   embryos	   stained	   for	   F-­‐actin	   (phalloidin,	  white)	   and	   for	   Dia::GFP	   or	  DiaΔDAD::GFP	   (GFP	   antibody,	   white);	   FCM	   (magenta),	   FC/Myotube	   (turquoise).	  Scale	  bar:	  5μM.	  A.	  Control	  DMef2-­Gal4>UAS-­dia::GFP	  myoblasts	  show	  colocalization	  of	   Dia::GFP	   and	   the	   F-­‐actin	   focus	   at	   the	   fusion	   site.	   B.	   DMef2-­Gal4>UAS-­
diaΔDAD::GFP	  myoblasts	  show	  that	  F-­‐actin	  does	  not	  form	  a	  well-­‐defined	  focus	  at	  the	  fusion	   site	   but	   appears	   diffuse.	   DiaΔDAD::GFP	   localizes	   to	   the	   plasma	  membrane	  and	   is	   enriched	   at	   cell	   contact	   sites.	   C.	   Fluorescent	   intensity	   curves	   confirm	   the	  distribution	   of	   F-­‐actin	   in	   embryos	   expressing	   Dia::GFP	   and	   DiaΔDAD::GFP.	   D-­E.	  Stage	   15	   embryos	   stained	   for	   F-­‐actin	   (phalloidin)	   and	   DiaΔDAD::HA	   (antibodies	  against	  HA)	  showing	  FCM	  (magenta)	  and	  FC/Myotube	  (turquoise).	  Scale	  bar:	  5μM.	  
D.	  DMef2-­Gal4	   driven	   expression	   of	  DiaΔDAD::HA	   in	  ketteJ4-­48	  mutant	   background.	  The	  morphology	   of	   the	   F-­‐actin	   focus	   at	   the	   fusion	   site	   appears	   similar	   to	  DMef2-­
Gal4>UAS-­diaΔDAD::GFP	   embryos.	   While	   F-­‐actin	   localizes	   at	   the	   cell	   cortex,	   it	  spreads	  out	  at	  the	  fusion	  site	  and	  does	  not	  make	  a	  concentrated	  focus.	  E.	  DMef2-­Gal4	  driven	   expression	   of	   DiaΔDAD::GFP	   in	   sltrs1946	   mutant	   background.	   Similar	   to	  expression	  of	  DiaCA	  alone,	  the	  F-­‐actin	  localizes	  at	  the	  cell	  cortex	  and	  spreads	  out	  at	  the	  fusion	  site.	  F-­G.	  Stage	  14	  embryos	  stained	  for	  F-­‐actin	  (phalloidin),	  DiaΔDAD::GFP	  (GFP	  antibody)	  and	  SCAR	  or	  WASp.	  Scale	  bar:	  5μM.	  F.	  SCAR	  localization	   in	  control	  and	   DMef2-­Gal4>UAS-­diaΔDAD::GFP	   embryos.	   In	   control	   embryos,	   SCAR	  accumulates	   at	   the	   fusion	   site,	   as	   confirmed	   by	   the	   fluorescent	   intensity	   curves.	  When	  expressing	  DiaΔDAD::GFP,	  SCAR	   loses	   its	  characteristic	  concentration	  at	   the	  fusion	  site	  and	  becomes	  found	  throughout	  the	  cytoplasm.	  The	  multiple	  peaks	  in	  the	  SCAR	   fluorescent	   intensity	   curve	   confirm	   SCAR’s	   change	   in	   localization.	   G.	  Localization	   of	   WASp	   in	   control	   and	   DMef2-­Gal4>UAS-­diaΔDAD::GFP	   embryo.	   In	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control	   embryos,	   WASp	   accumulates	   at	   the	   fusion	   site,	   as	   confirmed	   by	   the	  fluorescent	   intensity	   curves.	   When	   expressing	   DiaΔDAD::GFP,	   WASp	   displays	   a	  more	   diffused	   localization.	   Fluorescent	   intensity	   curves	   confirm	   the	   broader	  distribution	  of	  WASp	  signal	  in	  relation	  to	  the	  controls.	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Fig	   7.	   Constitutively	   active	  Dia	   alters	   the	   F-­actin	   structure	   at	   the	   fusion	   site	  
and	  regulates	  localization	  of	  Arp2/3	  regulators.	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Fig	  8.	  Model:	  Dia	  and	  Arp2/3	  function	  together	  to	  regulate	  myoblast	  fusion	  
During	  myoblast	   fusion,	   the	   transmembrane	  molecules	   (e.g.	   Sns	   and	  Duf)	  mediate	  recognition	   and	   adhesion	   between	   the	   FCM	   and	   the	   FC/myotube.	   After	   cell	  adhesion,	   Dia	   is	   recruited	   to	   the	   fusion	   site,	   where	   it	   collaborates	  with	   PI(4,5)P2	  signaling	  in	  making	  a	  functional	  F-­‐actin	  focus,	  How	  PI(4,5)P2	  signaling	  coordinates	  with	  Dia	  is	  unclear,	  but	  it	  may	  possibly	  be	  through	  the	  recruitment	  of	  small	  GTPases	  that	  activate	  Dia.	  Active	  Dia,	  in	  turn,	  nucleates	  F-­‐actin	  particularly	  on	  the	  FCM	  side,	  which	  serves	  as	  a	  substrate	  for	  Arp2/3.	  Coordinated	  Dia	  and	  Arp2/3	  activities	  allow	  the	   actin	   network	   to	   consolidate	   into	   invasive	   podosome-­‐like	   structures.	   Loss	   of	  filamentous	   actin	   and	   reduction	   in	  Arp2/3	  NPFs	   recruitment/maintenance	   due	   to	  Dia	  loss	  results	  in	  Arp2/3	  being	  unable	  to	  nucleate	  enough	  actin	  filaments	  to	  build	  an	   invasive	   podosome-­‐like	   structure.	   Hence	   no	   fusion	   can	   occur.	   In	   Dia	   gain	   of	  function	  embryos,	  Dia	  builds	  excessive	  actin	  filaments.	  Arp2/3	  NPFs	  fail	  to	  localize	  properly,	   leading	  to	  an	  alteration	  in	  the	  distribution	  of	  activated	  Arp2/3.	  Since	  the	  actin	   network	   fails	   to	   consolidate	   into	   invasive	   podosome-­‐like	   structures,	   no	  myoblast	  fusion	  can	  occur.	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Fig	  8.	  Model:	  Dia	  and	  Arp2/3	  function	  together	  to	  regulate	  myoblast	  fusion	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Supplemental	  Information	  	  
S1	  Table:	  Quantification	  of	  Dia	  enrichment	  at	   the	   fusion	  site	   in	  control	  and	  fusion	  mutants.	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S2	  Table:	  Quantification	  of	  muscle	  phenotypes	  in	  dia	  mutant	  and	  dia	  knockdown.	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S3	  Table:	  FRAP	  summary:	  Actin::GFP	  recovery	  rate	  and	  percentage	  of	  recovery	  in	  control	  embryos	  and	  constitutively	  active	  Diaphanous	  embryos	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S1	  Fig:	  Dia	  expression	  in	  fusing	  myoblasts	  
A.	  Projection	  of	   three	  hemisegments	  of	  a	  stage	  14	   twist-­actin::GFP	  embryo	  stained	  for	   GFP	   which	   reveals	   the	   myoblasts	   in	   each	   hemisegments	   as	   fusion	   occurs.	  Ai.	  Three	   hemisegments	   of	   a	   stage	   16	   control	   embryo	   stained	   for	   MHC.	   This	   image	  reveals	   the	  muscle	   pattern	   that	   results	   from	  myoblast	   fusion.	   Scale	   bar:	   10µM	  B.	  Higher	   magnification	   image	   showing	   single	   scan	   of	   the	   boxed	   area:	   one	  hemisegment	   from	   a	   stage	   14	   twist-­actin::GFP	   embryo	   stained	   for	   F-­‐actin	  (phalloidin)	  and	  antibodies	  against	  Dia	  and	  GFP.	  The	  F-­‐actin	  focus	  at	  the	  fusion	  site	  was	   visualized	   both	   by	   GFP	   antibody	   (green;	   twist-­actin::GFP)	   and	   phalloidin	  staining	   (white).	   Dia	   (red)	   is	   present	   in	   muscles	   and	   is	   enriched	   at	   fusion	   sites	  (arrows).	   Scale	   bar:	   10µM.	   C.	   Cell	   outline	   determination	   used	   in	   all	   Figures:	   we	  determine	  the	  FCM	  and	  myotube	  cell	  outlines	  manually	  by	  adjusting	  brightness	  and	  changing	  focal	  planes.	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  S1	  Fig:	  Dia	  expression	  in	  fusing	  myoblasts	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S2	  Fig:	  Pipeline	  of	  measuring	  fluorescent	  intensity.	  
For	  all	  Figures	  except	  Fig	  1:	  a	  line	  was	  drawn	  along	  cell	  cortex,	  with	  the	  center	  of	  the	  line	   localized	   at	   the	   actin	   focus	   or	   cell	   contact	   site.	   Fluorescent	   intensities	   were	  measured	  along	  the	  line	  and	  normalized	  using	  the	  equation	  shown	  in	  Figure.	  After	  the	   desired	   number	   of	   samples	   was	   measured,	   average	   relative	   intensities	   and	  standard	  deviations	  at	  each	  point	  were	  calculated	  and	  plotted.	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S2	  Fig:	  Pipeline	  of	  measuring	  fluorescent	  intensity.	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S3	  Fig:	  Muscle	  phenotypes	  in	  dia	  loss	  of	  function	  embryos.	  
A.	  Stage	  16	  dia2	  and	  dia5	  homozygous	  embryos	  were	  stained	  with	  MHC	  to	  visualize	  muscle	   pattern.	   GFP	   antibody	   was	   used	   to	   identify	   balancer.	   dia2	   is	   an	   amorphic	  allele	   and	   dia5	   is	   a	   hypomorphic	   allele;	   both	   result	   in	   Dia	   loss	   of	   function.	  Homozygous	   dia	   mutants	   display	   a	   range	   of	   muscle	   defects,	   including	   muscle	  detachment	   (arrowhead),	  missing	  muscles	   (asterisk),	   free	  myoblasts	   (arrow),	   and	  muscle	  shape	  changes.	  Scale	  bar:	  40µM.	  B.	  Fusion	  index	  of	  dia2	  and	  dia5	  homozygous	  mutants.	  apMe-­NLS::dsRed	  was	  expressed	   in	  LT	  muscles	   to	   label	  nuclei,	  and	   fusion	  index	   was	   assessed	   in	   stage	   17	   embryos.	   Fusion	   was	   impaired	   in	   dia2	   and	   dia5	  homozygous	  mutant	  embryos	  (dia2:	  14.1±1.3,	  n=21,	  dia5:	  21.5±1.3	  n=20	  vs	  control:	  27.8±0.3	  n=12,	  p<0.001).	  C.	  Expression	  of	  Dia::GFP	  rescued	   filopodia	  reduction	  by	  DiaDN.	   S2R+	   cells	   that	   were	   co-­‐transfected	   with	   Dia::GFP	   (green),	   and/or	  DiaDN::mCherry	  (red)	  (n=7).	  Expression	  of	  DiaDN::mCherry	  results	  in	  a	  significant	  reduction	  of	  filopodia	  (phalloidin,	  grey	  in	  single	  channel).	  By	  contrast,	  expression	  of	  Dia::GFP	   resulted	   in	   increased	   cell	   spreading	   and	   increased	   numbers	   of	   filopodia	  (phalloidin,	  grey)	  compared	  to	  control.	  Expression	  of	  both	  contructs	  simultaneously	  results	   in	   more	   filopodia-­‐like,	   protrusive	   structures	   relative	   to	   cells	   that	   are	  transfected	   with	   DiaDN::mCherry	   alone	   (n=5).	   Scale	   bar:	   10µM.	   D.	   Filopodia	  numbers	   were	   quantified	   in	   cells	   expressing	   DiaDN::mCherry,	  DiaDN::mCherry+Dia::GFP,	   Dia::GFP	   and	   mock	   treated	   control.	   E.	   Two	   copies	   of	  
DMef2-­Gal4	  driving	  two	  copies	  of	  UAS-­diaDN::GFP	   in	  myoblasts	  at	  29°C.	  Antibodies	  to	   GFP	   were	   used	   to	   visualize	   the	   muscle	   cells.	   Embryonic	   muscle	   defects	   were	  found,	  including	  free	  myoblasts	  (arrow)	  and	  missing	  muscles	  (asterisk)	  at	  Stage	  16	  and	  severe	  muscle	  detachment	  (arrowhead)	  at	  Stage	  17.	  Scale	  bar:	  20µM	  and	  40µM	  from	  left	  to	  right.	  F-­G.	   In	  male	  flies	  which	  carry	  net-­Gal4;nos-­Gal4>UAS-­diaDN::GFP,	  male	  fertility	  (F)	  and	  sperm	  number	  (G)	  were	  quantified	  and	  compared	  to	  control.	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H.	   Time-­‐lapse	   imaging	   showing	   a	   fusion	   site	   in	   embryos	   expressing	   DiaDN::GFP.	  Three	  copies	  of	  UAS-­diaDN::GFP	  and	  one	  copy	  of	  UAS-­moesin::mCherry	  were	  driven	  by	  two	  copies	  of	  Dmef2-­Gal4.	  F-­‐actin	  dynamics	  were	  visualized	  by	  moesin::mCherry.	  As	  DiaDN	  does	  not	  block	  myoblast	  fusion	  completely,	  fusion	  events	  can	  be	  observed.	  Still	   images	   from	   the	   time-­‐lapse	   sequence	   show	   a	  myoblast	   fusing	   to	   a	  myotube,	  with	   a	   normal	   F-­‐actin	   accumulation	   at	   the	   fusion	   site.	   Scale	   bar:	   5μm	   I.	  Quantification	   of	   actin	   focus	   size	   of	   blow1	   embryo	   and	   blow1;DMef2-­Gal4,UAS-­
diaDN::GFP	  embryos.	   The	   actin	   focus	   size	   is	   significantly	   reduced	   in	  blow1;DMef2-­
Gal4,UAS-­diaDN::GFP	  embryos	  (n=18)	  compared	  to	  that	  in	  the	  blow1	  embryo	  (n=18,	  P<0.01).	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S3	  Fig:	  Muscle	  phenotypes	  in	  dia	  loss	  of	  function	  embryos.	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S4	   Fig:	   Embryonic	   phenotypes	   found	   in	   embryos	   expressing	   different	  
constitutively	  active	  Dia	  constructs.	  
A.	  Schematic	  diagram	  of	  Dia	  domain	  structure	  and	  the	  different	  constitutively	  active	  Dia	  (DiaCA)	  deletion	  constructs	  (DiaΔDAD,	  diaDDFH1FH2,	  DiaFH1FH2)	  used	  in	  this	  study.	  B-­C.	  Muscle	   pattern	   in	   a	   single	   hemisegment	   and	   Fusion	   index	   in	   embryos	  expressing	   the	   different	   DiaCA	   constructs.	   UAS-­diaCA	   was	   expressed	   in	   muscles	  using	  the	  DMef2-­Gal4	  driver.	  MHC	  staining	  shows	  that	  myoblast	  fusion	  was	  blocked	  by	  DiaCA	  (high	  magnification	  of	   the	  LT	  Muscle	  area).	  To	  confirm	   this	  observation,	  apMe-­‐NLS::dsRed	   was	   expressed	   in	   LT	   muscles	   to	   measure	   the	   fusion	   index.	  Compared	  with	   controls,	   all	  diaCA	   constructs	   significantly	   reduce	  myoblast	   fusion	  (graph	  in	  B.	  p<0.001).	  D.	  F-­‐actin	  structure	  and	  DiaCA	  localization	  when	  expressing	  different	  diaCA	   constructs.	  F-­‐actin	  was	   labeled	  with	  phalloidin.	  DiaCA	   localizations	  were	   visualized	   with	   GFP	   immunofluorescence	   staining.	   Instead	   of	   forming	   a	  defined	   actin	   focus	   at	   the	   fusion	   site,	   F-­‐actin	   displayed	   a	   diffused	   localization	   in	  myoblasts	   expressing	   DiaCA.	   DiaDDFH1FH2	   and	   DiaFH1FH2	   both	   localize	   in	   the	  cytoplasm,	   while	   DiaΔDAD	   localizes	   primarily	   at	   the	   membrane.	   Intensity	   plot	  shows	  the	  colocalization	  of	  DiaCA	  (green)	  and	  actin	  structure	  (red)	  at	  the	  fusion	  site.	  Scale	  bars	  in	  B-­D:	  10µM	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S4	   Fig:	   Embryonic	   phenotypes	   found	   in	   embryos	   expressing	   different	  
constitutively	  active	  Dia	  constructs.	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S5	  Fig:	  Recognition	  and	  adhesion	  are	  not	  affected	  by	  constitutively	  active	  Dia.	  
A.	   Sns	   localization	   in	   control	   (DMef2-­‐Gal4>UAS-­‐dia::GFP)	   and	   DMef2-­‐Gal4>UAS-­‐diaΔDAD::GFP	   embryos.	   Stage	   14	   embryos	   stained	  with	   phalloidin	   and	   antibodies	  against	  GFP	  and	  Sns.	   In	   control	   embryos,	   Sns	   is	   localized	  at	   the	   fusion	   site	  on	   the	  FCM	   side.	   Constitutively	   active	   Dia	   does	   not	   change	   Sns	   localization	   at	   the	   fusion	  site.	  Fluorescent	  intensity	  curves	  confirm	  that	  the	  Sns	  peak	  colocalizes	  with	  F-­‐actin	  peak	   in	   both	   control	   and	   DMef2-­‐Gal4>UAS-­‐diaΔDAD::GFP	   embryos.	   B.	   Duf	  localization	   in	   control	   and	   DMef2-­‐Gal4>UAS-­‐diaΔDAD::GFP	   embryos.	   Stage	   14	  embryos	   stained	   with	   phalloidin	   and	   antibodies	   against	   GFP	   and	   Duf.	   In	   control	  embryos,	  Duf	  is	  localized	  at	  the	  fusion	  site	  on	  the	  FC/myotube	  side.	  Similar	  to	  Sns,	  Duf	   localization	   is	   not	   changed	   by	   DiaΔDAD::GFP.	   Fluorescent	   intensity	   curves	  confirm	   that	   the	   Duf	   peak	   colocalizes	   with	   the	   F-­‐actin	   peak	   for	   both	   control	   and	  DMef2-­‐Gal4/UAS-­‐diaΔDAD::GFP	   embryos.	   The	   peak	   of	   Duf	   is	   broader	   and	   less	  defined	   in	   DMef2-­‐Gal4>UAS-­‐diaΔDAD::GFP	   embryos.	   C-­D.	   Projection	   image	   of	  myoblasts	   expressing	   the	   constitutively	   active	   Dia	   construct	   DiaΔDAD.	   Actin	  (phalloidin,	  white);	  Dia	   (GFP	  antibody,	  green),	  Sns	  or	  Duf	   (antibody,	  Red).	  Dashed	  lines	   indicate	   FCMS	   adhered	   to	   the	   FC.	   Compared	   to	   the	   control	   embryo,	   the	  accumulation	   of	   Sns	   and	   Duf	   appears	   stronger	   due	   to	   an	   increased	   number	   of	  unfused	  and	  adhered	  myoblasts.	  Scale	  bar:	  2.5µM	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S5	  Fig:	  Recognition	  and	  adhesion	  are	  not	  affected	  by	  constitutively	  active	  Dia.	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CHAPTER	  FOUR	  
DIAPHANOUS	  REGULATES	  SCAR	  COMPLEX	  LOCALIZATION	  DURING	  
DROSOPHILA	  MYOBLAST	  FUSION*	  
	  
Abstract:	  	  
From	  Drosophila	  to	  man,	  multinucleated	  muscle	  cells	   form	  through	  cell-­‐cell	   fusion.	  	  Using	   Drosophila	   as	   a	   model	   system,	   researchers	   first	   identified,	   and	   then	  demonstrated,	   the	   importance	   of	   actin	   cytoskeletal	   rearrangements	   at	   the	   site	   of	  fusion.	   	   These	   actin	   rearrangements	   at	   the	   fusion	   site	   are	   regulated	   by	   SCAR	   and	  WASp	  mediated	  Arp2/3	  activation,	  which	  nucleates	  branched	  actin	  networks.	  	  Loss	  of	  SCAR,	  WASp	  or	  both	  leads	  to	  defects	  in	  myoblast	  fusion.	  	  Recently,	  we	  have	  found	  that	  the	  actin	  regulator	  Diaphanous	  (Dia)	  also	  plays	  a	  role	  both	  in	  organizing	  actin	  and	   in	   regulating	  Arp2/3	  activity	   at	   the	   fusion	   site.	   	   In	   this	  Extra	  View	  article,	  we	  provide	   additional	   data	   showing	   that	   the	   Abi-­‐SCAR	   complex	   accumulates	   at	   the	  fusion	   site	   and	   that	   excessive	   SCAR	   activity	   impairs	   myoblast	   fusion.	   	   Using	  constitutively	  active	  Dia	  constructs,	  we	  provide	  further	  evidence	  that	  Dia	  functions	  upstream	   of	   SCAR	   activity	   to	   regulate	   actin	   dynamics	   at	   the	   fusion	   site	   and	   to	  localize	  the	  Abi-­‐SCAR	  complex.	  	  
Introduction:	  	  
Cell-­‐cell	   fusion	   is	   a	   crucial	   step	   in	   muscle	   development	   and	   repair	   (Abmayr	   and	  Pavlath,	  2012;	  Kim	  et	  al.,	  2015;	  Simionescu	  and	  Pavlath,	  2011).	   	  During	  Drosophila	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muscle	  development,	  fusion	  occurs	  between	  the	  founder	  cells	  (FCs)/myotubes	  and	  the	  fusion	  competent	  myoblasts	  (FCMs).	  	  The	  FCs	  express	  transcription	  factors	  that	  determine	  the	  identity	  of	  individual	  muscles.	  	  When	  a	  naïve	  FCM	  fuses	  with	  a	  FC,	  the	  newly	   added	   myonucleus	   is	   reprogrammed	   to	   adopt	   the	   founder	   cell	   nucleus	  identity,	  and	  another	  round	  of	  fusion	  is	  initiated.	  	  During	  fusion,	  the	  formation	  of	  an	  actin-­‐enriched	  focus	  occurs	  at	   the	  fusion	  site;	   this	  actin	   focus	  provides	  an	   invasive	  force	  from	  the	  FCM	  into	  the	  FC/myotube,	  promoting	  fusion	  (Sens	  et	  al.,	  2010).	  	  Actin	  polymerization	   at	   the	   fusion	   site	   is	   regulated	   by	   the	   actin	   nucleating	   complex	  Arp2/3	   (Richardson	   et	   al.,	   2007;	   Rodal	   et	   al.,	   2015;	   Schulman	   et	   al.,	   2015).	   	   The	  activity	  of	  Arp2/3	  is	  controlled	  by	  the	  nucleation	  promoting	  factors	  WASp	  and	  SCAR	  (also	   known	   as	   WAVE).	   WASp	   and	   SCAR	   share	   a	   C-­‐terminal	   VCA	   domain	   that	  activates	   Arp2/3	   by	   both	   promoting	   conformational	   changes	   in	   Arp2/3	   and	  presenting	  G-­‐actin	  to	  Arp2/3	  (Eden	  et	  al.,	  2002;	  Ismail	  et	  al.,	  2009).	  	  The	  importance	  of	   WASp	   and	   SCAR	   during	   myoblast	   fusion	   has	   been	   demonstrated	   in	   previous	  studies	  from	  our	  lab	  and	  others	  in	  multiple	  systems	  (Berger	  et	  al.,	  2008;	  Gildor	  et	  al.,	  2009;	   Gruenbaum-­‐Cohen	   et	   al.,	   2012;	   Haralalka	   et	   al.,	   2011;	   Kaipa	   et	   al.,	   2013;	  Kesper	   et	   al.,	   2007;	   Kim	   et	   al.,	   2007;	   Massarwa	   et	   al.,	   2007;	   Nowak	   et	   al.,	   2009;	  Richardson	  et	  al.,	  2007;	  Schäfer	  et	  al.,	  2007;	  Sens	  et	  al.,	  2010).	  	  Loss	  or	  reduction	  of	  WASp	   and/or	   SCAR	   activity	   results	   in	   a	   fusion	   block:	   FCMs	   make	   contact	   with	  FC/myotubes,	  but	  are	  unable	  to	  form	  or	  expand	  fusion	  pores,	  preventing	  myoblast	  fusion.	   	  As	  both	  WASp	  and	  SCAR	  are	  required	  for	  Arp2/3	  activation,	  and	  therefore	  branched	  actin	  network	   formation	  at	   the	   fusion	  site,	   loss	  of	  both	  WASp	  and	  SCAR	  activity	   results	   in	   no	   actin	   focus	   formation	   (Bothe	   et	   al.,	   2014;	   Sens	   et	   al.,	   2010).	  	  Interestingly,	   loss	   of	  WASp	   function	   alone	   results	   in	   a	   fusion	   block	   with	   normal-­‐sized	   actin	   foci,	   while	   loss	   of	   SCAR	   function	   alone	   results	   in	   a	   fusion	   block	   with	  enlarged	  actin	  foci	  (Richardson	  et	  al.,	  2007;	  Sens	  et	  al.,	  2010).	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   In	   our	   recent	   PLoS	   Genetics	   paper,	   “The	   formin	   Diaphanous	   regulates	  myoblast	  fusion	  through	  actin	  polymerization	  and	  Arp2/3	  regulation”,	  we	  reported	  that	   the	   formin	   Diaphanous	   (Dia),	   which	   nucleates	   and	   polymerizes	   linear	   actin	  filaments	   rather	   than	   branched	   microfilament	   arrays,	   plays	   a	   critical	   role	   in	  myoblast	  fusion	  (Deng	  et	  al.,	  2015).	  	  Dia	  controls	  actin	  rearrangements	  at	  the	  fusion	  site	  by	  a)	  nucleating	  and	  polymerizing	  actin	   filaments	  and	  b)	   localizing	  WASp	  and	  SCAR.	   	  Although	  we	  have	  demonstrated	  the	  importance	  of	  Dia	  in	  localizing	  Arp2/3	  regulators,	   how	   Dia	   interacts	   with	   SCAR/WAVE	   and	   WASp	   and	   directs	   their	  localization	   to	   the	   fusion	   site	   remained	   unclear.	   	   In	   this	   Extra	   View	   article,	   we	  concentrate	  on	  the	  activity	  of	  the	  SCAR	  complex	  and	  investigate	  how	  Dia	  regulates	  SCAR	  at	  the	  fusion	  site.	  
	   The	   activity	   of	   SCAR/WAVE	   is	   controlled	   by	   the	   SCAR/WAVE	   regulatory	  complex	  (WRC).	  	  The	  WRC	  is	  a	  pentameric	  complex	  that	  contains	  SCAR/WAVE,	  Abi,	  Kette/Nap1,	  Hspc300,	  and	  Sra1/Cyfip1.	  	  In	  vitro	  experiments	  using	  purified	  protein	  suggest	  that	  when	  not	  associated	  with	  the	  complex,	  SCAR/WAVE	  exists	  in	  an	  active	  conformation	  and	  can	  stimulate	  Arp2/3	  activity	  through	  its	  VCA	  domain	  (Machesky	  et	  al.,	  1999).	  	  However,	  in	  the	  WRC,	  the	  VCA	  domain	  of	  SCAR/WAVE	  is	  bound	  by	  Sra-­‐1,	   and	   SCAR/WAVE’s	   activity	   is	   inhibited	   (Ismail	   et	   al.,	   2009).	   	   Rac-­‐GTP	   activates	  SCAR/WAVE	   by	   competitively	   binding	   to	   Sra1,	   triggering	   exposure	   of	   the	   VCA	  domain	  of	  SCAR/WAVE	  (Chen	  et	  al.,	  2010).	  	  In	  vitro	  experiments	  confirm	  that,	  when	  activated	   by	   Rac-­‐GTP,	   SCAR/WAVE	   does	   not	   dissociate	   from	  WRC	   complex:	   only	  that	  its	  C-­‐terminal	  VCA	  domain	  is	  no	  longer	  bound	  by	  Sra1	  (Chen	  et	  al.,	  2010;	  Ismail	  et	   al.,	   2009).	   	   In	   addition	   to	   regulating	   SCAR/WAVE	   activity,	   the	   formation	   of	   the	  WRC	   is	   crucial	   for	   SCAR/WAVE	   localization	   and	   stability	   (Davidson	   et	   al.,	   2013;	  Echarri	  et	  al.,	  2004;	  Richardson	  et	  al.,	  2007).	  	  Removal	  of	  WRC	  components,	  such	  as	  Abi	  or	  Kette/Nap1,	  results	  in	  SCAR/WAVE	  degradation	  (Kunda	  et	  al.,	  2003).	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   Abi	   is	   a	   key	   component	   of	   the	   WRC	   that	   is	   important	   for	   the	   stability,	  localization,	  and	  activity	  of	  SCAR/WAVE	  (Davidson	  et	  al.,	  2013;	  Echarri	  et	  al.,	  2004;	  Leng	  et	  al.,	  2005).	  	  Recent	  experiments	  have	  shown	  that	  Abi	  also	  interacts	  physically	  with	  Dia	   to	   regulate	   actin	   dynamics	   and	   adhesion	   in	   A431	   epidermoid	   carcinoma	  cells	  and	  293T	  human	  embryonic	  kidney	  cells	   (Ryu	  et	  al.,	  2009).	   	  Moreover,	   these	  experiments	   indicate	   that	   Dia	   and	   SCAR/WAVE	   physically	   bind	   to	   partially	  overlapping	  regions	  of	  Abi	  (Ryu	  et	  al.,	  2009).	  	  Since	  the	  interaction	  between	  Abi	  and	  SCAR/WAVE	   is	   critical	   in	   localizing	   and	   stabilizing	   SCAR/WAVE	   (Echarri	   et	   al.,	  2004;	  Leng	  et	  al.,	  2005),	  the	  authors	  suggest	  that	  Dia	  regulates	  SCAR/WAVE	  activity	  through	   competition	   for	   Abi	   binding.	   	   In	   this	   Extra	   View	   article,	   we	   investigate	  whether	  Dia	  regulates	  SCAR/WAVE	  during	  Drosophila	  myoblast	  fusion	  through	  the	  mechanisms	   described	   in	   mammalian	   cell	   culture.	  We	   also	   report	   an	   unexpected	  fusion	  phenotype	  that	  is	  associated	  with	  excessive	  SCAR	  activity	  in	  embryos.	  
Results:	  
Excessive	  Scar	  activity	  blocks	  myoblast	  fusion	  
Mammalian	  tissue	  culture	  experiments	  using	  different	  cell	  types	  suggested	  that	  the	  binding	   of	   Abi	   to	   SCAR	   is	   required	   for	   several	   aspects	   of	   SCAR/WAVE	   activity,	  including	   stability	   (Echarri	   et	   al.,	   2004),	   localization,	   and	   activation	   (Leng	   et	   al.,	  2005).	   	  We	   hypothesized	   that	   this	   relationship	   between	  Abi	   and	   SCAR	   also	   exists	  during	  Drosophila	  myoblast	  fusion.	  	  To	  test	  our	  hypothesis	  and	  investigate	  how	  Abi	  regulates	   SCAR,	  we	  employed	  a	  bimolecular	   fluorescence	   complementation	   (BiFC)	  technique	  to	  visualize	  Abi-­‐SCAR	  complex	  formation	  in	  vivo	  (Gohl	  et	  al.,	  2010).	  	  In	  the	  BiFC	   system,	   YFP	   is	   split	   into	   two	   non-­‐fluorescent	   fragments:	   N-­‐terminal	   YFP	  (NYFP)	   and	  C-­‐terminal	   YFP	   (CYFP),	   and	   each	   fragment	   is	   fused	   to	   either	   SCAR	  or	  Abi.	   	   YFP	   is	   reconstituted	  when	   the	   two	   fragments	  are	  brought	   in	   close	  proximity	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(Gohl	   et	   al.,	   2010).	   	   To	   visualize	   SCAR	   and	   Abi	   interaction	   during	   fusion,	   we	  expressed	  these	  split	  YFP-­‐tagged	  SCAR	  and	  Abi	  constructs	  in	  the	  developing	  muscles	  using	   the	   muscle	   specific	   driver,	   Dmef2-­Gal4.	   	   To	   control	   for	   background	  fluorescence,	   we	   used	   confocal	   microscopy	   to	   detect	   fluorescent	   levels	   when	  untagged	  NYFP	  and	  CYFP	  were	  similarly	  expressed.	  	  We	  did	  not	  observe	  fluorescent	  signal	   in	  the	  muscles	  expressing	  untagged	  split-­‐YFP	  fragments	  simultaneously	  (Fig	  1A,	   upper	   row);	   this	   indicated	   that	   the	   untagged	   split-­‐YFP	   did	   not	   interact	  spontaneously	   to	   reconstitute	   YFP.	   	   We	   then	   visualized	   the	   interaction	   between	  SCAR	  and	  Abi	  by	  expressing	  both	  SCAR-­‐NYFP	  and	  Abi-­‐CYFP,	  or	   the	  converse,	  Abi-­‐NYFP	   and	   SCAR-­‐CYFP	   simultaneously	   in	   muscles.	   	   With	   either	   combination,	   we	  observed	  strong	  fluorescent	  YFP	  signal	  at	  the	  fusion	  site,	  which	  is	  marked	  by	  the	  F-­‐actin	   focus	   (Fig	   1A,	  middle	   and	   lower	   rows).	   	   Together,	   these	   data	   confirmed	  our	  hypothesis	   that	   SCAR	   and	  Abi	   physically	   interact	   at	   the	   fusion	   site	   during	  muscle	  formation.	  	  
	   In	  tissue	  culture,	  Abi	  binding	  is	  known	  to	  enhance	  SCAR	  stability	  and	  activity	  (Echarri	   et	   al.,	   2004;	   Kunda	   et	   al.,	   2003;	   Leng	   et	   al.,	   2005).	   	   As	   the	   actin	  polymerization	  activity	  of	  SCAR	  is	  required	  during	   fusion	  (Richardson	  et	  al.,	  2007;	  Sens	  et	  al.,	  2010),	  it	  is	  possible	  that	  the	  interaction	  between	  Abi	  and	  SCAR	  is	  critical	  for	  controlling	  SCAR	  levels	  and	  activity,	  and	  thus	  actin	  polymerization,	  at	  the	  fusion	  site.	   	   To	   test	   the	   function	   of	   the	   Abi-­‐SCAR	   interaction	   at	   the	   fusion	   site,	   we	   next	  examined	   the	   impact	   of	   tagged	   Abi-­‐SCAR	   expression	   on	   muscle	   development.	  	  Analysis	   of	   developing	   muscle	   cells	   which	   overexpress	   both	   the	   SCAR-­‐	   and	   Abi-­‐	  tagged	  split	  YFP	  constructs	  revealed	  that	  myoblast	  fusion	  at	  stage	  16	  was	  impaired	  (Figure	  2A,	  middle	  and	  lower	  rows).	  	  To	  quantify	  the	  fusion	  block,	  we	  examined	  the	  fusion	  index	  in	  late	  stage	  16	  embryos.	  	  In	  contrast	  to	  control	  embryos	  in	  which	  5-­‐7	  fusion	   events	   occur	   to	   form	   each	   Lateral	   Transverse	   (LT)	  muscle	   (Metzger	   et	   al.,	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2012),	   we	   found	   that	   expression	   of	   Abi-­‐NYFP	   and	   SCAR-­‐CYFP	   resulted	   in	   severe	  fusion	  block	  with	  only	  0-­‐3	  rounds	  of	  fusion	  per	  LT	  muscle	  (p<0.001).	  	  A	  fusion	  block	  was	  also	  observed	  in	  muscles	  expressing	  the	  reverse	  combination	  (SCAR-­‐NYFP	  and	  Abi-­‐CYFP),	  but	   it	  was	   less	   severe	   (0-­‐4	   rounds	  of	   fusion	  per	  LT,	  p<0.001),	  possibly	  due	  to	  lower	  expression	  levels	  of	  these	  specific	  transgenic	  constructs.	  	  This	  block	  in	  myoblast	   fusion	   was	   not	   seen	   when	   expressing	   untagged	   split-­‐YFP	   constructs	  simultaneously	  (Fig	  2A,	  upper	  row).	  	  
	   The	  block	  in	  fusion	  detected	  upon	  expression	  of	  both	  SCAR	  and	  Abi	  could	  be	  explained	  in	  two	  ways:	  First,	  co-­‐expression	  of	  SCAR	  and	  Abi	  leads	  to	  excessive	  SCAR	  activity.	   	  This	  results	  in	  unregulated	  Arp2/3	  activity	  at	  the	  fusion	  site,	  and	  a	  fusion	  block.	  	  Alternatively,	  expression	  of	  both	  SCAR	  and	  Abi	  produce	  a	  dominant	  negative	  effect	  by	  preventing	  interactions	  between	  endogenous	  SCAR,	  Rac-­‐GTP,	  and	  Arp2/3.	  	  Due	  to	  this	  reduction	  in	  Arp2/3	  activation	  at	  the	  fusion	  site,	  a	  fusion	  block	  occurs.	  	  
	   To	   test	   these	   two	   models,	   we	   first	   measured	   actin	   focus	   size	   in	   stage	   15	  embryos.	   	   If	   overexpressed	  Abi	   and	  SCAR	  produce	   a	  dominant	  negative	   effect,	  we	  would	   expect	   to	   see	   enlarged	   actin	   foci	   similar	   to	   SCAR	   loss	   of	   function	   mutant	  embryos.	  	  In	  muscles	  with	  Abi-­‐NYFP	  and	  SCAR-­‐CYFP	  overexpression,	  actin	  foci	  had	  an	   average	   diameter	   of	   2.14±0.05μm,	  which	   is	   similar	   to	   and	  within	   the	   range	   of	  control	   foci	  (1.99±0.09μm,	  N=11).	   	  The	  wild-­‐type	  size	  of	   the	  actin	   focus,	   therefore,	  suggested	  that	  over-­‐expression	  of	  Abi	  and	  SCAR	  did	  not	  cause	  a	  dominant	  negative	  effect	   that	  suppresses	  SCAR	  activity.	   	   In	  addition,	  since	   it	   is	  Sra1,	  not	  SCAR	  or	  Abi,	  which	  binds	  to	  Rac-­‐GTP,	  overexpression	  of	  SCAR	  and	  Abi	  should	  not	  sequester	  Rac-­‐based	   WRC	   activation.	   	   When	   measuring	   the	   actin	   focus	   size,	   we	   observed	   that	  nearly	  every	  FCM	  in	  Abi-­‐SCAR	  overexpressing	  embryos	  had	  an	  actin	  focus,	  not	  just	  those	  that	  were	  adhered	  to	  an	  FC/Myotube	  and	  were	  undergoing	  myoblast	   fusion.	  	  This	   suggested	   that	   actin	   polymerization	   is	   misregulated	   by	   Abi	   and	   SCAR	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coexpression.	   	   Altogether,	   these	   observations	   indicated	   that	   fusion	   is	   blocked	   in	  these	  Abi	  and	  SCAR	  expressing	  embryos	  due	   to	  more	  SCAR	  activity,	  which	   in	   turn	  leads	  to	  more	  Arp2/3	  activity.	  	  
	   To	   further	   test	   our	   model,	   we	   overexpressed	   SCAR	   or	   Abi	   alone	   in	   the	  muscle-­‐forming	  mesoderm	  and	  examined	  the	  muscle	  pattern	   in	  stage	  16	  embryos.	  	  As	   described	   earlier,	   in	   vitro	  experiments	   suggested	   that	   SCAR	   itself	   can	   activate	  Arp2/3	   (Machesky	   et	   al.,	   1999).	   	   Therefore,	   if	   our	   model	   is	   correct,	   namely	   that	  fusion	   is	   blocked	   due	   to	   upregulated	  Arp2/3	   activity,	   just	   increasing	   the	   levels	   of	  SCAR	  itself	  should	  impair	  fusion.	   	  Indeed,	  when	  we	  overexpressed	  SCAR	  using	  two	  copies	  of	  the	  transgene,	  fusion	  was	  impaired.	  	  The	  size	  of	  the	  actin	  focus	  was	  similar	  to	   controls	   (2.02±0.09μm,	   N=11)	   and	   to	   simultaneous	   expression	   of	   both	   tagged	  SCAR	  and	  Abi.	   	  Expression	  of	  only	  one	  copy	  of	  SCAR	  was	  not	   sufficient	   to	   cause	  a	  fusion	  block,	  possibly	  due	  to	  the	  SCAR	  instability	  when	  not	  associated	  with	  the	  WRC.	  	  Nevertheless,	   the	   fusion	   phenotype	   in	   the	   low-­‐level	   SCAR	   overexpression	  background	  can	  be	  enhanced	  by	  co-­‐expression	  of	  Abi.	  	  This	  observation	  is	  consistent	  with	   the	   report	   that	   Abi	   can	   bind	   to	   SCAR	   and	   enhance	   its	   stability	   and	   activity	  (Echarri	  et	  al.,	  2004;	  Kunda	  et	  al.,	  2003;	  Leng	  et	  al.,	  2005).	   	  We	  also	  observed	  that	  expressing	   one	   or	   two	   copies	   of	   Abi	   did	   not	   result	   in	   a	   fusion	   block	   (Fig	   2B),	  suggesting	   that	   increasing	   the	   availability	   of	   Abi	   alone	   is	   not	   sufficient	   to	  misregulate	   Arp2/3	   activity	   and	   block	   fusion.	   	   Altogether	   we	   conclude	   that	  excessive	  SCAR	  activity	  impairs	  myoblast	  fusion.	  
Constitutively	   active	   Dia	   mislocalizes	   the	   Abi-­SCAR	   complex	   during	   muscle	  
formation	  
The	   split-­‐YFP	   system	   also	   allowed	   us	   to	   interrogate	  Abi-­‐SCAR	   interactions	   during	  myoblast	  fusion	  in	  other	  genetic	  backgrounds.	  	  Our	  previous	  work	  indicated	  that	  Dia	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regulated	  SCAR	  localization	  during	   fusion,	  as	   in	  both	  Dia	   loss	  and	  gain	  of	   function,	  SCAR	   was	   no	   longer	   restricted	   to	   the	   fusion	   site	   (Deng	   et	   al.,	   2015).	   	   Data	   from	  mammalian	   tissue	   culture	   indicated	   that	   the	   Dia-­‐binding	   SNARE	   domain	   in	   Abi	  partially	  overlaps	  with	   the	  SCAR/WAVE	  binding	  WAB	  domain,	   suggesting	   that	  Dia	  and	   SCAR	   compete	   for	   Abi	   binding	   (Ryu	   et	   al.,	   2009).	   	   Since	   binding	   to	   Abi	   is	  required	  for	  SCAR	  localization	  (Echarri	  et	  al.,	  2004),	  this	  competition	  might	  account	  for	   SCAR	  mislocalization	   in	   the	   Dia	   gain	   of	   function	   background	   during	  myoblast	  fusion.	  	  To	  test	  if	  competition	  between	  Dia	  and	  SCAR	  for	  Abi	  exists	  during	  myoblast	  fusion,	   we	   investigated	   whether	   Dia	   activity	   altered	   the	   Abi-­‐SCAR	   interaction	  detected	   by	   the	   split-­‐YFP	   constructs	   at	   the	   fusion	   site.	   	   To	   do	   this,	   we	   expressed	  constitutively	   active	   Dia	   (Dia.CA)	   specifically	   in	   the	   muscle-­‐forming	   mesoderm	  together	  with	  SCAR-­‐NYFP	  and	  Abi-­‐CYFP	  and	  examined	   the	  distribution	  of	   the	  YFP	  signal.	   	   We	   used	   two	   Dia.CA	   constructs,	   one	   with	   and	   the	   second,	   without,	   the	  putative	   Abi-­‐binding	   domain.	   	   In	   controls	   where	   there	   was	   no	   Dia.CA	   being	  expressed	   in	   the	   myoblasts,	   YFP	   reconstitution	   occurred	   through	   Abi-­‐SCAR	  interaction,	  and	  the	  YFP	  signal	  accumulated	  at	  the	  fusion	  site	  (Figure	  1A).	  	  When	  we	  expressed	  Dia.CA	  constructs	  together	  with	  split-­‐YFP	  tagged	  SCAR	  and	  Abi,	  however,	  we	   found	   a	   diffuse	   cytoplasmic	   localization	   of	   the	   YFP	   signal	   (Figure	   3A).	   	   No	  particular	  enrichment	  was	  found	  at	  between	  FC/Myotube	  and	  FCMS.	  	  We	  observed	  similar	  results	  with	  both	  constructs.	  	  The	  presence	  of	  the	  YFP	  signal	  suggested	  that	  the	   Abi-­‐SCAR	   complex	   still	   formed	   in	   a	   constitutively	   active	   Dia-­‐expressing	  background;	  however,	   the	  diffuse	  YFP	   signal	   indicated	   that	   the	  Abi-­‐SCAR	  complex	  was	   no	   longer	   recruited	   to	   the	   fusion	   site.	   	   The	   mislocalization	   of	   the	   Abi-­‐SCAR	  complex	   was	   consistent	   with	   our	   earlier	   report	   that	   constitutively	   active	   Dia	  changes	  the	  localization	  of	  SCAR	  (Deng	  et	  al.,	  2015).	  	  Since	  constitutively	  active	  Dia	  without	   the	   putative	   Abi	   binding	   domain	   also	   lead	   to	   a	   diffuse	   YFP	   signal,	   we	  suggest	   that	   Dia	   changes	   the	   localization	   of	   Abi-­‐SCAR	   complex	   through	   its	   actin	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polymerization	   activity.	   	   As	   we	   are	   unable	   to	   accurately	   quantify	   the	   diffuse	   YFP	  signal,	   it	   remains	   unclear,	   however,	   if	   Dia.CA	   only	   changes	   the	   localization	   of	   the	  Abi-­‐SCAR	  complex	  or	  disrupts	  both	  Abi-­‐SCAR	  interaction	  and	  localization.	  
Dia	  functions	  upstream	  of	  Arp2/3	  to	  regulate	  actin	  at	  the	  fusion	  site	  
In	  our	  previous	  work,	  we	  have	  demonstrated	  that	  Dia	  functions	  upstream	  of	  Arp2/3	  at	  the	  fusion	  site	  to	  polymerize	  linear	  actin	  filaments	  and	  to	  regulate	  the	  localization	  of	  SCAR	  and	  WASp	  (Deng	  et	  al.,	  2015).	  	  To	  further	  confirm	  these	  data,	  we	  performed	  epistasis	   experiments	   in	   embryos	   that	   overexpress	   Dia.CA,	   Abi,	   and	   SCAR.	   	   As	  discussed,	   the	   size	   of	   the	   actin	   focus	   provides	   insight	   to	   which	   step	   in	   fusion	   is	  disrupted	   in	  a	  particular	   fusion	  mutant	   (Richardson	  et	  al.,	  2007).	   	  Fusion	  mutants	  that	   impair	   SCAR-­‐regulated	   Arp2/3	   activation	   result	   in	   enlarged	   foci.	   	   Fusion	  mutants	  that	  impair	  WASp	  regulated	  Arp2/3	  activation	  result	   in	  normal-­‐sized	  foci.	  	  Fusion	   mutants	   that	   impair	   both	   SCAR	   and	   WASp-­‐regulated	   Arp2/3	   activation	  result	  in	  no	  actin	  focus	  (Bothe	  et	  al.,	  2014).	   	  Expression	  of	  constitutively	  active	  Dia	  (Dia.CA)	  changes	  actin	  dynamics	  during	  fusion	  and	  generates	  a	  diffuse	  distribution	  of	   F-­‐actin	   at	   the	   fusion	   site	   (Deng	   et	   al.,	   2015).	   	  When	   expressed	  Dia.CA,	   together	  with	  SCAR-­‐NYFP	  and	  Abi-­‐CYFP	  in	  myoblasts,	  we	  found	  that	  myoblast	  fusion	  is	  still	  blocked	  in	  this	  context	  with	  F-­‐actin	  organized	  into	  diffuse	  structures.	  	  These	  F-­‐actin	  structures	   are	   similar	   to	   those	   seen	   in	  myoblasts	   expressing	   Dia.CA	   alone,	   rather	  than	   the	   round	  and	  normal-­‐sized	   foci	   seen	   in	  a	  SCAR-­‐NYFP/Abi-­‐CYFP	  background	  (Fig	  1A,	  3A).	  	  These	  findings	  reinforce	  our	  conclusions	  that	  Dia	  functions	  upstream	  of	  Arp2/3	  to	  regulate	  actin	  organization	  at	  the	  fusion	  site.	  
Discussion:	  	  
In	  this	  Extra	  View	  article,	  we	  show	  that	  Abi	  and	  SCAR	  interact	  at	  the	  fusion	  site	  to	  promote	   Arp2/3	   activity.	   	   Excessive	   SCAR	   activity	   results	   in	   upregulated	   Arp2/3	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activity	   and	   blocked	   fusion.	   	   Dia	   functions	   upstream	   of	   Arp2/3	   to	   regulate	   actin	  polymerization.	   	   Excessive	   Dia	   leads	   to	   mislocalization	   of	   the	   Abi-­‐SCAR	   complex,	  possibly	  through	  its	  actin	  polymerization	  activity.	  
	   The	   importance	   of	   Arp2/3	   activity	   for	   myoblast	   fusion	   has	   been	  demonstrated	  in	  many	  studies	  (Kim	  et	  al.,	  2007;	  Massarwa	  et	  al.,	  2007;	  Richardson	  et	   al.,	   2007;	   Schäfer	   et	   al.,	   2007;	   Sens	   et	   al.,	   2010).	   	   Both	   SCAR	   and	   WASp	   can	  activate	  Arp2/3	  and	  are	  known	  to	  regulate	  myoblast	  fusion	  in	  a	  cell	  type	  dependent	  manner:	  WASp	   is	   specifically	   required	   in	   the	  FCM	  (Jin	  et	   al.,	   2011),	  while	  SCAR	   is	  required	   for	   both	   FC/myotube	   and	   FCM	   (Gildor	   et	   al.,	   2009).	   	   It	   has	   also	   been	  speculated	   that	   SCAR	   and	   WASp	   are	   playing	   distinct	   roles	   in	   FCMs,	   with	   SCAR	  mediating	  the	  migration	  of	  myoblasts	  and	  initiating	  fusion	  (Gildor	  et	  al.,	  2009)	  and	  WASp	  promoting	  the	  formation	  of	  podosome-­‐like	  structures	  and	  subsequent	  fusion	  pore	  expansion	  (Jin	  et	  al.,	  2011).	  	  The	  balance	  and	  switch	  between	  SCAR	  and	  WASp	  would	   allow	   for	   finely	   controlled	   regulation	   of	   Arp2/3	   activation,	   which,	   in	   turn,	  controls	  the	  formation	  of	  the	  F-­‐actin	  structures	  in	  the	  FC/myotube	  and	  FCM.	  	  In	  this	  study,	  we	  provided	  evidence	  that	  SCAR	  activity	  is	  highly	  regulated	  during	  myoblast	  fusion.	  	  Excessive	  SCAR	  activity	  results	  in	  mis-­‐	  and	  upregulated	  Arp2/3	  function	  and	  blocks	  myoblast	  fusion.	  	  It	  is	  still	  unclear	  how	  excessive	  SCAR	  mechanistically	  blocks	  fusion.	   	  However,	   the	  normal-­‐sized	  actin	   focus	  suggests	  a	  possible	  model	  of	  SCAR-­‐WASp	  interaction.	  	  In	  a	  WASp	  loss	  of	  function	  background,	  the	  size	  of	  the	  actin	  focus	  is	   similar	   to	   wildtype.	   	   A	   similar	   sized	   actin	   focus	   is	   also	   seen	   in	   SCAR	  overexpressing	   background.	   	   A	   possible	   explanation	   is	   that	   SCAR	   and	   WASp	  compete	  with	  each	  other	  for	  Arp2/3	  binding.	  	  Therefore,	  SCAR	  overexpression	  leads	  to	   suppressed	   WASp	   activity,	   resulting	   in	   a	   normal-­‐sized	   actin	   focus	   that	  phenocopies	   WASp	   loss	   of	   function.	   	   Similarly,	   in	   a	   SCAR	   loss	   of	   function	  background,	   where	   Arp2/3	   activity	   is	   regulated	   by	  WASp	   only,	   the	   actin	   focus	   is	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enlarged,	  as	  WASp	  is	  the	  major	  factor	  that	  promotes	  the	  formation	  of	  podosome-­‐like	  structures	  at	  the	  FCM	  side	  (Jin	  et	  al.,	  2011).	  	  Together,	  these	  data	  suggest	  a	  possible	  mutual	  inhibition	  model	  /competition	  model	  for	  SCAR	  and	  WASP.	  
	   We	  also	  provide	  evidence	  for	  two	  distinct	  ways	  to	  control	  SCAR	  activity.	  	  The	  first	   is	   through	   direct	   regulation	   of	   SCAR	   stability,	   and	   the	   second	   is	   through	   the	  regulation	  of	  SCAR	  localization	  in	  a	  Dia-­‐dependent	  manner.	   	  When	  we	  overexpress	  just	  one	  copy	  of	  SCAR,	  fusion	  is	  unaffected.	  	  We	  suggest	  that	  this	  may	  be	  a	  result	  of	  SCAR	   degradation	   when	   it	   is	   not	   associated	   with	   the	  WRC	   and	   reflects	   the	   cell’s	  capacity	   to	  buffer	   SCAR	  activity.	   	  However,	  when	  one	   copy	  of	  Abi	   is	   added	   to	   this	  background,	   it	   stabilizes	   exogenous	   SCAR,	   leading	   to	   an	   increase	   in	  both	   the	   level	  and	   activity	   of	   SCAR.	   	   This,	   in	   turn,	   results	   in	   a	   fusion	   block.	   	   Similarly,	   as	   the	  majority	  of	  endogenous	  SCAR	  is	  either	  part	  of	  the	  WRC	  or	  degraded,	  overexpression	  of	  Abi	  alone	  does	  not	  lead	  to	  a	  significant	  increase	  in	  endogenous	  SCAR	  activity,	  and	  therefore	   fusion	   is	  unaffected.	   	  Thus,	  overall	   SCAR	  activity	  during	  myoblast	   fusion	  depends	   on	   the	   expression	   level	   of	   SCAR	   and	  whether	   it	   is	   associated	  with	  WRC	  components.	  	  
	   In	   our	   recent	   PLoS	   Genetics	   paper,	   “The	   formin	   Diaphanous	   regulates	  myoblast	  fusion	  through	  actin	  polymerization	  and	  Arp2/3	  regulation”,	  we	  reported	  that	  Dia	  functions	  upstream	  of	  SCAR,	  and	  that	  both	  Dia	  loss	  of	  and	  gain	  of	  function	  results	   in	   mislocalized	   SCAR.	   	   However,	   we	   did	   not	   show	   whether	   SCAR	  mislocalization	  is	  due	  to	  SCAR	  dissociation	  from	  the	  WRC	  or	  due	  to	  mislocalization	  of	  the	  entire	  complex.	   	   In	  this	  study,	  we	  report	  that	   in	  the	  DiaCA	  background,	  Scar	  remains	   bound	   to	   Abi	   and	   that	   this	   complex	   is	   mislocalized.	   	   Experiments	   in	  mammalian	   tissue	   culture	   suggested	   that	   Dia	   and	   SCAR	   may	   compete	   for	   Abi	  binding	  (Ryu	  et	  al.,	  2009).	   	  Since	  Abi	   is	  one	  of	   the	  components	   that	  regulate	  SCAR	  localization,	   these	   findings	   suggest	   that	   Dia.CA	   overexpression	   could	   result	   in	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dissociation	   of	   SCAR	   from	   Abi.	   	   Our	   data,	   however,	   show	   that	   in	   a	   Dia.CA	  overexpression	   background,	   at	   least	   a	   portion	   of	   the	   mislocalized	   SCAR	   is	   still	  associated	  with	   Abi.	   	  We	   could	   not,	   however,	   exclude	   completely	   the	   competition	  model,	  as	  we	  are	  unable	  to	  measure	  whether	  the	  overall	  level	  of	  reconstituted	  GFP	  is	  altered.	  	  
	   It	   has	   also	   been	   reported	   that	   SCAR	   and	   Arp2/3	   can	   function	   together	   to	  inhibit	  Dia	  activity	  in	  HeLa	  cells	  (Beli	  et	  al.,	  2008).	  	  As	  Dia	  activity	  is	  required	  during	  myoblast	   fusion,	   these	  data	   suggested	   to	  us	   that	   SCAR	  may	   impair	   fusion	   through	  inhibiting	   Dia.	   	   Our	   results,	   however,	   do	   not	   support	   this	   hypothesis:	   Dia	   loss	   of	  function	   resulted	   in	   actin	   focus	   absence	   (Deng	   et	   al.,	   2015),	   while	   SCAR	  overexpression	  led	  to	  normal	  sized	  actin	  foci.	  
	   In	  summary,	  we	  have	  demonstrated	  that	  Abi	  physically	  interacts	  with	  SCAR	  at	   the	   fusion	  site	  and	  enhances	  SCAR	  activity.	   	  We	  also	  showed	   that	  constitutively	  active	   Dia	   polymerizes	   actin	   upstream	   of	   SCAR	   function	   and	   changes	   the	  distribution	  of	  the	  Abi-­‐SCAR	  complex.	  	  Lastly,	  we	  found	  that	  SCAR	  activity	  is	  highly	  regulated	  during	  fusion.	  	  Our	  data	  suggest	  that	  a	  balance	  between	  SCAR	  and	  WASp	  activities	  exist	  to	  spatially	  and	  temporally	  control	  Arp2/3	  activity.	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Figure	  1:	  Visualization	  of	  Abi-­SCAR	  complex	  formation	  using	  split	  YFP	  during	  
myoblast	  fusion.	  A.	  Stage	  15	  embryo	  stained	  for	  F-­‐actin	  (phalloidin,	  white)	  to	  label	  fusion	   site,	   and	   YFP	   (GFP	   antibody,	   green)	   to	   detect	   YFP	   reconstitution,	   FCM	  (magenta,	   false	   colored),	   and	   FC/myotube	   (turquoise,	   false	   colored).	   Top	   row:	   to	  visualize	   the	   background	   fluorescent	   level,	  UAS-­myc-­NYFP	   and	  UAS-­HA-­CYFP	  were	  expressed	   in	   the	  muscles	  under	   the	  control	  of	  muscles	   specific	  driver	  DMef2-­Gal4.	  Middle	   and	   lower	   rows:	   UAS-­SCAR-­myc-­NYFP	   and	   UAS-­Abi-­HA-­CYFP,	   or	   UAS-­Abi-­
myc-­NYFP	  and	  UAS-­SCAR-­HA-­CYFP	  were	  expressed	  in	  the	  muscles	  under	  the	  control	  of	  DMef2-­Gal4.	  The	  reconstituted	  YFP	  signals	  indicate	  sites	  of	  Abi-­‐SCAR	  interaction.	  Scale	  bar:	  5μm	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Figure	  2:	  Increased	  SCAR	  activity	  results	  in	  fusion	  block.	  A.	  Three	  hemisegments	  from	  a	  stage	  16	  embryo.	  Embryos	  are	  stained	  for	  F-­‐actin	  (phalloidin,	  white)	  to	  show	  the	  muscle	  pattern,	  and	  YFP	  (GFP	  antibody,	  green)	  to	  detect	  YFP	  reconstitution.	  Top	  row:	   in	   control	   embryos,	   UAS-­myc-­NYFP	   and	   UAS-­HA-­CYFP	   were	   expressed	   in	  muscles	   under	   the	   control	   of	   DMef2-­Gal4.	   Phalloidin	   staining	   shows	   wild-­‐type	  muscle	  pattern.	  Background	  fluorescent	   level	  was	  visualized	  with	  antibody	  against	  GFP.	   Middle	   and	   lower	   rows:	  UAS-­SCAR-­myc-­NYFP	   and	  UAS-­Abi-­HA-­CYFP,	   or	  UAS-­
Abi-­myc-­NYFP	  and	  UAS-­SCAR-­HA-­CYFP	  were	  expressed	  in	  muscles	  under	  the	  control	  of	  DMef2-­Gal4.	  Phalloidin	  staining	  shows	  impaired	  fusion	  and	  actin	  foci	  at	  the	  fusion	  site.	   GFP	   shows	   the	   localization	   of	   Abi-­‐SCAR	   interaction.	  B.	   Muscle	   pattern	   from	  stage	   16	   embryos	   (antibody	   against	   Myosin	   Heavy	   Chain.	   white).	   Three	  hemisegments	  are	  shown	  from	  each	  embryo.	  One	  or	  two	  copies	  of	  split-­‐YFP	  labeled	  Abi	   or	   SCAR	  were	   expressed	   in	   the	  muscles	   under	   the	   control	   of	  DMef2-­Gal4.	   Abi	  overexpression	   does	   not	   change	   muscle	   pattern.	   Increased	   expression	   of	   SCAR	  results	  in	  myoblast	  fusion	  block	  in	  a	  dosage	  dependent	  manner.	  Scale	  bar:	  20	  μm	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Figure	   3.	   Constitutively	   active	   Dia	   changes	   Abi-­SCAR	   localization	   and	   actin	  
structure	   at	   the	   fusion	   site.	   A.	   Stage	   16	   embryo	   stained	   for	   F-­‐actin	   (phalloidin,	  white)	   and	  YFP	   (GFP	  antibody,	   green),	   FCM	  (magenta,	   false	   colored),	   FC/myotube	  (turquoise/false	   colored).	   Upper	   row:	   as	   control,	   constitutively	   active	   Dia	   (UAS-­
Dia.CA)	   was	   expressed	   together	   with	   UAS-­myc-­NYFP	   and	   UAS-­HA-­CYFP	   in	   the	  muscles	   under	   the	   control	   of	   DMef2-­Gal4.	   Fusion	   is	   blocked	   in	   this	   context.	  Background	  fluorescent	  level	  was	  visualized	  with	  antibody	  against	  GFP.	  Middle	  and	  lower	  rows:	  UAS-­Dia.CA	  was	  expressed	  together	  with	  UAS-­SCAR-­myc-­NYFP	  and	  UAS-­





	   148	  
CHAPTER	  FIVE:	  
DIAPHANOUS	  AND	  FLIGHTLESS	  I	  CONTROL	  SARCOMERE	  SIZE	  IN	  DROSOPHILA	  
INDIRECT	  FLIGHT	  MUCLES	  
I.	  Abstract:	  	  
The	   sarcomere	   is	   the	   basic	   contractile	   unit	   of	   skeletal	   and	   cardiac	   muscles,	  composed	  of	  repeated	  units	  of	  actin	  thin	  filaments	  and	  myosin	  thick	  filaments.	  	  The	  shortening	   of	   sarcomeres	   by	   the	   sliding	   of	   the	   myosin	   filaments	   on	   the	   actin	  filaments	   generates	   the	   force	   for	   muscle	   contraction.	   	   In	   muscle	   fibers,	   uniform-­‐sized	  sarcomeres	  assemble	  into	  an	  aligned	  series,	  called	  the	  myofibril.	   	  A	  failure	  in	  the	   regulation	   of	   sarcomere	   size,	   uniformity,	   or	   alignment	   results	   in	   muscle	  dysfunction.	   	   Mutations	   in	   sarcomeric	   proteins	   have	   been	   linked	   to	   numerous	  muscle	   diseases,	   including	   actin	   myopathies,	   intranuclear	   rod	   myopathies	   and	  Nemaline	  Myopathies,	   further	   emphasizing	   the	   need	   to	   understand	   this	   structure.	  	  Since	  sarcomere	  structure	  is	  highly	  conserved	  from	  insects	  to	  humans,	  we	  used	  the	  
Drosophila	   indirect	   flight	   muscles	   (IFMs)	   to	   study	   sarcomere	   assembly	   and	  homeostasis	   and	   its	   impact	   on	   muscle	   function.	   	   We	   now	   show	   that	   the	   formin	  family	  protein	  Diaphanous	   (Dia)	   is	   critical	   for	   sarcomere	  assembly,	  particularly	   in	  setting	  sarcomere	  length	  and	  width.	  	  Knockdown	  of	  Dia	  leads	  to	  sarcomeres	  that	  are	  shorter	  and	  thinner,	  due	  to	  changes	  in	  number	  and	  length	  of	  the	  actin	  thin	  filaments.	  	  Dia	  localizes	  primarily	  to	  the	  M-­‐lines	  (actin	  pointed	  ends)	  during	  sarcomere	  growth,	  and	  then	  switches	  to	  the	  Z-­‐discs	  (actin	  barbed	  ends)	  during	  muscle	  maturation.	  	  The	  localization	   of	   Dia	   in	   the	   sarcomere	   is	  mediated	   by	   PI(4,5)P2.	   	   In	   addition,	   Dia	   is	  involved	  in	  maintaining	  myosin	  levels	  in	  thick	  filaments	  through	  organization	  of	  the	  microtubule	  network	  required	  for	  myosin	  trafficking.	  	  Dia	  genetically	  interacts	  with	  Flightless	   I	   (FliI),	   the	   fly	   Gelsolin	   ortholog,	   to	   regulate	   thin	   filament	   length	   and	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sarcomere	   size.	   	   Knockdown	   of	   FliI	   results	   in	   both	   smaller	   sarcomeres	   and	   long	  actin	  bundles.	  	  Double	  knockdown	  of	  dia	  and	  fliI	  further	  reduces	  sarcomere	  size.	  	  We	  propose	   that	   Dia	   and	   FliI	   regulate	   sarcomere	   growth	   through	   their	   actin	  polymerization	  and	  severing	  activity	  respectively,	  maintaining	  the	  G-­‐actin	  pool	  and	  regulating	   actin	   dynamics	   of	   the	   thin	   filaments.	   Together	   these	   actin	   regulators	  generate	  uniformly	  sized	  sarcomeres	  tuned	  for	  the	  muscle	  contractions	  required	  for	  flight.	  	  
Introduction:	  
	  	  	  	  	  	  	  	  	  	  Sarcomeres,	   the	   basic	   units	   of	   striated	   muscles,	   are	   structurally	   conserved	  from	  Drosophila	   to	  humans.	   	  Sarcomeres	  are	  primarily	  composed	  of	   thin	   filaments	  and	  thick	  filaments.	   	   In	  each	  sarcomere,	  actin	  filaments	  of	  uniform	  length	  organize	  into	  a	  parallel	  pattern	   to	   form	  an	  array	  of	   thin	   filaments.	   	  The	  barbed	  ends	  of	   the	  actin	  filaments	  are	  anchored	  to	  the	  Z-­‐disc	  through	  α-­‐actinin,	  and	  their	  pointed	  ends	  are	   localized	   to	   the	  edge	  of	   the	  M-­‐line.	   	  Thick	   filaments	  are	  composed	  of	   repeated	  myosin	   proteins.	   	   Upon	   stimulation,	   conformational	   changes	   in	   the	  myosin	  motor	  domain	   allow	   myosin	   to	   walk	   on	   the	   actin	   filaments.	   	   The	   relative	   movement	  between	   the	  myosin	   and	   actin	   filaments	   results	   in	   a	   shortening	   of	   the	   sarcomere,	  generating	   a	   contractile	   force.	   The	   uniform	   lengths	   of	   thin	   filaments	   and	   thick	  filaments	  are	  critical	  for	  the	  formation	  of	  uniform	  sized	  sarcomere.	  	  Sarcomeres	  are	  arranged,	  one	  after	   the	  other,	   to	   form	  multiple	  myofibrils	  within	   the	  muscle	   fiber.	  	  The	   uniform	   structure	   and	   simultaneous	   contraction	   of	   sarcomeres	   are	   the	  prerequisites	   for	   amplifying	  molecular-­‐level	   force	   into	   visible	  muscle	   contraction.	  
	   150	  
How	   muscles	   set	   the	   size	   of	   sarcomeres,	   and	   how	   precisely	   uniform	   sarcomeres	  assemble	  are	  not	  well	  understood.	  	  
	   Sarcomeres	  are	  highly	  dynamic	  during	  both	  growth	  and	  maintenance	  stages.	  	  In	   different	   types	   of	  muscle,	   actin	   incorporates	   into	   thin	   filaments	   from	   both	   the	  barbed	   and	   the	   pointed	   ends	   of	   the	   actin	   filaments	   during	   sarcomere	   growth	  (Littlefield	  et	  al.,	  2001;	  Perkins	  and	  Tanentzapf,	  2014).	  	  After	  muscle	  maturation,	  the	  dissociation	   and	   incorporation	  of	   actin	   into	  both	   ends	  of	   thin	   filaments	   still	   occur	  without	   disrupting	   the	   overall	   sarcomere	   organization	   and	   function	   (Ono,	   2010;	  Perkins	  and	  Tanentzapf,	  2014).	  	  The	  continuous	  turnover	  of	  actin	  suggests	  that	  the	  actin	  dynamics	  need	  to	  be	  precisely	  regulated	  to	  ensure	  uniform	  sarcomere	  length	  and	   thus	   optimal	   contraction.	   	   Previous	   studies	   have	   identified	   actin	   regulatory	  factors	   that	   regulate	   sarcomere	   size	   by	   controlling	   actin	   filament	   elongation,	  stabilization,	  and	  severing.	   	  These	   factors	   include	   the	  actin	  elongating	  protein	  Sals	  (Bai	  et	  al.,	  2007),	   capping	  proteins	  CapZ	  (Pappas	  et	  al.,	  2008;	  Schafer	  et	  al.,	  1995)	  and	  Tmod	   (Littlefield	   et	   al.,	   2001;	  Littlefield	   and	  Fowler,	   2008;	  Mardahl-­‐Dumesnil	  and	   Fowler,	   2001;	   Sussman	   et	   al.,	   1998),	   the	   scaffolding	   proteins	   Sallimus	   (Titin)	  (Orfanos	   et	   al.,	   2015)	   and	   Lasp	   (Nebulin)	   (Fernandes	   and	   Schöck,	   2014),	   and	   the	  severing	   protein	   Cofilin	   2	   (Kremneva	   et	   al.,	   2014).	   	  However,	   how	   these	   different	  types	  of	  proteins	  coordinate	  to	  ensure	  the	  uniform	  length	  of	  thin	  filaments	  remain	  largely	  unclear.	  
	   The	  assembly	  and	   stability	  of	   thick	   filaments	  also	  play	  a	   role	   in	   controlling	  sarcomere	  size	  (Contompasis	  et	  al.,	  2010;	  Reedy	  et	  al.,	  2000).	  	  Several	  studies	  have	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focused	   on	   the	   incorporation	   of	   muscle	   Myosin	   into	   thick	   filaments.	   	   The	   M-­‐line	  protein	  Obscurin	  has	  been	  reported	  to	   facilitate	   the	  assembly	  of	  myosin	   into	   thick	  filaments	   in	   both	   rats	   (reviewed	   by	   (Kontrogianni-­‐Konstantopoulos	   and	   Bloch,	  2005))	  and	  C.	  elegans	  (Qadota	  et	  al.,	  2008).	   	  Thick	  filament	  assembly	  also	  depends	  on	   its	   interaction	  with	  actin,	  as	  well	  as	  with	  elastic	   filaments,	  such	  as	   the	  Sallimus	  (Titin)-­‐based	  structure	  that	  anchors	  the	  thick	  filament	  to	  Z-­‐disc	  (Myhre	  and	  Pilgrim,	  2014;	  Orfanos	  et	  al.,	  2015).	  	  In	  mouse	  skeletal	  muscles,	  trafficking	  of	  myosin	  to	  the	  sarcomere	  depends	  on	  microtubules	  (Pizon	  et	  al.,	  2005;	  2002).	   	  During	  Drosophila	  IFM	   sarcomerogenesis,	   microtubule	   networks	   form	   a	   “sleeve”	   within	   which	  myofibrils	   assemble.	   	   The	   microtubule	   “sleeve”	   later	   disassembles	   after	  myofibrillogenesis	   is	   completed	   (Reedy	   and	   Beall,	   1993).	   	   Whether	   myosin	   is	  trafficked	  to	  the	  sarcomere	  via	  the	  microtubules	  in	  Drosophila	  IFMs	  is	  unknown	  
	   The	  similarity	  of	  proteins	  required	  to	  regulate	  sarcomere	  length	  in	  different	  types	  of	  muscles	  suggest	  that	  sarcomere	  assembly	  is	  controlled	  through	  a	  conserved	  mechanism.	  	  Moreover,	  mutations	  in	  these	  sarcomeric	  proteins	  are	  linked	  to	  muscle	  weakness	  in	  a	  number	  of	  human	  muscle	  diseases	  (Sevdali	  et	  al.,	  2013).	  Mutations	  on	  thin	   filament	   protein	   genes	   such	   as	  ACTA1,	   TNNI2,	   TNNT1,	   TNNT3,	   TPM2,	   TPM3,	  NEB	   are	   known	   to	   cause	   congenital	   myopathies	   such	   as	   actin	   myopathy,	  intranuclear	   rod	  myopathy	  and	  Nemaline	  Myopathy	   (reviewed	  by	   (Clarkson	  et	  al.,	  2004;	   Ochala,	   2008)).	   Therefore,	   an	   investigation	   of	   sarcomere	   formation	   and	  homeostasis	  in	  one	  muscle	  system	  can	  provide	  valuable	  insights	  to	  the	  same	  process	  in	  different	  species	  as	  well	  as	  to	  human	  muscle	  disease.	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   The	   Drosophila	   indirect	   flight	   muscles	   (IFMs)	   provide	   an	   ideal	   system	   to	  study	  muscle	  formation.	  	  Due	  to	  the	  strong	  and	  continuous	  forces	  required	  for	  flight,	  IFMs	  are	  a	  sensitive	  system	  in	  which	  to	  record	  muscle	  function,	  as	  minor	  changes	  in	  muscle	   structure,	   myotendinous	   junctions,	   and	   neuromuscular	   junctions	   lead	   to	  changes	   in	   flight	   (Reedy	   et	   al.,	   2000).	   	   Moreover,	   in	   mammalian	   systems,	   severe	  defects	  in	  striated	  muscle	  usually	  result	  in	  lethality,	  especially	  in	  cardiac	  muscles.	  	  In	  contrast,	  defects	  in	  IFMs,	  which	  resemble	  human	  cardiac	  muscles	  both	  structurally	  (Spletter	  et	  al.,	  2015)	  and	  functionally	  (Tu	  and	  Daniel,	  2004),	  affect	  only	  the	  ability	  of	  Drosophila	  to	  fly	  and	  do	  not	  affect	  survival	  rates.	  	  
	   Formins	   are	   family	   of	   proteins	   that	   control	   actin	   nucleation	   and	  polymerization.	   	   Due	   to	   their	   nature	   in	   elongating	   actin	   filaments,	   an	   increasing	  number	   of	   studies	   focused	   on	   the	   roles	   that	   the	   formin	   family	   in	   sarcomere	  development	  has	  emerged.	  	  In	  C.	  elegans	  body	  wall	  muscles,	  FHOD-­‐1	  and	  CYK-­‐1	  are	  involved	   in	   determining	   and	   maintaining	   sarcomere	   size	   and	   in	   anchoring	   thin	  filaments	   to	   Z-­‐discs	   (Mi-­‐Mi	   and	  Pruyne,	   2015;	  Mi-­‐Mi	   et	   al.,	   2012).	   	   In	  mammalian	  cardiac	   muscles,	   thirteen	   formins	   are	   expressed	   and	   play	   roles	   in	   myofibril	  development	  and	  maintenance	  (Arimura	  et	  al.,	  2013;	  Iskratsch	  et	  al.,	  2013;	  Kan-­‐O	  et	  al.,	   2012;	   Rosado	   et	   al.,	   2014;	   Taniguchi	   et	   al.,	   2009;	   Wooten	   et	   al.,	   2013).	   	   In	  
Drosophila	  IFMs,	  DAAM	  is	  required	  for	  thin	  filament	  assembly	  (Molnár	  et	  al.,	  2014).	  	  Moreover,	   in	   cancer-­‐related	   skeletal	   muscle	   degeneration,	   mDia1	   is	   reported	   to	  regulate	   sarcomere	   integrity	   by	   functioning	   downstream	   of	   the	   retinoblastoma	  protein	   (Rb)	   (Araki	   et	   al.,	   2013).	   	   Despite	   our	   understanding	   that	   formins	   are	  involved	  in	  thin	  filament	  assembly	  and	  maintenance,	  much	  remains	  unknown:	  	  it	  is	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unclear	  how	  formins	  are	  recruited	  to	   their	  site	  of	  activity,	  how	  they	  regulate	  actin	  turnover,	   the	   types	   of	   proteins	   with	   which	   they	   interact	   at	   the	   sarcomere,	   and	  whether	  thin	  filaments	  are	  the	  only	  targets	  of	  formin	  function	  in	  sarcomeres.	  	  
	   Diaphanous	  (Dia),	  the	  first	  identified	  member	  of	  the	  Drosophila	  formin	  family	  of	  proteins	  (Afshar	  et	  al.,	  2000),	  has	  been	  shown	  to	  regulate	  actin	  polymerization	  in	  various	  developmental	  events,	  such	  as	  myoblast	  fusion	  (Deng	  et	  al.,	  2015),	  wing	  hair	  morphogenesis	   (Lu	   and	   Adler,	   2015),	   dorsal	   closure	   (Bilancia	   et	   al.,	   2014;	  Nowotarski	  et	  al.,	  2014),	  wound	  healing	  (Matsubayashi	  et	  al.,	  2015),	  apical	  secretion	  of	  epithelial	  tubes	  (Rousso	  et	  al.,	  2013),	  synaptic	  growth	  (Pawson	  et	  al.,	  2008)	  and	  cytokinesis	  (Afshar	  et	  al.,	  2000).	  	  Dia	  is	  also	  known	  to	  stabilize	  microtubules	  (Daou	  et	  al.,	  2014)	  by	  interacting	  with	  the	  microtubule	  plus	  end	  tracking	  proteins,	  EB1	  and	  adenomatous	   polyposis	   coli	   (APC)	   (Palazzo	   et	   al.,	   2001;	   Wen	   et	   al.,	   2004).	   	   The	  function	   of	  Dia	   has	   been	   extensively	   studied	   in	  migrating	   cells,	   dividing	   cells,	   and	  epithelial	  cells;	  these	  studies	  provided	  insights	  to	  the	  mechanisms	  by	  which	  Dia,	  and	  potentially	  other	  formins,	  regulate	  cell	  behaviors.	   	  However,	   the	  role	  of	  Dia	  during	  sarcomere	  assembly	  is	  still	  unknown.	  	  	  
	   In	   this	   study,	   we	   show	   that	   the	   Diaphanous	   (Dia)	   is	   required	   during	  sarcomere	  assembly	  in	  indirect	  flight	  muscles.	   	  Using	  a	  PI(4,5)P2	  cue,	  Dia	  localizes	  to	  both	  pointed	  and	  barbed	  ends	  of	   thin	   filaments	   and	  determines	   the	   length	  and	  width	   of	   each	   sarcomere.	   	  Moreover,	  we	   find	   that	   Dia	   does	   not	   only	   regulate	   the	  actin	   dynamics	   of	   thin	   filaments,	   but	   also	   controls	   thick	   filament	  maintenance,	   by	  organizing	  microtubule	   networks	   around	   the	  myobrils.	   Altogether,	   we	   show	   how	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Dia	   is	   localized	   to	   sarcomere	  and	  what	   sarcomeric	   structures	   require	  Dia	   activity.	  Taking	  advantage	  of	  the	  highly	  sensitive	  IFM	  system,	  we	  also	  identified	  Flightless	  I	  (FliI),	   the	   Gesolin	   ortholog	   and	   an	   actin	   severing	   protein,	   as	   a	   Dia	   interacting	  partner.	   	   Together	   these	   proteins	   regulate	   actin	   dynamics	   through	   regulation	   of	  available	   G-­‐actin	   pools	   during	   sarcomere	   formation;	   this,	   in	   turn,	   generates	  sarcomeres	  with	  optimal	  thin	  filament	  number	  and	  length	  and	  sets	  the	  stage	  for	  the	  proper	  muscle	  contraction	  required	  for	  flight.	  	  	  
Results:	  
Diaphanous	  loss	  of	   function	  impairs	  flight	  ability	  and	  thin	  filament	  assembly	  
in	  IFMs	  
We	   first	   tested	   the	   role	   of	   Dia	   in	   indirect	   flight	   muscles	   by	   reducing	   Dia	   levels	  specifically	   in	   muscles	   and	   examining	   the	   behavioral	   and	   muscular	   phenotypes.	  	  When	   we	   knocked	   down	   Dia	   with	   RNAi,	   we	   found	   that	   the	   ability	   to	   fly	   was	  significantly	   impaired	   (Figure	   1A;	   Percentage	   of	   flightless	   flies:	   control:	  1.3%±2.31%,	  dia	  RNAi	   (IR):	   100%±0%,	  dia	  RNAi	   (TRiP):	   98.7%±2.31%,	   n=25/day	  x3	   days,	   P<0.0001).	   	   Similar	   phenotypes	   were	   found	   in	   flies	   that	   expressed	   a	  dominant	  negative	  Dia	  (Deng	  et	  al.,	  2015)	  in	  the	  muscles	  (Figure	  1A;	  Percentage	  of	  flightless	   flies:	   control:	   1.3%±2.31%,	   diaDN	   (intermediate):	   97.3%±2.31%,	   diaDN	  (high):	   97.3%±2.31%,	  n=25	   flies/trial,	   3	   trial/genotype,	   P<0.0001).	   	   The	   flightless	  phenotype	   associated	   with	   Dia	   knockdown	   was	   specific	   for	   abrogation	   of	   Dia	  function.	  Expression	  of	  Dia::GFP	  in	  muscles	  rescued	  the	  flight	  phenotype	  associated	  with	   dia	   RNAi	   (Figure	   1A;	   percentage	   of	   flightless	   flies:	   dia-­RNAi	   (TRiP):	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98.7%±2.31%,	   rescue:	   49.7%±19.86%,	   n=25	   flies/trial,	   3	   trials/genotype,	  P<0.0001).	  
	   As	  Dia	  is	  known	  to	  play	  a	  role	  in	  myoblast	  fusion	  and	  cell	  adhesion	  (Deng	  et	  al.,	   2015),	   we	   examined	   whether	   aberrations	   in	   these	   cellular	   functions	   could	  correlate	  with	   the	   loss	   in	   flight	   ability	   seen	  upon	  Dia	   knockdown	  using	   either	  dia	  RNAi	  or	  diaDN.	  	  The	  fusion	  index	  was	  derived	  by	  counting	  the	  number	  of	  myonuclei	  in	  the	  IFMs.	  	  We	  found	  no	  significant	  change	  in	  myonuclear	  number	  between	  wild-­‐type	  and	  Dia-­‐knockdown	  flies	  (Supplemental	  Figure	  1B-­‐C).	  As	  Dia	  is	  required	  for	  cell	  adhesion,	  we	  also	  tested	  whether	  the	  loss	  of	  flight	  ability	  was	  due	  to	  detachment	  of	  IFM	  from	  tendon	  cells.	  The	  integrity	  of	  the	  myotendinous	  junctions	  (MTJ)	  was	  tested	  by	   immunostaining	  with	   antibodies	   to	   β-­‐PS	   integrin,	   a	   critical	   component	   of	   MTJ	  (Leptin	   et	   al.,	   1989).	   We	   found	   β-­‐PS	   integrin	   was	   present	   at	   the	   myotendinous	  junctions	  similar	  to	  that	  seen	  in	  controls.	  No	  obvious	  change	  in	  distribution	  or	  levels	  was	  noted	  in	  dia	  RNAi	  conditions	  (Supplemental	  Figure	  1D).	  Our	  data	  suggested	  Dia	  plays	  a	  role	  in	  flight	  muscle	  development	  beyond	  fusion	  and	  attachment.	  	  	  
	   As	  an	  additional	  control,	  we	  confirmed	  the	  dia-­RNAi	   reduction	  of	  Dia	   levels	  by	  immunostaining	  for	  Dia.	  	  We	  found	  that	  dia-­RNAi	  significantly	  reduced	  Dia	  levels	  in	   the	   knockdown	   muscles	   compared	   to	   the	   controls	   (Supplemental	   Figure	   1E).	  	  However,	  when	  we	  adjusted	  the	  brightness	  and	  over	  saturated	  the	  image	  (increase	  signal	  to	  3	  fold	  using	  Volocity	  software),	  we	  found	  that	  residual	  Dia	  was	  detected	  in	  muscles	   expressing	   dia-­RNAi.	   	   These	   data	   indicated	   that	   Dia	   knockdown	  was	   not	  100%	   efficient	   (Supplemental	   Figure	   1F)	   and	  may	   explain	   why	  muscles	   with	   dia	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knockdown	   can	   surpass	   earlier	   events	   in	   myogenesis,	   such	   as	   fusion.	   	   Taken	  together,	   our	   results	   suggest	   that	  Dia	   loss	   of	   function	   impairs	   flight	   by	   disrupting	  adult	  muscle	  function	  after	  cell	  fusion	  and	  tendon	  attachment.	  
	   We	   next	   examined	   how	   dia	   loss	   of	   function	   impairs	   flight	   ability.	   	   Dia	   is	  known	   to	   regulate	   actin	   filament	   formation,	   and	   actin	   is	   the	  major	   component	   of	  thin	   filaments	   in	   sarcomeres.	   	   Therefore,	   we	   examined	   the	   morphology	   of	  sarcomeres	  in	  IFMs	  by	  immunostaining	  for	  F-­‐actin.	  	  We	  found	  that	  the	  assembly	  of	  actin	   filaments	   was	   disrupted,	   which	   led	   to	   irregular	   myofibrils	   in	   dia	   loss	   of	  function	  IFMs	  (Figure	  1B,	  Supplemental	  Figure	  1A).	  	  Actin	  consistently	  organize	  into	  smaller-­‐sized	  sarcomere.	  Disorganized	  actin	  filaments	  are	  also	  seen	  at	  the	  surface	  of	  muscle	  fiber	  and	  around	  nucleus	  (Supplemental	  Figure	  1A).	  We	  determined	  through	  quantification	  that	  in	  dia	  loss	  of	  function	  muscles,	  the	  sarcomeres	  were	  shorter	  and	  thinner	  compared	  to	  controls	  (Figure	  1C-­‐D;	  Sarcomere	  length:	  control:	  3.6±0.15μm,	  
diaDN	   (intermediate):	   2.9±0.32μm,	   dia-­RNAi	   (IR):	   2.3±0.39μm,	   dia-­RNAi	   (TRiP):	  2.6±0.28μm,	   n=100,	   P<0.0001,	   20%-­‐40%	   reduction	   in	   length.	   Sarcomere	   width:	  control:	  1.6±0.13μm,	  diaDN	  (intermediate):	  1.6±0.17μm,	  dia-­RNAi	  (IR):	  1.0±0.10μm,	  
dia-­RNAi	   (TRiP):	  1.1±0.11μm.	  n=100,	  P<0.0001,	  30%-­‐40%	  reduction	   in	  width).	   	   In	  muscles	   expressing	   DiaDN	   (intermediate),	   individual	   myofibrils	   were	   difficult	   to	  distinguish,	   due	   to	   the	   frequent	   splitting	   and	   converging	   of	   the	  myofibrils.	   	  When	  examined	  flies	  in	  which	  the	  flight	  ability	  is	  restored	  by	  Dia::GFP,	  we	  found	  that	  the	  length	  and	  width	  of	   thin	   filaments	  were	   rescued	  by	  Dia::GFP	   (length:	  3.5±0.14μm,	  width:	  1.6±0.14μm,	  n=100,	  p<0.0001).	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   Using	   electron	   microscopy	   (EM),	   we	   further	   investigated	   the	   sarcomere	  morphological	   modifications	   in	   dia	   loss	   of	   function	   muscles.	   Similar	   to	   what	   we	  observed	  through	  immunostaining,	  the	  phenotype	  of	  range	  from	  reduced	  sarcomere	  size	  to	  highly	  irregular	  myofibrils.	  EM	  showed	  that	  reduced	  Dia	  levels	  could	  result	  in	  a	  reduced	  number	  of	  thin	  and	  thick	  filaments,	  which	  led	  to	  sarcomeres	  with	  reduced	  widths	  (Figure	  1E-­‐F).	  The	  distance	  between	  Z-­‐discs	  was	  also	  significantly	  reduced	  in	  
dia	  loss	  of	  function	  muscles,	  which	  led	  to	  sarcomeres	  with	  reduced	  lengths	  (Figure	  1E-­‐F).	  	  
	   Taken	   together,	   these	   results	   indicated	   that	   Dia	   controls	   IFM	   development	  and	  function	  by	  determining	  the	  length	  and	  width	  of	  sarcomeres.	  
The	   localization	  of	  Dia	   in	   sarcomeres	   changes	  during	   IFM	  development,	   and	  
PI(4,5)P2	  functions	  as	  a	  localization	  cue	  for	  Dia	  
To	  better	  understand	  how	  Dia	  functions	  to	  regulate	  sarcomere	  length	  and	  width,	  we	  investigated	   Dia	   localization	   and	   the	   cues	   required	   for	   Dia	   localization	   in	   the	  sarcomere.	  Using	  antibodies	  generated	  against	  Dia,	  we	  examined	  Dia	  localization	  in	  
Drosophila	   IFMs	   1-­‐7	   days	   after	   eclosion.	   	   We	   found	   that	   in	   flies	   which	   have	   just	  eclosed	  (day	  1),	  Dia	   localizes	  mainly	  to	  the	  M-­‐line	  (Figure	  2A,	  arrows).	  As	  the	  flies	  aged	   (days	   3	   and	   7),	   a	   higher	   level	   of	   Dia	   was	   found	   at	   the	   Z-­‐discs	   (Figure	   2A,	  arrowheads).	   	   This	   change	   in	   Dia’s	   localization	   was	   confirmed	   by	   measuring	  fluorescence	  intensity	  across	  the	  sarcomere	  at	  the	  different	  time	  points	  (Figure	  2A,	  Supplemental	   Figure	  2C).	   Studies	  have	   shown	   that	  during	   sarcomere	   growth,	   thin	  filaments	   elongate	   at	   both	   the	   barbed	   and	   pointed	   ends;	   however,	   more	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incorporation	  has	  been	  detected	  at	   the	  pointed	  end	  at	   the	  M-­‐line	  (Littlefield	  et	  al.,	  2001;	  Perkins	  and	  Tanentzapf,	  2014).	   	  We	  found	  that	  sarcomere	  growth	  continues	  in	  both	   length	  and	  width	  over	   the	   first	   few	  days	   following	  eclosion	  (Supplemental	  Figure	   2A-­‐B).	   The	   change	   in	   Dia	   localization	   suggested	   that	   Dia	   regulates	   the	  number	  and	  elongation	  thin	  filaments	  near	  the	  M-­‐lines	  during	  sarcomere	  growth;	  it	  subsequently	   relocates	   to	   the	   Z-­‐discs	   as	   muscles	   mature	   and	   sarcomere	   size	  stabilizes.	  
	   We	   next	   examined	   the	   cues	   for	   Dia	   localization	   in	   sarcomeres.	   Studies	   in	  
Drosophila	   epithelial	   tracheal	   tubes	   suggested	   that	   PI(4,5)P2	   and	   Rho	   GTPase	  controls	  the	  localization	  and	  targeting	  of	  Dia	  (Rousso	  et	  al.,	  2013).	  	  To	  test	  whether	  the	   same	   mechanism	   applied	   to	   Dia	   localization	   in	   sarcomeres,	   we	   expressed	  constructs	  containing	  GFP-­‐tagged	  domains	  of	  Dia	  in	  the	  muscle.	   	  We	  reasoned	  that	  those	  that	  localized	  like	  endogenous	  Dia	  would	  provide	  important	  information	  as	  to	  how	  Dia	  is	  recruited	  to	  particular	  locales	  within	  the	  sarcomere.	  	  When	  we	  expressed	  a	  construct	  that	  contained	  the	  N-­‐terminal	  basic	  domain	  (BD)	  of	  Dia	  (Dia-­‐BD::GFP)	  in	  the	   muscles,	   we	   found	   that	   it	   reproduced	   the	   Dia	   pattern	   of	   expression	  (Supplemental	  Figure	  2D-­‐E).	  Since	  the	  Dia	  	  BD	  is	  responsible	  for	  binding	  PI(4,5)P2,	  these	  data	  suggested	  that	  PI(4,5)P2	  could	  function	  as	  cue	  for	  Dia	  localization.	  	  
	   To	  further	  test	  this	  hypothesis,	  we	  used	  a	  PI(4,5)P2	  reporter	  (Bothe	  2014)	  to	  examine	  the	  pattern	  of	  PI(4,5)P2	  localization;	  we	  found	  that	  PI(4,5)P2	  showed	  the	  same	   spatial	   and	   temporal	   localization	   pattern	   as	   Dia.	   	   Similar	   to	   Dia,	   PI(4,5)P2	  localized	  to	  the	  M-­‐line	  at	  day	  1	  after	  eclosion	  	  and	  subsequently	  accumulated	  at	  the	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Z-­‐discs	   as	  muscles	  mature	   (day	  3,	   Figure	  2B).	   This	   observation	  was	   confirmed	  by	  plotting	  a	  fluorescent	  intensity	  curve	  of	  the	  PI(4,5)P2	  reporter	  (Figure	  2B).	  	  
	   The	   same	   pattern	   of	   localization	   of	   PI(4,5)P2	   and	   Dia	   suggested	   that	  PI(4,5)P2	   functions	   as	   a	   localization	   cue	   for	   Dia.	   	   If	   this	   hypothesis	   is	   true,	   then	  reducing	  PI(4,5)P2	  levels	  should	  result	  in	  Dia	  mislocalization,	  changes	  in	  sarcomere	  morphology,	  and	  a	  loss	  of	  the	  fly’s	  flight	  ability.	  	  Previous	  studies	  have	  indicated	  that	  overexpression	  of	  PI(4,5)P2	  reporter	  results	   in	  PI(4,5)P2	  sequestering	  and	   loss	  or	  reduction	  in	  PI(4,5)P2	  signaling	  (Bothe	  et	  al.,	  2014).	   	  We	  found	  that	  increasing	  the	  level	  of	  PI(4,5)P2	  reporter	  by	  placing	   flies	   to	  higher	  temperature	  (29°C)	   increased	  the	   percentage	   of	   flightless	   flies	   by	   20%.	   	   In	   these	   flightless	   flies,	   Dia	   displayed	   a	  more	  diffused	  localization	  compared	  to	  controls	  (Supplemental	  Figure	  2F-­‐G).	  	  As	  Dia	  loss	   of	   function	   impaired	   flight	   in	   100%	   of	   the	   flies,	   we	   sought	   to	   increase	   the	  expression	   of	   PI(4,5)P2	   reporter	   to	   levels	   that	   would	   recapitulate	   the	   flightless	  phenotype	  seen	  in	  the	  Dia	  loss	  of	  function	  background.	  Unfortunately,	  increasing	  the	  PI(4,5)P2	   reporter	   levels	   by	   increasing	   genetic	   copy	   numbers	   led	   to	   embryonic	  lethality	  due	  to	  blocked	  myoblast	  fusion	  (Bothe	  et	  al.,	  2014).	  	   	  
	   To	  investigate	  in	  detail	  the	  impact	  of	  PI(4,5)P2	  on	  Dia	  localization,	  we	  turned	  to	   an	   alternative	  way	   to	   reduce	   PI(4,5)P2	   levels	   through	  manipulation	   of	   Skittles	  (Sktl).	   	   Sktl	   is	   the	   kinase	   that	   catalyzes	   the	   phosphorylation	   of	   PI(4)P	   to	   produce	  PI(4,5)P2.	  	  A	  specific	  mutated	  form	  of	  Sktl	  (Sktl.KD)	  with	  an	  inactive	  kinase	  domain	  decrease	  the	  level	  and	  localization	  of	  PI(4,5)P2	  (Rousso	  et	  al.,	  2013).	  	  When	  Sktl.KD	  was	   expressed	   in	   the	   muscles,	   100%	   of	   flies	   were	   flightless.	   	   We	   next	   examined	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sarcomere	   morphology	   and	   the	   Dia	   localization	   in	   the	   sktl.KD	   background.	   	   We	  found	   that	   the	  morphology	   of	   sarcomeres	  was	   altered	   in	   the	   sktl.KD	   background,	  like	   that	   seen	   in	   the	  Dia	   loss	   of	   function	   background	   (Supplemental	   Figure	   2H-­‐I).	  	  However,	   the	   expressivity	   of	   the	   phenotype	   varied:	   100%	   of	   flies	   had	   thinner	  sarcomeres	  (control:	  1.5±0.03	  vs	  sktl.KD:	  1.3±0.03,	  n=25,	  p<0.0001,	  13%	  reduction	  in	  width),	   but	   only	   approximately	   20%	  of	   those	  with	   thinner	   sarcomeres	   showed	  significantly	  shorter	  sarcomeres	  compared	  to	  control	  (control:	  3.5±0.04	  vs	  sktl.KD:	  3.1±0.08,	  n=25,	  p<0.0001,	  11%	  reduction	  in	  length).	  	  	  
	   We	   next	   examined	   Dia	   localization	   in	   the	   flies	   with	   thinner	   and	   shorter	  sarcomeres	  at	  3	  days	  after	  eclosion.	  	  At	  this	  time,	  Dia	  should	  distribute	  evenly	  at	  the	  M-­‐line	   and	   Z-­‐discs.	   	   By	   examining	   these	   day-­‐3	   adult	   flies,	   we	   would	   determine	  whether	  PI(4,5)P2	  controls	   the	  Dia	   localization	  at	   the	  M-­‐line,	   the	   redistribution	  of	  Dia	   to	   the	   Z-­‐discs,	   or	   both.	   	   We	   found	   that	   in	   sktl.KD	   expressing	   muscles,	   Dia	  localized	   to	   both	   the	   M-­‐line	   and	   Z-­‐discs,	   but	   at	   a	   lower	   level	   (Figure	   2C).	   	   This	  observation	   was	   confirmed	   by	   measuring	   Dia	   fluorescent	   intensity	   (Figure	   2C).	  	  Together,	   these	   findings	   indicated	   that	   PI(4,5)P2	   controls	   the	   localization	   of	   Dia	  during	  sarcomere	  growth,	  but	  that	  it	  acts	  redundantly	  with	  other	  cues.	  	  
	   Another	  factor	  that	  could	  function	  as	  cue	  for	  Dia	  localization	  is	  Rho	  GTPase.	  The	  Rho	  binding	  domain	  (RBD)	  of	  Dia	   is	  the	   interacting	  domain	  of	  Rho	  (Rousso	  et	  al.,	  2013).	  	  When	  we	  examined	  the	  localization	  of	  Dia-­‐RBD::GFP	  1	  day	  after	  eclosion,	  we	   found	   that,	   similar	   as	   full-­‐length	  Dia,	  Dia-­‐RBD	  was	   also	   present	   in	   the	  M-­‐lines	  (Supplemental	   Figure	   2D-­‐E).	   These	   data	   suggest	   that	   Rho	   GTPase	   functions	   as	  
	   161	  
another	  cue	  for	  Dia	  localization.	  Interestingly,	  another	  construct	  that	  contained	  the	  Dia	   N-­‐terminus	   but	   without	   the	   basic	   (PI(4,5)P2)	   and	   Rho	   binding	   domains	   also	  showed	  M-­‐line	   localization	   (Supplemental	   Figure	  2D-­‐E).	  These	  data	   indicated	   that	  additional	  factors	  could	  regulate	  Dia	  distribution.	  	  
Sarcomere	   localization	  of	  microtubules	  was	  disrupted	   in	  dia	  loss-­of-­function	  
muscles	  
In	  addition	  to	  functioning	  in	  both	  actin	  nucleation	  and	  elongation,	  Dia	   is	  known	  to	  regulate	   microtubule	   formation	   and	   stabilization.	   	   Since	   these	   studies	   were	  conducted	  only	  in	  3T3	  fibroblasts	  in	  cell	  culture	  (Palazzo	  et	  al.,	  2001),	  we	  examined	  whether	  microtubule	  structures	  were	  affected	  in	  vivo	  in	  Dia-­‐knockdown	  muscle.	  We	  first	   characterized	   microtubule	   organization	   in	   wild-­‐type	   muscles	   using	  immunostaining.	   	  We	   found	   that	  microtubules	   are	   localized	   to	  M-­‐lines	   as	   well	   as	  around	  the	  myonuclei	  in	  wild-­‐type	  muscles	  after	  eclosion	  (Figure	  3A,	  Supplemental	  Figure	   3A).	   	   We	   confirmed	   this	   microtubule	   organization	   by	   expressing	   the	  microtubule	  binding	  protein	  Jupiter::GFP	  in	  the	  IFMs	  (Supplemental	  Figure	  3B).	  	  We	  next	  examined	  microtubule	  organization	  in	  dia	  knockdown	  muscles.	  	  In	  flies	  3	  days	  after	  eclosion,	  we	  found	  that	  microtubules	  still	  localized	  around	  myonuclei,	  but	  they	  were	   absent	   from	   the	   M-­‐lines	   (Figure	   3A).	   	   We	   further	   investigated	   whether	   the	  aberrant	   localization	  of	  microtubules	  could	  be	  due	  to	  a	  disrupted	  M-­‐line	  structure.	  	  We	   uncovered	   that	   the	   M-­‐line	   marker,	   Obscurin,	   was	   present	   at	   the	   M-­‐line	   in	  muscles	  with	  dia	  knockdown	  (Figure	  3B).	  	  This	  result	  suggested	  that	  the	  absence	  of	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microtubules	  at	  the	  M-­‐line	  was	  not	  due	  to	  loss	  of	  M-­‐line	  integrity,	  but	  rather	  a	  result	  of	  a	  disrupted	  microtubule	  network	  due	  to	  dia	  loss	  of	  function.	  
	   We	  next	   examined	   the	   consequence	   of	   the	   disrupted	  microtubule	   network.	  	  Microtubules	  have	  been	  reported	  to	  transport	  muscle	  myosin	  to	  the	  M	  line	  to	  form	  the	  thick	  filaments	  (Pizon	  et	  al.,	  2005).	   	  Therefore,	  we	  examined	  thick	  filaments	  by	  immunostaining	  for	  Myosin	  heavy	  chain	  (MHC).	   	  We	  found	  that	  in	  flies	  which	  have	  just	   eclosed	   (3	   days	   after	   eclosion),	  Myosin	   is	   present	   in	   sarcomeres	   (Figure	   3C).	  However,	   in	  older	   flies	   (10	  days	  after	  eclosion),	   the	   levels	  of	  myosin	   in	  sarcomere	  thick	  filaments	  were	  decreased	  (Figure	  3C).	  Together,	  these	  data	  suggested	  that	  M-­‐line	   localization	   of	   microtubules	   is	   important	   for	   myosin	   maintenance	   of	   thick	  filaments	   and	   that	  Dia	   regulates	   thick	   filament	  maintenance	   through	  building	   and	  stabilizing	  microtubule	  networks.	  
Dia	  interacts	  with	  FliI	  to	  regulate	  sarcomere	  assembly	  
To	  further	  understand	  how	  Dia	  controls	  sarcomere	  growth,	  we	  performed	  a	  limited	  genetic	   screen	   to	   identify	   Dia-­‐interacting	   proteins	   (Supplemental	   Table	   1).	   	   We	  selected	   our	   candidate	   genes	   based	   on	   their	   known	   involvement	   in	   sarcomere	  structure,	   actin	   polymerization	   activity,	   or	   actin	   depolymerization	   activity	  (Supplemental	  Table	  2).	   	  We	  examined	  whether	  knock	  down	  of	  these	  genes	  would	  enhance	  the	  Dia	   loss-­‐of-­‐function	  phenotypes,	   leading	  to	  a	  change	   in	  viability	  rates.	  Using	  this	  assay,	  we	   isolated	  two	  genes	   that	  genetically	   interacted	  with	  dia	  during	  adult	  myogenesis:	  chickadee	   (chic)	  and	   flightless	  I	   (fliI).	   	  Flies	  expressing	  chic	  RNAi	  alone	   in	   the	  muscles	   are	   viable	   and	   able	   to	   fly.	   	   Flies	   expressing	   fliI	   RNAi	   in	   the	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muscles	  are	  viable	  but	  flightless.	  Double	  knockdowns	  of	  dia	  and	  chic,	  or	  dia	  and	  fliI,	  in	  the	  developing	  musculature	  resulted	  in	  pupae	  lethality	  (Supplemental	  Table	  2).	  	  	  
	   Chickadee	  (Chic),	  the	  Drosophila	  Profilin,	   is	  a	  known	  Dia	  interacting	  protein	  that	  promotes	  actin	  filament	  elongation	  (Geisbrecht	  and	  Montell,	  2004;	  Webb	  et	  al.,	  2009).	   	   Knockdown	   of	   dia	   does	   not	   change	   Chic	   localization	   in	   muscles	  (Supplemental	   Figure	   4C).	   	   Examination	   of	   the	   developing	   IFMs	   at	   100h	   APF	  revealed	  that	  reducing	  both	  Dia	  and	  Chic	  blocked	  myoblast	  fusion	  and	  impaired	  the	  formation	   of	   both	   the	   myotendinous	   junctions	   and	   the	   myofibrils	   (Supplemental	  Figure	   4A-­‐B).	   	   As	   the	   focus	   of	   this	   paper	   is	   sarcomere	  morphology,	  we	   no	   longer	  examined	  the	  interaction	  between	  Chic	  and	  Dia	  in	  this	  context.	  
Flightless	   I	   (FliI)	   is	   a	  member	  of	   the	  Gelsolin	   family	  of	  proteins	   that	   severs	  actin	   filaments.	   	  Studies	   in	  mammalian	  cell	  culture	  have	  shown	  that	  FliI	  physically	  interacts	   with	   Dia	   to	   promote	   Dia	   activity.	   	   To	   investigate	   if	   there	   is	   a	   direct	  interaction	  between	  Dia	  and	  FliI	   in	  Drosophila,	  we	  expressed	  FliI::HA	  and	  Dia::GFP	  in	  S2	  cells	  and	  tested	  FliI-­‐Dia	  biochemical	  interactions	  by	  co-­‐IP.	  	  Despite	  the	  strong	  genetic	   interaction	   in	   developing	   adult	   musculature,	   we	   found	   no	   evidence	   of	  physical	  interactions	  between	  FliI	  and	  Dia	  in	  this	  context	  (Supplemental	  Figure	  5A).	  	  To	  further	  study	  the	  genetic	  interaction	  between	  FliI	  and	  Dia	  during	  IFM	  growth,	  we	  examined	   localization	   of	   FliI	   in	   wild-­‐type	   muscles.	   	   Using	   antibody	   staining,	   we	  found	   that	   FliI	   localizes	   to	   sarcomere	   Z-­‐discs	   (Figure	   4A).	   	   Unlike	   Dia,	   the	  localization	   of	   FliI	   does	   not	   change	   during	   muscle	   maturation.	   	   The	   different	  localization	  patterns	  supported	  our	  data	   that	  FliI	  does	  not	  physically	   interact	  with	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Dia	  during	  IFM	  growth.	  Together,	  these	  data	  suggested	  an	  indirect,	  yet	  unidentified	  way	  of	  interaction	  between	  Dia	  and	  FliI	  to	  regulate	  sarcomere	  size	  and	  muscle	  
	  To	  better	  understand	  how	  FliI	   interact	  with	  Dia	  during	   sarcomere	  growth,	  we	  examined	   the	  muscle	  phenotype	   in	   fliI	   loss-­‐of-­‐function	   flies.	   	  Consistent	  with	  a	  previous	   screen	   (Schnorrer	   et	   al.,	   2010),	   fliI	   loss	   of	   function	   resulted	   in	   frayed	  myofibrils	   (Figure	   4B).	   	   To	   confirm	   that	   the	   fliI	   phenotype	  was	   not	   due	   to	   an	   off	  target	   effect,	   we	   expressed	   FliI::HA	   in	   muscles	   to	   rescue	   fliI	   loss	   of	   function.	   We	  found	  that	  both	  the	  ability	  to	  fly	  and	  the	  sarcomere	  phenotype	  is	  100%	  rescued	  by	  FliI::HA	  (Figure	  4B).	  	  
	   We	  next	  examined	   in	  more	  detail	  myofibrils	   in	   fliI	   loss	  of	   function	  muscles.	  We	  categorized	  the	  myofibrils	  within	  an	  individual	  muscle	  into	  two	  classes.	  The	  first	  type	   was	   composed	   of	   bundles	   of	   actin	   and	   exhibited	   longer,	   thin	   filaments	   in	  comparison	   to	   the	   wild-­‐type	   controls	   (Figure	   4B).	   	   This	   phenotype	   could	   be	  explained	  by	  loss	  of	  the	  actin	  severing	  activity	  of	  FliI.	  	  The	  second	  class	  of	  myofibrils	  was	   composed	   of	   shorter	   and	   thinner	   sarcomeres	   (Figure	   4B),	   possibly	   due	   to	   a	  limited	  actin	  pool	  resulting	   from	  insufficient	  actin	  severing	  and	  recycling	   from	  the	  first	   class	   of	   sarcomeres.	   	   Consistent	   with	   our	   interpretation,	   overexpression	   of	  FliI::HA	  in	  otherwise	  wild-­‐type	  muscles	  resulted	  in	  shorter	  (control:	  3.6±0.11	  vs	  fliI-­
HA:	   2.8±0.11,	   n=25,	   p<0.0001,	   22%	   reduction	   in	   length	   on	   average)	   and	   slightly	  thinner	  (control:	  1.7±0.15	  vs	  fliI-­HA:	  1.5±0.20,	  n=25,	  p<0.1,	  12%	  reduction	  in	  width	  on	  average)	  sarcomeres	  (Figure	  4F-­‐G),	   indicating	  that	  the	  actin	  severing	  activity	  of	  FliI	  controls	  sarcomere	  size.	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   We	  then	  investigated	  the	  mechanisms	  through	  which	  Dia	  and	  FliI	  genetically	  interact	   to	   regulate	   IFM	   development.	   	   By	   examining	   sarcomeres	   in	   100h	   APF	  pupae,	   we	   found	   that	   a	   double	   knockdown	   of	   dia	   and	   fliI	   resulted	   in	   shorter	  (2.1±0.05µm,	  n=25,	   30%	   reduction	   compare	   to	   control)	   and	   thinner	   (0.5±0.02µm,	  n=25,	  50%	  reduction	  compare	  to	  control)	  sarcomeres	  compare	  to	  a	  knockdown	  of	  either	  dia	   (length:	  2.3±0.03,	   p<0.01,	  width:	  0.9±0.02µm,	  p<0.0001),	   or	   fliI	   (length:	  2.3±0.04µm,	  p<0.01,	  width:	  0.7±0.02µm,	  p<0.0001)	  alone.	  	  Based	  on	  the	  phenotype	  of	  sarcomeres	   in	  the	  knockdown	  muscles,	  we	  hypothesized	  that	  Dia	   interacts	  with	  FliI	   by	   controlling	   the	   G-­‐actin	   pool:	   actin	   severed	   by	   FliI	   from	   a	   thin	   filament’s	  barbed	  end	  re-­‐enters	  the	  G-­‐actin	  pool,	  while	  Dia	  incorporates	  G-­‐actin	  from	  this	  pool	  into	  thin	  filaments	  to	  regulate	  sarcomere	  length	  and	  width.	  	  
	   We	   tested	   this	   model	   by	   expressing	   dia	   RNAi	   in	   a	   fliI	   overexpression	  background	   and	   examining	   the	   sarcomere	   phenotype	   (Figure	   4F-­‐G).	   	   Consistent	  with	  our	  hypothesis,	  excessive	  severing	  and	  insufficient	  polymerization	  of	  actin	  led	  to	   thin	   filaments	   that	   were	   both	   shorter	   (2.4±0.04µm,	   n=25,	   33%	   reduction	  compare	   to	   control)	   and	   thinner	   (1.4±0.03µm,	   n=25,	   18%	   reduction	   compare	   to	  control)	  compared	  to	  expression	  of	  dia	  RNAi	  alone	  (length:	  3.6±0.04µm,	  p<0.0001,	  width:	  1.5±0.04µm,	  p<0.1),	  or	  FliI::HA	  alone	  (length:	  2.8±0.02µm,	  p<0.0001,	  width:	  1.6±0.04µm,	  p<0.1).	  	  
	   Together,	  our	  data	   showed	   that	  Dia	  and	  FliI	   genetically	   interact	   to	   regulate	  sarcomere	   size.	   I	   provided	   evidence	   that	   Dia	   and	   FliI	   do	   not	   physically	   interact.	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Instead,	   Dia	   and	   FliI	   localize	   at	   different	   ends	   of	   thin	   filament	   and	   control	   actin	  dynamics	  of	  the	  thin	  filament	  through	  balancing	  F-­‐actin	  and	  G-­‐actin	  levels.	  
Discussion:	  In	  this	  study,	  we	  have	  identified	  Diaphanous	  as	  a	  novel	  regulator	  of	  sarcomere	  size.	  	  We	   found	   loss	   of	   Dia	   function	   in	   these	   muscles	   resulted	   in	   thinner	   and	   shorter	  sarcomeres,	   as	   well	   as	   disorganized	   myofibrils.	   As	   a	   functional	   readout	   of	  sarcomeric	  defects	   that	  we	  have	  uncovered,	   the	   flies	  are	   flightless.	   	  We	   found	  that	  Dia	  localizes	  primarily	  to	  the	  M-­‐lines	  during	  sarcomere	  assembly,	  but	  relocates	  to	  Z-­‐discs	   as	   muscles	   mature.	   	   Using	   domain	   analysis,	   our	   data	   indicate	   that	   that	  PI(4,5)P2	  is	  involved	  in	  Dia	  localization	  (Supplemental	  Figure	  2C-­‐D).	  	  In	  addition	  to	  controlling	  actin	  dynamics,	  we	  found	  Dia	  is	  also	  involved	  in	  organizing	  microtubule	  networks.	  	  The	  role	  of	  microtubules	  during	  sarcomere	  assembly	  is	  still	  unclear,	  but	  we	  have	  shown	  that	  the	  maintenance	  of	  myosin	  thick	  filaments	  is	  impaired	  with	  Dia	  loss	   of	   function.	   Importantly,	   we	   also	   find	   that	   Dia	   genetically	   interacts	   with	   the	  actin	   severing	   protein	   Flightless	   I	   (FliI),	   and	   together	   these	   key	   actin	   regulators	  control	  sarcomere	  formation	  through	  their	  abilities	  to	  control	  the	  balance	  between	  F-­‐actin	  and	  G-­‐actin	  pools.	  	  	  
	  
Dia	  determines	  sarcomere	  size	  by	  regulating	  thin	  filament	  formation	  	  The	  actin-­‐based	  thin	  filament	  is	  critical	  for	  muscle	  structure	  and	  function.	  	  Thus	  far,	  mutations	   on	   seven	   thin	   filament	   protein	   genes	   (ACTA1,	   TNNI2,	   TNNT1,	   TNNT3,	  TPM2,	   TPM3,	   NEB)	   are	   known	   to	   cause	   congenital	   myopathies	   such	   as	   actin	  myopathy,	   intranuclear	   rod	   myopathy	   and	   Nemaline	   Myopathy	   (reviewed	   by	  (Clarkson	  et	   al.,	   2004;	  Ochala,	   2008)).	  How	   thin	   filaments	   are	  organized	  has	  been	  under	   extensive	   investigation,	   and	   studies	   have	   reported	   numerous	   proteins	   that	  regulate	   thin	   filament	   length,	   such	   as	   Sallimus	   (Titin),	   Lasp	   (nebulin)	   and	   DAAM.	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We	   now	   report	   that	   the	   formin	   Dia	   is	   a	   novel	   thin	   filament	   regulator.	   	   With	  immunostaining	  and	  electron	  microscopy,	  we	  show	  that	  Dia	  controls	  the	  length	  and	  number	  of	  thin	  filaments	  in	  each	  sarcomere,	  thus	  determining	  sarcomere	  length	  and	  width.	   	   Changes	   in	   these	   sarcomere	   parameters	   impacts	   muscle	   function,	   as	  reduction	  of	  Dia	  activity	  in	  muscles	  result	  in	  a	  flightless	  phenotype.	  	  	  	   Our	  observations	  about	  the	  role	  of	  Dia	  at	  the	  sarcomere	  are	  consistent	  with	  Dia’s	  activity	  in	  both	  nucleating	  and	  elongating	  actin	  filaments.	  We	  found	  Dia	  loss	  of	  function	  does	  not	  affect	  the	  localization	  of	  CapZ,	  which	  caps	  actin	  barbed	  end	  at	  the	  Z-­‐discs	  (Supplemental	  Figure	  4C),	  but	  changes	  the	  localization	  of	  Tmod,	  which	  caps	  actin	  pointed	  end	  near	  the	  M-­‐line	  (Supplemental	  Figure	  4E-­‐F).	  It	  is	  reported	  that	  the	  formin,	  DAAM,	  antagonizes	  the	  function	  of	  Tropomodulin	  (Tmod)	  during	  sarcomere	  assembly.	  The	  temporal	  localization	  of	  Dia	  is	  similar	  to	  DAAM	  (Molnár	  et	  al.,	  2014).	  Together,	  these	  data	  suggest	  a	  compensatory	  relationship	  between	  Dia	  and	  DAAM.	  The	   possible	   redundant	   effect	   between	   formin	   family	   members	   suggested	   the	  importance	  of	   actin	  polymerization	   in	   regulating	   sarcomere	   structures	   and	  hence,	  muscle	  function.	  	  	   We	  identified	  FliI	  as	  a	  functional	  partner	  of	  Dia	  during	  sarcomere	  formation.	  	  
In	  vitro	  experiments	  have	  reported	  that	  FliI	  enhances	  the	  activity	  of	  Dia	  by	  directly	  binding	  to	  the	  C-­‐teminal	  of	  Dia.	  	  However,	  examination	  of	  the	  localization	  of	  Dia	  and	  FliI	  in	  sarcomeres,	  as	  well	  as	  Co-­‐IP	  of	  FliI::HA	  and	  Dia::GFP	  from	  S2	  cells,	  suggests	  an	  indirect	   interaction	  between	  Dia	  and	  FliI.	   	  We	  note	   that	  we	  could	  not	   rule	  out	   the	  possibility	  that	  Dia	  and	  FliI	  physically	  interact	  through	  different	  mechanisms	  in	  S2	  cells	   and	   muscles.	   In	   addition,	   we	   did	   find	   that	   Dia	   localization	   switches	   to	   thin	  filaments’	   barbed	   ends	   as	  muscle	  mature.	   	   Therefore,	   it	   remains	  possible	   that	  Dia	  and	  FliI	  directly	  interact	  to	  maintain	  sarcomere	  structure	  in	  mature	  muscle.	  	   Staining	   for	  F-­‐actin	   in	  muscles	  with	  FliI	  knockdown	  revealed	  two	  classes	  of	  sarcomeres:	   class	   one	   has	   long	   and	   thick	   actin	   bundles	   and	   class	   two	  has	   shorter	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and	  thinner	  sarcomeres	  with	  M-­‐line	  and	  Z-­‐disc	  proteins.	  	  Based	  on	  the	  two	  classes	  of	  myofibrils,	   as	   well	   as	   FliI's	   role	   in	   actin	   severing,	   we	   propose	   that	   FliI	   and	   Dia	  function	  together	  to	  regulate	  actin	  pools	  (Figure	  5).	  	  Our	  model	  suggests	  that	  during	  sarcomere	  formation,	  FliI	  localizes	  to	  the	  barbed	  ends	  of	  thin	  filaments,	  severing	  the	  actin	  filaments.	  	  The	  severed	  and	  depolymerized	  G-­‐actin	  then	  enters	  into	  the	  muscle	  G-­‐actin	   pool	   and	   is	   then	   used	   by	   Diaphanous	   to	   integrate	   into	   the	   thin	   filaments’	  pointed	   ends.	   	   Our	  model	   (Figure	   5)	   explains	   the	   sarcomere	   phenotypes	   that	   we	  observed	   in	   the	   FliI-­‐Dia	   genetic	   experiments.	   	   In	   FliI	   and	   Dia	   double	   knockdown,	  both	   the	   G-­‐actin	   pool	   and	   Dia	   activity	   are	   reduced,	   hence	   sarcomeres	   are	   both	  shorter	   and	   thinner	   than	   in	   the	   single	   knockdown.	   	   In	   muscles	   with	   FliI	  overexpression	   and	   Dia	   knockdown,	   sarcomeres	   are	   still	   shorter,	   despite	   an	  elevated	  G-­‐actin	  pool,	   than	   those	   sarcomeres	  generated	  with	  either	  knockdown	  of	  Dia	   alone	   or	   an	   overexpression	   of	   FliI	   alone,	   due	   to	   excessive	   severing	   and	  insufficient	  polymerization.	  	  	   The	  Drosophila	  fliI	  gene	  encodes	  a	  protein	  that	  shares	  a	  56%	  identity	  with	  its	  human	   homologue.	   	   The	   human	   FLII	   gene	   locates	   at	   chromosome	   17p11.2.	   	   This	  region	  of	  chromosome	   is	  deleted	   in	  patients	  with	  Smith-­‐Magenis	  Syndrome.	   	  With	  the	  29	  genes	   located	  on	  chromosome	  17p11.2,	  RAI1	   is	  believed	   to	  be	   the	  cause	  of	  Smith-­‐Magenis	   Syndrome.	   	   However,	   there	   are	   clinical	   features	   that	   are	   seen	   in	  patients	   carrying	   the	   chromosome	  deletion	  more	  often	   than	   in	  patients	  with	  RAI1	  mutations	  alone,	  including	  cardiac	  abnormality	  (45%	  vs	  20%),	  renal	  anomaly	  (19%	  vs	   0%),	   and	   hearing	   loss	   (67%	   vs	   20%)	   (Bi	   et	   al.,	   2004).	   	   Interestingly,	   these	  features	   are	   all	   related	   to	   mutations	   in	   Dia	   or	   Dia-­‐related	   formins	   (Lynch	   et	   al.,	  1997;	   Rosado	   et	   al.,	   2014;	   Sun	   et	   al.,	   2014;	   Thelen	   et	   al.,	   2015).	   	   Hence,	   the	  interactions	   that	   we	   have	   uncovered	   between	   Dia	   and	   FliI	   provide	   a	   potential	  explanation	  for	  the	  expressivity	  and	  penetrance	  of	  Smith-­‐Magenis	  Syndrome.	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Dia	  localization	  in	  the	  sarcomere	  is	  control	  by	  PI(4,5)P2	  	  Similar	  to	  epithelial	  cells,	  we	  found	  that	  Dia	  localization	  is	  controlled	  by	  PI(4,5)P2.	  Similar	  to	  the	  Dia	  RNAi	  experiments,	  we	  found	  that	  PI(4,5)P2	  sequestering	  resulted	  in	   myofibril	   misalignment	   and	   loss	   of	   flight	   ability	   in	   ~20%	   flies.	   	   Due	   to	   the	  requirement	   of	   PI(4,5)P2	   during	   embryonic	   myoblast	   fusion,	   we	   were	   unable	   to	  sequester	   PI(4,5)P2	   to	   a	   level	   that	   enhanced	   this	   sarcomeric	   phenotype	   while	  allowing	  sufficient	  fusion	  for	  embryos	  to	  survive.	  	  Hence,	  we	  depleted	  PI(4,5)P2	  by	  another	  means,	  by	  expressing	  a	  kinase-­‐dead	  version	  of	  PIP5-­‐kinase	  Sktl	   (Sktl.KD).	  We	   found	   loss	   of	   flight	   ability	   in	   100%	   of	   flies	   that	   express	   Sktl.KD,	   and	  we	   also	  found	   that	   sarcomere	   size	   is	   altered	   due	   to	   insufficient	   targeting	   of	   Dia.	   	   Domain	  analysis	   also	   provides	   some	   evidence	   that	   Rho	   GTPase	   serves	   as	   cue	   for	   Dia	  localization	  (Supplemental	  Figure	  2C-­‐D).	   	  Future	  studies	  directed	  at	  examining	  the	  IFM	   phenotype	   and	   Dia	   localization	   in	   reduced	   Rho	   background	   would	   provide	  further	   support	   for	   Rho	   function	   of	   Rho	   in	   Dia	   localization.	   Interestingly,	   when	  PI(4,5)P2	  and	  the	  Rho	  GTPase	  binding	  domain	  of	  Dia	  are	  removed	  or	  mutated,	  the	  N-­‐terminal	  of	  Dia	  still	  shows	  weak	  accumulation	  at	  the	  M-­‐line	  (Supplemental	  Figure	  2C-­‐D).	  Hence,	  while	  our	  data	  support	  PI(4,5)P2	  and	  RhoGTPase	  in	  Dia	  localization	  in	  the	   sarcomere,	   these	   data	   also	   suggest	   additional	   localization	   cues	   for	   Dia	   during	  sarcomere	  formation.	  
	  
Microtubule	  networks	  in	  sarcomeres	  Microtubule	  networks	  play	  an	  important	  role	  in	  positioning	  myonuclei.	  	  In	  stage	  16	  embryos,	  microtubules	  emanate	  from	  myonuclei	  along	  the	  longitudinal	  axis	  (Folker	  et	  al.,	  2014).	  In	  larva	  muscles,	  microtubules	  radiate	  from	  the	  perinuclear	  region	  and	  to	  the	  Z-­‐discs	  as	  well	  as	  along	  the	  long	  axis	  of	  the	  myofiber	  (reviewed	  by	  (Elhanany-­‐Tamir	  et	  al.,	  2012;	  Folker	  and	  Baylies,	  2013)).	  	  In	  pupae,	  microtubules	  organize	  into	  sleeves	  around	  myofibrils	  (Reedy	  and	  Beall,	  1993).	   	  However,	  there	  are	  no	  reports	  
	   170	  
describing	  the	  microtubule	  network	   in	  adult	   flight	  muscles.	  We	  found	  in	  wild-­‐type	  adult	   IFMs,	  microtubule	  networks	  are	  also	  present	  at	   the	  perinuclear	   region,	   as	   is	  seen	   in	   embryos	   and	   larvae.	   However,	   unlike	   in	   embryos	   and	   larvae,	   a	   strong	  accumulation	  of	  microtubules	  is	  detected	  along	  the	  M-­‐lines	  in	  IFM	  sarcomeres.	  The	  pattern	   of	   Drosophila	  microtubule	   localization	   is	   similar	   to	   the	   pattern	   found	   in	  mammalian	   muscles,	   in	   which	   some	  microtubules	   run	   transversely	   at	   the	   I-­‐band	  level	   (Boudriau	   et	   al.,	   1993;	   Kano	   et	   al.,	   1991).	   	   In	   IFMs	   expressing	   dia	   RNAi,	  microtubules	  still	  localize	  around	  the	  nuclei,	  but	  its	  localization	  to	  the	  M-­‐line	  is	  lost.	  	  Microtubules	  are	  required	  for	  trafficking	  myosin	  in	  mouse	  skeletal	  muscle	  (Pizon	  et	  al.,	   2002;	   2005).	   In	   muscles	   with	   dia	   loss	   of	   function,	   we	   did	   not	   see	   changes	   in	  myosin	   signals	   in	   newly	   formed	   myofibrils;	   instead,	   we	   detected	   a	   decrease	   of	  myosin	  signals	  over	  time,	  which	  suggests	  that	  a	  microtubule	  network	  is	  required	  for	  thick	  filament	  maintenance.	  
	  
Using	   indirect	   flight	  muscles	   as	   a	  model	   system	   to	   study	  muscle	   formation,	  
disease	  and	  aging	  The	  Drosophila	   indirect	   flight	  muscles	  (IFMs)	  provide	  an	   ideal	  system	  for	  studying	  muscle	  development	  and	  muscle	  related	  defects	  for	  several	  reasons.	  	  First,	  the	  basic	  muscle	  structure	  is	  conserved	  from	  Drosophila	  to	  humans.	  	  Compared	  to	  single-­‐cell	  muscle	  fiber	   in	  Drosophila	  embryonic	  and	  larva	  muscles,	   the	  muscle	  fibers	   in	  IFMs	  are	   composed	   of	   multiple	   myofibrils,	   which	   is	   similar	   to	   mammalian	   skeleton	  muscles	   (Schnorrer	   et	   al.,	   2010).	   Secondly,	  muscle	   defects	   that	   result	   in	   flightless	  flies	   are	   simple	   to	   identify	   using	   large-­‐scale	   screening	  methodologies.	   	   Indeed,	   by	  screening	  for	  flightless	  flies,	  researchers	  have	  identified	  proteins	  that	  are	  crucial	  for	  muscle	   structure	   and	   function,	   such	   as	   myosin	   heavy	   chain	   (MHC),	   muscle	   actin	  (actin88F)	  and	  Tropomyosin	  (reviewed	  by	  (Vigoreaux,	  2001)).	  	  More	  recent	  studies	  have	   used	   IFMs	   to	   screen	   for	   genes	   that	   are	   related	   to	   muscle	   differentiation,	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myofibrillogenesis	  (Schnorrer	  et	  al.,	  2010)	  and	  muscular	  dystrophy	  (Kucherenko	  et	  al.,	  2011).	  	  Moreover,	  the	  activation	  and	  contraction	  patterns	  in	  IFMs	  resemble	  those	  patterns	   found	   in	  mammalian	   cardiac	  muscles,	   which	   provides	   a	   potential	  model	  system	  for	  studying	  heart	  disease	  (Vu	  Manh	  et	  al.,	  2005).	  	  In	  addition,	  the	  Gal4-­‐UAS	  system	  and	  temperature	  sensitive	  Gal80	  system	  allow	  genes	  to	  be	  switched	  on	  and	  off	  in	  specific	  tissues	  at	  a	  given	  time.	  	  In	  this	  study,	  we	  used	  the	  Gal4-­‐UAS	  system	  to	  show	  that	  Dia	  is	  required	  in	  muscles	  during	  sarcomerogenesis.	  	  	   In	   summary,	   we	   report	   that	   Diaphanous	   is	   a	   novel	   actin	   regulator	   that	  controls	   sarcomere	   assembly	   and	   maintenance.	   We	   identified	   PI(4,5)P2	   as	   the	  upstream	   localization	   cue	   that	   controls	   the	   temporal	   localization	   of	   Dia.	   Dia	  regulates	   the	   formation	  of	  both	  actin	  and	  microtubule	  networks	   in	  myofibrils,	  and	  therefore	  controls	  thin	  filament	  formation	  and	  microtubule-­‐dependent	  maintenance	  of	  myosin	   thick	   filaments.	  We	  also	   identified	  FliI	   as	   the	   interacting	  partner	  of	  Dia.	  We	  propose	  a	  model	  that	  describes	  FliI	  and	  Dia	  working	  together	  to	  maintain	  a	  G-­‐actin	  pool	  that	  regulates	  the	  uniform	  size	  of	  sarcomeres.	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Figure	  Legend:	  
Figure	  1:	  Diaphanous	   loss	  of	   function	   impairs	   flight	  ability	  and	  thin	   filament	  
assembly	  in	  IFMs	  
A.	  Flight	  assay.	  The	  ability	   to	   fly	  was	  tested	  3	  days	  after	  adult	   flies	  eclosed.	  DiaDN	  alleles	  were	  expressed	   in	  muscles	  with	  a	  DMef2-­Gal4	  driver.	  dia	  RNAi	  alleles	  were	  expressed	  in	  muscles	  with	  DMef2-­Gal4;	  UAS-­dicer2.	  Reduced	  Dia	  activity	  resulted	  in	  impaired	   flight	   ability	   (P<0.0001).	   Rescue	   experiments	   were	   performed	   by	  expressing	   Dia::GFP	   in	  muscles	   that	   expressed	   dia	   RNAi	   (TRiP).	   The	   ability	   to	   fly	  was	   partially	   rescued	   by	   Dia::GFP	   (P<0.0001).	   B.	   Sarcomere	   phenotype	   of	   flight	  muscles.	   The	   Gal4	   driver	   information	   is	   the	   same	   as	   described	   above.	   Sarcomere	  length	   is	  marked	  by	   the	  horizontal	   arrow,	   and	   sarcomere	  width	   is	  marked	  by	   the	  vertical	  arrow.	  Scale	  bar:	  5μm	  C-­D.	  Quantification	  of	  sarcomere	  length	  and	  width.	  In	  muscles	   with	   reduced	   Dia	   activity,	   sarcomere	   length	   is	   significantly	   reduced	  (P<0.0001).	   In	  muscles	  with	   reduced	  Dia	  activity,	   sarcomere	  width	   is	   significantly	  reduced	   (P<0.0001),	   except	   for	   diaDN	   (intermediate),	   where	   myofibrils	   split	   and	  converge	  as	  shown	  in	  panel	  B	   (arrowhead).	   In	  flies	  whose	  flight	  ability	   is	  restored	  by	  expressing	  Dia::GFP,	  sarcomere	  length	  and	  width	  is	  rescued	  (P<0.0001).	  E-­F.	  IFM	  morphology	   under	   electron	   microscopy.	   Dia	   knockdown	   results	   in	   shorter	   and	  thinner	  sarcomeres.	  Scale	  bar:	  2μm	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Figure	  1:	  Diaphanous	   loss	  of	   function	   impairs	   flight	  ability	  and	  thin	   filament	  
assembly	  in	  IFMs	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Figure	  2:	  The	  localization	  of	  Dia	  to	  the	  sarcomere.	  	  
A.	  The	  localization	  of	  Dia	  is	   investigated	  in	  flies	  1-­‐7	  days	  after	  eclosion.	  Sarcomere	  thin	   filaments	   are	   stained	   with	   phalloidin	   (white).	   Z-­‐discs	   are	   labeled	   with	  antibodies	   against	  α-­‐actinin	   (red).	   The	   localization	  of	  Dia	   is	   visualized	  by	   staining	  with	   antibodies	   against	  Dia	   (green).	  Dia	   localizes	  mainly	   to	   the	  M-­‐lines	   (arrow)	  1	  day	  after	  eclosion,	  and	  shift	  to	  the	  Z-­‐discs	  as	  muscles	  mature	  (arrow	  head).	  The	  shift	  in	  Dia	  localization	  is	  verified	  by	  plotting	  the	  fluorescent	  signals	  in	  the	  boxed	  area.	  B.	  Localization	  of	  PI(4,5)P2	  in	  flies	  1	  or	  3	  days	  after	  eclosion.	  PlcγPH::GFP	  is	  expressed	  in	  muscles	   to	   label	   PIP2.	   IFMs	   are	   stained	  with	   phalloidin	   and	   antibodies	   against	  GFP.	  The	  shift	  of	  PIP2	  signal	  is	  quantified	  by	  plotting	  the	  fluorescence	  signals	  in	  the	  boxed	  area.	  C.	  Dia	  localization	  in	  wild-­‐type	  muscles	  and	  muscles	  expressing	  sktl.KD	  to	   reduce	  PI(4,5)P2.	   Flies	   are	   dissected	  3	   days	   after	   eclosion.	  Muscles	   are	   stained	  with	   phalloidin	   and	   antbodies	   against	   Dia.	   Images	   of	   different	   phenotypes	   are	  captured	   with	   the	   same	   setting	   to	   make	   the	   signal	   comparable.	   In	   muscles	  expressing	   sktl.KD,	   the	   level	   of	   Dia	   localized	   to	   the	   M-­‐line	   and	   Z-­‐discs	   are	   both	  reduced,	  as	  quantified	  by	  fluorescence	  intensity	  plotting.	  	  Scale	  bars:	  5μm	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Figure	  2:	  The	  localization	  of	  Dia	  to	  the	  sarcomere.	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Figure	   3.	   Dia	   loss	   of	   function	   impairs	   microtubule	   networks	   and	   myosin	  
trafficking.	   A.	   Microtubule	   localization	   in	   IFMs.	   Flies	   are	   dissected	   3	   days	   after	  eclosion.	   Muscles	   are	   stained	   with	   phalloidin	   (white)	   and	   antibodies	   against	   α-­‐tubulin	   (red).	   Nuclei	   are	   labeled	   with	   Hoechst	   (blue).	   B.	   The	   M-­‐line	   protein	   is	  present	  in	  muscles	  with	  dia	  loss	  of	  function.	  Flies	  are	  dissected	  3	  days	  after	  eclosion.	  Muscles	  are	  stained	  with	  phalloidin	  (white)	  and	  antibodies	  against	  obscurin	  (green).	  Obscurin	  is	  present	  at	  the	  M-­‐line	  in	  both	  wildtype	  and	  dia	  loss	  of	  function	  muscles.	  
C.	  Thick	  filament	  maintenance	  is	  disrupted	  by	  dia	  knockdown.	  Flies	  are	  dissected	  at	  3	   days	   and	   10	   days	   after	   eclosion.	   Thick	   filaments	   are	   labeled	   with	   antibodies	  against	  myosin	  heavy	  chain	  (MHC).	  All	  images	  are	  taken	  with	  the	  same	  settings.	  	  
	  
	  
	   177	  
	  
Figure	  4:	  Dia	  and	  FliI	  genetically	  interact	  to	  regulate	  sarcomere	  size.	  	  
A.	   Localization	   of	   FliI	   in	   an	   IFM.	   Flies	   are	   dissected	   1	   to	   7	   days	   after	   eclosion.	  Muscles	   are	   stained	  with	   phalloidin	   (white)	   and	   antibodies	   against	   α-­‐actinin.	   The	  localization	   of	   FliI	   is	   visualized	   with	   a	   FliI	   antibody,	   which	   co-­‐localizes	   with	   α-­‐actinin	  at	  the	  Z-­‐discs.	  B.	  Sarcomere	  phenotype	  in	  muscles	  with	  FliI	  knockdown.	  Flies	  are	  dissected	  3	  days	  after	  eclosion.	  Myofibrils	   are	   stained	  with	  phalloidin	   (white),	  myofibrils	  without	  M-­‐lines	  are	  marked	  with	  an	  arrow.	  Short	  sarcomeres	  are	  marked	  with	   an	   arrowhead,	   and	   shown	   in	   enlarged	  pictures.	  The	  bottom	  panel	   shows	   the	  sarcomere	   phenotype	   in	   flies	   that	   are	   rescued	   with	   FliI::HA.	   Scale	   bars:	   5	   μm.	   C.	  Survival	  assay.	  25	  embryos/genotype/day	  are	  selected	  for	  3	  days.	  Survival	  rates	  are	  calculated	  at	  larvae,	  pupae	  and	  adult	  stages.	  Knockdown	  of	  both	  Dia	  and	  FliI	  results	  in	  100%	  lethality	  at	  pupae	  stage.	  D.	  Sarcomere	  phenotypes	  in	  pupae.	  100	  APF	  pupae	  are	   dissected.	   The	   morphology	   of	   myofibrils	   and	   sarcomeres	   are	   visualized	   by	  phalloidin	  staining.	  Scale	  bar:	  5	  μm	  E.	  Quantification	  of	  sarcomere	  size.	  Knockdown	  of	   both	   FliI	   and	   Dia	   significantly	   reduce	   sarcoemre	   length	   (p<0.01)	   and	   with	  (p<0.0001)	  compare	  to	  single	  knock	  down.	  F.	  Sarcomere	  phenotype	  in	  IFM	  with	  FliI	  overexpression	   and	   Dia	   knockdown.	   Morphology	   of	   myofibril	   and	   sarcomere	   are	  visualized	  by	  Phalloidin	  staining.	  Scale	  bar:	  5µm.	  G.	  quantification	  of	  sarcomere	  size.	  Expressing	   both	   dia	   RNAi	   and	   FliI::HA	   in	   muscles	   with	   two	   copy	   of	   DMef2-­Gal4	  significantly	   reduce	   sarcoemre	   length	   (p<0.001)	  and	  with	   (p<0.1)	   compare	   to	   just	  expressing	  dia	  RNAi	  or	  FliI::HA.	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Figure	  4:	  Dia	  and	  FliI	  genetically	  interact	  to	  regulate	  sarcomere	  size.	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Figure	  5:	  Model:	  Dia	  and	  FliI	  interact	  to	  maintain	  the	  G-­actin	  pool	  in	  muscles	  
and	  regulate	  the	  size	  and	  uniformity	  of	  sarcomeres.	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Supplementary	  Figure	  1:	  A.	  The	  phenotype	  of	  muscles	  with	  reduced	  Dia	  function.	  Flies	  are	  dissected	  3	  days	  after	  eclosion	  and	  stained	  with	  phalloidin	  to	  label	  muscle	  structures.	   In	   muscles	   expressing	   DiaDN	   (intermediate),	   myofibrils	   undergo	  splitting	   and	   converge	   (arrow).	   No	   sarcomere	   structure	   could	   be	   detected	   in	  muscles	  expressing	  DiaDN	  (high).	  Both	  types	  of	  dia	  RNAi	  tested	  lead	  to	  shorter	  and	  thinner	  sarcomeres,	  as	  well	  as	  disorganized	  myofibrils.	  Scale	  bar:	  5μm	  B.	  Myoblast	  fusion	  is	  sufficient	  in	  muscles	  with	  dia	  knockdown.	  Flies	  are	  dissected	  3	  days	  after	  eclosion.	  Muscles	  are	  labeled	  with	  phalloidin	  (white),	  and	  muscle	  nuclei	  are	  labeled	  with	  Hoechst	   (blue).	   Enlarged	   pictures	   showing	   the	   even	   distribution	   of	   nuclei	   in	  both	   control	   muscles	   and	   muscles	   with	   dia	   knockdown.	   Scale	   bar:	   upper	   panel:	  100μm;	  lower	  panel:	  5μm	  C.	  Fusion	  index	  in	  muscles	  with	  dia	  knockdown.	  A	  fusion	  index	  of	  IFMs	  is	  quantified	  by	  counting	  the	  number	  of	  nuclei	  in	  a	  100μm	  x	  5μm	  area.	  No	   significant	   difference	   is	   found	   in	   control	   muscles	   and	   muscles	   with	   dia	  knockdown.	   D.	   The	   myotendinous	   junction	   is	   not	   affected	   in	   muscles	   with	   dia	  knockdown.	   Flies	   are	   dissected	   3	   days	   after	   eclosion.	   Muscles	   are	   labeled	   with	  phalloidin	   (white),	   the	  myotendinous	   junction	   is	   labeled	  with	   β-­‐PS-­‐integrin	   (red).	  No	   significant	   difference	   of	   β-­‐PS-­‐integrin	   signal	   is	   seen	   between	   control	   and	   dia	  knockdown	  muscles.	  E.	  Knockdown	  efficiency	  of	  dia	  RNAi	  (IR).	  An	  IFM	  is	  dissected	  and	   stained	   with	   phalloidin	   (red)	   and	   Dia	   (green).	   Images	   are	   captured	   with	   the	  same	  settings	  and	  show	  a	  decreased	  level	  of	  Dia	  due	  to	  dia	  knockdown.	  	  In	  muscles	  with	  dia	  knockdown,	  we	  brought	  the	  signal	  up	  to	  300%	  to	  show	  a	  residue	  of	  Dia	  in	  the	  sarcomere	  after	  dia	  knockdown.	  Scale	  bars:	  5μm	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Supplementary	  Figure	  1	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Supplemental	   Figure	   2.	   A-­B.	   The	   changes	   in	   IFM	   sarcomere	   size	   in	   adult	   flies.	  Wild-­‐type	   flies	   are	   dissected	   from	   1	   to	   7	   days	   after	   eclosion.	   Sarcomeres	   are	  visualized	   with	   phalloidin	   staining.	   The	   size	   of	   each	   sarcomere	   is	   measured	   and	  compared.	   Sarcomeres	   in	   flies	   that	   have	   just	   eclosed	   are	   significantly	   shorter	  (p<0.0001)	   and	   thinner	   (p<0.0001)	   than	   the	   sarcomeres	   of	   flies	  measured	  3	  days	  after	   eclosion.	   There	   is	   no	   significant	   difference	   of	   sarcomere	   size	   between	   day	   3	  and	  day	  7	  adult	  flies.	  C.	  Diagram	  of	  Dia	  construct	  used	  in	  detecting	  Dia	  localization.	  The	   diagram	   is	   modified	   from	   (Tal	   Rousso,	   2013).	   BD:	   basic	   domain.	   RBD:	  RhoGTPase	  binding	  domain.	  Dia-­‐N’ΔBD-­‐mutG:	  Dia	  N-­‐terminl	  domain	  without	  basic	  domain	  and	  Rho	  binding	  affinity.	  D.	  Localization	  of	  different	  Dia	  domains.	  Muscles	  are	  labeled	  with	  phalloidin	  (white).	  Antibodies	  against	  GFP	  label	  the	  localization	  of	  GFP	   fusion	   proteins.	   E.	   Dia	   localization	   in	   PI(4,5)P2	   sequestered	   IFMs.	   Flies	   are	  dissected	   3	   days	   after	   eclosion.	   Localization	   of	   Dia	   is	   detected	   with	   antibodies	  stained	  against	  Dia.	  F.	  Fluorescent	  intensity	  in	  the	  boxed	  area.	  In	  PIP2	  sequestering	  IFMs,	  higher	  levels	  of	  Dia	  are	  detected	  that	  are	  not	  specifically	  localized	  to	  either	  the	  Z-­‐discs	   or	  M-­‐line.	  G-­H.	   Sarcomere	   size	   changes	   in	  muscles	  with	   reduced	   levels	   of	  PI(4,5)P2.	  Flies	  are	  dissected	  3	  days	  after	  eclosion.	   In	  muscles	   that	  express	  kinase	  dead	  PIP5-­‐kinase	  Sktl	   (Sktl.KD),	   sarcomere	   is	   significantly	   shorter	   (p<0.0001)	  and	  thinner	  (p<0.0001)	  than	  control.	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Supplemental	  Figure	  2.	  	  
	  




Supplemental	   Figure	   3.	   A.	   3-­‐D	   reconstruction	   of	   six	   myofibrils	   showing	  microtubule	  network.	  Wild-­‐type	  flies	  are	  dissected	  3	  days	  after	  eclosion.	  Muscles	  are	  labeled	  with	  phalloidin	  (white),	  antibody	  against	  α-­‐tubulin	  (green)	  and	  Zasp	  (red).	   Nuclei	   are	   labeled	   with	   Hoechst	   (blue).	   The	   surface	   view	   shows	  microtubule	  networks	  at	   the	  periphery	  of	   the	  muscles.	  The	   interior	  view	  shows	  the	   localization	   of	   microtubules	   at	   the	   M-­‐line.	   B.	   Jupiter::GFP	   is	   expressed	   in	  muscles	   with	   a	   DMef2-­Gal4	   driver.	   Flies	   are	   dissected	   at	   day	   3	   after	   eclosion.	  Muscles	   are	   stained	  with	   phalloidin	   (white),	   and	   antibodies	   against	   GFP	   (red).	  Nuclei	   are	   labeled	   with	   Hoechst	   (blue).	   Microtubule	   networks	   in	   muscles	   are	  visualized	  by	  Jupiter::GFP.	  Scale	  bar:	  5	  μm.	  
	   185	  
Supplemental	  Figure	  4.	  A-­B.	  Muscle	  phenotypes	  in	  IFMs	  with	  chic	  and	  dia	  double	  knockdown.	   100	   APF	   pupae	   are	   dissected.	   Muscles	   are	   stained	   with	   phalloidin	  (white),	  and	  nuclei	  are	  labeled	  with	  Hoechst	  (green).	  Double	  knockdown	  of	  chic	  and	  
dia	  result	  in	  few	  nuclei	  in	  the	  IFMs,	  and	  IFMs	  are	  not	  attached	  to	  the	  myotendinous	  junction.	  Enlarged	  picture	  are	  shown	  in	  B,	  with	  details	  of	  myofibrils.	  Scale	  bars:	  A:	  40	  μm,	  B:	  5	  μm.	  C-­D.	  Chic	  and	  CapZ	  localization	  in	  dia	  loss	  of	  function	  IFMs.	  	  Flies	  are	  dissected	   3	   days	   after	   eclosion.	   Muscles	   are	   labeled	   with	   phalloidin	   (white)	   and	  antibodies	  against	  Chic	  (C)	  and	  Cpa	  (D),	  respectively.	  E-­F.	  Tmod	  localization	  in	  dia	  loss	  of	   function	   IFMs.	   	  Flies	  are	  dissected	  1	  and	  3	  days	  after	  eclosion.	  Muscles	  are	  labeled	   with	   phalloidin	   (white)	   and	   antibodies	   against	   Tmod.	   Note	   the	   Z-­‐disc	  localization	  of	  Tmod,	  which	  is	  seen	  in	  muscles	  expressing	  dia	  RNAi,	  but	  not	  in	  wild-­‐type	  muscles.	  Scale	  bars:	  5	  μm.	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Supplemental	  Figure	  4.	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Supplemental	   Figure	   5.	   A.	   Co-­‐immunoprecipitation	   of	   Dia::GFP	   and	   FliI::HA.	  Dia::GFP	   and	   GFP	   (negative	   control)	   are	   immunoprecipitated	   from	   S2	   cells	   with	  antibodies	   against	   GFP.	   Immunoprecipitation	   with	   nospecific	   lgGs	   are	   used	   as	  control	  (mock).	  Samples	  are	  analyzed	  by	  western	  blotting	  using	  antibodies	  against	  HA.	  No	  FliI::HA	  pulldown	  was	  detected	  (asterisk).	  B.	  Co-­‐localization	  of	  Dia	  and	  FliI	  in	  mature	   IFMs.	   Flies	   expressing	   Dia::GFP	   in	   muscles	   are	   dissected	   7	   days	   after	  eclosion.	   Muscles	   are	   labeled	   with	   phalloidin,	   antibodies	   against	   GFP	   and	   FliI.	  Dia::GFP	  and	  FliI	  co-­‐localize	  to	  the	  Z-­‐discs.	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Supplemental	  Table	  1:	  Flow	  chart	  of	  Dia-­interacting	  protein	  screen	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Supplemental	  Table	  2:	  Candidate	  genes	  and	  RNAi	  lines	  used	  in	  Dia-­interacting	  
protein	  screen.	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CHAPTER	  SIX:	  
CONCLUSION	  
I.	  	  Elucidating	  the	  mechanisms	  of	  myoblast	  fusion	  	  
Cell-­‐cell	   fusion	   is	   a	   highly	   regulated	   process	   that	   is	   critical	   for	   events	  including	   fertilization,	   bone	   remodeling,	   and	   the	   generation	   and	   homeostasis	   of	  skeletal	  muscle.	  	  Organisms	  in	  different	  species	  use	  this	  strategy	  to	  exchange	  genetic	  information,	   increase	   cell	   volume,	   and	   maintain	   cell	   function.	   	   Despite	   the	  differences	   in	   biological	   context,	   the	   steps	   required	   for	   cell-­‐cell	   fusion	   are	  conserved:	  two	  cells	  make	  contact	  and	  their	  cell	  membranes	  align,	  then	  fusion	  pores	  form	  on	  the	  membranes	  that	  allow	  the	  separate	  lipid	  bilayers	  to	  merge	  and	  achieve	  cytoplasmic	  continuity.	  	  Studying	  cell	  fusion	  in	  one	  cell	  type	  may	  provide	  insights	  to	  how	   fusion	   is	   regulated	   in	  different	  cell	   types	  across	  species.	   	   In	  my	   thesis,	   I	  have	  demonstrated	   how	   the	   phospholipid	   PI(4,5)P2,	   as	  well	   as	   the	   formin	   Diaphanous	  are	   involved	   in	   regulating	   myoblast	   fusion	   during	   Drosophila	   embryonic	   muscle	  formation.	  	  
	   The	   process	   of	   Drosophila	   embryonic	   myoblast	   fusion	   has	   been	   well	  documented	   through	   fixed	   and	   live	   imaging,	   both	   in	   vivo	  and	   in	   vitro	   (Dobi	   et	   al.,	  2011;	  Richardson	  et	  al.,	  2008a;	  Shilagardi	  et	  al.,	  2013).	  	  Researchers	  have	  identified	  numerous	   factors	   that	   are	   prerequisites	   for	   fusion.	   	   These	   include	   transcription	  factors	  needed	  for	  myoblast	  specification	  (Dohrmann	  et	  al.,	  1990;	  Duan	  et	  al.,	  2001),	  membrane	  proteins	  required	  for	  cell	  recognition	  (Bour	  et	  al.,	  2000;	  Ruiz	  Gomez	  et	  al.,	   2000),	   cytoskeleton	   regulators	   that	   play	   roles	   in	   cell	   migration	   and	   adhesion	  (Geisbrecht	   et	   al.,	   2008;	   Gildor	   et	   al.,	   2009),	   and	   proteins	   that	   mediate	   the	  membrane	  fusion	  events	  (reviewed	  in	  (Kim	  et	  al.,	  2015)).	   	  These	  studies	  have	   laid	  the	  foundation	  for	  my	  thesis	  research.	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   In	  my	   thesis	   studies,	   I	   addressed	   two	  critical	  questions	   related	   to	  myoblast	  fusion:	   1)	   In	   addition	   to	   transmembrane	   proteins,	   are	   there	   any	   other	  membrane	  components	   that	   transduce	   signals	   from	   the	   membrane	   and	   trigger	   cytoskeleton	  remodeling	   during	   fusion	   (Chapter	   2)?	   	   And	   2)	   Most	   of	   the	   actin	   regulators	   are	  known	   to	   play	   a	   role	   in	   fusion	   function	   through	   activating	   Arp2/3.	   	   Arp2/3	  nucleates	   branched	   actin	   networks,	   but	   does	   not	   elongate	   actin	   filaments.	   	   Some	  studies	  propose	  that	  the	  actin	  regulators,	  WIP	  and	  WASp,	  can	  recruit	  G-­‐actin	  to	  the	  fusion	  site,	  and	  therefore	  increase	  local	  G-­‐actin	  concentration,	  allowing	  spontaneous	  elongation	  of	  actin	  filaments	  locally	  (Jin	  et	  al.,	  2011).	  	  This	  hypothesis	  however,	  has	  not	   been	   validated.	   	   And	   it	   is	   unknown	  whether	   there	   is	   any	   actin	   regulator	   that	  elongates	  the	  filaments	  that	  Arp2/3	  binds	  to	  or	  nucleates	  (Chapter	  3,	  Chapter	  4).	  	  
	   Experiments	   in	   mammalian	   systems	   provided	   potential	   targets	   to	   address	  the	  first	  question:	  in	  mammalian	  muscles,	  phosphoinositide	  signaling	  is	  required	  for	  myogenesis	  (Bach	  et	  al.,	  2010;	  Leikina	  et	  al.,	  2013;	  Nowak	  et	  al.,	  2009).	  	  PI(4,5)P2	  is	  one	  of	   the	  phosphoinositides	   that	   regulate	  actin	  polymerization	  by	  controlling	   the	  localization	   and	   activity	   of	   Arp2/3	   activators.	   	   We	   therefore	   used	   PI(4,5)P2	  reporters	   to	   record	   the	   spatial	   and	   temporal	   distribution	   of	   PI(4,5)P2	   during	  myoblast	   fusion	   (Chapter	   2).	   	   The	   accumulation	   of	   PI(4,5)P2	   at	   the	   fusion	   site	  suggested	   a	   role	   of	   PI(4,5)P2	   in	   myoblast	   fusion.	   	   Decreasing	   the	   availability	   of	  PI(4,5)P2	   blocks	   myoblast	   fusion	   and	   confirms	   that	   PI(4,5)P2	   is	   required	   during	  fusion.	   	   How	   PI(4,5)P2	   regulates	   actin	   remodeling	   during	   Drosophila	   myoblast	  fusion	  has	  been	  examined	  through	  both	  in	  vitro	  and	  in	  vivo	  assays.	  	  We	  have	  shown	  that	  PI(4,5)P2	  regulates	  the	  localization	  of	  Mbc,	  thereby	  controlling	  the	  localization	  of	  active	  Arp2/3.	  	  
	   To	   address	   the	   second	   question	   about	   additional	   actin	   regulators,	   we	  examined	  the	  muscle	  phenotypes	  of	  mutations	  in	  different	  formin	  family	  members.	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Formins	  are	  a	  family	  of	  proteins	  that	  nucleate	  and	  elongate	  actin	  filaments.	  	  Because	  of	  their	  activity,	  formins	  can	  work	  upstream	  of	  Arp2/3,	  building	  the	  actin	  filaments	  to	   which	   Arp2/3	   can	   then	   bind.	   	   Alternatively	   formins	   can	   act	   downstream	   of	  Arp2/3,	   capping	   or	   elongating	   the	   actin	   filaments	   that	   Arp2/3	   seeded.	   	   We	  examined	   muscle	   phenotypes	   in	   all	   the	   available	   formin	   mutants.	   Some	   of	   the	  mutants	   tested	  were	   generated	   through	   random	   transposable	   element	   insertions,	  and	   the	   nature	   of	   these	  mutations	   has	   not	   been	   characterized.	   	   Nevertheless,	   we	  found	   that	   at	   least	   4	   formins	   in	  Drosophila	  are	   involved	  with	  muscle	   formation:	   a	  mild	  muscle	  detachment	  phenotype	  was	  observed	   in	  daam	   (daamG1567)	  mutants;	  a	  severe	  muscle	  morphological	   change	  was	  observed	   in	   fhos	   (fhosA055)	  mutants;	   and	  Cappuccino	   (Capu)	  mutants	   either	   failed	   to	   reach	   the	   stages	   of	  muscle	   formation	  (due	  to	  Capu’s	  role	  in	  early	  embryogenesis	  events),	  or	  the	  mutant	  embryos	  formed	  muscle	   with	   normal	   patterns.	   	   However,	   when	   examining	   double	   heterozygous	  embryos	  for	  a	  putative	  capu	  null	  allele	  (capu12344)	  and	  blow1,	  some	  embryos	  showed	  a	   mild	   reduction	   of	   fusion	   and	   a	   minor	   muscle	   detachment	   phenotype.	   	   When	  examining	  doubly	  heterozygous	  embryos	  for	  capu12344	  and	  mbcc1,	  the	  numbers	  of	  LT	  muscles	  in	  some	  embryos	  was	  significantly	  increased.	  	  Similar	  to	  Capu,	  Diaphanous	  (Dia)	   is	   also	   required	   in	   early	   embryogenesis	   events,	   therefore	   only	   a	   small	  proportion	  of	  dia	  mutant	  embryos	  proceeded	  to	  stages	   in	  which	  muscle	   formation	  could	  be	  assessed.	  	  Among	  these	  embryos,	  we	  observed	  a	  variety	  of	  muscle	  defects,	  including	   insufficient	   fusion,	  missing	  muscles,	  muscle	  morphological	   changes,	   and	  muscle	  detachment.	  	  We	  also	  noticed	  that	  overexpression	  of	  constitutively	  active	  Dia	  significantly	  blocks	  myoblast	  fusion.	  	  The	  muscle	  phenotypes	  in	  dia	  loss	  of	  function	  and	  overexpression	  backgrounds	  gave	  us	  the	  rationale	  to	  investigate	  the	  role	  of	  Dia	  during	  fusion.	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   In	   Chapter	   3	   we	   elucidated	   the	   function	   of	   Dia	   during	   fusion.	   I	   provided	  evidence	  that	  Dia	  and	  Arp2/3	  cooperate	  in	  a	  highly	  regulated	  manner	  to	  build	  actin	  networks	  at	   the	   fusion	  site.	   	  We	  showed	  that	  Dia	   functions	  upstream	  of	  Arp2/3	  to	  build	  linear	  actin	  filaments	  upon	  which	  Arp2/3	  can	  bind.	  	  We	  also	  showed	  that	  Dia	  is	  required	  for	  the	  proper	  localization	  of	  Arp2/3	  NPFs,	  SCAR	  and	  WASp.	  	  Our	  work	  suggested	   a	   balance	   exists	   between	   Arp2/3-­‐mediated	   actin	   branching	   and	   Dia-­‐mediated	   actin	   elongation.	   	   In	   Chapter	   4,	   we	   took	   our	   research	   a	   step	   further	   to	  demonstrate	  that,	   like	  Dia,	  the	  activity	  of	  SCAR	  is	  also	  highly	  regulated	  to	  facilitate	  fusion,	  as	  either	  loss	  of	  function	  or	  overexpression	  of	  SCAR	  results	  in	  blocked	  fusion.	  	  Our	   work	   emphasized	   the	   importance	   of	   balanced	   activity	   between	   Dia	   and	   the	  ARP2/3	  NFPs,	   SCAR	   and	  WASp.	   	   The	   expression	   levels	   and	   activity	   of	   these	   actin	  regulators	  determined	   the	   structure	  and	  dynamics	  of	  actin	  networks	  at	   the	   fusion	  site,	  and	  they	  are	  therefore	  essential	  if	  fusion	  is	  to	  proceed.	  	  
	   Collectively,	   this	   work	   has	   expanded	   our	   understanding	   of	   how	   myoblast	  fusion	   progresses	   and	   has	   identified	   two	   more	   factors	   that	   are	   required	   in	  
Drosophila	  myoblast	   fusion.	   	   However,	   our	   data	   also	   raise	   more	   questions	   about	  how	   fusion	   is	   initiated	   and	   how	   it	   proceeds:	   what	   triggers	   the	   aggregation	   of	  transmembrane	   proteins	   Sns	   and	   Duf	   and	   recruits	   PI(4,5)P2	   to	   the	   fusion	   site?	  Expression	   of	   Duf	   or	   Rst	   in	   S2	   cells	   suggests	   these	   proteins	   localize	   at	   cell-­‐cell	  contacts	  and	  mediate	  homotypic	  cell	  aggregation.	  	  Expression	  of	  Sns	  does	  not	  trigger	  homotypic	   aggregation	   (Galletta	   et	   al.,	   2004).	   	   In	   Drosophila	   embryos,	   ectopic	  expression	  of	  Duf	  or	  Rst	  induces	  migration	  and	  aggregation	  of	  FCMs	  at	  ectopic	  sites	  (Ruiz	   Gomez	   et	   al.,	   2000;	   Strünkelnberg	   et	   al.,	   2001).	   	   These	   FCM	   behaviors	   are	  mediated	  by	   Sns	   and	   its	   interacting	  proteins	   that	   transduce	   Sns	   signaling	   to	   actin	  cytoskeleton	   (Kim	   et	   al.,	   2007;	   Kocherlakota	   et	   al.,	   2008).	   	   However,	   it	   is	   unclear	  whether	   there	   is	   a	   feedback	  mechanism	   that	   triggers	   the	   aggregation	  of	   Sns.	   	  Our	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data	   indicate	   that	   the	   PI(4,5)P2	   enrichment	   at	   the	   fusion	   is	   dependent	   on	   Sns.	  	  However,	  the	  mechanism	  by	  which	  Sns	  recruits	  PI(4,5)P2	  has	  not	  been	  investigated:	  it	   remains	   to	   be	   tested	  whether	   Sns	   recruits	   PI(4,5)P2	   via	   a	   direct	   interaction	   or	  through	  interaction	  with	  	  PI(4,5)P2	  binding	  proteins.	  	  To	  address	  this	  question,	  one	  can	   examine	   the	   enrichment	   of	   PI(4,5)P2	   in	   Sns	   deletion	   backgrounds	   and	  determine	   the	   minimal	   Sns	   regions	   required	   for	   PI(4,5)P2	   localization.	   	   By	  examining	   the	   required	   sequences	   and	   identifying	   potential	   binding	   partners	   of	  these	   regions,	   one	   can	   determine	   how	   Sns	   recruit	   PI(4,5)P2	   to	   the	   fusion	   site.	   	   A	  series	   of	   deletion	   and	   site	   directed	   mutations	   are	   available	   for	   this	   purpose	  (Kocherlakota	  et	  al.,	  2008).	  	  
	   Another	  question	  that	  needs	  to	  be	  addressed	  is	  how	  Dia	  accumulates	  at	  the	  fusion	  site	  and	  how	  is	  it	  regulated	  there.	  	  Experiments	  in	  Drosophila	  epithelial	  tubes	  showed	   that	   PI(4,5)P2	   regulates	   the	   apical	   localization	   of	   Dia.	   	   During	   myoblast	  fusion,	  both	  PI(4,5)P2	  and	  Dia	  are	  enriched	  at	  the	  fusion	  site,	  suggesting	  Dia	  might	  be	   recruited	   to	   the	   fusion	   site	   through	   similar	   mechanisms.	   	   However,	   when	   we	  examined	  Dia	   localization	   in	  muscles	  under	  PI(4,5)P2	   sequestering	   conditions,	  we	  found	   that	   Dia	   still	   accumulates	   at	   the	   fusion	   site.	   	   One	   explanation	   for	   this	  observation	  is	  that	  PI(4,5)P2	  is	  not	  completely	  sequestered.	  	  The	  presence	  of	  a	  small	  actin	   focus	   in	  PI(4,5)P2	  sequestering	  conditions,	  rather	  than	  no	  actin	   focus	  as	  that	  seen	  in	  wip	  and	  kette	  double	  mutant,	  supports	  this	  explanation.	  	  Another	  possibility	  is	   that	   there	   are	   redundant	   factors,	   in	   addition	   to	   PI(4,5)P2,	   that	   regulate	   Dia	  localization.	  	  	  
Our	  study	  showed	  that	  in	  wip	  and	  kette	  double	  mutant,	  Dia	  is	  present	  at	  the	  fusion	   site	   even	   when	   Arp2/3	   activity	   is	   compromised.	   	   We	   use	   these	   data	   to	  support	   our	  model	   that	  Dia	   function	   upstream	  of	  Arp2/3	   and	   its	   regulators.	   	   One	  aspect	   to	   note	   is	   that	   in	  wip	   and	   kette	   double	  mutant	   embryos,	   no	   actin	   focus	   is	  
	   195	  
formed,	  despite	   the	   fact	   that	  Dia	   is	  present	  at	   the	   fusion	  site.	   	  One	  explanation	   for	  this	   observation	   is	   that	   Dia,	   while	   present	   at	   the	   fusion	   site,	   is	   not	   actively	  polymerizing	   actin.	   	   Another	   explanation	   is	   that	   Dia	   is	   present	   and	   active	   at	   the	  fusion	  site,	  but	   the	  actin	   filaments	  that	   it	  polymerizes	  do	  not	  organize	   into	  a	   focus	  structure.	  	  Our	  model	  favors	  the	  second	  explanation.	  	  In	  fact,	  residual	  actin	  filaments	  are	  found	  at	  the	  fusion	  site	  in	  wip	  and	  kette	  double	  mutant	  embryos;	  these	  organize	  into	   a	   cortical	   actin	   cap-­‐like	   structure	   (Bothe	   et	   al.,	   2014)	   or	   filopodia-­‐like	  protrusions	  (Deng	  et	  al.,	  2015).	  	  
Our	  data	  suggest	  that	  a	  balance	  between	  Dia	  and	  Arp2/3	  activities	  is	  crucial	  for	  myoblast	  fusion	  to	  proceed.	  	  What	  are	  the	  mechanisms	  that	  maintain	  the	  balance	  between	  Dia	  and	  Arp2/3?	  	  We	  have	  found	  that	  the	  activity	  of	  Arp2/3	  during	  fusion	  can	  be	  evaluated	  by	  examining	  the	  localization	  of	  Arp2/3	  regulatory	  proteins,	  such	  as	   SCAR	   and	   WASp.	   	   However,	   we	   have	   not	   examined	   the	   localization	   of	   Dia	  regulatory	   proteins.	   	   Instead,	   the	   activity	   of	   Dia	   has	   been	   only	   evaluated	   by	  examining	  Dia	  localization	  and	  actin	  structure	  as	  a	  readout.	  	  In	  the	  future,	  examining	  the	  localization	  and	  activity	  of	  Dia	  regulators,	  such	  as	  RhoGTPase	  and	  Profilin,	  will	  provide	  important	  information	  about	  how	  Dia	  is	  regulated	  during	  fusion.	  	  
	  	   Another	   question	   that	   attracts	   our	   attention	   is	   what	   are	   the	   actin	  depolymerization	   factors	   that	   resolve	   the	   actin	   focus	   after	   fusion	  pore	   formation?	  	  Studies	   in	   our	   lab	   have	   suggested	   that	   actin	   depolymerization	   factors,	   such	   as	  Twinstar/Cofilin	  (Tsr),	  play	  a	  critical	  role	  in	  myoblast	  fusion.	   	  However,	  due	  to	  the	  requirement	   for	   depolymerization	   activities	   in	   earlier	   embryogenesis	   events,	  maternal	  loading,	  and	  redundant	  depolmerization	  factors	  such	  as	  Gelsolin,	  we	  have	  found	  it	  difficult	  to	  recover	  mutants	  that	  specifically	  block	  fusion	  without	  disrupting	  embryonic	  patterning	  in	  general.	   	  Therefore,	  investigating	  muscle-­‐specific	  isoforms	  of	   these	   actin	   depolymerization	   factors,	   or	   knocking	   down	   a	   combination	   of	   actin	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depolymerization	   factors	   in	  muscles	  may	   provide	   the	   needed	   insights	   to	   how	   the	  actin	  focus	  is	  resolved	  prior	  to	  fusion.	  
These	  questions	  proposed	  above	  merit	  further	  investigation;	  the	  knowledge	  gained	  would	  illuminate	  how	  the	  key	  steps	  of	  fusion	  are	  controlled.	  	  
II.	   The	   balance	   between	   actin	   polymerization	   and	   depolymerization	   both	  
determines	  actin	  structures	  and	  maintains	  the	  G-­actin	  pool	  in	  muscle	  cells	  
The	  Drosophila	  flight	  muscles	  provide	  a	  sensitive	  and	  simple	  system	  to	  study	  sarcomere	  structure	  (Reedy	  and	  Beall,	  1993;	  Vigoreaux,	  2001).	  	  In	  my	  thesis,	  I	  used	  the	  indirect	  flight	  muscles	  to	  identify	  factors	  that	  control	  sarcomere	  size	  and	  to	  test	  for	  genetic	  interactions	  between	  these	  factors.	  	  The	  formin	  family	  of	  proteins,	  which	  both	   nucleate	   and	   polymerize	   actin	   filaments,	   has	   been	   shown	   to	   regulate	  sarcomere	   thin	   filament	   size	   and	   integrity	   in	   different	   systems:	   in	   the	   C.	   elegans	  body	   wall	   muscles,	   FHOD-­‐1	   and	   CYK-­‐1	   are	   required	   to	   determine	   and	   maintain	  sarcomere	  size	  (Mi-­‐Mi	  and	  Pruyne,	  2015;	  Mi-­‐Mi	  et	  al.,	  2012).	  	  In	  cardiac	  muscle	  cells	  in	   culture,	   13	   formins	   are	   expressed	  and	  play	   roles	   in	  myofibril	   development	   and	  maintenance	  (Arimura	  et	  al.,	  2013;	  Iskratsch	  et	  al.,	  2013;	  Kan-­‐O	  et	  al.,	  2012;	  Rosado	  et	  al.,	  2014;	  Taniguchi	  et	  al.,	  2009;	  Wooten	  et	  al.,	  2013).	  	  In	  Drosophila	  flight	  muscles,	  DAAM	  plays	  an	  important	  role	  in	  thin	  filament	  assembly	  (Molnár	  et	  al.,	  2014).	   	  My	  thesis	  work	  expanded	  our	  knowledge	  and	  identified	  the	  formin	  Dia	  as	  another	  key	  regulator	   that	   controls	   sarcomere	   size.	   	   In	   addition,	   I	   identified	   the	   actin	   severing	  protein	  Flightless	   I	   (FliI),	  a	  Gelsolin	   family	  member,	  as	  a	   functional	  partner	  of	  Dia.	  	  Unlike	  Dia,	  which	  localizes	  at	  the	  M-­‐line	  and	  elongates	  actin	  filaments,	  FliI	  localizes	  at	   the	   Z-­‐discs	   and	   severs	   actin	   filaments.	   Because	   of	   the	   activity	   of	   these	   two	  proteins,	  one	  would	  expect	  to	  see	  a	  rescue	  of	  sarcomere	  size	  in	  a	  knockdown	  of	  FliI	  in	  a	  Dia	  loss	  of	  function	  background.	  	  Instead,	  what	  we	  found	  is	  even	  smaller-­‐sized	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sarcomeres	   in	   this	  background.	   	  A	  reasonable	  explanation	  of	   this	  result	   is	   that	  FliI	  and	  Dia	  work	   together	   to	  regulate	   the	  homeostasis	  of	   the	  G-­‐actin	  pool	  and,	  hence,	  sarcomere	  size.	  	  	  
	   As	   described	   in	   Chapter	   1,	   the	   structures	   that	   are	   composed	   of	   actin	  filaments	   are	   regulated	   at	   different	   levels:	   at	   the	   signaling	   level	   that	   determines	  when	   and	  where	   actin	   remodeling	   occurs,	   at	   the	   regulatory	   level	   that	   determines	  actin	   turnover	   and	   dynamics,	   and	   at	   the	   organizational	   level	   that	   controls	   the	  arrangement	  of	  actin	  filaments.	  	  My	  thesis	  work	  suggests	  that,	  although	  actin	  is	  one	  of	  the	  most	  abundant	  proteins	  in	  eukaryotic	  cells,	  the	  available	  pool	  of	  monomeric	  G-­‐actin	  serves	  as	  an	  important	  regulatory	  factor	  in	  the	  building	  and	  maintenance	  of	  F-­‐actin	  structures.	  	  Moreover,	  using	  sarcomere	  size	  as	  an	  output,	  we	  elucidated	  how	  the	  G-­‐actin	  pool	  is	  maintained	  through	  Dia	  and	  FliI	  (Chapter	  5).	  	  
In	  addition	  to	  our	  work	  here,	  a	  broader	  discussion	  of	  how	  a	   limited	  G-­‐actin	  pool	  is	  maintained	  and	  partitioned	  has	  been	  trending	  in	  the	  literature.	  	  For	  example,	  in	   fission	   yeast,	   Profilin	   was	   identified	   as	   one	   of	   the	   key	   factors	   that	   control	   the	  partitioning	  of	  the	  G-­‐actin	  pool	  between	  Arp2/3	  and	  formins	  through	  a	  competition	  mechanism	  (Suarez	  et	  al.,	  2015).	  	  Nevertheless,	  additional	  questions	  are	  raised:	  how	  does	   the	  muscle	   cell	   partition	   and	   distribute	   G-­‐actin	   into	   different	   regions	   of	   the	  cytoplasm?	   	   Our	   data	   (Chapter	   3	   and	   4)	   suggest	   Dia	   and	   Arp2/3	   might	   directly	  compete	   for	   actin	   during	   fusion.	   	   Whether	   Chickadee/Profilin	   plays	   a	   role	   in	  partitioning	   G-­‐actin	   between	   Dia	   and	   Arp2/3	   remains	   unknown.	   	   In	   addition,	  whether	  muscle	  cells	  employ	  other	  mechanisms	  that	  partition	  G-­‐actin,	  such	  as	  local	  synthesis	  of	  G-­‐actin	  or	  directional	  transport	  of	  G-­‐actin,	   is	  still	  unclear	  and	  requires	  further	  study.	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Another	   area	   that	   attracts	   our	   interest	   focuses	   on	   the	   mechanisms	   that	  maintain	  the	  G-­‐actin	  pool	   in	  different	  cell	   types.	   	  We	  have	  demonstrated	  that	  actin	  polymerization	   and	   depolymerization	   factors	   contribute	   to	   actin	   homeostasis	   in	  
Drosophila	   adult	   muscles.	   	   Interestingly,	   low	   levels	   of	   G-­‐actin	   trigger	   the	  transcription	   of	   actin	   through	   transcription	   factor	  MAL/SRF	   and	  maintain	   G-­‐actin	  levels	  in	  the	  border	  cells	  in	  Drosophila	  ovary	  as	  well	  as	  MDA-­‐MB-­‐231	  human	  breast	  cancer	   cells	   (Salvany	   et	   al.,	   2014).	   	   It	   would	   be	   exciting	   to	   examine	   the	   gene	  expression	   profile	   that	   responds	   to	   G-­‐actin	   level	   change	   through	   RNA-­‐Seq	   in	   the	  flight	  muscles.	  
Resolving	   these	  questions	  will	  not	  only	  help	  us	  understand	  how	  sarcomere	  size	  is	  determined	  in	  muscle,	  but	  it	  will	  also	  expand	  our	  understanding	  of	  how	  actin	  structures	  are	  regulated	  and	  how	  they	  ultimately	  determine	  cell	  shape,	  function,	  and	  behavior.	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CHAPTER	  SEVEN:	  
METHODS	  AND	  MATERIALS	  
Fly	  stocks:	  	  The	   following	   stocks	   were	   used:	   Oregon	   R	   (control,	   wild-­‐type),	   UAS-­diaFH1FH2	  (Bloomington	   #27616),	   twist-­actin::GFP,	   apME-­NLS::dsRed,	   UAS-­dia::GFP,	   UAS-­
DiaΔDAD::GFP;	   UAS-­diaFH1FH2::GFP,	   UAS-­	   DiaΔDAD::HA,	   UAS-­DiaDDFH1FH2::GFP	  (M	   Peifer),	   UAS-­SCAR-­HA-­CYFP,	   UAS-­Abi-­HA-­CYFP,	   UAS-­SCAR-­Myc-­NYFP,	   UAS-­Abi-­
Myc-­NYFP,	  UAS-­HA-­CYFP,	  UAS-­Myc-­NYFP	  (Gohl	  et	  al.,	  2010).	  UAS-­DiaCA-­HA	  (Bilancia	  et	   al.,	   2014;	   Nowotarski	   et	   al.,	   2014).	   duf5.1-­GAL4	   (5.1kb	   enhancer	   region	   of	   duf	  fused	   with	   Gal4,	   sequence	   information	   based	   on	   (Guruharsha	   et	   al.,	   2009;	   Ruiz	  Gomez	   et	   al.,	   2000),	   Dmef2-­Gal4,	   blow[1],	   sns[XB3],	   mbc[c1],	   kette[J4-­48],	   loner[T1032],	  
sltr[S1946],	  Rac1[J11],Rac2[Δ],	  Mtl[Δ],	  wsp[3D3-­35].	  Stocks	  were	  balanced	  over	  CyO,	  dfd-­GMR-­
YFP	   or	   TM3,	   dfd-­GMR-­YFP,	   and	   identified	   by	   GFP	   staining.	   UAS-­moesin::mCherry,	  
DMef2-­‐Gal4,	  dia5,	  dia2.	  UAS-­‐DiaDN::GFP	   (this	   study),	   fhosA055,	   fhosEY09842,	   fhosKG05956,	  
daamG1567,	   daamMB03627,	   CG32138ET03931,	   capu12344,	   UAS-­capu::GFP;	   UAS-­capu-­RNAi,	  	  
UAS-­dicer;;Dmef2-­Gal4,	  MHC-­Gal4,	   fliI3,	   UAS-­fliI-­RNAi,	   UAS-­D-­fliI::HA,	   UAS-­H-­fliI::HA,	  
UAS-­PHplcγ::GFP.	  The	  Gal4-­‐UAS	  system	  was	  used	   for	  expression	  studies	  (Brand	  and	  Perrimon,	   1993).	   Embryos	   were	   staged	   according	   to	   (Campos-­‐Ortega	   and	  Hartenstein,	  1985).	  	  
	  
Immunohistochemistry:	  	  Embryos	   were	   collected,	   fixed	   in	   4%	   PFA,	   and	   stained	   according	   to	   standard	   lab	  protocol	   (Richardson	   et	   al.,	   2007).	   	   Antibodies	   were	   used	   at	   the	   following	  concentrations:	   α-­‐Dia	   (1:500)	   (S.	  Wasserman),	   α-­‐Duf	   (1:200)	   (K.-­‐F.	   Fischbach),	   α-­‐Sns	   (1:250)	   (S.	   Abmayr),	   α-­‐WASp	   (1:500)	   (E.	   Schejter),	   α-­‐SCAR(1:100)	   (J	   Zallen)	  (Zallen	  et	  al.,	  2002),	  α-­‐GFP	  (1:500)(Invitrogen	  A-­‐11120),	  α-­‐dsRed	  (1:	  500)	  (Clontech	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32392),	  α-­‐Blow	  (1:100;	  E.	  Chen,	   Johns	  Hopkins,	  USA),	  α-­‐Loner	  (1:100;	  E.	  Chen),	  α-­‐Mbc	   (1:100;	   S.	   Abmayr,	   Stowers	   Institute,	   USA),	   α-­‐Rac1GTP	   (1:250;	   Neweast	  Bioscience	   26903),	   Alexa	   Fluor	   647-­‐phalloidin	   (1:100)	   (Invitrogen	   A22287).	   	   For	  secondary	   antibodies,	   Alexa	   Fluor	   488-­‐,	   Alexa	   Fluor	   555-­‐,	   and	   Alexa	   Fluor	   647-­‐conjugated	   fluorescent	   secondary	   antibodies	   at	   1:200	   dilution	   (Invitrogen)	   were	  used.	   	   Fluorescent	   images	   were	   acquired	   on	   a	   Leica	   SP5	   laser	   scanning	   confocal	  microscope	  equipped	  with	  a	  63X	  1.4	  NA	  HCX	  PL	  Apochromat	  oil	  objective	  and	  LAS	  AF	  2.2	  software.	  	  Maximum	  intensity	  projections	  of	  confocal	  Z-­‐stacks	  were	  rendered	  using	  Volocity.	  	  	  
Fusion	  index	  quantification:	  Nuclei	   in	   LT	   muscles	   were	   specifically	   labeled	   by	   expressing	   DsRed	   fused	   to	   a	  nuclear	   localization	  signal	  under	  the	  control	  of	  the	  apterous	  mesodermal	  enhancer	  (apRed)	   (Metzger	   et	   al.,	   2012;	   Richardson	   et	   al.,	   2007).	   	   The	   fusion	   index	   was	  quantified	  by	  counting	  the	  number	  of	  dsRed	  positive	  nuclei	  in	  each	  hemisegment	  in	  stage	  17	  embryos.	  	  	  
Line	  scan	  for	  measuring	  fluorescence	  enrichment	  at	  actin	  foci:	  	  Line	  scans	  were	  done	  in	  ImageJ	  (Schneider	  et	  al.,	  2012).	  	  The	  focal	  plane	  was	  chosen	  where	  the	  cross	  section	  area	  of	  the	  F-­‐actin	  focus	  was	  the	  largest	  (Richardson	  et	  al.,	  2007).	  	  A	  line	  was	  drawn	  across	  the	  F-­‐actin	  focus,	  with	  the	  center	  of	  the	  line	  aligned	  with	   the	   F-­‐actin	   focus	   center.	   	   Grey	   values	   were	   measured	   along	   the	   line.	   	   The	  relative	   intensity	   was	   calculated	   at	   each	   point	   following	   the	   equation:	   yrelative=(y-­‐ymin)/(ymax-­‐ymin).	   	   Ten	   F-­‐actin	   foci	  were	  measured	   in	   the	   same	  way.	   	   The	   average	  relative	  intensity	  and	  standard	  deviation	  of	  mean	  at	  each	  point	  were	  calculated	  from	  those	  samples.	   Signal	  enrichment	   in	  different	   channels	  was	  measured	   in	   the	  same	  way.	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Spermatogenesis	  Male	  adult	  flies	  carrying	  net-­Gal4;nos-­Gal4>UAS-­diaDN::GFP	  or	  net-­Gal4;nos-­Gal4>w	  (ctrl)	  (Schulz	  et	  al.,	  2004;	  Shivdasani	  and	  Ingham,	  2003)	  were	  crossed	  to	  w	  female	  in	  a	  1:2	  ratio.	   	  Mated	  females	  were	  allowed	  to	   lay	  eggs	   for	   four	  days	   in	  29°C.	   	  The	  number	  of	  larvae	  were	  counted,	  and	  this	  number	  was	  used	  to	  determine	  the	  number	  of	  larvae	  produced	  per	  male	  per	  day.	  Testis	  and	  seminal	  vesicles	  were	  dissected	  (n	  =	  5),	  fixed	  in	  4%	  PFA,	  and	  stained	  with	  DAPI	  (Wen	  et	  al.,	  2015).	  	  Sperm	  numbers	  were	  quantified	  using	  images	  taken	  on	  confocal	  microscope.	  	  
Fluorescence	  recovery	  after	  photobleaching:	  	  Actin::GFP	  was	  used	  to	  label	  F-­‐actin	  foci	  at	  the	  fusion	  site.	  	  FRAP	  experiments	  were	  performed	  on	  a	  Zeiss	  LSM710,	  with	  40x	  oil	  objective.	  	  488nm	  laser	  was	  set	  at	  14%.	  	  Pinhole	  was	   set	   at	   AU	   1.0.	   	   Region	   of	   interest	   (ROI)	  were	   identified	   and	   selected	  manually,	  two	  scans	  were	  taken	  before	  bleaching.	  	  100%	  488nm	  and	  458nm	  lasers	  were	   used	   to	   quickly	   bleach	   ROI	   to	   around	   30%	   of	   the	   original	   intensity.	   	   After	  photobleaching,	   images	  were	  acquired	  every	  3s.	   	  For	  data	  analysis,	   the	  size	  of	  ROI	  was	  fixed	  for	  each	  movie,	  but	  the	  location	  was	  adjusted	  manually	  for	  each	  frame	  as	  the	  F-­‐actin	   focus	  shifts	  over	   time.	   	  Fluorescence	   intensity	  was	  measured	   in	   ImageJ	  and	   was	   normalized	   to	   background.	   	   Half	   time	   was	   determined	   by	   y=ymin+(ymax-­‐ymin)(1-­‐e-­‐kt),	  and	  kinetic	  curves	  were	  plotted	  according	  to	  the	  calculation	  (Jin	  et	  al.,	  2011).	  	  	  
Molecular	  cloning:	  	  Dominant	  negative	  Dia	  (DiaDN)	  was	  designed	  according	  to	  (Staus	  et	  al.,	  2007).	   	   In	  mDia,	  the	  567-­‐1182	  minus	  21	  amino	  acid	  from	  the	  750-­‐770	  region	  is	  considered	  a	  dominant	   negative	  mDia.	   	   Alignment	   of	  mDia1	  with	  Drosophila	   Dia	   identified	   the	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497-­‐1029	   minus	   21	   amino	   acid	   from	   599-­‐619	   (DiaDN)	   as	   a	   potential	   dominant	  negative	  Dia	   in	  Drosophila.	   	   DiaDN	   contains	   the	   FH1	   domain	   and	   part	   of	   the	   FH2	  domain.	   	   We	   cloned	   DiaDN	   into	   pUAST	   vector	   using	   two	   pairs	   of	   primers:	  5’CACCGAATTCATGGGTGTGGCGGCTCCGTC3’	   and	  5’AAAAGATCTGCCATGAGGCAGAACGGG3’,	  5’CACCGGATCCGTCCCGGCCAAAATGTCC3’	   and	  5'AAAGGATCCCATCACGCCTTCCTGCG	   3'.	   The	   DiaDN	   constructs	   were	   validated	   by	  sequencing	  and	  tested	  in	  S2	  cells	  and	  in	  vivo	  before	  being	  sent	  out	  for	  injection.	  
Drosophila	  fliI	  was	  amplified	  from	  cDNA	  (BDGP	  DGC	  clones:	  LD21753)	  with	  primer	  :	  forward:	  5'CACCATGAGCGTGCTGCCGTT3',	  reverse:5'	  TAAATACACCTTGAAGGC3'	  Human	   FLII	   was	   amplified	   from	   cDNA	   (GE	   healthcare,	   BC025300)	   with	   primer:	  forward:	   5'CACCATGGAGGCCACCGGGGTG	   3',	   reverse:	  5'GGCCAGGGCCTTGCAGAAG3'.	   	  Both	  genes	  were	  cloned	  into	  pUAST	  vectors	  with	  a	  C-­‐terminal	  HA	  tag	  and	  sequenced.	  	  	  
Time-­lapse	  imaging:	  Embryos	   were	   raised	   at	   25°C,	   collected,	   dechorinated	   and	   mounted	   on	   a	   Teflon	  membrane	  in	  Halocarbon	  oil	  700	  (Halocarbon	  Products	  Corp.,	  Series	  700,	  9002-­‐83-­‐9).	   	  Images	  were	  acquired	  every	  30	  or	  60	  seconds	  as	  indicated,	  single	  z=0.5µm	  18-­‐20mm	  total	  on	  an	  upright	  Leica	  SP5	   laser	   scanning	  confocal	  microscope	  equipped	  with	   a	   63X	   1.4	   NA	   HCX	   PL	   Apochromat	   oil	   objective	   and	   LAS	   AF	   2.2	   software.	  	  Maximum	   intensity	   projections	   of	   confocal	   Z-­‐stacks	  were	   rendered	   using	   Volocity	  Visualization	  software	  (Improvision).	  	  
Western	  blot:	  	  
DMef2-­Gal4>UAS-­DiaDN::GFP	  embryos	  were	  incubated	  at	  25°C	  to	  stage	  16.	  	  Embryos	  were	   harvested	   and	   lysed	   in	   cytoplasmic	   protein	   lysis	   buffer	   (10mM	  Tris	   PH	   7.5,	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2mM	  EDTA	  PH	  8,	  2mM	  EGTA	  PH7.5,	  150mM	  NaCl,	  1%	  Triton,	  1%	  NP40,	  1mM	  PMSF,	  DTT	  1mM,	  1µg/ml	  Leupeptin,	  1µg/ml	  Pepstatin).	   	   Embryo	   lysates	  were	   separated	  on	   a	   12.5%	   SDS-­‐PAGE	   gel	   and	   then	   transferred	   to	   nitrocellulose	   membrane	   for	  Western	   analysis.	   	   DiaDN::GFP	  was	   detected	   by	   an	   α-­‐GFP	   antibody	   (Torrey	   Pines	  TP401).	  	  
	  
Cell	  culture:	  	  S2R+	   cells	  were	   grown	   in	   Schneider’s	  medium.	   	   Transfection	  was	   done	   in	  Grace’s	  medium	   with	   Cellfectin	   II	   reagent	   (invitrogen	   10362-­‐100).	   	   0.5µg	   of	   UAS-­‐DiaDN::GFP	  and	  0.5µg	  of	   actin-­‐Gal4	  were	   co-­‐transfected	   in	   S2R+	   cells.	   	   Cells	  were	  incubated	  in	  25°C	  for	  24h,	  and	  fixed	  in	  4%	  PFA.	  	  Phalloidin	  was	  used	  to	  label	  F-­‐actin	  in	  S2R+	  cells.	  	  	  
Co-­Immunoprecipitation:	  
Drosophila	  S2	  cells	  were	  co-­‐transfected	  with	  Ubiquitin-­‐Gal4,	  UAS-­‐	  Dia::GFP	  (or	  UAS-­‐GFP	  alone)	  and	  UAS-­‐3xHA::FliI	  constructs.	   	  Cells	  were	  lysed	  at	  day	  3	  in	  lysis	  buffer	  (150mM	  NaCl,	   2mM	  MgOAc,	   20mM	  Tris,	   pH	   7.5,	   5%	  Glycerol,	   0.5%	  NP40)	   for	   30	  minutes.	   	   Protein	   levels	   in	   the	   lysates	   were	   quantified.	   	   Cell	   lysates	   were	   then	  incubated	   with	   Protein	   G-­‐Agarose	   beads	   overnight	   at	   4°C	   using	   rabbit	   anti-­‐GFP	  (Torrey	   Pines	   #TP401)	   or	   anti-­‐rabbit	   IgG	   (Santa	   Cruz	   #	   SC-­‐7392)	   for	   mock	  immunoprecipitation	  controls.	  	  The	  beads	  were	  washed	  four	  times	  with	  lysis	  buffer	  and	  boiled	  in	  4x	  Laemmli	  Buffer.	  	  GFP-­‐purified	  samples	  were	  then	  run	  on	  SDS-­‐PAGE	  and	  blotted	  with	  rat	  anti-­‐HA	  (Roche	  #	  1867423).	  	  	  
Cloning	  for	  lipid	  strip:	  	  To	  make	  GST	  fusion	  protein,	  Mbc-­‐PH(short),	  Loner-­‐PH,	  Blow-­‐PH,	  WASp-­‐PH	  domains	  were	   cloned	   into	   pENTR/D-­‐TOPO	   vector	   (Invitrogen)	   and	   recombined	   into	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pDEST15	  vector	  using	  LR	  ClonaseTM	  II	  Enzyme	  Mix	  Kit	  (Invitrogen).	  mbc-­‐PH(long)	  domain	   was	   cloned	   into	   pGEX-­‐6p-­‐1	   vector	   (GE	   Healthcare	   Life	   Science).	   	   All	  constructs	  were	  sequenced	  after	  amplification.	  	  
Protein	  Expression	  and	  Purification	  GST::PH	   constructs	   were	   transformed	   into	   BL21-­‐CodonPlus	   competent	   cells	  (Stratagene).	   	   Protein	   expression	   was	   induced	   by	   0.5mM	   IPTG,	   and	   incubated	   at	  37°C	  for	  3h.	  	  Cell	  pellets	  were	  collected	  and	  treated	  with	  lysis	  B	  buffer	  (50mM	  Tris	  PH7.5,	   1mM	   EDTA,	   1mM	   EGTA,	   5mM	   MgCl2	   1mM	   DTT,	   1mM	   PMSF,	   1ug/ml	  Leupeptin	  (Sigma),	  1ug/ml	  Pepstatin	  (Sigma))	  followed	  by	  sonication,	  10%	  triton	  x-­‐100	   treatment	   and	   centrifuge.	   	   Proteins	   were	   purified	   from	   supernatant	   with	  Glutathione	   Sepharose	   4B	   (Amersham	   Pharmacia	   Biotech	   Inc),	   and	   concentrated	  though	  centrifugal	  filter	  units	  (Millipore).	  	  The	  concentration	  of	  GST::PH	  protein	  was	  determined	  by	  protein	  assay	  (Bio-­‐Rad	  protein	  assay	  dye	  reagent)	  and	  Western	  blot.	  	  	  
Lipid	  Strip	  0.5μg/mL	   purified	   protein	   was	   applied	   to	   each	   strip	   membrane	   (echelon	  biosciences	   Inc)	  and	   incubated	   for	  1h	  at	   room	  temperature.	   	  Proteins	   that	  bind	   to	  lipids	   were	   detected	   by	   HRP	   conjugated	   GST	   antibody	   (1:1000	   Santa	   Cruz),	   and	  visualized	  using	  HyGLO	  HRP	  detection	  kit	  (Denville	  Scientific	  Inc).	  	  
Flight	  assay:	  	  Flies	   were	   dropped	   into	   a	   cylinder	   and	   each	   insect’s	   ability	   to	   fly	   was	   recorded	  (Banerjee	  et	  al.,	  2004).	  	  For	  each	  genotype,	  25	  flies	  were	  tested	  each	  day	  for	  3	  days	  (n=75).	  	  Flies	  were	  separated	  by	  their	  ability	  to	  fly	  and	  dissected	  for	  IFM	  staining.	  	  	  
Flight	  muscle	  dissection:	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For	   adult	   flies:	   Flies	   were	   collected	   immediately	   after	   eclosion	   and	   were	   kept	   in	  room	  temperature.	  	  Thoraces	  from	  3-­‐day	  old	  adult	  flies	  were	  dissected	  according	  to	  a	   revised	   protocol	   (Hunt	   and	   Demontis,	   2013;	   Schnorrer	   et	   al.,	   2010).	   	   After	  anaesthetizing	  flies	  with	  CO2,	  we	  removed	  the	  head,	  abdomen,	  legs	  and	  wings	  from	  each	   thorax	   with	   scissors.	   Thoraces	   were	   kept	   in	   relaxing	   buffer	   before	   fixation	  (20mM	   PBS,	   pH=7.0,	   5mM	  MgCl2,	   5mM	   EGTA).	   	   Thoraces	   were	   then	   pre-­‐fixed	   in	  fresh	   4%	   paraformaldehyde	   (PFA)	   in	   relaxing	   buffer	   for	   10	   minutes.	   	   After	   pre-­‐fixation,	   thoraces	  were	  dissected	   into	  hemi-­‐thoraces	  by	  cutting	   longitudinally	  with	  scissors	  and	  transferred	  into	  24	  well	  plates.	  	  Samples	  were	  washed	  twice	  with	  PBT	  (PBS+0.3%	  Triton	  x-­‐100),	  and	  incubated	  in	  relaxing	  buffer	  for	  15	  minutes,	  followed	  by	  fixation	  in	  4%	  PFA	  for	  10	  minutes.	  	  After	  fixation,	  samples	  were	  washed	  in	  PBT	  2	  x	   10	  minutes,	   and	   incubated	   in	   a	   primary	   antibody	  overnight	   at	   4°C.	   	   The	   second	  day,	  thoraces	  were	  removed	  from	  the	  primary	  antibody,	  and	  washed	  in	  PBT	  3	  x	  20	  minutes.	   	   After	   washing,	   samples	   were	   incubated	   in	   a	   secondary	   antibody	   for	   2	  hours	   at	   room	   temperature.	   	   After	   rinsing	   in	   PBT	   3	   x	   20	  minutes,	   hemi-­‐thoraces	  were	  mounted	  in	  prolong	  gold,	  and	  analyzed	  using	  a	  Leica	  SP5	  confocal	  microscope.	  	  
Electron	  Microscopy:	  IFM	  muscles	  were	   each	   dissected	   into	   a	   half	   thorax	   as	   described	   above	   and	  were	  fixed	   in	   a	   solution	   composed	   of	   2%	   glutaraldehyde,	   4%	   paraformaldehyde,	   2mM	  Cacl2,	  0.5%	  tannic	  acid	  in	  0.1M	  sodium	  cacodylate	  buffer,	  pH	  7.4.	  	  The	  samples	  were	  then	  fixed	  for	  3	  minutes	  using	  the	  Pelco	  Biowave	  (Ted	  Pella),	  followed	  by	  overnight	  fixation	  at	  4°C.	  	  Samples	  were	  post-­‐fixed	  with	  1%	  osmium	  tetroxide	  containing	  1.5%	  potassium	   ferrocyanide	   in	   cacodylate	   buffer	   for	   1	   hour	   on	   ice.	   	   After	   fixation,	  samples	   were	   stained	   with	   1%	   uranyl	   acetate	   aqueous	   solution	   at	   room	  temperature	  for	  30	  minutes.	  	  The	  samples	  were	  then	  dehydrated	  in	  a	  graded	  series	  of	   ethanol	   using	   the	   Pelco	   Biowave,	   followed	   by	   acetone	   dehydration	   at	   room	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temperature	  for	  10	  minutes.	  	  After	  dehydration,	  each	  half	  thorax	  was	  infiltrated	  and	  embedded	   with	   Eponate	   12™	   (Ted	   Pella)	   and	   sectioned	   into	   60-­‐70nm	   ultrathin	  sections.	   	   For	   each	   genotype,	   3	   samples	   were	   sectioned	   using	   a	   Reichert	   Jung	  Ultracut	   E	   microtome.	   	   After	   sectioning,	   samples	   were	   stained	   with	   2%	   Uranyl	  acetate	  and	  Sato’s	  lead	  stain.	  Images	  were	  taken	  under	  a	  JEOL	  100CX	  Transmission	  Electron	   Microscope	   at	   80kV	   equipped	   with	   an	   XR41-­‐C	   camera	   and	   AmtV600	  software	  (Advanced	  Microscopy	  Technology	  Corp.,	  Woburn,	  MA).	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